{
  "file_name": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
  "total_pages": 51,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "26.018733978271484": 3,
      "21.94206428527832": 1,
      "20.02363395690918": 1,
      "11.99020004272461": 13,
      "11.030982971191406": 62,
      "14.987749099731445": 2,
      "17.02608299255371": 1,
      "12.94941520690918": 5,
      "14.028532981872559": 7,
      "20.855199813842773": 2,
      "12.960000038146973": 130,
      "9.960000038146973": 1195,
      "18.0": 2,
      "15.0": 24,
      "12.0": 2504,
      "7.679999828338623": 4,
      "17.513427734375": 1,
      "11.039999961853027": 37,
      "8.521920204162598": 2,
      "7.079999923706055": 3,
      "15.960000038146973": 4,
      "9.414793968200684": 1,
      "11.275192260742188": 38,
      "7.4979448318481445": 30,
      "6.59579610824585": 1,
      "10.31684398651123": 448,
      "13.135591506958008": 9,
      "8.039999961853027": 40,
      "20.040000915527344": 2
    },
    "heading_sizes": [
      26.018733978271484,
      20.855199813842773,
      20.040000915527344,
      18.0,
      15.960000038146973,
      15.0,
      14.987749099731445,
      14.028532981872559,
      13.135591506958008,
      12.960000038146973,
      12.94941520690918
    ]
  },
  "table_analysis": {
    "total_tables": 2,
    "tables_info": [
      {
        "bbox": [
          69.44236755371094,
          188.77798461914062,
          531.6718139648438,
          741.4180908203125
        ],
        "num_rows": 9,
        "num_cols": 2
      },
      {
        "bbox": [
          71.99789428710938,
          318.8090515136719,
          527.0040893554688,
          605.3700561523438
        ],
        "num_rows": 4,
        "num_cols": 2
      }
    ]
  },
  "text_blocks": [
    {
      "text": "혈장분획제제 제조공정 중 감염성",
      "font_size": 26.018733978271484,
      "font_name": "MalgunGothicBold",
      "bbox": [
        89.59144592285156,
        217.3011474609375,
        507.9596252441406,
        285.5817565917969
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온 단백 제거 검증 가이드라인",
      "font_size": 26.018733978271484,
      "font_name": "MalgunGothicBold",
      "bbox": [
        89.59144592285156,
        217.3011474609375,
        507.9596252441406,
        285.5817565917969
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[민원인 안내서]",
      "font_size": 26.018733978271484,
      "font_name": "MalgunGothicBold",
      "bbox": [
        205.08885192871094,
        284.7873840332031,
        391.18798828125,
        319.38482666015625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2009",
      "font_size": 21.94206428527832,
      "font_name": "H2hdrM",
      "bbox": [
        271.772705078125,
        501.1618347167969,
        323.0677795410156,
        523.097900390625
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정 이력서",
      "font_size": 20.02363395690918,
      "font_name": "MalgunGothicBold",
      "bbox": [
        230.2751922607422,
        94.36575317382812,
        364.6021728515625,
        120.99142456054688
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연번",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        251.38473510742188,
        451.1954650878906,
        267.3282470703125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정번호",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        251.38473510742188,
        451.1954650878906,
        267.3282470703125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "승인일자",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        251.38473510742188,
        451.1954650878906,
        267.3282470703125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요내용",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.4828872680664,
        251.38473510742188,
        451.1954650878906,
        267.3282470703125
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        281.23211669921875,
        347.0918884277344,
        297.1756286621094
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B1-2009-3-020",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        281.23211669921875,
        347.0918884277344,
        297.1756286621094
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2009.",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        281.23211669921875,
        347.0918884277344,
        297.1756286621094
      ],
      "page_num": 2,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제정",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        281.23211669921875,
        347.0918884277344,
        297.1756286621094
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        314.0762023925781,
        200.42074584960938,
        330.01971435546875
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서-0259-01",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        77.2381362915039,
        314.0762023925781,
        200.42074584960938,
        330.01971435546875
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "「혈장분획제제 제조공정 중 감염성 프리온",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        319.62677001953125,
        303.73236083984375,
        536.7501831054688,
        340.4562683105469
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백 제거 검증 가이드라인(민원인 안내서)」",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        319.62677001953125,
        303.73236083984375,
        536.7501831054688,
        340.4562683105469
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭변경 및 제‧개정 점검표 등 추가",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        319.62677001953125,
        303.73236083984375,
        536.7501831054688,
        340.4562683105469
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인",
      "font_size": 14.987749099731445,
      "font_name": "MalgunGothicBold",
      "bbox": [
        91.75027465820312,
        163.73538208007812,
        511.0364685058594,
        183.66477966308594
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[민원인 안내서]",
      "font_size": 14.987749099731445,
      "font_name": "MalgunGothicBold",
      "bbox": [
        252.7030487060547,
        187.7091827392578,
        345.621337890625,
        207.63858032226562
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침서ᆞ안내서 제ᆞ개정 점검표",
      "font_size": 17.02608299255371,
      "font_name": "H2hdrM",
      "bbox": [
        170.78744506835938,
        108.85392761230469,
        425.6492919921875,
        125.87532806396484
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.95449829101562,
        136.58534240722656,
        512.1218872070312,
        163.0501708984375
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.95449829101562,
        136.58534240722656,
        512.1218872070312,
        163.0501708984375
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(민원인 안내서)",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicBold",
      "bbox": [
        293.0011901855469,
        157.4425506591797,
        373.5560607910156,
        174.6615447998047
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        167.7890625,
        173.55462646484375,
        429.0168762207031,
        188.22267150878906
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등록대상",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        72.20086669921875,
        328.1856384277344,
        116.2166748046875,
        342.8536682128906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.2348861694336,
        345.8063659667969,
        105.30292510986328,
        360.4743957519531
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        188.77798461914062,
        423.6513366699219,
        203.44602966308594
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서가 있습니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        151.238037109375,
        205.20004272460938,
        297.5997314453125,
        219.8680877685547
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        189.25747680664062,
        507.804443359375,
        219.38861083984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        189.25747680664062,
        507.804443359375,
        219.38861083984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        223.18038940429688,
        531.6714477539062,
        237.8484344482422
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        239.72232055664062,
        535.5512084960938,
        270.9322509765625
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        239.72232055664062,
        535.5512084960938,
        270.9322509765625
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(사유 :                                                                 )",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        272.686279296875,
        526.6383666992188,
        287.35430908203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법ㆍ시행령ㆍ시행규칙) 또는",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        291.3858337402344,
        315.94976806640625,
        306.0538635253906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        151.238037109375,
        307.9277648925781,
        416.93505859375,
        339.0178527832031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나열한 것입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        151.238037109375,
        307.9277648925781,
        416.93505859375,
        339.0178527832031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        300.25616455078125,
        507.804443359375,
        330.2674255371094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        300.25616455078125,
        507.804443359375,
        330.2674255371094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        341.6109619140625,
        507.804443359375,
        371.6222229003906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        341.6109619140625,
        507.804443359375,
        371.6222229003906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        341.6109619140625,
        507.804443359375,
        371.6222229003906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        373.3762512207031,
        451.71612548828125,
        388.0442810058594
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        388.719482421875,
        210.643798828125,
        403.38751220703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        373.3762512207031,
        507.804443359375,
        403.38751220703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        373.3762512207031,
        507.804443359375,
        403.38751220703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        405.14154052734375,
        507.804443359375,
        435.1528015136719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        405.14154052734375,
        507.804443359375,
        435.1528015136719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        405.14154052734375,
        507.804443359375,
        435.1528015136719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        436.9068298339844,
        440.0824279785156,
        451.5748596191406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정리한 자료입니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        452.25006103515625,
        252.8639678955078,
        466.9180908203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        436.9068298339844,
        507.804443359375,
        466.9180908203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        436.9068298339844,
        507.804443359375,
        466.9180908203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        468.6720886230469,
        528.8347778320312,
        499.8820495605469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        468.6720886230469,
        528.8347778320312,
        499.8820495605469
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.64496612548828,
        524.7708129882812,
        127.65259552001953,
        539.4388427734375
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구분",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        84.67411041259766,
        542.3915405273438,
        103.74420166015625,
        557.0595703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        501.6360778808594,
        448.0770263671875,
        516.3041381835938
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        517.0991821289062,
        432.84918212890625,
        531.7672119140625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        501.6360778808594,
        507.804443359375,
        531.7672119140625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        501.6360778808594,
        507.804443359375,
        531.7672119140625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        534.12060546875,
        451.956298828125,
        548.7886352539062
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        549.4638671875,
        448.1968078613281,
        579.594970703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 것입니까? (민원인용)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        549.4638671875,
        448.1968078613281,
        579.594970703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        541.792236328125,
        507.804443359375,
        571.803466796875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        541.792236328125,
        507.804443359375,
        571.803466796875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타 확인",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        69.44236755371094,
        597.4114379882812,
        118.97551727294922,
        612.0794677734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        83.2348861694336,
        614.9122924804688,
        105.30292510986328,
        629.580322265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        581.9483642578125,
        434.6850280761719,
        596.6163940429688
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원인을 구속하는 내용이 있습니까?",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.6383514404297,
        597.2915649414062,
        337.0552978515625,
        611.9595947265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        581.9483642578125,
        507.804443359375,
        611.9595947265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        458.3915710449219,
        581.9483642578125,
        507.804443359375,
        611.9595947265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        134.0873260498047,
        613.83349609375,
        531.6718139648438,
        628.5015258789062
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서 제ㆍ개정 절차를 진행하시기 바랍니다.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        150.51841735839844,
        630.2555541992188,
        372.0533752441406,
        644.923583984375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        216.0029296875,
        646.0782470703125,
        381.7624816894531,
        660.7462768554688
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2017 년    6 월    1 일",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        225.71766662597656,
        678.92236328125,
        360.6445617675781,
        693.5903930664062
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "담당자",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        330.4209289550781,
        712.4856567382812,
        405.2516784667969,
        741.4180908203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확  인(부서장)",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicBold",
      "bbox": [
        330.4209289550781,
        712.4856567382812,
        405.2516784667969,
        741.4180908203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임종미",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        490.8939514160156,
        710.8074951171875,
        523.9959716796875,
        725.4755249023438
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정혜주",
      "font_size": 11.030982971191406,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        490.4142150878906,
        728.4282836914062,
        523.9951782226562,
        743.0963134765625
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        115.99240112304688,
        524.6121215820312,
        134.6463165283203
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        145.3603057861328,
        508.30010986328125,
        164.01422119140625
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        184.67733764648438,
        519.7985229492188,
        203.3312530517578
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        214.0452423095703,
        524.6116333007812,
        232.69915771484375
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 사항이 아님을 알려드립니다. 또한, 본 안내서는 2009년 현재의 과학적ㆍ기",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        243.41314697265625,
        519.6783447265625,
        262.0670471191406
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        272.7810363769531,
        524.6119384765625,
        291.4349365234375
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 14.028532981872559,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        302.1489562988281,
        437.6587219238281,
        320.8028564453125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        71.00151824951172,
        354.2674560546875,
        524.2320556640625,
        371.4864501953125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        95.10845184326172,
        371.1689758300781,
        530.7086181640625,
        406.1285705566406
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조)",
      "font_size": 12.94941520690918,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        95.10845184326172,
        371.1689758300781,
        530.7086181640625,
        406.1285705566406
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        62.48613357543945,
        435.0240173339844,
        497.8689270019531,
        450.967529296875
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이오생약심사부 생물제제과에 문의하시기 바랍니다.",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        56.609317779541016,
        454.20306396484375,
        383.41717529296875,
        470.1465759277344
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전화번호 : 043-719-3468",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        56.609317779541016,
        473.3821105957031,
        219.0106658935547,
        489.32562255859375
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "팩스번호 : 043-719-3450",
      "font_size": 11.99020004272461,
      "font_name": "MalgunGothicRegular",
      "bbox": [
        56.609317779541016,
        492.5611572265625,
        219.0106658935547,
        508.5046691894531
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목",
      "font_size": 20.855199813842773,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        262.8009948730469,
        117.45693969726562,
        331.7772521972656,
        138.3121337890625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차",
      "font_size": 20.855199813842773,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        262.8009948730469,
        117.45693969726562,
        331.7772521972656,
        138.3121337890625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ. 서론",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60208892822266,
        203.07394409179688,
        536.6420288085938,
        216.03395080566406
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "····························································································································1",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60208892822266,
        203.07394409179688,
        536.6420288085938,
        216.03395080566406
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 목적",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55986022949219,
        226.47622680664062,
        536.643310546875,
        239.4362335205078
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·························································································································2",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.55986022949219,
        226.47622680664062,
        536.643310546875,
        239.4362335205078
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 용어 정의",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56059265136719,
        249.87460327148438,
        536.6434326171875,
        262.8345947265625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "···············································································································2",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56059265136719,
        249.87460327148438,
        536.6434326171875,
        262.8345947265625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 제거율",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6037368774414,
        296.6753845214844,
        536.643310546875,
        309.6353759765625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사연구",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6037368774414,
        296.6753845214844,
        536.643310546875,
        309.6353759765625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6037368774414,
        296.6753845214844,
        536.643310546875,
        309.6353759765625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(clearance)",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6037368774414,
        296.6753845214844,
        536.643310546875,
        309.6353759765625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6037368774414,
        296.6753845214844,
        536.643310546875,
        309.6353759765625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "··········································3",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6037368774414,
        296.6753845214844,
        536.643310546875,
        309.6353759765625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 일반 원칙",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56044006347656,
        320.07379150390625,
        536.6432495117188,
        333.0337829589844
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "···············································································································3",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56044006347656,
        320.07379150390625,
        536.6432495117188,
        333.0337829589844
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 규모 축소 공정",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56114196777344,
        343.4761047363281,
        536.644287109375,
        356.43609619140625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·····································································································4",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56114196777344,
        343.4761047363281,
        536.644287109375,
        356.43609619140625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. Spiking 물질 선택",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56200408935547,
        366.87451171875,
        536.6441650390625,
        379.8345031738281
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "································································································4",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56200408935547,
        366.87451171875,
        536.6441650390625,
        379.8345031738281
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 시험법 선택",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56169128417969,
        390.2729187011719,
        536.6443481445312,
        403.23291015625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "···········································································································7",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56169128417969,
        390.2729187011719,
        536.6443481445312,
        403.23291015625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. 제조공정 선택",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56138610839844,
        413.67523193359375,
        536.64404296875,
        426.6352233886719
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·······································································································8",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56138610839844,
        413.67523193359375,
        536.64404296875,
        426.6352233886719
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. 자료의 해석과 제한사항",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56111145019531,
        437.0736389160156,
        536.6437377929688,
        450.03363037109375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·····················································································9",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56111145019531,
        437.0736389160156,
        536.6437377929688,
        450.03363037109375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7. 감염성 프리온 단백 제거율 재평가",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56083679199219,
        460.4759521484375,
        536.6402587890625,
        473.4359436035156
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·······························································10",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56083679199219,
        460.4759521484375,
        536.6402587890625,
        473.4359436035156
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8. 장비 위생",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56053161621094,
        483.8743591308594,
        536.6402587890625,
        496.8343505859375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·············································································································11",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        82.56053161621094,
        483.8743591308594,
        536.6402587890625,
        496.8343505859375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ. 결론",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60364532470703,
        530.6752319335938,
        536.6412353515625,
        543.6351928710938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·························································································································12",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60364532470703,
        530.6752319335938,
        536.6412353515625,
        543.6351928710938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ. 참고문헌",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6048355102539,
        577.4760131835938,
        536.6422729492188,
        590.4359741210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "·················································································································13",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6048355102539,
        577.4760131835938,
        536.6422729492188,
        590.4359741210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부록",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.644771575927734,
        624.2728881835938,
        536.6420288085938,
        637.2328491210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 제거 조사연구 시험방법",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.644771575927734,
        624.2728881835938,
        536.6420288085938,
        637.2328491210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.644771575927734,
        624.2728881835938,
        536.6420288085938,
        637.2328491210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ">",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.644771575927734,
        624.2728881835938,
        536.6420288085938,
        637.2328491210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "············································14",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.644771575927734,
        624.2728881835938,
        536.6420288085938,
        637.2328491210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<참고자료",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64461898803711,
        671.0736694335938,
        536.6426391601562,
        684.0336303710938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "> ························································································································27",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64461898803711,
        671.0736694335938,
        536.6426391601562,
        684.0336303710938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline on the Investigation of Manufacturing Processes for Plasma-Derived",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.52362060546875,
        694.4760131835938,
        538.4540405273438,
        707.4359741210938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Medicinal Products with regard to vCJD Risk, EMEA, 2004",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.52362060546875,
        717.8743896484375,
        408.7574157714844,
        730.8343505859375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 6,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제 제조공정 중 감염성 프리온 단백 제거",
      "font_size": 18.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.60160064697266,
        99.15081787109375,
        513.6015625,
        117.15081787109375
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사연구 가이드라인",
      "font_size": 18.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        212.03961181640625,
        127.94769287109375,
        383.03961181640625,
        145.94769287109375
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 서론",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        183.68310546875,
        114.12161254882812,
        198.68310546875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        183.68310546875,
        114.12161254882812,
        198.68310546875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크로이츠펠트 야콥병 인간 광우병",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64111328125,
        234.14111328125,
        538.5623168945312,
        246.14111328125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 퇴행성 신",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64111328125,
        234.14111328125,
        538.5623168945312,
        246.14111328125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64111328125,
        234.14111328125,
        538.5623168945312,
        246.14111328125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", Creutzfeldt-Jakob disease, CJD)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64111328125,
        234.14111328125,
        538.5623168945312,
        246.14111328125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경계 질환으로 산발성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가족성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의원성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변종",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(sporadic),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(familial),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(iatrogenic),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(variant)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64111328125,
        255.73883056640625,
        538.5668334960938,
        267.73883056640625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가지 형태로 분류된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64126968383789,
        277.3404541015625,
        538.4402465820312,
        289.3404541015625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64126968383789,
        277.3404541015625,
        538.4402465820312,
        289.3404541015625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64126968383789,
        277.3404541015625,
        538.4402465820312,
        289.3404541015625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64126968383789,
        277.3404541015625,
        538.4402465820312,
        289.3404541015625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64126968383789,
        277.3404541015625,
        538.4402465820312,
        289.3404541015625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "병",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641265869140625,
        298.93817138671875,
        538.5593872070312,
        310.93817138671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641265869140625,
        298.93817138671875,
        538.5593872070312,
        310.93817138671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "년에 처음으로 영국에서 확인되",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641265869140625,
        298.93817138671875,
        538.5593872070312,
        310.93817138671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", variant Creutzfeldt-Jakob disease, vCJD)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641265869140625,
        298.93817138671875,
        538.5593872070312,
        310.93817138671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1996",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641265869140625,
        298.93817138671875,
        538.5593872070312,
        310.93817138671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "었다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641265869140625,
        320.5397644042969,
        84.64907836914062,
        332.5397644042969
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 소 해면상 뇌증 광우병",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        363.73895263671875,
        538.5636596679688,
        375.73895263671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 일으",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        363.73895263671875,
        538.5636596679688,
        375.73895263671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vCJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        363.73895263671875,
        538.5636596679688,
        375.73895263671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        363.73895263671875,
        538.5636596679688,
        375.73895263671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", bovine spongiform encephalopathy, BSE)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        363.73895263671875,
        538.5636596679688,
        375.73895263671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "키는 병원체에 의해 야기된다는 유력한 증거가 있고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        385.3405456542969,
        538.5064697265625,
        397.3405456542969
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 가장 가능성이 있는 가설은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        385.3405456542969,
        538.5064697265625,
        397.3405456542969
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        385.3405456542969,
        538.5064697265625,
        397.3405456542969
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 오염된 음식에 노출되어 발생한다는 것이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        406.938232421875,
        318.6493835449219,
        418.938232421875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전염성 해면상 뇌증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        450.1413269042969,
        538.5638427734375,
        462.1413269042969
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 실험용 설",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        450.1413269042969,
        538.5638427734375,
        462.1413269042969
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(transmissible spongiform encephalopathy, TSE)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64157104492188,
        450.1413269042969,
        538.5638427734375,
        462.1413269042969
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치류 모델에서 얻은 연구결과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642555236816406,
        471.739013671875,
        538.5525512695312,
        483.739013671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액 성분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642555236816406,
        471.739013671875,
        538.5525512695312,
        483.739013671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 의해 감염될 수 있음",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642555236816406,
        471.739013671875,
        538.5525512695312,
        483.739013671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642555236816406,
        471.739013671875,
        538.5525512695312,
        483.739013671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(blood components)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642555236816406,
        471.739013671875,
        538.5525512695312,
        483.739013671875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 밝혀졌다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 실험실적",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 천연 스크래피",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염이 양",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(scrapie)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(sheep)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        493.3406066894531,
        538.5594482421875,
        505.3406066894531
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수혈에 의해 전염될 수 있다는 사실이 밝혀졌다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "야생형 마우스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형질전환",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "間",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642539978027344,
        514.9382934570312,
        538.4472045898438,
        526.9382934570312
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마우스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642948150634766,
        536.5399169921875,
        538.5606689453125,
        548.5399169921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영장류를 이용하여 사람 혈액에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642948150634766,
        536.5399169921875,
        538.5606689453125,
        548.5399169921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642948150634766,
        536.5399169921875,
        538.5606689453125,
        548.5399169921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 검출하는 실험에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642948150634766,
        536.5399169921875,
        538.5606689453125,
        548.5399169921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642948150634766,
        536.5399169921875,
        538.5606689453125,
        548.5399169921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vCJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642948150634766,
        536.5399169921875,
        538.5606689453125,
        548.5399169921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(infectivity)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642948150634766,
        536.5399169921875,
        538.5606689453125,
        548.5399169921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        558.1414794921875,
        538.4320068359375,
        570.1414794921875
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        579.7391967773438,
        538.5729370117188,
        591.7391967773438
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        579.7391967773438,
        538.5729370117188,
        591.7391967773438
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        579.7391967773438,
        538.5729370117188,
        591.7391967773438
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 발병한 헌",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        579.7391967773438,
        538.5729370117188,
        591.7391967773438
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        579.7391967773438,
        538.5729370117188,
        591.7391967773438
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        579.7391967773438,
        538.5729370117188,
        591.7391967773438
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vCJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        579.7391967773438,
        538.5729370117188,
        591.7391967773438
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈자의 적혈구를 수혈받고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        601.3408203125,
        538.5623779296875,
        613.3408203125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차 전염이 된 예가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        601.3408203125,
        538.5623779296875,
        613.3408203125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건이 보고되었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        601.3408203125,
        538.5623779296875,
        613.3408203125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지금까지의 역학적",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        601.3408203125,
        538.5623779296875,
        613.3408203125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        601.3408203125,
        538.5623779296875,
        613.3408203125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        601.3408203125,
        538.5623779296875,
        613.3408203125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        601.3408203125,
        538.5623779296875,
        613.3408203125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        622.9384765625,
        538.5582275390625,
        634.9384765625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 발병",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        622.9384765625,
        538.5582275390625,
        634.9384765625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        622.9384765625,
        538.5582275390625,
        634.9384765625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        622.9384765625,
        538.5582275390625,
        634.9384765625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642913818359375,
        622.9384765625,
        538.5582275390625,
        634.9384765625
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 예는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        644.5401000976562,
        538.552734375,
        656.5401000976562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건도 없었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        644.5401000976562,
        538.552734375,
        656.5401000976562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        644.5401000976562,
        538.552734375,
        656.5401000976562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        644.5401000976562,
        538.552734375,
        656.5401000976562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64292907714844,
        644.5401000976562,
        538.552734375,
        656.5401000976562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6429328918457,
        666.1417236328125,
        353.9317626953125,
        678.1417236328125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6429328918457,
        666.1417236328125,
        353.9317626953125,
        678.1417236328125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람 혈장으로 제조되는 혈장분획제제를 통해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6429443359375,
        709.3408813476562,
        538.5574951171875,
        721.3408813476562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6429443359375,
        709.3408813476562,
        538.5574951171875,
        721.3408813476562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 전염되는 것을 사",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6429443359375,
        709.3408813476562,
        538.5574951171875,
        721.3408813476562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6429443359375,
        709.3408813476562,
        538.5574951171875,
        721.3408813476562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vCJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6429443359375,
        709.3408813476562,
        538.5574951171875,
        721.3408813476562
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6429443359375,
        730.9385986328125,
        538.4512939453125,
        742.9385986328125
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 2 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64100646972656,
        99.14019775390625,
        538.4258422851562,
        111.14019775390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 만약의 경우를 대",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64100646972656,
        99.14019775390625,
        538.4258422851562,
        111.14019775390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64100646972656,
        99.14019775390625,
        538.4258422851562,
        111.14019775390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6409912109375,
        120.7379150390625,
        538.4432983398438,
        132.7379150390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통하여 제품의 안전성을 보증하는 것이 필요하다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6409912109375,
        142.33953857421875,
        330.6488037109375,
        154.33953857421875
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목적",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        187.35513305664062,
        113.8818359375,
        200.3151397705078
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        187.35513305664062,
        113.8818359375,
        200.3151397705078
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        210.73779296875,
        538.55078125,
        222.73779296875
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법에 대한 가이드로서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        232.33941650390625,
        538.4453125,
        244.33941650390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        232.33941650390625,
        538.4453125,
        244.33941650390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        232.33941650390625,
        538.4453125,
        244.33941650390625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보하는데 그 목적이 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        253.9371337890625,
        538.4342651367188,
        265.9371337890625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        253.9371337890625,
        538.4342651367188,
        265.9371337890625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        253.9371337890625,
        538.4342651367188,
        265.9371337890625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        275.53875732421875,
        538.4459228515625,
        287.53875732421875
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는지를 평가하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        297.140380859375,
        538.4342041015625,
        309.140380859375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        297.140380859375,
        538.4342041015625,
        309.140380859375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        297.140380859375,
        538.4342041015625,
        309.140380859375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        318.73809814453125,
        450.64849853515625,
        330.73809814453125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        318.73809814453125,
        450.64849853515625,
        330.73809814453125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        318.73809814453125,
        450.64849853515625,
        330.73809814453125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용어 정의",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6012954711914,
        363.75384521484375,
        146.40115356445312,
        376.7138366699219
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.6012954711914,
        363.75384521484375,
        146.40115356445312,
        376.7138366699219
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 프리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(prion)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 비리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 합성어로 바이러스처럼 감",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(protein)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(virion)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64030456542969,
        387.1404113769531,
        538.4382934570312,
        399.1404113769531
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염력을 가진 단백질 입자로 광우병을 유발하는 인자",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6017074584961,
        408.73809814453125,
        538.5545043945312,
        420.73809814453125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온은 정상적인 상태",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6017074584961,
        408.73809814453125,
        538.5545043945312,
        420.73809814453125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6017074584961,
        408.73809814453125,
        538.5545043945312,
        420.73809814453125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60171508789062,
        430.3396911621094,
        538.5545043945312,
        442.3396911621094
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60171508789062,
        430.3396911621094,
        538.5545043945312,
        442.3396911621094
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60171508789062,
        430.3396911621094,
        538.5545043945312,
        442.3396911621094
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같은 정상 프리온을 PrPC",
      "font_size": 7.679999828338623,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60171508789062,
        449.6456604003906,
        492.0,
        463.9373779296875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라 명명함",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60171508789062,
        449.6456604003906,
        492.0,
        463.9373779296875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(cellular isoform of prion protein)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60171508789062,
        449.6456604003906,
        492.0,
        463.9373779296875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.5389709472656,
        538.5589599609375,
        485.5389709472656
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력을 가진 변형된 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.5389709472656,
        538.5589599609375,
        485.5389709472656
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정상적 프리온이 변",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.5389709472656,
        538.5589599609375,
        485.5389709472656
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.5389709472656,
        538.5589599609375,
        485.5389709472656
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        473.5389709472656,
        538.5589599609375,
        485.5389709472656
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "형이 일어난 형태로 뇌에 치명적인 질환을 일으킴",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        495.14056396484375,
        538.4462280273438,
        507.14056396484375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백 분해효소에 의해 분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        495.14056396484375,
        538.4462280273438,
        507.14056396484375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        495.14056396484375,
        538.4462280273438,
        507.14056396484375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해되지 않으며 자외선",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        516.73828125,
        538.438720703125,
        528.73828125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화학물질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        516.73828125,
        538.438720703125,
        528.73828125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "열 등에 저항성이 강함",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        516.73828125,
        538.438720703125,
        528.73828125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 걸린 뇌 조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        516.73828125,
        538.438720703125,
        528.73828125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        516.73828125,
        538.438720703125,
        528.73828125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        516.73828125,
        538.438720703125,
        528.73828125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". TSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        516.73828125,
        538.438720703125,
        528.73828125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60152435302734,
        536.048095703125,
        538.5131225585938,
        550.33984375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라 명명함",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60108947753906,
        559.9375,
        303.12109375,
        571.9375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "isoform of prion protein)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60108947753906,
        559.9375,
        303.12109375,
        571.9375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 전염성 해면상 뇌증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64012145996094,
        581.5391235351562,
        538.437255859375,
        593.5391235351562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(TSE)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64012145996094,
        581.5391235351562,
        538.437255859375,
        593.5391235351562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원인체는 변형된 프리온으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64012145996094,
        581.5391235351562,
        538.437255859375,
        593.5391235351562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물 종에 따라 소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64012145996094,
        581.5391235351562,
        538.437255859375,
        593.5391235351562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64012145996094,
        581.5391235351562,
        538.437255859375,
        593.5391235351562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64012145996094,
        581.5391235351562,
        538.437255859375,
        593.5391235351562
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해면상 뇌증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        603.1407470703125,
        538.5659790039062,
        615.1407470703125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양이나 염소의 스크래피",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        603.1407470703125,
        538.5659790039062,
        615.1407470703125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "밍크에서 발생되는 전염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        603.1407470703125,
        538.5659790039062,
        615.1407470703125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(BSE),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        603.1407470703125,
        538.5659790039062,
        615.1407470703125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(scrapie),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        603.1407470703125,
        538.5659790039062,
        615.1407470703125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 밍크 뇌증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        624.7384033203125,
        538.5546264648438,
        636.7384033203125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사슴류의 만성 소모",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        624.7384033203125,
        538.5546264648438,
        636.7384033203125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(transmissble mink encephalopathy, TME),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60104370117188,
        624.7384033203125,
        538.5546264648438,
        636.7384033203125
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 질환",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60143280029297,
        646.3400268554688,
        538.5584716796875,
        658.3400268554688
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고양이에서 발생되는 고양이 해면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60143280029297,
        646.3400268554688,
        538.5584716796875,
        658.3400268554688
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(chronic wasting disease, CWD),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60143280029297,
        646.3400268554688,
        538.5584716796875,
        658.3400268554688
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상 뇌증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60134887695312,
        667.937744140625,
        443.9993591308594,
        679.937744140625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등이 있음",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60134887695312,
        667.937744140625,
        443.9993591308594,
        679.937744140625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(feline spongiform encephalopathy, FSE)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60134887695312,
        667.937744140625,
        443.9993591308594,
        679.937744140625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64036560058594,
        689.539306640625,
        538.4393310546875,
        701.539306640625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64036560058594,
        689.539306640625,
        538.4393310546875,
        701.539306640625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백은 바이러스와 같이 여러",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64036560058594,
        689.539306640625,
        538.4393310546875,
        701.539306640625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64036560058594,
        689.539306640625,
        538.4393310546875,
        701.539306640625
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 갖고 있으며 각",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 종",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잠복기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(species),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        711.1409301757812,
        538.443115234375,
        723.1409301757812
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60105895996094,
        732.7386474609375,
        423.60107421875,
        744.7386474609375
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 3 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) PrPres(resistant prion protein)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        96.84848022460938,
        538.4448852539062,
        111.14019775390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백과 유사하게 단백 분해효",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        96.84848022460938,
        538.4448852539062,
        111.14019775390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        96.84848022460938,
        538.4448852539062,
        111.14019775390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60128784179688,
        120.7379150390625,
        466.081298828125,
        132.7379150390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 저항성을 나타내는 비정상적인 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60128784179688,
        120.7379150390625,
        466.081298828125,
        132.7379150390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "proteinase K",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60128784179688,
        120.7379150390625,
        466.081298828125,
        132.7379150390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ.",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64038848876953,
        169.2838134765625,
        416.04302978515625,
        184.28399658203125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 제거율",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64038848876953,
        169.2838134765625,
        416.04302978515625,
        184.28399658203125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사연구",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64038848876953,
        169.2838134765625,
        416.04302978515625,
        184.28399658203125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(clearance)",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64038848876953,
        169.2838134765625,
        416.04302978515625,
        184.28399658203125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반 원칙",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60160064697266,
        219.75393676757812,
        146.40145874023438,
        232.7139434814453
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60160064697266,
        219.75393676757812,
        146.40145874023438,
        232.7139434814453
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64070129394531,
        243.1405029296875,
        538.5547485351562,
        255.1405029296875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64070129394531,
        243.1405029296875,
        538.5547485351562,
        255.1405029296875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64070129394531,
        243.1405029296875,
        538.5547485351562,
        255.1405029296875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64070129394531,
        243.1405029296875,
        538.5547485351562,
        255.1405029296875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20, 2006)”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64070129394531,
        243.1405029296875,
        538.5547485351562,
        255.1405029296875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“Note",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guidance",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "on",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Virus",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Validation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Studies:",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Design,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67918395996094,
        264.73822021484375,
        538.4750366210938,
        276.73822021484375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Contribution",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Interpretation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Studies",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Validating",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "the",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Inactivation",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        286.33984375,
        538.4696044921875,
        298.33984375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Removal of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        307.93756103515625,
        538.5592651367188,
        319.93756103515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        307.93756103515625,
        538.5592651367188,
        319.93756103515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        329.5391540527344,
        494.68701171875,
        341.5391540527344
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64019775390625,
        351.1407470703125,
        538.4448852539062,
        363.1407470703125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64019775390625,
        351.1407470703125,
        538.4448852539062,
        363.1407470703125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        372.7384338378906,
        538.5621337890625,
        384.7384338378906
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(scale-down)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        372.7384338378906,
        538.5621337890625,
        384.7384338378906
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조공정 산물에 최대",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        394.34002685546875,
        538.4366455078125,
        406.34002685546875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 넘지 않는 양으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        394.34002685546875,
        538.4366455078125,
        406.34002685546875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 수행하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        394.34002685546875,
        538.4366455078125,
        406.34002685546875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 실",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        394.34002685546875,
        538.4366455078125,
        406.34002685546875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        394.34002685546875,
        538.4366455078125,
        406.34002685546875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spike",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        394.34002685546875,
        538.4366455078125,
        406.34002685546875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        394.34002685546875,
        538.4366455078125,
        406.34002685546875
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "험은 제품 생산과는 엄격하게 분리되어야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        415.9377136230469,
        538.4879150390625,
        427.9377136230469
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 적절히 훈련된 사람에 의해 관리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        415.9377136230469,
        538.4879150390625,
        427.9377136230469
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6792984008789,
        415.9377136230469,
        538.4879150390625,
        427.9377136230469
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문서화",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행되어져야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증연구와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마찬가지로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규모",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67929077148438,
        437.539306640625,
        538.4338989257812,
        449.539306640625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67830657958984,
        459.1408996582031,
        538.4330444335938,
        471.1408996582031
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(manufacturing scale)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67830657958984,
        459.1408996582031,
        538.4330444335938,
        471.1408996582031
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67830657958984,
        480.73858642578125,
        538.4361572265625,
        492.73858642578125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67830657958984,
        480.73858642578125,
        538.4361572265625,
        492.73858642578125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라미터",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67831420898438,
        502.3402099609375,
        518.2021484375,
        514.3402099609375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67831420898438,
        502.3402099609375,
        518.2021484375,
        514.3402099609375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67831420898438,
        502.3402099609375,
        518.2021484375,
        514.3402099609375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63934326171875,
        523.9378662109375,
        538.4323120117188,
        535.9378662109375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6784439086914,
        545.5394287109375,
        538.553466796875,
        557.5394287109375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 냉 에탄올 분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6784439086914,
        545.5394287109375,
        538.553466796875,
        557.5394287109375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6784439086914,
        545.5394287109375,
        538.553466796875,
        557.5394287109375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "침전",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크로마토그래피",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심층여과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 나노",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(fractionation), PEG-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(depth filtration)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        567.1410522460938,
        538.556884765625,
        579.1410522460938
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        588.73876953125,
        538.553466796875,
        600.73876953125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 같은 제거 분할",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        588.73876953125,
        538.553466796875,
        600.73876953125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정에 연구의 초점을 맞추어야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        588.73876953125,
        538.553466796875,
        600.73876953125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(nanofiltration)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        588.73876953125,
        538.553466796875,
        600.73876953125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        588.73876953125,
        538.553466796875,
        600.73876953125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(partitioning)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        588.73876953125,
        538.553466796875,
        600.73876953125
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 것이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        610.34033203125,
        128.68624877929688,
        622.34033203125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63933563232422,
        631.9380493164062,
        538.43310546875,
        643.9380493164062
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고 비용이 많이 소요되어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        653.5396728515625,
        538.557373046875,
        665.5396728515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        653.5396728515625,
        538.557373046875,
        665.5396728515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        653.5396728515625,
        538.557373046875,
        665.5396728515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조공정의 완건성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        675.1401977539062,
        538.5579833984375,
        687.1412353515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(robustness)을 검토하거나 적절히 검증된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        675.1401977539062,
        538.5579833984375,
        687.1412353515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "in vitro 시험법을 사용하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67843627929688,
        675.1401977539062,
        538.5579833984375,
        687.1412353515625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 것도 가능하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        696.7379150390625,
        538.5549926757812,
        708.7379150390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        696.7379150390625,
        538.5549926757812,
        708.7379150390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        696.7379150390625,
        538.5549926757812,
        708.7379150390625
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기 쉽다는 점을 명심해야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000030517578,
        718.3395385742188,
        538.4335327148438,
        730.3395385742188
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 공정 중 한계",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000030517578,
        718.3395385742188,
        538.4335327148438,
        730.3395385742188
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 분할 공정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000030517578,
        718.3395385742188,
        538.4335327148438,
        730.3395385742188
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000030517578,
        718.3395385742188,
        538.4335327148438,
        730.3395385742188
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(in-process limit)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000030517578,
        718.3395385742188,
        538.4335327148438,
        730.3395385742188
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 대한 조사연구를 디자인하는데 중요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        739.9371948242188,
        538.551513671875,
        751.9371948242188
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 이 조사연구는 감염성 프리온 단백이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        739.9371948242188,
        538.551513671875,
        751.9371948242188
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 4 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "옆 분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.441650390625,
        111.14019775390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(side fraction)으로 분할되는 것을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.441650390625,
        111.14019775390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "in vitro 시험법을 이용하여 입증하여야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.441650390625,
        111.14019775390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감소 인수",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미만이면 유의하지 않다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(reduction factor)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 log",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        449.26715087890625,
        132.7379150390625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64093017578125,
        142.33953857421875,
        538.5551147460938,
        154.33953857421875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64093017578125,
        142.33953857421875,
        538.5551147460938,
        154.33953857421875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64093017578125,
        142.33953857421875,
        538.5551147460938,
        154.33953857421875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64093017578125,
        142.33953857421875,
        538.5551147460938,
        154.33953857421875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spike",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64093017578125,
        142.33953857421875,
        538.5551147460938,
        154.33953857421875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(titer)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64093017578125,
        142.33953857421875,
        538.5551147460938,
        154.33953857421875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "충분히 높아야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.679931640625,
        163.937255859375,
        538.554931640625,
        175.937255859375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.679931640625,
        163.937255859375,
        538.554931640625,
        175.937255859375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.679931640625,
        163.937255859375,
        538.554931640625,
        175.937255859375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67993927001953,
        185.53887939453125,
        538.48876953125,
        197.53887939453125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        207.1405029296875,
        538.4462280273438,
        219.1405029296875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감소 인수를 구하는데 도움이 될 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        228.73822021484375,
        538.4293823242188,
        240.73822021484375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "더욱이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        228.73822021484375,
        538.4293823242188,
        240.73822021484375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여러 단계의 연구는 감염성 프리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        228.73822021484375,
        538.4293823242188,
        240.73822021484375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        228.73822021484375,
        538.4293823242188,
        240.73822021484375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        228.73822021484375,
        538.4293823242188,
        240.73822021484375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        250.33984375,
        538.429931640625,
        262.33984375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있는데",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        271.93756103515625,
        538.5573120117188,
        283.93756103515625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        271.93756103515625,
        538.5573120117188,
        283.93756103515625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        271.93756103515625,
        538.5573120117188,
        283.93756103515625
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제거에 영향을 주는 경우가 이에 해당된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        293.5391845703125,
        538.4345092773438,
        305.5391845703125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체 공정을 포함하는 조사연구가 이상",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        293.5391845703125,
        538.4345092773438,
        305.5391845703125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        293.5391845703125,
        538.4345092773438,
        305.5391845703125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적이지만 바이러스 경우와 마찬가지로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        315.14080810546875,
        538.5507202148438,
        327.14080810546875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대다수의 경우 초기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        315.14080810546875,
        538.5507202148438,
        327.14080810546875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도가 너무 낮아",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        315.14080810546875,
        538.5507202148438,
        327.14080810546875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        315.14080810546875,
        538.5507202148438,
        327.14080810546875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spike",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67996215820312,
        315.14080810546875,
        538.5507202148438,
        327.14080810546875
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68016052246094,
        336.7384948730469,
        388.36798095703125,
        348.7384948730469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단계 이상을 수행하기에는 실험에 한계가 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68016052246094,
        336.7384948730469,
        388.36798095703125,
        348.7384948730469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68016052246094,
        336.7384948730469,
        388.36798095703125,
        348.7384948730469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68016052246094,
        336.7384948730469,
        388.36798095703125,
        348.7384948730469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68016052246094,
        336.7384948730469,
        388.36798095703125,
        348.7384948730469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조사연구 시 고려해야 할 주요 항목은 다음과 같다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64117431640625,
        358.340087890625,
        372.64898681640625,
        370.340087890625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규모 축소 공정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64156341552734,
        379.9377746582031,
        190.20016479492188,
        391.9377746582031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64156341552734,
        379.9377746582031,
        190.20016479492188,
        391.9377746582031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질 선택",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        401.53936767578125,
        207.00096130371094,
        413.53936767578125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        401.53936767578125,
        207.00096130371094,
        413.53936767578125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험법 선택",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        423.1409606933594,
        172.20016479492188,
        435.1409606933594
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        423.1409606933594,
        172.20016479492188,
        435.1409606933594
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조공정 선택",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        444.7386474609375,
        184.20016479492188,
        456.7386474609375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        444.7386474609375,
        184.20016479492188,
        456.7386474609375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료의 해석과 제한사항",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        466.3402404785156,
        238.20016479492188,
        478.3402404785156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        466.3402404785156,
        238.20016479492188,
        478.3402404785156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 제거율 재평가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        487.93792724609375,
        298.2001647949219,
        499.93792724609375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        487.93792724609375,
        298.2001647949219,
        499.93792724609375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장비 위생",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        509.53955078125,
        160.20016479492188,
        521.53955078125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64155578613281,
        509.53955078125,
        160.20016479492188,
        521.53955078125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규모 축소 공정",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        554.55517578125,
        178.8037109375,
        567.51513671875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        554.55517578125,
        178.8037109375,
        567.51513671875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        577.9378051757812,
        538.434326171875,
        589.9378051757812
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스 검증연구와 동일하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        599.5394287109375,
        538.4342651367188,
        611.5394287109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        599.5394287109375,
        538.4342651367188,
        611.5394287109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        599.5394287109375,
        538.4342651367188,
        611.5394287109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산물의 수율",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.1409912109375,
        538.5642700195312,
        633.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질 및 조성에 관한 자료를 제공하여야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.1409912109375,
        538.5642700195312,
        633.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실 제조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.1409912109375,
        538.5642700195312,
        633.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.1409912109375,
        538.5642700195312,
        633.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.1409912109375,
        538.5642700195312,
        633.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.1409912109375,
        538.5642700195312,
        633.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(full-scale)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.1409912109375,
        538.5642700195312,
        633.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대표 배치",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67901611328125,
        642.7387084960938,
        373.245849609375,
        654.7387084960938
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(batch)에서 얻어진 자료와 비교하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67901611328125,
        642.7387084960938,
        373.245849609375,
        654.7387084960938
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67901611328125,
        642.7387084960938,
        373.245849609375,
        654.7387084960938
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질 선택",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.600830078125,
        687.7544555664062,
        197.15850830078125,
        700.7144165039062
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. Spiking",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.600830078125,
        687.7544555664062,
        197.15850830078125,
        700.7144165039062
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63993072509766,
        711.1409912109375,
        538.432861328125,
        723.1409912109375
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염성 프리온 단백은 혈액에서 발견됨을 알 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67903137207031,
        732.7387084960938,
        538.5540771484375,
        744.7387084960938
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 혈액에서의 감염력 수준은 뇌에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67903137207031,
        732.7387084960938,
        538.5540771484375,
        744.7387084960938
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 5 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 발견되는 수준에 비해 최소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.5520629882812,
        111.14019775390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배 정도는 낮은 것으로 나타나 뇌 조직이 실",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.5520629882812,
        111.14019775390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10,000",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.5520629882812,
        111.14019775390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질적으로 유일한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        120.7379150390625,
        538.5548095703125,
        132.7379150390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        120.7379150390625,
        538.5548095703125,
        132.7379150390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능한 한 고농도를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        120.7379150390625,
        538.5548095703125,
        132.7379150390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여야 하나 조사연",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        120.7379150390625,
        538.5548095703125,
        132.7379150390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        120.7379150390625,
        538.5548095703125,
        132.7379150390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        120.7379150390625,
        538.5548095703125,
        132.7379150390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spike",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        120.7379150390625,
        538.5548095703125,
        132.7379150390625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        142.33953857421875,
        538.441650390625,
        154.33953857421875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 초과해서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        142.33953857421875,
        538.441650390625,
        154.33953857421875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        142.33953857421875,
        538.441650390625,
        154.33953857421875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안 된다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        163.937255859375,
        116.68780517578125,
        175.937255859375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요 고려사항은 다음과 같다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        185.53887939453125,
        252.64871215820312,
        197.53887939453125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접종에 사용되는 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64130401611328,
        207.1405029296875,
        514.8014526367188,
        219.1405029296875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과 이로부터 제조되는 동물 종",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64130401611328,
        207.1405029296875,
        514.8014526367188,
        219.1405029296875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64130401611328,
        207.1405029296875,
        514.8014526367188,
        219.1405029296875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64130401611328,
        207.1405029296875,
        514.8014526367188,
        219.1405029296875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백의 물리화학적 특성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64171600341797,
        228.73822021484375,
        322.2003173828125,
        240.73822021484375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64171600341797,
        228.73822021484375,
        322.2003173828125,
        240.73822021484375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.1. 종과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        273.73822021484375,
        163.06214904785156,
        285.73822021484375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        273.73822021484375,
        163.06214904785156,
        285.73822021484375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료물질을 결정하는 요인으로는 공급",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64019775390625,
        295.33984375,
        538.4373779296875,
        307.33984375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64019775390625,
        295.33984375,
        538.4373779296875,
        307.33984375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장 내에 존재할 수",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64019775390625,
        295.33984375,
        538.4373779296875,
        307.33984375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64019775390625,
        295.33984375,
        538.4373779296875,
        307.33984375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64019775390625,
        295.33984375,
        538.4373779296875,
        307.33984375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64019775390625,
        295.33984375,
        538.4373779296875,
        307.33984375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다. vCJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        316.93756103515625,
        538.4633178710938,
        328.93756103515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증례로부터 얻은 계대배양하지 않은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        338.5391540527344,
        538.5503540039062,
        350.5391540527344
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질은 윤리적인 이유 등으로 사",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        338.5391540527344,
        538.5503540039062,
        350.5391540527344
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(unpassaged)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        338.5391540527344,
        538.5503540039062,
        350.5391540527344
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용이 제한적이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정상 마우스를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 생물시험법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 이용할 수 있고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vCJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(bioassay)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64019775390625,
        360.1407470703125,
        538.4830322265625,
        372.1407470703125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람 유래 물질을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        381.7384338378906,
        538.4448852539062,
        393.7384338378906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구에 사용한 예가 최소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        381.7384338378906,
        538.4448852539062,
        393.7384338378906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건 있지만",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        381.7384338378906,
        538.4448852539062,
        393.7384338378906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 사용하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        381.7384338378906,
        538.4448852539062,
        393.7384338378906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spike",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        381.7384338378906,
        538.4448852539062,
        393.7384338378906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        381.7384338378906,
        538.4448852539062,
        393.7384338378906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", vCJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        381.7384338378906,
        538.4448852539062,
        393.7384338378906
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것이 필수적이지는 않다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64021301269531,
        403.34002685546875,
        538.4720458984375,
        415.34002685546875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". BSE에 감염된 동물로부터 많은 양의 소 뇌",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64021301269531,
        403.34002685546875,
        538.4720458984375,
        415.34002685546875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(bovine brain)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64021301269531,
        403.34002685546875,
        538.4720458984375,
        415.34002685546875
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 얻는 것이 가능하지만",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        424.9377136230469,
        538.5610961914062,
        436.9377136230469
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적절한 품질의 물질을 얻는 것이 어렵다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        424.9377136230469,
        538.5610961914062,
        436.9377136230469
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 그 물질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        424.9377136230469,
        538.5610961914062,
        436.9377136230469
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        424.9377136230469,
        538.5610961914062,
        436.9377136230469
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        424.9377136230469,
        538.5610961914062,
        436.9377136230469
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 대한 시험법은 더욱 힘들 가능성이 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        446.539306640625,
        538.4478759765625,
        458.539306640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한 사실은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        446.539306640625,
        538.4478759765625,
        458.539306640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 감염된 양에도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        446.539306640625,
        538.4478759765625,
        458.539306640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        446.539306640625,
        538.4478759765625,
        458.539306640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        446.539306640625,
        538.4478759765625,
        458.539306640625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당되며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        468.1408996582031,
        538.4439086914062,
        480.1408996582031
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스크래피에 감염된 양의 경우 더욱 그러하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        468.1408996582031,
        538.4439086914062,
        480.1408996582031
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모델 병원체뿐만 아니라",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        468.1408996582031,
        538.4439086914062,
        480.1408996582031
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        468.1408996582031,
        538.4439086914062,
        480.1408996582031
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        468.1408996582031,
        538.4439086914062,
        480.1408996582031
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        489.73858642578125,
        538.55322265625,
        501.73858642578125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프로젝트",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        489.73858642578125,
        538.55322265625,
        501.73858642578125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(demonstration)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        489.73858642578125,
        538.55322265625,
        501.73858642578125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 제외하면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스크래피",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", familial CJD, BSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        511.3402099609375,
        538.4971923828125,
        523.3402099609375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        532.9378662109375,
        538.4517822265625,
        544.9378662109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 적용시킨 설치류를 사용하는 것이 가장 적합하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        532.9378662109375,
        538.4517822265625,
        544.9378662109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        532.9378662109375,
        538.4517822265625,
        544.9378662109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vCJD)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        532.9378662109375,
        538.4517822265625,
        544.9378662109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.63922119140625,
        532.9378662109375,
        538.4517822265625,
        544.9378662109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        554.5394287109375,
        538.5609130859375,
        566.5394287109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        554.5394287109375,
        538.5609130859375,
        566.5394287109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 이용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        554.5394287109375,
        538.5609130859375,
        566.5394287109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        554.5394287109375,
        538.5609130859375,
        566.5394287109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        554.5394287109375,
        538.5609130859375,
        566.5394287109375
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 조사연구 되어 왔다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        576.1410522460938,
        538.4451904296875,
        588.1410522460938
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 시험법에 사용되는 원리도 잘 확립되어 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        576.1410522460938,
        538.4451904296875,
        588.1410522460938
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지금까",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        576.1410522460938,
        538.4451904296875,
        588.1410522460938
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        576.1410522460938,
        538.4451904296875,
        588.1410522460938
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.638916015625,
        576.1410522460938,
        538.4451904296875,
        588.1410522460938
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지 발표된 연구에서는 열처리 불활화에 대한 저항성은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        597.73876953125,
        538.4757080078125,
        609.73876953125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain마다 다르긴 하지만",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        597.73876953125,
        538.4757080078125,
        609.73876953125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        597.73876953125,
        538.4757080078125,
        609.73876953125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제거 연구에 있어서 종이나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        619.34033203125,
        538.550048828125,
        631.34033203125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 명백한 영향은 없었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        619.34033203125,
        538.550048828125,
        631.34033203125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 제거 연구의 경",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        619.34033203125,
        538.550048828125,
        631.34033203125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        619.34033203125,
        538.550048828125,
        631.34033203125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        619.34033203125,
        538.550048828125,
        631.34033203125
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우 실질적인 근거에 따라",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        640.9380493164062,
        538.44091796875,
        652.9380493164062
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 결정하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        640.9380493164062,
        538.44091796875,
        652.9380493164062
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선택에 대한 이론적 근거를 제시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        640.9380493164062,
        538.44091796875,
        652.9380493164062
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        640.9380493164062,
        538.44091796875,
        652.9380493164062
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        640.9380493164062,
        538.44091796875,
        652.9380493164062
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.639892578125,
        662.5396728515625,
        144.647705078125,
        674.5396728515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질의 물리화학적 형태",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6399154663086,
        707.5396728515625,
        281.280517578125,
        719.5396728515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.2. Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6399154663086,
        707.5396728515625,
        281.280517578125,
        719.5396728515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6399154663086,
        729.1412963867188,
        538.428955078125,
        741.1412963867188
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 6 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음에도 불구하고 물리화학적 특성은 알려져 있지 않다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4373779296875,
        111.14019775390625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력이 뇌 이외의 조직에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4373779296875,
        111.14019775390625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4373779296875,
        111.14019775390625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        120.7379150390625,
        538.5511474609375,
        132.7379150390625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력과 유사한 것으로 나타났다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        142.33953857421875,
        538.4417724609375,
        154.33953857421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 혈액에서의 감염력이 동물모델의 어느",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        142.33953857421875,
        538.4417724609375,
        154.33953857421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        142.33953857421875,
        538.4417724609375,
        154.33953857421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직에서 유래되었는지는 명확하지 않다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액에서의 감염력은 뇌가 퇴화하면서 유",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리된 물질일 가능성이 있고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        185.53887939453125,
        538.42578125,
        197.53887939453125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 경우 뇌는 적절한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        185.53887939453125,
        538.42578125,
        197.53887939453125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질이 될 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        185.53887939453125,
        538.42578125,
        197.53887939453125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        185.53887939453125,
        538.42578125,
        197.53887939453125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        185.53887939453125,
        538.42578125,
        197.53887939453125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        185.53887939453125,
        538.42578125,
        197.53887939453125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        185.53887939453125,
        538.42578125,
        197.53887939453125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        204.84878540039062,
        538.4382934570312,
        219.1405029296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 매우 응집된 불용성의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        204.84878540039062,
        538.4382934570312,
        219.1405029296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64097595214844,
        204.84878540039062,
        538.4382934570312,
        219.1405029296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백과 유사할 수도 있고 그렇지 않을 수도 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        228.73822021484375,
        538.4458618164062,
        240.73822021484375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질의 물리적 형태를 신",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        228.73822021484375,
        538.4458618164062,
        240.73822021484375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        228.73822021484375,
        538.4458618164062,
        240.73822021484375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중하게 고려하여 다음과 같은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        250.33984375,
        499.4880676269531,
        262.33984375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4가지 형태의 물질 중에서 선택하여 실험한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        250.33984375,
        499.4880676269531,
        262.33984375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        250.33984375,
        499.4880676269531,
        262.33984375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 가공하지 않은 뇌 균질현탁액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        293.53924560546875,
        423.1100769042969,
        305.53924560546875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(crude brain homogenates)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        293.53924560546875,
        423.1100769042969,
        305.53924560546875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406021118164,
        315.140869140625,
        538.4424438476562,
        327.140869140625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "며 고농도를 함유하고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6015396118164,
        336.7385559082031,
        538.4461669921875,
        348.7385559082031
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구 수행에 있어서 가장 중요한 요소는 균질현",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6015396118164,
        336.7385559082031,
        538.4461669921875,
        348.7385559082031
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6015396118164,
        336.7385559082031,
        538.4461669921875,
        348.7385559082031
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "탁액의 균질성과 재현성이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        358.34014892578125,
        538.5543212890625,
        370.34014892578125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약 입자 크기가 광범위하다면 여과와 같은 물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        358.34014892578125,
        538.5543212890625,
        370.34014892578125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        358.34014892578125,
        538.5543212890625,
        370.34014892578125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리적 기술에 의해 광범위하게 제거됨을 보여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        379.9378356933594,
        538.5543212890625,
        391.9378356933594
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질현탁액을 재현성 있",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        379.9378356933594,
        538.5543212890625,
        391.9378356933594
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        379.9378356933594,
        538.5543212890625,
        391.9378356933594
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60153198242188,
        401.5394287109375,
        451.6093444824219,
        413.5394287109375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64082336425781,
        423.1410217285156,
        198.238525390625,
        435.1410217285156
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) Microsomal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64082336425781,
        423.1410217285156,
        198.238525390625,
        435.1410217285156
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분획은 뇌 균질현탁액을 분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64082336425781,
        444.73870849609375,
        538.4376831054688,
        456.73870849609375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원심분리 해서 큰 응집",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64082336425781,
        444.73870849609375,
        538.4376831054688,
        456.73870849609375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Microsomal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64082336425781,
        444.73870849609375,
        538.4376831054688,
        456.73870849609375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(differential)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64082336425781,
        444.73870849609375,
        538.4376831054688,
        456.73870849609375
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체는 제거하고 막에 결합된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60176086425781,
        466.3403015136719,
        538.5648803710938,
        478.3403015136719
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력을 나타내는 물질을 얻",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60176086425781,
        466.3403015136719,
        538.5648803710938,
        478.3403015136719
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(membrane-bound)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60176086425781,
        466.3403015136719,
        538.5648803710938,
        478.3403015136719
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 것이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60176086425781,
        487.93798828125,
        538.4462890625,
        499.93798828125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60176086425781,
        487.93798828125,
        538.4462890625,
        499.93798828125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60176086425781,
        487.93798828125,
        538.4462890625,
        499.93798828125
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 예상되며 감염력도 여전히 높은 편이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60176086425781,
        509.53955078125,
        343.60955810546875,
        521.53955078125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) Caveolae-like domains(CLDs)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6407470703125,
        531.1411743164062,
        274.6993103027344,
        543.1411743164062
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64073944091797,
        552.7388916015625,
        538.4456176757812,
        564.7388916015625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64073944091797,
        552.7388916015625,
        538.4456176757812,
        564.7388916015625
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(sucrose-density)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64073944091797,
        552.7388916015625,
        538.4456176757812,
        564.7388916015625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초원심분리 해서 얻는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        574.3404541015625,
        538.5695190429688,
        586.3404541015625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력 수준은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        574.3404541015625,
        538.5695190429688,
        586.3404541015625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획보다 낮으며 세포로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        574.3404541015625,
        538.5695190429688,
        586.3404541015625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        574.3404541015625,
        538.5695190429688,
        586.3404541015625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "microsomal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        574.3404541015625,
        538.5695190429688,
        586.3404541015625
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부터 막 부분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        595.9381713867188,
        465.3714599609375,
        607.9381713867188
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(membrane domain)이 떨어지도록 자극할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        595.9381713867188,
        465.3714599609375,
        607.9381713867188
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60174560546875,
        595.9381713867188,
        465.3714599609375,
        607.9381713867188
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 정제된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408462524414,
        615.248046875,
        174.55686950683594,
        629.539794921875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PrPSc",
      "font_size": 7.679999828338623,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408462524414,
        615.248046875,
        174.55686950683594,
        629.539794921875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64085388183594,
        636.849609375,
        538.43408203125,
        651.141357421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64085388183594,
        636.849609375,
        538.43408203125,
        651.141357421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64085388183594,
        636.849609375,
        538.43408203125,
        651.141357421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64085388183594,
        636.849609375,
        538.43408203125,
        651.141357421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(salt)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64085388183594,
        636.849609375,
        538.43408203125,
        651.141357421875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "침전시키고 초원심분리 해서 얻는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60195922851562,
        660.7390747070312,
        538.5548095703125,
        672.7390747070312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이것은 세포나 막과는 관련이 없는 형태",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60195922851562,
        660.7390747070312,
        538.5548095703125,
        672.7390747070312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60195922851562,
        660.7390747070312,
        538.5548095703125,
        672.7390747070312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60195922851562,
        682.3406982421875,
        463.6097717285156,
        694.3406982421875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "침전 연구",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64096069335938,
        725.5398559570312,
        538.4454345703125,
        737.5398559570312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과에 의하면 막에 결합된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64096069335938,
        725.5398559570312,
        538.4454345703125,
        737.5398559570312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64096069335938,
        725.5398559570312,
        538.4454345703125,
        737.5398559570312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(precipitation studies)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64096069335938,
        725.5398559570312,
        538.4454345703125,
        737.5398559570312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64096069335938,
        725.5398559570312,
        538.4454345703125,
        737.5398559570312
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 7 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질현탁액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4415283203125,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4415283203125,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 유사하게 반응을 나타내어 모두",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4415283203125,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4415283203125,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", microsomal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4415283203125,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", CLDs",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4415283203125,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64100646972656,
        99.14019775390625,
        538.4415283203125,
        111.14019775390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질로 적합한 것으로 나타났다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        120.7379150390625,
        538.4491577148438,
        132.7379150390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획은 큰 응집체도 제거되고 감염력도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        120.7379150390625,
        538.4491577148438,
        132.7379150390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Microsomal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        120.7379150390625,
        538.4491577148438,
        132.7379150390625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "높으면서 일관성 있게 만들어지므로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질로 좋다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정제된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPSc는 다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64102172851562,
        140.04782104492188,
        538.559326171875,
        154.33953857421875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다른 형태",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        163.937255859375,
        538.4423828125,
        175.937255859375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 감염성 프리온 단백도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        185.53887939453125,
        388.22418212890625,
        197.53887939453125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking 물질로 사용 가능하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        185.53887939453125,
        388.22418212890625,
        197.53887939453125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        185.53887939453125,
        388.22418212890625,
        197.53887939453125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 이와 같은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64132690429688,
        207.1405029296875,
        538.4393310546875,
        219.1405029296875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질이 혈장에서 발견되는 감염력의 형태를 대표하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64132690429688,
        207.1405029296875,
        538.4393310546875,
        219.1405029296875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64132690429688,
        207.1405029296875,
        538.4393310546875,
        219.1405029296875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는지는 명확하지 않다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        228.73822021484375,
        538.567138671875,
        240.73822021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질은 공정 단계 연구에 매우 중요하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        228.73822021484375,
        538.567138671875,
        240.73822021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최악의 조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        228.73822021484375,
        538.567138671875,
        240.73822021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        228.73822021484375,
        538.567138671875,
        240.73822021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        228.73822021484375,
        538.567138671875,
        240.73822021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        250.33984375,
        538.44580078125,
        262.33984375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 평가할 수 있도록 선택되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        250.33984375,
        538.44580078125,
        262.33984375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질의 선",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        250.33984375,
        538.44580078125,
        262.33984375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(worst case condition)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        250.33984375,
        538.44580078125,
        262.33984375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        250.33984375,
        538.44580078125,
        262.33984375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "택에 대한 이론적 근거를 제시하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64132690429688,
        271.93756103515625,
        312.6491394042969,
        283.93756103515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험법 선택",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        316.9531555175781,
        159.36231994628906,
        329.91314697265625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        316.9531555175781,
        159.36231994628906,
        329.91314697265625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염력 시험법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3397216796875,
        538.4437255859375,
        352.3397216796875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 감염성 프리온 단백을 검출하는데 표준시험법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3397216796875,
        538.4437255859375,
        352.3397216796875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(infectivity assay)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3397216796875,
        538.4437255859375,
        352.3397216796875
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 인정되고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67969512939453,
        361.9374084472656,
        538.5546875,
        373.9374084472656
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67969512939453,
        361.9374084472656,
        538.5546875,
        373.9374084472656
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67969512939453,
        361.9374084472656,
        538.5546875,
        373.9374084472656
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "델의 감염을 통해 입증이 되었고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67969512939453,
        383.53900146484375,
        538.4342041015625,
        395.53900146484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배양기간 후에 신경질환이 발생하면 감염성 프리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67969512939453,
        383.53900146484375,
        538.4342041015625,
        395.53900146484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67969512939453,
        383.53900146484375,
        538.4342041015625,
        395.53900146484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "온 단백이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있음이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입증되는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물에서 종말",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적정법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(end",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "point",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        405.1405944824219,
        538.4546508789062,
        417.1405944824219
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 이용하여 측정된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67908477783203,
        426.73828125,
        538.428955078125,
        438.73828125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약 종말 적정법이 검증되었다면 배양기간 지속시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67908477783203,
        426.73828125,
        538.428955078125,
        438.73828125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "titration)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67908477783203,
        426.73828125,
        538.428955078125,
        438.73828125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67908477783203,
        426.73828125,
        538.428955078125,
        438.73828125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간으로 시험물질에서 나타나는 감염력을 정량할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67908477783203,
        448.3398742675781,
        538.4368286132812,
        460.3398742675781
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전염에 대한 종간 벽",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67908477783203,
        448.3398742675781,
        538.4368286132812,
        460.3398742675781
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67908477783203,
        448.3398742675781,
        538.4368286132812,
        460.3398742675781
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 존재와 종 및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        469.93756103515625,
        538.5618896484375,
        481.93756103515625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 영향은 분석해야 할 물질에 제약을 가져",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        469.93756103515625,
        538.5618896484375,
        481.93756103515625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(species barrier)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        469.93756103515625,
        538.5618896484375,
        481.93756103515625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        469.93756103515625,
        538.5618896484375,
        481.93756103515625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "온다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        491.5391540527344,
        538.448974609375,
        503.5391540527344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예를 들면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        491.5391540527344,
        538.448974609375,
        503.5391540527344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람의 산발성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        491.5391540527344,
        538.448974609375,
        503.5391540527344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 경우 야생형 마우스는 거의 감염시키지 못",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        491.5391540527344,
        538.448974609375,
        503.5391540527344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        491.5391540527344,
        538.448974609375,
        503.5391540527344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        491.5391540527344,
        538.448974609375,
        503.5391540527344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CJD",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        491.5391540527344,
        538.448974609375,
        503.5391540527344
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        513.1407470703125,
        538.4417114257812,
        525.1407470703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물시험법은 배양기간 때문에 수행하기가 복잡하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        513.1407470703125,
        538.4417114257812,
        525.1407470703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "즉",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        513.1407470703125,
        538.4417114257812,
        525.1407470703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가장 빠른 경우가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        513.1407470703125,
        538.4417114257812,
        525.1407470703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        513.1407470703125,
        538.4417114257812,
        525.1407470703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        513.1407470703125,
        538.4417114257812,
        525.1407470703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        513.1407470703125,
        538.4417114257812,
        525.1407470703125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주사한 동물 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "햄스터 모델",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 관찰과 임상적 모니터링에 최소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개월",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 263K)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6~9",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        534.7384033203125,
        538.4829711914062,
        546.7384033203125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비 형질전환 쥐 모델에서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        556.3400268554688,
        538.5703125,
        568.3400268554688
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개월이 소요된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        556.3400268554688,
        538.5703125,
        568.3400268554688
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 시험해야 할 물질에 따라",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        556.3400268554688,
        538.5703125,
        568.3400268554688
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        556.3400268554688,
        538.5703125,
        568.3400268554688
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15~18",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        556.3400268554688,
        538.5703125,
        568.3400268554688
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        556.3400268554688,
        538.5703125,
        568.3400268554688
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        577.937744140625,
        538.483642578125,
        589.937744140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 수여받는 동물의 조합에 제한이 따른다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        577.937744140625,
        538.483642578125,
        589.937744140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다시 말하면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        577.937744140625,
        538.483642578125,
        589.937744140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        577.937744140625,
        538.483642578125,
        589.937744140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        577.937744140625,
        538.483642578125,
        589.937744140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        577.937744140625,
        538.483642578125,
        589.937744140625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증연구 수행 시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67840576171875,
        599.539306640625,
        538.432373046875,
        611.539306640625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67840576171875,
        599.539306640625,
        538.432373046875,
        611.539306640625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67840576171875,
        599.539306640625,
        538.432373046875,
        611.539306640625
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67839813232422,
        621.1409301757812,
        538.55810546875,
        633.1409301757812
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이나 종에서 시험하는 것이 불가능하다는 것을 의미한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67839813232422,
        621.1409301757812,
        538.55810546875,
        633.1409301757812
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이것은 감염성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67839813232422,
        621.1409301757812,
        538.55810546875,
        633.1409301757812
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67839813232422,
        621.1409301757812,
        538.55810546875,
        633.1409301757812
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67839813232422,
        621.1409301757812,
        538.55810546875,
        633.1409301757812
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        642.7386474609375,
        538.42919921875,
        654.7386474609375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 또 하나의 제약이 된다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67919921875,
        664.3402099609375,
        218.68701171875,
        676.3402099609375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물시험법은 사용할",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64019775390625,
        685.9379272460938,
        538.517333984375,
        697.9379272460938
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain에 적합한 안전수준 감염성 프리온 단백은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64019775390625,
        685.9379272460938,
        538.517333984375,
        697.9379272460938
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64019775390625,
        685.9379272460938,
        538.517333984375,
        697.9379272460938
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "biosafety",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64019775390625,
        685.9379272460938,
        538.517333984375,
        697.9379272460938
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 가진 지정된 실험실과 동물실험실에서 수행해야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67900085449219,
        707.53955078125,
        538.4322509765625,
        719.53955078125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험의 복잡성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67900085449219,
        707.53955078125,
        538.4322509765625,
        719.53955078125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67900085449219,
        707.53955078125,
        538.4322509765625,
        719.53955078125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "level 3)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67900085449219,
        707.53955078125,
        538.4322509765625,
        719.53955078125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67900085449219,
        707.53955078125,
        538.4322509765625,
        719.53955078125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67900085449219,
        707.53955078125,
        538.4322509765625,
        719.53955078125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양기간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67898559570312,
        729.14111328125,
        538.43603515625,
        741.14111328125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구되는 안전수준 때문에 시험 비용이 매우 비싸다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67898559570312,
        729.14111328125,
        538.43603515625,
        741.14111328125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그럼에도 불구하고 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67898559570312,
        729.14111328125,
        538.43603515625,
        741.14111328125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67898559570312,
        729.14111328125,
        538.43603515625,
        741.14111328125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67898559570312,
        729.14111328125,
        538.43603515625,
        741.14111328125
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 8 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 시험을 수행",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고자 한다면 시스템이 잘 확립된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        538.44580078125,
        132.7379150390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 지표",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        538.44580078125,
        132.7379150390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물을 사용하여 감염성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        538.44580078125,
        132.7379150390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        538.44580078125,
        132.7379150390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(indicator)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        120.7379150390625,
        538.44580078125,
        132.7379150390625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온 단백 제거 조사연구를 수행하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        142.33953857421875,
        332.68780517578125,
        154.33953857421875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64048767089844,
        163.937255859375,
        538.5584106445312,
        175.937255859375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "N2a, GT1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64048767089844,
        163.937255859375,
        538.5584106445312,
        175.937255859375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        185.53887939453125,
        538.429443359375,
        197.53887939453125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 의해 감염되고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        185.53887939453125,
        538.429443359375,
        197.53887939453125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        185.53887939453125,
        538.429443359375,
        197.53887939453125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 어떤 세포주는 일부 스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        185.53887939453125,
        538.429443359375,
        197.53887939453125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        185.53887939453125,
        538.429443359375,
        197.53887939453125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", PrP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        185.53887939453125,
        538.429443359375,
        197.53887939453125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "transfection",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        185.53887939453125,
        538.429443359375,
        197.53887939453125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크래피",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        207.1405029296875,
        538.5599975585938,
        219.1405029296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 복제할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        207.1405029296875,
        538.5599975585938,
        219.1405029296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 현재까지 감염력 존재를 확인하고 감염력",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        207.1405029296875,
        538.5599975585938,
        219.1405029296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        207.1405029296875,
        538.5599975585938,
        219.1405029296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        207.1405029296875,
        538.5599975585938,
        219.1405029296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수준을 정량할 수 있는 in vitro 시험은 없다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        228.73822021484375,
        318.40582275390625,
        240.73822021484375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        248.04812622070312,
        538.546142578125,
        262.33984375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "현재 감염성 프",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        248.04812622070312,
        538.546142578125,
        262.33984375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6400146484375,
        248.04812622070312,
        538.546142578125,
        262.33984375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리온 단백은 숙주 단백질인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        271.93756103515625,
        538.55908203125,
        283.93756103515625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 비정상적인 형태로 축적된 것이라는 많은 연구결",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        271.93756103515625,
        538.55908203125,
        283.93756103515625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        271.93756103515625,
        538.55908203125,
        283.93756103515625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과들이 제시되고 있지만",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        293.5391845703125,
        538.4341430664062,
        305.5391845703125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        293.5391845703125,
        538.4341430664062,
        305.5391845703125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        293.5391845703125,
        538.4341430664062,
        305.5391845703125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        312.8490905761719,
        538.5588989257812,
        327.14080810546875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 비정상적 형태의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        312.8490905761719,
        538.5588989257812,
        327.14080810546875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPSc는 상대적으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        312.8490905761719,
        538.5588989257812,
        327.14080810546875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "proteinase K에 저항성이 있어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        312.8490905761719,
        538.5588989257812,
        327.14080810546875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPres를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        312.8490905761719,
        538.5588989257812,
        327.14080810546875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생성시키고,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67990112304688,
        334.44677734375,
        538.441650390625,
        348.7384948730469
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPC를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67990112304688,
        334.44677734375,
        538.441650390625,
        348.7384948730469
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변성시키는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67990112304688,
        334.44677734375,
        538.441650390625,
        348.7384948730469
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67990112304688,
        334.44677734375,
        538.441650390625,
        348.7384948730469
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변성제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67990112304688,
        334.44677734375,
        538.441650390625,
        348.7384948730469
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "guanidinium",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67990112304688,
        334.44677734375,
        538.441650390625,
        348.7384948730469
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "hydrocholoride",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67990112304688,
        334.44677734375,
        538.441650390625,
        348.7384948730469
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 농도에 저항성을 나타낸다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67964935302734,
        352.340087890625,
        538.55859375,
        370.340087890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물조직에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67964935302734,
        352.340087890625,
        538.55859375,
        370.340087890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(denaturing agent)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67964935302734,
        352.340087890625,
        538.55859375,
        370.340087890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67964935302734,
        352.340087890625,
        538.55859375,
        370.340087890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPSc 또는 PrPres가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67964935302734,
        352.340087890625,
        538.55859375,
        370.340087890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출되는 것은 감염력의 대리 지표",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        379.9377746582031,
        538.5464477539062,
        391.9377746582031
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 고려되어질 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        379.9377746582031,
        538.5464477539062,
        391.9377746582031
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        379.9377746582031,
        538.5464477539062,
        391.9377746582031
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(surrogate marker)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        379.9377746582031,
        538.5464477539062,
        391.9377746582031
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        379.9377746582031,
        538.5464477539062,
        391.9377746582031
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나 감염력과 PrPres의 상관관계는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        399.2476501464844,
        538.42578125,
        413.53936767578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 각각의 파라미터를 측정하는 방법에 따",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        399.2476501464844,
        538.42578125,
        413.53936767578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67959594726562,
        399.2476501464844,
        538.42578125,
        413.53936767578125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라 달라질 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67927551269531,
        423.1409606933594,
        538.5582275390625,
        435.1409606933594
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67927551269531,
        423.1409606933594,
        538.5582275390625,
        435.1409606933594
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67927551269531,
        423.1409606933594,
        538.5582275390625,
        435.1409606933594
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67926788330078,
        438.7386474609375,
        538.4361572265625,
        456.7386474609375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않다. PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67964935302734,
        464.04852294921875,
        538.43603515625,
        478.3402404785156
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67963409423828,
        487.93792724609375,
        538.4452514648438,
        499.93792724609375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것이 충분할 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67963409423828,
        509.53955078125,
        188.68743896484375,
        521.53955078125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생화학적",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물시험법에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계적",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접근",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6405258178711,
        531.14111328125,
        538.4486694335938,
        543.14111328125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67953491210938,
        552.73876953125,
        538.4286499023438,
        564.73876953125
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67951965332031,
        574.3403930664062,
        458.8892822265625,
        586.3403930664062
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항을 참조한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67951965332031,
        574.3403930664062,
        458.8892822265625,
        586.3403930664062
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Products(CPMP/BWP/2879/02/rev 1, 2004)”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67951965332031,
        574.3403930664062,
        458.8892822265625,
        586.3403930664062
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.2.3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67951965332031,
        574.3403930664062,
        458.8892822265625,
        586.3403930664062
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67951965332031,
        574.3403930664062,
        458.8892822265625,
        586.3403930664062
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조공정 선택",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        619.3551635742188,
        172.3232421875,
        632.3151245117188
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        619.3551635742188,
        172.3232421875,
        632.3151245117188
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        642.73779296875,
        538.43359375,
        654.73779296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        664.3394165039062,
        538.4459228515625,
        676.3394165039062
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거 또는 분할이 어느 정도 예상되는 단계이어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        685.9371337890625,
        538.4453125,
        697.9371337890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 따라서 유기용매 계면활성제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        685.9371337890625,
        538.4453125,
        697.9371337890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        685.9371337890625,
        538.4453125,
        697.9371337890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67971801757812,
        707.5386962890625,
        538.488525390625,
        719.5386962890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67971801757812,
        707.5386962890625,
        538.488525390625,
        719.5386962890625
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67971801757812,
        729.1403198242188,
        538.4297485351562,
        741.1403198242188
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 9 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        285.1210021972656,
        789.4503784179688,
        310.02288818359375,
        799.4103393554688
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "올 분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        460.60980224609375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "침전",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        460.60980224609375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "크로마토그래피 및 여과 공정에 초점을 맞추어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        460.60980224609375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        460.60980224609375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        460.60980224609375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        99.14019775390625,
        460.60980224609375,
        111.14019775390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한편",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4467163085938,
        132.7379150390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 단계에서의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4467163085938,
        132.7379150390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 바로 전 단계에 의해 영향 받을 수 있다는 점을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4467163085938,
        132.7379150390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4467163085938,
        132.7379150390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spike",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4467163085938,
        132.7379150390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명심하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        142.33953857421875,
        538.4337158203125,
        154.33953857421875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예를 들면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        142.33953857421875,
        538.4337158203125,
        154.33953857421875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "처리를 하면 분해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        142.33953857421875,
        538.4337158203125,
        154.33953857421875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어 필터를 쉽게",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        142.33953857421875,
        538.4337158203125,
        154.33953857421875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        142.33953857421875,
        538.4337158203125,
        154.33953857421875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", S/D",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        142.33953857421875,
        538.4337158203125,
        154.33953857421875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(disaggreate)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        142.33953857421875,
        538.4337158203125,
        154.33953857421875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통과한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        163.937255859375,
        538.56591796875,
        175.937255859375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 여과와 같은 후속 단계에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        163.937255859375,
        538.56591796875,
        175.937255859375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "처리를 하지 않은 물질은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        163.937255859375,
        538.56591796875,
        175.937255859375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "처",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        163.937255859375,
        538.56591796875,
        175.937255859375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        163.937255859375,
        538.56591796875,
        175.937255859375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "S/D",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        163.937255859375,
        538.56591796875,
        175.937255859375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "S/D",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009185791016,
        163.937255859375,
        538.56591796875,
        175.937255859375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리를 한 물질에 비해 제거율이 과대평가될 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        185.53887939453125,
        356.6878967285156,
        197.53887939453125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64108276367188,
        207.1405029296875,
        538.4367065429688,
        219.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64108276367188,
        207.1405029296875,
        538.4367065429688,
        219.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64108276367188,
        207.1405029296875,
        538.4367065429688,
        219.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품 특이적인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사연구에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계적",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접근",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“Creutzfeldt-Jakob",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        228.73822021484375,
        538.4789428710938,
        240.73822021484375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Disease",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        250.33984375,
        538.524169921875,
        262.33984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        250.33984375,
        538.524169921875,
        262.33984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Plasma-Derived",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        250.33984375,
        538.524169921875,
        262.33984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        250.33984375,
        538.524169921875,
        262.33984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Urine-Derived",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        250.33984375,
        538.524169921875,
        262.33984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Medicinal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        250.33984375,
        538.524169921875,
        262.33984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Products(CPMP/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68008422851562,
        250.33984375,
        538.524169921875,
        262.33984375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009948730469,
        271.93756103515625,
        365.77777099609375,
        283.93756103515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항을 참조한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009948730469,
        271.93756103515625,
        365.77777099609375,
        283.93756103515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BWP/2879/02/rev 1, 2004)”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009948730469,
        271.93756103515625,
        365.77777099609375,
        283.93756103515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.2.3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009948730469,
        271.93756103515625,
        365.77777099609375,
        283.93756103515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68009948730469,
        271.93756103515625,
        365.77777099609375,
        283.93756103515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료의 해석과 제한사항",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        316.9531555175781,
        230.88185119628906,
        329.91314697265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        316.9531555175781,
        230.88185119628906,
        329.91314697265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3397216796875,
        538.55859375,
        352.3397216796875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면에서 더욱 주의가 필요하다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        361.9374084472656,
        236.68751525878906,
        373.9374084472656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조공정 모델링이 불완전하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 기초한 공정 단계",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특히",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(separation)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64020538330078,
        405.1405029296875,
        538.5578002929688,
        417.1405029296875
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60110473632812,
        426.7381896972656,
        538.43359375,
        438.7381896972656
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같은 경우는 신뢰성 있게 모델화하는 것이 어렵다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60110473632812,
        448.33978271484375,
        385.6089172363281,
        460.33978271484375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64000701904297,
        469.9374694824219,
        538.4329833984375,
        481.9374694824219
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64000701904297,
        469.9374694824219,
        538.4329833984375,
        481.9374694824219
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이것은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 경우에는 해당되지 않는데",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "heterogenous",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        491.5390625,
        538.4326171875,
        503.5390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        513.140625,
        538.49462890625,
        525.140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 같은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        513.140625,
        538.49462890625,
        525.140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "sub",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60090637207031,
        513.140625,
        538.49462890625,
        525.140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60092163085938,
        534.7383422851562,
        529.7257080078125,
        546.7383422851562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60092163085938,
        534.7383422851562,
        529.7257080078125,
        546.7383422851562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60092163085938,
        534.7383422851562,
        529.7257080078125,
        546.7383422851562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6395034790039,
        556.3399658203125,
        538.5574340820312,
        568.3399658203125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예를 들면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6395034790039,
        556.3399658203125,
        538.5574340820312,
        568.3399658203125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6395034790039,
        556.3399658203125,
        538.5574340820312,
        568.3399658203125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6395034790039,
        556.3399658203125,
        538.5574340820312,
        568.3399658203125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6395034790039,
        556.3399658203125,
        538.5574340820312,
        568.3399658203125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6395034790039,
        556.3399658203125,
        538.5574340820312,
        568.3399658203125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염성 프리온 단백을 계면활성제로 처리하면 분산",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60049438476562,
        577.9376220703125,
        538.5574951171875,
        589.9376220703125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어 처리하지 않",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60049438476562,
        577.9376220703125,
        538.5574951171875,
        589.9376220703125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(dispersal)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60049438476562,
        577.9376220703125,
        538.5574951171875,
        589.9376220703125
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60049438476562,
        599.5392456054688,
        469.6083068847656,
        611.5392456054688
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용되는 시험법이 이상적인 방법은 아니다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63959503173828,
        621.140869140625,
        538.43798828125,
        633.140869140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력 시험법은 비싸고 매우 느",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63959503173828,
        621.140869140625,
        538.43798828125,
        633.140869140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63959503173828,
        621.140869140625,
        538.43798828125,
        633.140869140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63959503173828,
        621.140869140625,
        538.43798828125,
        633.140869140625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60057067871094,
        640.44677734375,
        538.5501708984375,
        654.738525390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 일반적으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60057067871094,
        640.44677734375,
        538.5501708984375,
        654.738525390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPSc와 감염력 사이에 상관관계가 있지만",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60057067871094,
        640.44677734375,
        538.5501708984375,
        654.738525390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 관련성은 감",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60057067871094,
        640.44677734375,
        538.5501708984375,
        654.738525390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60057067871094,
        640.44677734375,
        538.5501708984375,
        654.738525390625
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60064697265625,
        662.0484008789062,
        538.5596923828125,
        676.3401489257812
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지금까지 대",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60064697265625,
        662.0484008789062,
        538.5596923828125,
        676.3401489257812
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60064697265625,
        662.0484008789062,
        538.5596923828125,
        676.3401489257812
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60113525390625,
        685.9378662109375,
        538.4488525390625,
        697.9378662109375
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인되었다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60113525390625,
        707.5394287109375,
        157.60894775390625,
        719.5394287109375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64018249511719,
        729.1410522460938,
        538.4412841796875,
        741.1410522460938
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 종에 의해 시험법이 결정될 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64018249511719,
        729.1410522460938,
        538.4412841796875,
        741.1410522460938
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지금까지 이들",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64018249511719,
        729.1410522460938,
        538.4412841796875,
        741.1410522460938
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64018249511719,
        729.1410522460938,
        538.4412841796875,
        741.1410522460938
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64018249511719,
        729.1410522460938,
        538.4412841796875,
        741.1410522460938
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64018249511719,
        729.1410522460938,
        538.4412841796875,
        741.1410522460938
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 10 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 제거 공정에 중요한 영향을 미친다는 증거는 없지만",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.5619506835938,
        111.14019775390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.5619506835938,
        111.14019775390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.5619506835938,
        111.14019775390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.5619506835938,
        111.14019775390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(recorded)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.5619506835938,
        111.14019775390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거율이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        120.7379150390625,
        527.207763671875,
        132.7379150390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        120.7379150390625,
        527.207763671875,
        132.7379150390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        120.7379150390625,
        527.207763671875,
        132.7379150390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질의 물리화학적 특성이 중요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64125061035156,
        142.33953857421875,
        538.55126953125,
        154.33953857421875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약 혈액에 감염성 프리온 단",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64125061035156,
        142.33953857421875,
        538.55126953125,
        154.33953857421875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6) Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64125061035156,
        142.33953857421875,
        538.55126953125,
        154.33953857421875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64125061035156,
        142.33953857421875,
        538.55126953125,
        154.33953857421875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백이 존재한다면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        163.937255859375,
        538.5514526367188,
        175.937255859375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        163.937255859375,
        538.5514526367188,
        175.937255859375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        163.937255859375,
        538.5514526367188,
        175.937255859375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "태의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "징조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구결과에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의하면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다른",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "막 함유",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(indication)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60223388671875,
        185.53887939453125,
        538.44091796875,
        197.53887939453125
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질을 시험한 결과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        207.1405029296875,
        538.4432983398438,
        219.1405029296875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가한 모든 침전 공정에서 매유 유사한 방법으",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        207.1405029296875,
        538.4432983398438,
        219.1405029296875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        207.1405029296875,
        538.4432983398438,
        219.1405029296875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        207.1405029296875,
        538.4432983398438,
        219.1405029296875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 제거되었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        228.73822021484375,
        538.443359375,
        240.73822021484375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 막과 관련 없는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        228.73822021484375,
        538.443359375,
        240.73822021484375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질은 특정 침전 공정에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        228.73822021484375,
        538.443359375,
        240.73822021484375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        228.73822021484375,
        538.443359375,
        240.73822021484375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60234069824219,
        228.73822021484375,
        538.443359375,
        240.73822021484375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보다 쉽게 제거되었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        250.33984375,
        538.4436645507812,
        262.33984375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 흡착과 같은 비 침전 공정은 반대 결과가 나타날 수",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        250.33984375,
        538.4436645507812,
        262.33984375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        250.33984375,
        538.4436645507812,
        262.33984375
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        271.93756103515625,
        538.4442138671875,
        283.93756103515625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 가장 엄격한 시험을 가능하게 하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        271.93756103515625,
        538.4442138671875,
        283.93756103515625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질은 공정 단계에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        271.93756103515625,
        538.4442138671875,
        283.93756103515625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        271.93756103515625,
        538.4442138671875,
        283.93756103515625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60233306884766,
        271.93756103515625,
        538.4442138671875,
        283.93756103515625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 달라질 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60232543945312,
        293.5391845703125,
        223.61013793945312,
        305.5391845703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동물실험 연구에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64142608642578,
        315.14080810546875,
        538.43994140625,
        327.14080810546875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64142608642578,
        315.14080810546875,
        538.43994140625,
        327.14080810546875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64142608642578,
        315.14080810546875,
        538.43994140625,
        327.14080810546875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64142608642578,
        315.14080810546875,
        538.43994140625,
        327.14080810546875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "첨가하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60232543945312,
        336.7384948730469,
        538.5633544921875,
        348.7384948730469
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질의 농도는 가능한 한 높아야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60232543945312,
        336.7384948730469,
        538.5633544921875,
        348.7384948730469
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질은 고농",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60232543945312,
        336.7384948730469,
        538.5633544921875,
        348.7384948730469
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60232543945312,
        336.7384948730469,
        538.5633544921875,
        348.7384948730469
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60232543945312,
        336.7384948730469,
        538.5633544921875,
        348.7384948730469
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6025390625,
        358.340087890625,
        427.6103515625,
        370.340087890625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64173889160156,
        379.9377746582031,
        538.4346923828125,
        391.9377746582031
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64173889160156,
        379.9377746582031,
        538.4346923828125,
        391.9377746582031
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기 위하여 완건성 평가를 포함하고 있다. In vitro 시험법만 단독으로 하는 경",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6026382446289,
        401.5392150878906,
        538.436767578125,
        413.53936767578125
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우를 제외하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60101318359375,
        423.14080810546875,
        538.4387817382812,
        435.14080810546875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60101318359375,
        423.14080810546875,
        538.4387817382812,
        435.14080810546875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60101318359375,
        423.14080810546875,
        538.4387817382812,
        435.14080810546875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60101318359375,
        444.7384948730469,
        538.44873046875,
        456.7384948730469
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60101318359375,
        466.340087890625,
        121.60882568359375,
        478.340087890625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6401138305664,
        509.539306640625,
        538.4338989257812,
        521.539306640625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67921447753906,
        531.140869140625,
        524.68701171875,
        543.140869140625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 제거율 재평가",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        576.1561889648438,
        295.8037109375,
        589.1161499023438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        576.1561889648438,
        295.8037109375,
        589.1161499023438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        599.538818359375,
        538.4335327148438,
        611.538818359375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.140380859375,
        538.484130859375,
        633.140380859375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.140380859375,
        538.484130859375,
        633.140380859375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        621.140380859375,
        538.484130859375,
        633.140380859375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한 제조공정 변경은 매우 중요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6793212890625,
        642.7380981445312,
        538.433837890625,
        654.7380981445312
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과학 분야의 발전으로 앞으로의 연구를 정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6793212890625,
        642.7380981445312,
        538.433837890625,
        654.7380981445312
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6793212890625,
        642.7380981445312,
        538.433837890625,
        654.7380981445312
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6793212890625,
        664.3397216796875,
        538.433349609375,
        676.3402099609375
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백 제거 조사연구를 용이하게 할 수 있을 것이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67900085449219,
        685.9379272460938,
        356.68682861328125,
        697.9379272460938
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 11 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장비 위생",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        99.15615844726562,
        146.4013671875,
        112.11616516113281
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        99.15615844726562,
        146.4013671875,
        112.11616516113281
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        122.538818359375,
        538.5567016601562,
        134.538818359375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구를 통해 평가되어 왔다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        144.14044189453125,
        538.55859375,
        156.14044189453125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        144.14044189453125,
        538.55859375,
        156.14044189453125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        144.14044189453125,
        538.55859375,
        156.14044189453125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        165.7381591796875,
        538.433349609375,
        177.7381591796875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 정상적인 처리 방법 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        165.7381591796875,
        538.433349609375,
        177.7381591796875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        165.7381591796875,
        538.433349609375,
        177.7381591796875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알킬화제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계면활성제 으로는 불활화 효과가 없는 반면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일부 처리 방법 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 2%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        187.33978271484375,
        538.4949340820312,
        199.33978271484375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표백제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담금",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조건의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "압력과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1~2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "N",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6795883178711,
        208.9375,
        538.4256591796875,
        220.9375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        230.53912353515625,
        538.5661010742188,
        242.53912353515625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일부 세척 공정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        230.53912353515625,
        538.5661010742188,
        242.53912353515625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "134~138",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        230.53912353515625,
        538.5661010742188,
        242.53912353515625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        230.53912353515625,
        538.5661010742188,
        242.53912353515625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        230.53912353515625,
        538.5661010742188,
        242.53912353515625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67938232421875,
        230.53912353515625,
        538.5661010742188,
        242.53912353515625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        252.1407470703125,
        538.4335327148438,
        264.1407470703125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 여러 가지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        252.1407470703125,
        538.4335327148438,
        264.1407470703125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        252.1407470703125,
        538.4335327148438,
        264.1407470703125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이유로 적용에 다소 제한이 따른다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67965698242188,
        273.73846435546875,
        538.4367065429688,
        285.73846435546875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "즉",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67965698242188,
        273.73846435546875,
        538.4367065429688,
        285.73846435546875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대부분의 방법이 가혹하여 대부분의 생물의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67965698242188,
        273.73846435546875,
        538.4367065429688,
        285.73846435546875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67965698242188,
        273.73846435546875,
        538.4367065429688,
        285.73846435546875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67965698242188,
        273.73846435546875,
        538.4367065429688,
        285.73846435546875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약품에 손상을 가져오며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        295.340087890625,
        538.4335327148438,
        307.340087890625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        295.340087890625,
        538.4335327148438,
        307.340087890625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        295.340087890625,
        538.4335327148438,
        307.340087890625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 물질에 대해서는 제한적인 효과 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        316.93780517578125,
        538.4375610351562,
        328.93780517578125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 포자를 죽이지는 못하는 것으로 보",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        316.93780517578125,
        538.4375610351562,
        328.93780517578125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        316.93780517578125,
        538.4375610351562,
        328.93780517578125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67967224121094,
        316.93780517578125,
        538.4375610351562,
        328.93780517578125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고됨 를 나타낸다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여러 가지 실험실적 처리법 예",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알킬화제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백 분해효소 등 이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        338.5393981933594,
        538.5546875,
        350.5393981933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6796875,
        360.1409912109375,
        488.6875,
        372.1409912109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64068603515625,
        381.7386779785156,
        538.4336547851562,
        393.7386779785156
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        403.34027099609375,
        538.5626220703125,
        415.34027099609375
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        424.9379577636719,
        538.5626220703125,
        436.9379577636719
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 것이 특히 중요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        446.53955078125,
        538.5587158203125,
        458.53955078125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        446.53955078125,
        538.5587158203125,
        458.53955078125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        446.53955078125,
        538.5587158203125,
        458.53955078125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        468.1411437988281,
        538.5587158203125,
        480.1411437988281
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "많은 분획 공정",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        468.1411437988281,
        538.5587158203125,
        480.1411437988281
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.6797866821289,
        468.1411437988281,
        538.5587158203125,
        480.1411437988281
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        489.73883056640625,
        538.4429931640625,
        501.73883056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 제거된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        489.73883056640625,
        538.4429931640625,
        501.73883056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        489.73883056640625,
        538.4429931640625,
        501.73883056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(aid)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        489.73883056640625,
        538.4429931640625,
        501.73883056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        489.73883056640625,
        538.4429931640625,
        501.73883056640625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 단계가 효과적인 단계로 밝혀진다면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        511.3404541015625,
        538.434326171875,
        523.3404541015625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조 설비로부터 나온 감염성 물질에 의한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        511.3404541015625,
        538.434326171875,
        523.3404541015625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        511.3404541015625,
        538.434326171875,
        523.3404541015625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 오염 위험성을 감소시킬 수 있을 것이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67977905273438,
        532.9381103515625,
        338.6875915527344,
        544.9381103515625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64077758789062,
        554.5396728515625,
        538.5587158203125,
        566.5396728515625
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어렵다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987823486328,
        576.1412963867188,
        538.56640625,
        588.1412963867188
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백에 담근 강철선",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987823486328,
        576.1412963867188,
        538.56640625,
        588.1412963867188
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 감수성이 있는 동물의 뇌",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987823486328,
        576.1412963867188,
        538.56640625,
        588.1412963867188
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987823486328,
        576.1412963867188,
        538.56640625,
        588.1412963867188
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(steel wire)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987823486328,
        576.1412963867188,
        538.56640625,
        588.1412963867188
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 이식하여 질병을 유발시킨 모델이 개발되어 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        597.739013671875,
        538.4343872070312,
        609.739013671875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "강철선의 위생은 감염성 물질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        597.739013671875,
        538.4343872070312,
        609.739013671875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        597.739013671875,
        538.4343872070312,
        609.739013671875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 농도를 달리하여 강철선에 로딩",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        619.340576171875,
        538.433837890625,
        631.340576171875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 동물모델에서 감염력이 소실되는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        619.340576171875,
        538.433837890625,
        631.340576171875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(loading)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        619.340576171875,
        538.433837890625,
        631.340576171875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것을 구함으로써 모니터링 할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        640.9382934570312,
        538.558837890625,
        652.9382934570312
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이와 같은 방법으로 감염성 프리온 단백으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        640.9382934570312,
        538.558837890625,
        652.9382934570312
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        640.9382934570312,
        538.558837890625,
        652.9382934570312
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        662.5399169921875,
        538.5514526367188,
        674.5399169921875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설비에 대한 이와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        662.5399169921875,
        538.5514526367188,
        674.5399169921875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        662.5399169921875,
        538.5514526367188,
        674.5399169921875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같은 연구결과를 제조공정 수준으로 외삽",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        684.1414794921875,
        538.4348754882812,
        696.1414794921875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(extrapolation) 하는 것은 어렵다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        684.1414794921875,
        538.4348754882812,
        696.1414794921875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 0.1 M",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67987060546875,
        684.1414794921875,
        538.4348754882812,
        696.1414794921875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67975616455078,
        703.4474487304688,
        538.437255859375,
        717.7391967773438
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPSc를 단백 분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67975616455078,
        703.4474487304688,
        538.437255859375,
        717.7391967773438
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67922973632812,
        727.3408203125,
        538.43310546875,
        739.3408203125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 이 연구결과는 감염력",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67922973632812,
        727.3408203125,
        538.43310546875,
        739.3408203125
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 12 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구를 통해 확인이 필요하다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67999267578125,
        99.14019775390625,
        236.68780517578125,
        111.14019775390625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기의 사항들을 고려하여 볼 때",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4464111328125,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장 처리 공정 설비에 대한 새로운 과학적인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4464111328125,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6409912109375,
        120.7379150390625,
        538.4464111328125,
        132.7379150390625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        142.33953857421875,
        538.4299926757812,
        154.33953857421875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68000793457031,
        163.937255859375,
        86.68782043457031,
        175.937255859375
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 결론",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        212.4830322265625,
        114.12110137939453,
        227.4830322265625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        212.4830322265625,
        114.12110137939453,
        227.4830322265625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        262.9371337890625,
        538.4453125,
        274.9371337890625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        284.53875732421875,
        538.4832763671875,
        296.53875732421875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 특이적인 조사연구에 대한 단계적 접근 방법은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        284.53875732421875,
        538.4832763671875,
        296.53875732421875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        284.53875732421875,
        538.4832763671875,
        296.53875732421875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        284.53875732421875,
        538.4832763671875,
        296.53875732421875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        284.53875732421875,
        538.4832763671875,
        296.53875732421875
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        284.53875732421875,
        538.4832763671875,
        296.53875732421875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“Creutzfeldt-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        284.53875732421875,
        538.4832763671875,
        296.53875732421875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Jakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        306.140380859375,
        538.5181884765625,
        318.140380859375
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        327.7380676269531,
        538.4420166015625,
        339.7380676269531
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항을 참조한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        327.7380676269531,
        538.4420166015625,
        339.7380676269531
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 제거 연구의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        327.7380676269531,
        538.4420166015625,
        339.7380676269531
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BWP/2879/02/rev 1, 2004)”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        327.7380676269531,
        538.4420166015625,
        339.7380676269531
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9.2.3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        327.7380676269531,
        538.4420166015625,
        339.7380676269531
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        327.7380676269531,
        538.4420166015625,
        339.7380676269531
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실질적인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이유에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근거하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내려야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640594482421875,
        349.33966064453125,
        538.484375,
        361.33966064453125
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질은 조사연구 대상 공정 단계에 가장 큰 영향",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402702331543,
        370.9373474121094,
        538.4646606445312,
        382.9373474121094
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 주여야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402702331543,
        370.9373474121094,
        538.4646606445312,
        382.9373474121094
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402702331543,
        370.9373474121094,
        538.4646606445312,
        382.9373474121094
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(challenge)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402702331543,
        370.9373474121094,
        538.4646606445312,
        382.9373474121094
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402702331543,
        370.9373474121094,
        538.4646606445312,
        382.9373474121094
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최악의 조건을 평가할 수 있도록 선택되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        392.5389404296875,
        538.4449462890625,
        404.5389404296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        392.5389404296875,
        538.4449462890625,
        404.5389404296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질의 선택에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        392.5389404296875,
        538.4449462890625,
        404.5389404296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        392.5389404296875,
        538.4449462890625,
        404.5389404296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        392.5389404296875,
        538.4449462890625,
        404.5389404296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 이론적 근거를 제시하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        414.1405334472656,
        264.6480712890625,
        426.1405334472656
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        457.3397216796875,
        538.4337158203125,
        469.3397216796875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "때문",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        457.3397216796875,
        538.4337158203125,
        469.3397216796875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(approximation)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6402587890625,
        457.3397216796875,
        538.4337158203125,
        469.3397216796875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 자료의 해석에는 한계가 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        478.9374084472656,
        538.4449462890625,
        490.9374084472656
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 이러한 조사연구를 통해 혈장분획제제의 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        478.9374084472656,
        538.4449462890625,
        490.9374084472656
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        478.9374084472656,
        538.4449462890625,
        490.9374084472656
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        500.53900146484375,
        538.4605712890625,
        512.5390014648438
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 것으로 기대된다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6402587890625,
        522.140625,
        168.6480712890625,
        534.140625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 13 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 참고문헌",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        144.12109375,
        114.08502197265625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        144.12109375,
        114.08502197265625
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 혈장분획제제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가가이드 식품의약품안전청",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.640602111816406,
        154.5782470703125,
        538.4953002929688,
        166.5782470703125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1470000-001176-01, 생물의약품평가가이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55857849121094,
        176.17987060546875,
        389.5241394042969,
        188.17987060546875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20), 2006",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55857849121094,
        176.17987060546875,
        389.5241394042969,
        188.17987060546875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. Note for Guidance on Virus Validation Studies: The Design, Contribution and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.64057922363281,
        202.6993408203125,
        538.332763671875,
        214.6993408203125
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Interpretation of Studies Validating the Inactivation and Removal of Viruses",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.39761352539062,
        224.30096435546875,
        538.3355102539062,
        236.30096435546875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CPMP/BWP/268/95), EMEA, 1996",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.39761352539062,
        245.898681640625,
        279.0671081542969,
        257.898681640625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63981628417969,
        272.539306640625,
        538.4774169921875,
        284.539306640625
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        294.14093017578125,
        538.4838256835938,
        306.14093017578125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Urine-Derived",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        294.14093017578125,
        538.4838256835938,
        306.14093017578125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Medicinal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        294.14093017578125,
        538.4838256835938,
        306.14093017578125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Products(CPMP/BWP/2879/02/rev",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        294.14093017578125,
        538.4838256835938,
        306.14093017578125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        294.14093017578125,
        538.4838256835938,
        306.14093017578125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        294.14093017578125,
        538.4838256835938,
        306.14093017578125
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        315.7386474609375,
        107.08151245117188,
        327.7386474609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        342.3792419433594,
        538.4471435546875,
        354.3792419433594
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "pathies, WHO, 2006",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        363.9808349609375,
        196.34109497070312,
        375.9808349609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        390.5003356933594,
        538.5555419921875,
        402.5003356933594
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확립 및 프리온 단백항체 개발",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        412.0980224609375,
        526.120849609375,
        424.0980224609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전청 용역연구결과보고서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        412.0980224609375,
        526.120849609375,
        424.0980224609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        412.0980224609375,
        526.120849609375,
        424.0980224609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        412.0980224609375,
        526.120849609375,
        424.0980224609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 2001",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        412.0980224609375,
        526.120849609375,
        424.0980224609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅰ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        412.0980224609375,
        526.120849609375,
        424.0980224609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        438.7386169433594,
        538.5555419921875,
        450.7386169433594
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확립 및 프리온 단백항체 개발",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        460.3402099609375,
        526.120849609375,
        472.3402099609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전청 용역연구결과보고서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        460.3402099609375,
        526.120849609375,
        472.3402099609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        460.3402099609375,
        526.120849609375,
        472.3402099609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        460.3402099609375,
        526.120849609375,
        472.3402099609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 2002",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        460.3402099609375,
        526.120849609375,
        472.3402099609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅱ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        460.3402099609375,
        526.120849609375,
        472.3402099609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        486.9808044433594,
        538.5555419921875,
        498.9808044433594
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확립 및 프리온 단백항체 개발",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        508.5784912109375,
        526.120849609375,
        520.5784912109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전청 용역연구결과보고서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        508.5784912109375,
        526.120849609375,
        520.5784912109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        508.5784912109375,
        526.120849609375,
        520.5784912109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "),",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        508.5784912109375,
        526.120849609375,
        520.5784912109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 2003",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        508.5784912109375,
        526.120849609375,
        520.5784912109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅲ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        508.5784912109375,
        526.120849609375,
        520.5784912109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        535.0980224609375,
        538.5397338867188,
        547.0980224609375
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        535.0980224609375,
        538.5397338867188,
        547.0980224609375
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        535.0980224609375,
        538.5397338867188,
        547.0980224609375
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전청 용역연구결과보고서, 2004",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        556.6995849609375,
        255.04263305664062,
        568.6995849609375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        62.63983154296875,
        583.3402099609375,
        538.4317626953125,
        595.3402099609375
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        604.9378662109375,
        349.0036315917969,
        616.9378662109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 식품의약품안전청 용역연구결과보고서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        604.9378662109375,
        349.0036315917969,
        616.9378662109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 2005",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.55783081054688,
        604.9378662109375,
        349.0036315917969,
        616.9378662109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. Laboratory Biosafety Manual 3rd Ed, WHO, 2004",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.63983154296875,
        631.5784912109375,
        365.05010986328125,
        643.5784912109375
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 14 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<부록",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6406364440918,
        99.15615844726562,
        98.8188247680664,
        112.11616516113281
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ">",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6406364440918,
        99.15615844726562,
        98.8188247680664,
        112.11616516113281
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 제거 조사연구 시험방법",
      "font_size": 17.513427734375,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.5199966430664,
        144.15081787109375,
        472.66937255859375,
        162.15081787109375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 서론",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        203.4830322265625,
        114.12110137939453,
        218.4830322265625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        203.4830322265625,
        114.12110137939453,
        218.4830322265625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전염성 해면상 뇌증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        253.9371337890625,
        538.5629272460938,
        265.9371337890625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 경우 자연",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        253.9371337890625,
        538.5629272460938,
        265.9371337890625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(transmissible spongiform encephalopathy, TSE)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        253.9371337890625,
        538.5629272460938,
        265.9371337890625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적인 질병 발생에 있어서 공기 전염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641578674316406,
        275.53875732421875,
        538.44580078125,
        287.53875732421875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 되지 않는 것으로 알려져",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641578674316406,
        275.53875732421875,
        538.44580078125,
        287.53875732421875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(aerosol transmission)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641578674316406,
        275.53875732421875,
        538.44580078125,
        287.53875732421875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64158630371094,
        297.140380859375,
        538.4384765625,
        309.140380859375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64158630371094,
        318.73809814453125,
        538.4462890625,
        330.73809814453125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염된 조",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64158630371094,
        318.73809814453125,
        538.4462890625,
        330.73809814453125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64158630371094,
        318.73809814453125,
        538.4462890625,
        330.73809814453125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        340.3396911621094,
        538.4306640625,
        352.3396911621094
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 실험복이나 장갑을 착용해야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        361.9373779296875,
        538.4467163085938,
        373.9373779296875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 포름알데히드로 고정한 조직 및 파라핀 포매한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        361.9373779296875,
        538.4467163085938,
        373.9373779296875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641571044921875,
        361.9373779296875,
        538.4467163085938,
        373.9373779296875
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        383.5389709472656,
        538.439453125,
        395.5389709472656
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        383.5389709472656,
        538.439453125,
        395.5389709472656
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        383.5389709472656,
        538.439453125,
        395.5389709472656
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        405.14056396484375,
        114.65036010742188,
        417.14056396484375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 실험실 생물안전등급",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        453.68255615234375,
        340.74578857421875,
        468.68255615234375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(biosafety level)",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        453.68255615234375,
        340.74578857421875,
        468.68255615234375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        453.68255615234375,
        340.74578857421875,
        468.68255615234375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물안전등급",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64254760742188,
        504.14056396484375,
        538.4457397460938,
        516.1405639648438
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이란 어떤 미생물을 대상으로 실험할 때 미생물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64254760742188,
        504.14056396484375,
        538.4457397460938,
        516.1405639648438
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(biosafety level, BSL)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64254760742188,
        504.14056396484375,
        538.4457397460938,
        516.1405639648438
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        525.73828125,
        538.4628295898438,
        537.73828125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        547.33984375,
        538.5598754882812,
        559.33984375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장비 및 실험자에 대한 조건을 설정한 것으로서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        547.33984375,
        538.5598754882812,
        559.33984375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        547.33984375,
        538.5598754882812,
        559.33984375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "까지 분류되고 있",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        547.33984375,
        538.5598754882812,
        559.33984375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        547.33984375,
        538.5598754882812,
        559.33984375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", level 1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        547.33984375,
        538.5598754882812,
        559.33984375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        547.33984375,
        538.5598754882812,
        559.33984375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        568.9375,
        94.61144256591797,
        580.9375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 즉",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        568.9375,
        94.61144256591797,
        580.9375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.642547607421875,
        568.9375,
        94.61144256591797,
        580.9375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64254760742188,
        590.5391235351562,
        463.322265625,
        602.5391235351562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "①",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64254760742188,
        590.5391235351562,
        463.322265625,
        602.5391235351562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64254760742188,
        612.1407470703125,
        433.322265625,
        624.1407470703125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "②",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64254760742188,
        612.1407470703125,
        433.322265625,
        624.1407470703125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6424560546875,
        633.7384033203125,
        538.5487670898438,
        645.7384033203125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "③",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6424560546875,
        633.7384033203125,
        538.5487670898438,
        645.7384033203125
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물로서 인체 내 기생체나 전염체를 다루는 경우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        145.68154907226562,
        655.3400268554688,
        421.6815490722656,
        667.3400268554688
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64247131347656,
        676.937744140625,
        421.3221740722656,
        688.937744140625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64247131347656,
        676.937744140625,
        421.3221740722656,
        688.937744140625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64247131347656,
        720.1408081054688,
        538.4861450195312,
        732.1408081054688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64247131347656,
        720.1408081054688,
        538.4861450195312,
        732.1408081054688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64247131347656,
        720.1408081054688,
        538.4861450195312,
        732.1408081054688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        74.64247131347656,
        720.1408081054688,
        538.4861450195312,
        732.1408081054688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "호",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64116287231445,
        741.738525390625,
        538.4959716796875,
        753.738525390625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 따르면 감염성 프리온 단백은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64116287231445,
        741.738525390625,
        538.4959716796875,
        753.738525390625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서만 취급할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64116287231445,
        741.738525390625,
        538.4959716796875,
        753.738525390625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-95",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64116287231445,
        741.738525390625,
        538.4959716796875,
        753.738525390625
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 2006.11.28)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64116287231445,
        741.738525390625,
        538.4959716796875,
        753.738525390625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSL-3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64116287231445,
        741.738525390625,
        538.4959716796875,
        753.738525390625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64116287231445,
        741.738525390625,
        538.4959716796875,
        753.738525390625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 15 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        99.14019775390625,
        538.4390258789062,
        111.14019775390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSL-3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        99.14019775390625,
        538.4390258789062,
        111.14019775390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험한 작업이 수행되는 임상",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        120.7379150390625,
        538.4312744140625,
        132.7379150390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        120.7379150390625,
        538.4312744140625,
        132.7379150390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구 또는 생산 시설에 적용된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        120.7379150390625,
        538.4312744140625,
        132.7379150390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 실험자는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        120.7379150390625,
        538.4312744140625,
        132.7379150390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        120.7379150390625,
        538.4312744140625,
        132.7379150390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        120.7379150390625,
        538.4312744140625,
        132.7379150390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128494262695,
        120.7379150390625,
        538.4312744140625,
        132.7379150390625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        142.33953857421875,
        538.4303588867188,
        154.33953857421875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자나 전문가에 의해 관리되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        163.937255859375,
        538.4339599609375,
        175.937255859375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 감염성 물질을 다루는 모든 절차는 생물안",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        163.937255859375,
        538.4339599609375,
        175.937255859375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        163.937255859375,
        538.4339599609375,
        175.937255859375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전작업대",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        185.53887939453125,
        538.551025390625,
        197.53887939453125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 다른 보호시설 안에서 수행되어야 하고 적절",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        185.53887939453125,
        538.551025390625,
        197.53887939453125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(biosafety cabinet, BSC)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        185.53887939453125,
        538.551025390625,
        197.53887939453125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 개인보호 장비를 착용하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64128112792969,
        207.1405029296875,
        264.64910888671875,
        219.1405029296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미생물 취급 요령",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        252.15615844726562,
        191.88185119628906,
        265.11614990234375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        252.15615844726562,
        191.88185119628906,
        265.11614990234375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        275.538818359375,
        438.0464172363281,
        287.538818359375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        275.538818359375,
        438.0464172363281,
        287.538818359375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모든 실험자는 생체를 취급한 후에는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        297.14044189453125,
        538.5545654296875,
        309.14044189453125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회용 장갑을 벗은 후와 실험실을 나가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        297.14044189453125,
        538.5545654296875,
        309.14044189453125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        297.14044189453125,
        538.5545654296875,
        309.14044189453125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        297.14044189453125,
        538.5545654296875,
        309.14044189453125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기 전에 반드시 손을 씻는다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60148620605469,
        318.7381591796875,
        265.60931396484375,
        330.7381591796875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        340.3397521972656,
        538.429931640625,
        352.3397521972656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        340.3397521972656,
        538.429931640625,
        352.3397521972656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        361.93743896484375,
        481.609619140625,
        373.93743896484375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입을 이용해 시약을 빨아들이는 것",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64090728759766,
        383.5390319824219,
        538.4423828125,
        395.5390319824219
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 금지하고 마이크로 피펫과 같",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64090728759766,
        383.5390319824219,
        538.4423828125,
        395.5390319824219
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64090728759766,
        383.5390319824219,
        538.4423828125,
        395.5390319824219
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(pipetting)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64090728759766,
        383.5390319824219,
        538.4423828125,
        395.5390319824219
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 측정용 기기를 사용한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60189819335938,
        405.140625,
        259.6097106933594,
        417.140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        426.7383117675781,
        462.04632568359375,
        438.7383117675781
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        426.7383117675781,
        462.04632568359375,
        438.7383117675781
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6399154663086,
        448.33990478515625,
        538.428955078125,
        460.33990478515625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6399154663086,
        448.33990478515625,
        538.428955078125,
        460.33990478515625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60081481933594,
        469.9375915527344,
        121.60862731933594,
        481.9375915527344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6399154663086,
        491.5391845703125,
        498.0457458496094,
        503.5391845703125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6399154663086,
        491.5391845703125,
        498.0457458496094,
        503.5391845703125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 감염성 폐기물은 반드시 멸균하여 폐기한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63914489746094,
        513.1407470703125,
        538.4444580078125,
        525.1407470703125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 배양액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63914489746094,
        513.1407470703125,
        538.4444580078125,
        525.1407470703125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "저장용기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63914489746094,
        513.1407470703125,
        538.4444580078125,
        525.1407470703125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8) BSL-3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63914489746094,
        513.1407470703125,
        538.4444580078125,
        525.1407470703125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63914489746094,
        513.1407470703125,
        538.4444580078125,
        525.1407470703125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63914489746094,
        513.1407470703125,
        538.4444580078125,
        525.1407470703125
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60012817382812,
        534.7384643554688,
        538.4326171875,
        546.7384643554688
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균한 후 폐기한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60012817382812,
        556.340087890625,
        538.5529174804688,
        568.340087890625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60012817382812,
        556.340087890625,
        538.5529174804688,
        568.340087890625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60012817382812,
        556.340087890625,
        538.5529174804688,
        568.340087890625
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있어야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60013580322266,
        577.937744140625,
        175.60794067382812,
        589.937744140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실 출입구에 감염성 물질을 표지하여 알린다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63912963867188,
        599.5393676757812,
        538.4281005859375,
        611.5393676757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하는 물질명과 연구자",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63912963867188,
        599.5393676757812,
        538.4281005859375,
        611.5393676757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63912963867188,
        599.5393676757812,
        538.4281005859375,
        611.5393676757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63912963867188,
        599.5393676757812,
        538.4281005859375,
        611.5393676757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 전화번호 등을 기재한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60012817382812,
        621.1409912109375,
        259.6079406738281,
        633.1409912109375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특별 사항",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.59972381591797,
        666.15673828125,
        146.3995819091797,
        679.11669921875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.59972381591797,
        666.15673828125,
        146.3995819091797,
        679.11669921875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6388168334961,
        689.5393676757812,
        538.4278564453125,
        701.5393676757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6388168334961,
        689.5393676757812,
        538.4278564453125,
        701.5393676757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59971618652344,
        711.1409301757812,
        538.5489501953125,
        723.1409301757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59971618652344,
        711.1409301757812,
        538.5489501953125,
        723.1409301757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59971618652344,
        711.1409301757812,
        538.5489501953125,
        723.1409301757812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 실험실이나 동물실험실 출입을 금지한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59971618652344,
        732.7386474609375,
        538.548828125,
        744.7386474609375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 실험실 감독자는 주위환경 평가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59971618652344,
        732.7386474609375,
        538.548828125,
        744.7386474609375
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 16 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        433.60980224609375,
        111.14019775390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64070129394531,
        120.7379150390625,
        538.43896484375,
        132.7379150390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64070129394531,
        120.7379150390625,
        538.43896484375,
        132.7379150390625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60160064697266,
        142.33953857421875,
        493.6094055175781,
        154.33953857421875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물재해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64059448242188,
        163.937255859375,
        538.4847412109375,
        175.937255859375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표지는 실험실 출입구에 붙여 놓는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64059448242188,
        163.937255859375,
        538.4847412109375,
        175.937255859375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하는 물질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64059448242188,
        163.937255859375,
        538.4847412109375,
        175.937255859375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64059448242188,
        163.937255859375,
        538.4847412109375,
        175.937255859375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(biohazard)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64059448242188,
        163.937255859375,
        538.4847412109375,
        175.937255859375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64059448242188,
        163.937255859375,
        538.4847412109375,
        175.937255859375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64059448242188,
        163.937255859375,
        538.4847412109375,
        175.937255859375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구되는 면역사항",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감독자 이름",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전화번호",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실에서 착용해야 될 개",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSL,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        185.53887939453125,
        538.4397583007812,
        197.53887939453125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인보호 장구",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        207.1405029296875,
        491.6876220703125,
        219.1405029296875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        207.1405029296875,
        491.6876220703125,
        219.1405029296875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        207.1405029296875,
        491.6876220703125,
        219.1405029296875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64051818847656,
        228.73822021484375,
        538.4387817382812,
        240.73822021484375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64051818847656,
        228.73822021484375,
        538.4387817382812,
        240.73822021484375
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6014175415039,
        250.33984375,
        471.76922607421875,
        262.33984375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        105.6014175415039,
        250.33984375,
        471.76922607421875,
        262.33984375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64029693603516,
        271.93756103515625,
        538.4341430664062,
        283.93756103515625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64029693603516,
        271.93756103515625,
        538.4341430664062,
        283.93756103515625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "저장한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6011962890625,
        293.5391845703125,
        389.68701171875,
        305.5391845703125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 혈청 표본도 주기적으로 수집할 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6011962890625,
        293.5391845703125,
        389.68701171875,
        305.5391845703125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6011962890625,
        293.5391845703125,
        389.68701171875,
        305.5391845703125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주사기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주사침",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주사바늘",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "슬라이드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피펫",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외과용 메스 등 날카로운 도구들의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63980865478516,
        315.14080810546875,
        538.4327392578125,
        327.14080810546875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용에 각별히 주의한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6007080078125,
        336.7384948730469,
        538.5658569335938,
        348.7384948730469
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능하다면 플라스틱 제품으로 대체한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6007080078125,
        336.7384948730469,
        538.5658569335938,
        348.7384948730469
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전용 폐기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6007080078125,
        336.7384948730469,
        538.5658569335938,
        348.7384948730469
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6007080078125,
        336.7384948730469,
        538.5658569335938,
        348.7384948730469
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6007080078125,
        336.7384948730469,
        538.5658569335938,
        348.7384948730469
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.5997314453125,
        358.340087890625,
        445.6075439453125,
        370.340087890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 물질을 다루는 모든 조작은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63844299316406,
        379.9377746582031,
        538.4323120117188,
        391.9377746582031
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나 다른 보호시설이 갖추어진 장소에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63844299316406,
        379.9377746582031,
        538.4323120117188,
        391.9377746582031
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63844299316406,
        379.9377746582031,
        538.4323120117188,
        391.9377746582031
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSC",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63844299316406,
        379.9377746582031,
        538.4323120117188,
        391.9377746582031
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 수행한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59944152832031,
        401.53936767578125,
        467.68524169921875,
        413.53936767578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 일반 실험대에서는 어떠한 작업도 수행하지 않는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59944152832031,
        401.53936767578125,
        467.68524169921875,
        413.53936767578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59944152832031,
        401.53936767578125,
        467.68524169921875,
        413.53936767578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6388168334961,
        423.1409606933594,
        538.4278564453125,
        435.1409606933594
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6388168334961,
        423.1409606933594,
        538.4278564453125,
        435.1409606933594
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59971618652344,
        444.7386474609375,
        487.6075439453125,
        456.7386474609375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조직",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표본 또는 잠재적 감염성 폐기물은 수집",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "취급",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "저장 및 운반하는 동안",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63863372802734,
        466.3402404785156,
        538.4361572265625,
        478.3402404785156
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "새지 않도록 뚜껑이 있는 저장용기에 보관한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.59963989257812,
        487.93792724609375,
        367.6074523925781,
        499.93792724609375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63893127441406,
        509.53955078125,
        538.5628662109375,
        521.53955078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63893127441406,
        509.53955078125,
        538.5628662109375,
        521.53955078125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.5998306274414,
        531.14111328125,
        323.6856384277344,
        543.14111328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 감독 및 처리가 수행되어져야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.5998306274414,
        531.14111328125,
        323.6856384277344,
        543.14111328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.5998306274414,
        531.14111328125,
        323.6856384277344,
        543.14111328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63853454589844,
        552.73876953125,
        414.88836669921875,
        564.73876953125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63853454589844,
        552.73876953125,
        414.88836669921875,
        564.73876953125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전장비",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        597.7542114257812,
        235.1395721435547,
        610.7141723632812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "차 보호 장비",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        597.7542114257812,
        235.1395721435547,
        610.7141723632812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        597.7542114257812,
        235.1395721435547,
        610.7141723632812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        597.7542114257812,
        235.1395721435547,
        610.7141723632812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        597.7542114257812,
        235.1395721435547,
        610.7141723632812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        621.1407470703125,
        538.43505859375,
        633.1407470703125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보호 의류는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        621.1407470703125,
        538.43505859375,
        633.1407470703125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        621.1407470703125,
        538.43505859375,
        633.1407470703125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        621.1407470703125,
        538.43505859375,
        633.1407470703125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실 이외의 장소에서는 입지 않는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60061645507812,
        642.7384033203125,
        538.553466796875,
        654.7384033203125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재활용 실험복은 재사용 전에 소독하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60061645507812,
        642.7384033203125,
        538.553466796875,
        654.7384033203125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60061645507812,
        642.7384033203125,
        538.553466796875,
        654.7384033203125
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60061645507812,
        664.3400268554688,
        425.6864318847656,
        676.3400268554688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 명백하게 오염된 경우는 폐기하고 교체한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60061645507812,
        664.3400268554688,
        425.6864318847656,
        676.3400268554688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60061645507812,
        664.3400268554688,
        425.6864318847656,
        676.3400268554688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장갑은 감염성 물질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63922882080078,
        685.937744140625,
        500.08502197265625,
        697.937744140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염 동물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63922882080078,
        685.937744140625,
        500.08502197265625,
        697.937744140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오염 장비를 다룰 때 착용하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63922882080078,
        685.937744140625,
        500.08502197265625,
        697.937744140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63922882080078,
        685.937744140625,
        500.08502197265625,
        697.937744140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63922882080078,
        685.937744140625,
        500.08502197265625,
        697.937744140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63922882080078,
        685.937744140625,
        500.08502197265625,
        697.937744140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63922882080078,
        685.937744140625,
        500.08502197265625,
        697.937744140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자주 손을 씻고 장갑은 자주 교체하는 것이 좋다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63990783691406,
        707.539306640625,
        538.5548706054688,
        719.539306640625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회용 장갑은 세척하여 재",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63990783691406,
        707.539306640625,
        538.5548706054688,
        719.539306640625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63990783691406,
        707.539306640625,
        538.5548706054688,
        719.539306640625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.63990783691406,
        707.539306640625,
        538.5548706054688,
        719.539306640625
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하지 않는다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60092163085938,
        729.1409301757812,
        199.60873413085938,
        741.1409301757812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 17 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 물질의 모든 조작은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 해당하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안에서 수행한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Class II",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "III",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSC",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6408920288086,
        99.14019775390625,
        538.44189453125,
        111.14019775390625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60179138183594,
        120.7379150390625,
        121.60960388183594,
        132.7379150390625
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64083862304688,
        142.33953857421875,
        538.4391479492188,
        154.33953857421875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64083862304688,
        142.33953857421875,
        538.4391479492188,
        154.33953857421875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "절하게 조합하여 사용한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60173797607422,
        163.937255859375,
        253.60955810546875,
        175.937255859375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64034271240234,
        185.53887939453125,
        480.0461730957031,
        197.53887939453125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64034271240234,
        185.53887939453125,
        480.0461730957031,
        197.53887939453125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실 시설",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        230.55514526367188,
        254.5807342529297,
        243.51515197753906
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "차 보호 시설",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        230.55514526367188,
        254.5807342529297,
        243.51515197753906
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        230.55514526367188,
        254.5807342529297,
        243.51515197753906
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        230.55514526367188,
        254.5807342529297,
        243.51515197753906
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        230.55514526367188,
        254.5807342529297,
        243.51515197753906
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        253.93780517578125,
        538.4296264648438,
        265.93780517578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        253.93780517578125,
        538.4296264648438,
        265.93780517578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입이 제한되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60150146484375,
        275.5394287109375,
        538.4459838867188,
        287.5394287109375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개의 자동문으로 된 좁은 통로가 출입구에 필수적이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60150146484375,
        275.5394287109375,
        538.4459838867188,
        287.5394287109375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60150146484375,
        275.5394287109375,
        538.4459838867188,
        287.5394287109375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "며 문이 잠겨야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60150146484375,
        297.14105224609375,
        538.551513671875,
        309.14105224609375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60150146484375,
        297.14105224609375,
        538.551513671875,
        309.14105224609375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60150146484375,
        297.14105224609375,
        538.551513671875,
        309.14105224609375
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있어야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60150909423828,
        318.73876953125,
        175.60931396484375,
        330.73876953125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 실험실은 손 씻는 싱크대가 있어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3403625488281,
        538.43505859375,
        352.3403625488281
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "싱크대는 자동으로 작동되어야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3403625488281,
        538.43505859375,
        352.3403625488281
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3403625488281,
        538.43505859375,
        352.3403625488281
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        340.3403625488281,
        538.43505859375,
        352.3403625488281
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하며 출입문 가까이에 위치하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60159301757812,
        361.93804931640625,
        325.6094055175781,
        373.93804931640625
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험 인자를 다루는 지역의 벽",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        383.5396423339844,
        538.4451904296875,
        395.5396423339844
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바닥",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        383.5396423339844,
        538.4451904296875,
        395.5396423339844
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "천정의 내부 표면은 쉽게 세척",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        383.5396423339844,
        538.4451904296875,
        395.5396423339844
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) BSL-3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        383.5396423339844,
        538.4451904296875,
        395.5396423339844
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        383.5396423339844,
        538.4451904296875,
        395.5396423339844
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64049530029297,
        383.5396423339844,
        538.4451904296875,
        395.5396423339844
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 소독이 가능하도록 설계되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60139465332031,
        405.1412353515625,
        538.4371337890625,
        417.1412353515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "갈라진 틈은 봉합되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60139465332031,
        405.1412353515625,
        538.4371337890625,
        417.1412353515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60139465332031,
        405.1412353515625,
        538.4371337890625,
        417.1412353515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60139465332031,
        405.1412353515625,
        538.4371337890625,
        417.1412353515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60139465332031,
        405.1412353515625,
        538.4371337890625,
        417.1412353515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 벽",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        426.7389221191406,
        538.4437255859375,
        438.7389221191406
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "천장",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        426.7389221191406,
        538.4437255859375,
        438.7389221191406
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        426.7389221191406,
        538.4437255859375,
        438.7389221191406
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        426.7389221191406,
        538.4437255859375,
        438.7389221191406
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        426.7389221191406,
        538.4437255859375,
        438.7389221191406
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "액체가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "침투하지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부드러운",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재질이어야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바닥은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모놀리식",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60137939453125,
        448.34051513671875,
        538.550537109375,
        460.34051513671875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일체식",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        469.9382019042969,
        444.5278015136719,
        481.9382019042969
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이어야 하며 미끄럼이 방지되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        469.9382019042969,
        444.5278015136719,
        481.9382019042969
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(monolithic,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        469.9382019042969,
        444.5278015136719,
        481.9382019042969
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        469.9382019042969,
        444.5278015136719,
        481.9382019042969
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        469.9382019042969,
        444.5278015136719,
        481.9382019042969
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험대는 방수 방열되고 유기용매",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64079284667969,
        491.539794921875,
        538.56640625,
        503.539794921875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64079284667969,
        491.539794921875,
        538.56640625,
        503.539794921875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알칼리 및 작업대와 장비를 소독하기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64079284667969,
        491.539794921875,
        538.56640625,
        503.539794921875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64079284667969,
        491.539794921875,
        538.56640625,
        503.539794921875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64079284667969,
        491.539794921875,
        538.56640625,
        503.539794921875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64079284667969,
        491.539794921875,
        538.56640625,
        503.539794921875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "․",
      "font_size": 12.0,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        86.64079284667969,
        491.539794921875,
        538.56640625,
        503.539794921875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해 사용되는 화학약품에 견딜 수 있어야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60169219970703,
        513.141357421875,
        373.6094970703125,
        525.141357421875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64107513427734,
        534.7390747070312,
        538.4301147460938,
        546.7390747070312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64107513427734,
        534.7390747070312,
        538.4301147460938,
        546.7390747070312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여 세척이나 소독이 쉬워야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60197448730469,
        556.3406982421875,
        538.3799438476562,
        568.3406982421875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 의자와 다른 가구는 쉽게 소독 가능한 비",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60197448730469,
        556.3406982421875,
        538.3799438476562,
        568.3406982421875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60197448730469,
        556.3406982421875,
        538.3799438476562,
        568.3406982421875
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "섬유물질로 만들어져야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60293579101562,
        577.9383544921875,
        265.6107482910156,
        589.9383544921875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64153289794922,
        599.5399780273438,
        408.04736328125,
        611.5399780273438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64153289794922,
        599.5399780273438,
        408.04736328125,
        611.5399780273438
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64125061035156,
        621.1416015625,
        538.4395141601562,
        633.1416015625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64125061035156,
        621.1416015625,
        538.4395141601562,
        633.1416015625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하며 실험실 내에 갖추어져 있는 것이 좋다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6021499633789,
        642.7392578125,
        538.547119140625,
        654.7392578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만일 실험실 외부로 옮겨야 하면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6021499633789,
        642.7392578125,
        538.547119140625,
        654.7392578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6021499633789,
        642.7392578125,
        538.547119140625,
        654.7392578125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적절하게 봉합하여 운반하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60215759277344,
        664.3408813476562,
        307.6099853515625,
        676.3408813476562
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 필수이며 출입문",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64137268066406,
        685.9385986328125,
        490.3681640625,
        697.9385986328125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저장고에서 떨어진 장소에 위치하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64137268066406,
        685.9385986328125,
        490.3681640625,
        697.9385986328125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) BSC",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64137268066406,
        685.9385986328125,
        490.3681640625,
        697.9385986328125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64137268066406,
        685.9385986328125,
        490.3681640625,
        697.9385986328125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64137268066406,
        685.9385986328125,
        490.3681640625,
        697.9385986328125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적절한 환기 시스템이 요구된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.641845703125,
        707.5401611328125,
        538.434814453125,
        719.5401611328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환기 시스템은 방향성 기류를 만들어",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.641845703125,
        707.5401611328125,
        538.434814453125,
        719.5401611328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "깨끗",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.641845703125,
        707.5401611328125,
        538.434814453125,
        719.5401611328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.641845703125,
        707.5401611328125,
        538.434814453125,
        719.5401611328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.641845703125,
        707.5401611328125,
        538.434814453125,
        719.5401611328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.641845703125,
        707.5401611328125,
        538.434814453125,
        719.5401611328125
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60284423828125,
        729.1417846679688,
        538.5717163085938,
        741.1417846679688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지역의 공기를 실험실로 들이고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60284423828125,
        729.1417846679688,
        538.5717163085938,
        741.1417846679688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오염된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60284423828125,
        729.1417846679688,
        538.5717163085938,
        741.1417846679688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지역으로 배출하는 시스템이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60284423828125,
        729.1417846679688,
        538.5717163085938,
        741.1417846679688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60284423828125,
        729.1417846679688,
        538.5717163085938,
        741.1417846679688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", “",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60284423828125,
        729.1417846679688,
        538.5717163085938,
        741.1417846679688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60284423828125,
        729.1417846679688,
        538.5717163085938,
        741.1417846679688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 18 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구된다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.437744140625,
        111.14019775390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.437744140625,
        111.14019775390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배출",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.437744140625,
        111.14019775390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.437744140625,
        111.14019775390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        99.14019775390625,
        538.437744140625,
        111.14019775390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        120.7379150390625,
        538.446533203125,
        132.7379150390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 물질이나 사",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        120.7379150390625,
        538.446533203125,
        132.7379150390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        120.7379150390625,
        538.446533203125,
        132.7379150390625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용 조건에 따라 요구될 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        142.33953857421875,
        538.5469970703125,
        154.33953857421875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외부로의 배출은 그 지역과 공기 흡입구로부",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        142.33953857421875,
        538.5469970703125,
        154.33953857421875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        142.33953857421875,
        538.5469970703125,
        154.33953857421875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "터 떨어져 분산되거나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        163.937255859375,
        538.438232421875,
        175.937255859375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필터를 사용하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        163.937255859375,
        538.438232421875,
        175.937255859375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HEPA(high efficiency particulate air)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198974609375,
        163.937255859375,
        538.438232421875,
        175.937255859375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        185.53887939453125,
        538.4420166015625,
        197.53887939453125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        185.53887939453125,
        538.4420166015625,
        197.53887939453125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험실",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        185.53887939453125,
        538.4420166015625,
        197.53887939453125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        185.53887939453125,
        538.4420166015625,
        197.53887939453125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60198211669922,
        185.53887939453125,
        538.4420166015625,
        197.53887939453125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60256958007812,
        207.1405029296875,
        538.4402465820312,
        219.1405029296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60256958007812,
        228.73822021484375,
        538.56396484375,
        240.73822021484375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제어 시스템은 실험실의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60256958007812,
        228.73822021484375,
        538.56396484375,
        240.73822021484375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". HVAC(heating, ventilation and air conditioning)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60256958007812,
        228.73822021484375,
        538.56396484375,
        240.73822021484375
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여압을 차단하여 준다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60256958007812,
        250.33984375,
        485.6883850097656,
        262.33984375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 그 작동 여부는 경보기를 통하여 알 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60256958007812,
        250.33984375,
        485.6883850097656,
        262.33984375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60256958007812,
        250.33984375,
        485.6883850097656,
        262.33984375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64186096191406,
        271.93756103515625,
        538.5657958984375,
        283.93756103515625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64186096191406,
        271.93756103515625,
        538.5657958984375,
        283.93756103515625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공기는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필터를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방출하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장치가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함되어야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "HEPA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.6027603149414,
        293.5391845703125,
        538.5609741210938,
        305.5391845703125
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시스템은 최소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60276794433594,
        315.14080810546875,
        370.25335693359375,
        327.14080810546875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "년마다 점검하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60276794433594,
        315.14080810546875,
        370.25335693359375,
        327.14080810546875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEPA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60276794433594,
        315.14080810546875,
        370.25335693359375,
        327.14080810546875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60276794433594,
        315.14080810546875,
        370.25335693359375,
        327.14080810546875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60276794433594,
        315.14080810546875,
        370.25335693359375,
        327.14080810546875
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진공 라인은 액체 비 감염성 트랩과",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        336.7384948730469,
        490.12921142578125,
        348.7384948730469
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필터로 보호되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        336.7384948730469,
        490.12921142578125,
        348.7384948730469
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        336.7384948730469,
        490.12921142578125,
        348.7384948730469
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        336.7384948730469,
        490.12921142578125,
        348.7384948730469
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEPA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        336.7384948730469,
        490.12921142578125,
        348.7384948730469
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        336.7384948730469,
        490.12921142578125,
        348.7384948730469
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "눈 세척 전용시설이 실험실에 갖추어져야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        358.340087890625,
        538.5675659179688,
        370.340087890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 활동에 적절한 조명이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        358.340087890625,
        538.5675659179688,
        370.340087890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "12)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        358.340087890625,
        538.5675659179688,
        370.340087890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64181518554688,
        358.340087890625,
        538.5675659179688,
        370.340087890625
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능해야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        105.60281372070312,
        379.9377746582031,
        187.61062622070312,
        391.9377746582031
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64191436767578,
        401.53936767578125,
        487.6147155761719,
        413.53936767578125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64191436767578,
        401.53936767578125,
        487.6147155761719,
        413.53936767578125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험 평가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64161682128906,
        423.1409606933594,
        490.96942138671875,
        435.1409606933594
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조건에 따라 부가적인 환경보호 시설이 고려되어야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64161682128906,
        423.1409606933594,
        490.96942138671875,
        435.1409606933594
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64161682128906,
        423.1409606933594,
        490.96942138671875,
        435.1409606933594
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64161682128906,
        423.1409606933594,
        490.96942138671875,
        435.1409606933594
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64161682128906,
        423.1409606933594,
        490.96942138671875,
        435.1409606933594
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실험실",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        192.1208038330078,
        597.2422485351562,
        445.3209533691406,
        608.2822875976562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표준 보호장구",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        192.1208038330078,
        597.2422485351562,
        445.3209533691406,
        608.2822875976562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BSL-3",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        192.1208038330078,
        597.2422485351562,
        445.3209533691406,
        608.2822875976562
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        186.8395538330078,
        629.777587890625,
        408.35955810546875,
        641.777587890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. BSL-3 실험실과 표준 보호장구",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        186.8395538330078,
        629.777587890625,
        408.35955810546875,
        641.777587890625
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 19 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 감염성 프리온 단백 제거 조사연구를 위한 시험방법",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        444.00390625,
        114.08502197265625
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        99.08502197265625,
        444.00390625,
        114.08502197265625
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정 단계에",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        149.55496215820312,
        384.1240234375,
        162.5149688720703
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 감염성 프리온 단백 선택",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        149.55496215820312,
        384.1240234375,
        162.5149688720703
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        149.55496215820312,
        384.1240234375,
        162.5149688720703
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        149.55496215820312,
        384.1240234375,
        162.5149688720703
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.6406021118164,
        172.9376220703125,
        538.434326171875,
        184.9376220703125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        194.53924560546875,
        538.4364013671875,
        206.53924560546875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 잠복기가 가장 짧은 햄스터 계대배양용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        194.53924560546875,
        538.4364013671875,
        206.53924560546875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 추천한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        194.53924560546875,
        538.4364013671875,
        206.53924560546875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        194.53924560546875,
        538.4364013671875,
        206.53924560546875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "263K",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67970275878906,
        194.53924560546875,
        538.4364013671875,
        206.53924560546875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67971801757812,
        216.140869140625,
        86.68753051757812,
        228.140869140625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.64061737060547,
        237.73858642578125,
        538.551513671875,
        249.73858642578125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 적합한 실험동물 표",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67962646484375,
        259.3402099609375,
        538.4359130859375,
        271.3402099609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 구입하여 동물실험실에서 약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67962646484375,
        259.3402099609375,
        538.4359130859375,
        271.3402099609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주정도 안정화 시킨 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67962646484375,
        259.3402099609375,
        538.4359130859375,
        271.3402099609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67962646484375,
        259.3402099609375,
        538.4359130859375,
        271.3402099609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67962646484375,
        259.3402099609375,
        538.4359130859375,
        271.3402099609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67962646484375,
        259.3402099609375,
        538.4359130859375,
        271.3402099609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주된 실험동물을 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        280.93792724609375,
        538.4534912109375,
        292.93792724609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러나 실험 공간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        280.93792724609375,
        538.4534912109375,
        292.93792724609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 및 비용 절감을 위해 형질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        280.93792724609375,
        538.4534912109375,
        292.93792724609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6~7",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        280.93792724609375,
        538.4534912109375,
        292.93792724609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        280.93792724609375,
        538.4534912109375,
        292.93792724609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        280.93792724609375,
        538.4534912109375,
        292.93792724609375
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전환 마우스를 사용한다면 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        302.53955078125,
        538.560791015625,
        314.53955078125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 같은 종의 프리온 단백을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        302.53955078125,
        538.560791015625,
        314.53955078125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        302.53955078125,
        538.560791015625,
        314.53955078125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과발현 하는 마우스를 사용하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        324.1411437988281,
        538.4429931640625,
        336.1411437988281
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예를 들면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        324.1411437988281,
        538.4429931640625,
        336.1411437988281
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 사용하고자 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        324.1411437988281,
        538.4429931640625,
        336.1411437988281
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        324.1411437988281,
        538.4429931640625,
        336.1411437988281
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 263K strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        324.1411437988281,
        538.4429931640625,
        336.1411437988281
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        345.73883056640625,
        538.5176391601562,
        357.73883056640625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mouse)를 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        367.3404235839844,
        182.665283203125,
        379.3404235839844
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68002319335938,
        367.3404235839844,
        182.665283203125,
        379.3404235839844
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        177.84002685546875,
        415.9381103515625,
        423.35955810546875,
        427.9381103515625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        177.84002685546875,
        415.9381103515625,
        423.35955810546875,
        427.9381103515625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과 감염동물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        177.84002685546875,
        415.9381103515625,
        423.35955810546875,
        427.9381103515625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        177.84002685546875,
        415.9381103515625,
        423.35955810546875,
        427.9381103515625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        177.84002685546875,
        415.9381103515625,
        423.35955810546875,
        427.9381103515625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 strain",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        115.9219970703125,
        446.04327392578125,
        475.25830078125,
        457.0832824707031
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염 동물",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        115.9219970703125,
        446.04327392578125,
        475.25830078125,
        457.0832824707031
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잠복기(day)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        115.9219970703125,
        446.04327392578125,
        475.25830078125,
        457.0832824707031
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "263K",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.32000732421875,
        471.1252746582031,
        462.691162109375,
        482.165283203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "golden syrian hamster",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.32000732421875,
        471.1252746582031,
        462.691162109375,
        482.165283203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70±10",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.32000732421875,
        471.1252746582031,
        462.691162109375,
        482.165283203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ME7",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        171.23800659179688,
        496.324462890625,
        465.78460693359375,
        507.3644714355469
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mouse(C57BL)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        171.23800659179688,
        496.324462890625,
        465.78460693359375,
        507.3644714355469
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150±10",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        171.23800659179688,
        496.324462890625,
        465.78460693359375,
        507.3644714355469
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "139A",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.19894409179688,
        521.4025268554688,
        465.77947998046875,
        532.4425659179688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mouse(C57BL)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.19894409179688,
        521.4025268554688,
        465.77947998046875,
        532.4425659179688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150±10",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.19894409179688,
        521.4025268554688,
        465.77947998046875,
        532.4425659179688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22L",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        172.92160034179688,
        546.6017456054688,
        465.77685546875,
        557.6417846679688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mouse(C57BL)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        172.92160034179688,
        546.6017456054688,
        465.77685546875,
        557.6417846679688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150±10",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        172.92160034179688,
        546.6017456054688,
        465.77685546875,
        557.6417846679688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "87V",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        172.67941284179688,
        571.6837158203125,
        465.7991943359375,
        582.7237548828125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mouse(IM, MB)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        172.67941284179688,
        571.6837158203125,
        465.7991943359375,
        582.7237548828125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "300±10",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        172.67941284179688,
        571.6837158203125,
        465.7991943359375,
        582.7237548828125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 질환 실험동물 제조방법",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        627.8751831054688,
        354.2451171875,
        640.8351440429688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60150146484375,
        627.8751831054688,
        354.2451171875,
        640.8351440429688
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        674.66015625,
        343.0780944824219,
        686.66015625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 실험동물 감염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        674.66015625,
        343.0780944824219,
        686.66015625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.1.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        674.66015625,
        343.0780944824219,
        686.66015625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        674.66015625,
        343.0780944824219,
        686.66015625
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백에 감염된 햄스터를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6405029296875,
        696.2578125,
        538.4413452148438,
        708.2578125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일을 전후하여 임상증상이 나타나면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6405029296875,
        696.2578125,
        538.4413452148438,
        708.2578125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6405029296875,
        696.2578125,
        538.4413452148438,
        708.2578125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "뇌를 적출하여 뇌의 반쪽은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        717.8594360351562,
        538.4447021484375,
        729.8594360351562
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중성 포르말린에 고정한 후 병리소견 상 신경세포",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        717.8594360351562,
        538.4447021484375,
        729.8594360351562
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        717.8594360351562,
        538.4447021484375,
        729.8594360351562
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소실에 의한 해면상 뇌증이 나타난 것을 확인한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        739.4571533203125,
        538.5225219726562,
        751.4571533203125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 나머지 반쪽을 멸균된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        739.4571533203125,
        538.5225219726562,
        751.4571533203125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Dounce",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6405029296875,
        739.4571533203125,
        538.5225219726562,
        751.4571533203125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 20 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "homogenizer를 이용하여 멸균된 인산염 완충액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        99.14019775390625,
        538.39697265625,
        111.14019775390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(phosphate buffered saline, PBS)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        99.14019775390625,
        538.39697265625,
        111.14019775390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        120.7379150390625,
        538.5528564453125,
        132.7379150390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질액을 만든다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        120.7379150390625,
        538.5528564453125,
        132.7379150390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 감염군은 동물을 전신마취",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        120.7379150390625,
        538.5528564453125,
        132.7379150390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        120.7379150390625,
        538.5528564453125,
        132.7379150390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        120.7379150390625,
        538.5528564453125,
        132.7379150390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(sodium",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64149475097656,
        120.7379150390625,
        538.5528564453125,
        132.7379150390625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미세주입",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "pentobarbital,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "50",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mg/kg)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "stereotaxic",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "apparatus",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64228820800781,
        142.33953857421875,
        538.438232421875,
        154.33953857421875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법으로 위에서 만든",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질액을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "씩 각각 대뇌피질 내",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(microinjection)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "50",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "L",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64229583740234,
        163.937255859375,
        538.5679931640625,
        175.937255859375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 주사하여 감염시키고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64230346679688,
        185.53887939453125,
        538.4461669921875,
        197.53887939453125
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조군은 같은 방법으로 정상 햄스터",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64230346679688,
        185.53887939453125,
        538.4461669921875,
        197.53887939453125
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(intracerebral route)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64230346679688,
        185.53887939453125,
        538.4461669921875,
        197.53887939453125
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64230346679688,
        185.53887939453125,
        538.4461669921875,
        197.53887939453125
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "뇌 조직 균질액 동량을 주입한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64230346679688,
        207.1405029296875,
        258.6501159667969,
        219.1405029296875
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Stereotaxic apparatus",
      "font_size": 8.521920204162598,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        202.07839965820312,
        356.5246887207031,
        386.4200439453125,
        365.167724609375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Homogenizer",
      "font_size": 8.521920204162598,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        202.07839965820312,
        356.5246887207031,
        386.4200439453125,
        365.167724609375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        93.71880340576172,
        377.5392150878906,
        522.3779296875,
        389.5392150878906
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 감염을 위한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        93.71880340576172,
        377.5392150878906,
        522.3779296875,
        389.5392150878906
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        93.71880340576172,
        377.5392150878906,
        522.3779296875,
        389.5392150878906
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        93.71880340576172,
        377.5392150878906,
        522.3779296875,
        389.5392150878906
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "homogenizer",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        93.71880340576172,
        377.5392150878906,
        522.3779296875,
        389.5392150878906
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "stereotaxic apparatus",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        93.71880340576172,
        377.5392150878906,
        522.3779296875,
        389.5392150878906
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뇌조직의 신경병리학적 관찰",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        426.14080810546875,
        258.3594055175781,
        438.14080810546875
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        426.14080810546875,
        258.3594055175781,
        438.14080810546875
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조군과 감염군의 일부는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64060974121094,
        447.7384948730469,
        538.5654296875,
        459.7384948730469
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "파라포름알데히드를 심장을 통해 관류",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64060974121094,
        447.7384948730469,
        538.5654296875,
        459.7384948730469
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고정시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64060974121094,
        447.7384948730469,
        538.5654296875,
        459.7384948730469
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64060974121094,
        447.7384948730469,
        538.5654296875,
        459.7384948730469
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64060974121094,
        447.7384948730469,
        538.5654296875,
        459.7384948730469
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "킨 후 탈수과정을 거쳐 파라핀에 포매한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416015625,
        469.340087890625,
        538.4306640625,
        481.340087890625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직 절편기로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416015625,
        469.340087890625,
        538.4306640625,
        481.340087890625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "두께로 뇌 절편을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416015625,
        469.340087890625,
        538.4306640625,
        481.340087890625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416015625,
        469.340087890625,
        538.4306640625,
        481.340087890625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416015625,
        469.340087890625,
        538.4306640625,
        481.340087890625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "m",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416015625,
        469.340087890625,
        538.4306640625,
        481.340087890625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416015625,
        469.340087890625,
        538.4306640625,
        481.340087890625
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제작한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64161682128906,
        490.9377746582031,
        538.5560302734375,
        502.9377746582031
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염색법 및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64161682128906,
        490.9377746582031,
        538.5560302734375,
        502.9377746582031
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체를 이용하여 조직면역화학염색",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64161682128906,
        490.9377746582031,
        538.5560302734375,
        502.9377746582031
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "hematoxylin-eosin",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64161682128906,
        490.9377746582031,
        538.5560302734375,
        502.9377746582031
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64161682128906,
        490.9377746582031,
        538.5560302734375,
        502.9377746582031
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후 광학현미경으로 공포현상, PrPSc",
      "font_size": 7.679999828338623,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416244506836,
        510.2476501464844,
        530.8060302734375,
        524.5393676757812
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "deposit과 신경아교세포의 활성화를 관찰한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416244506836,
        510.2476501464844,
        530.8060302734375,
        524.5393676757812
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6416244506836,
        510.2476501464844,
        530.8060302734375,
        524.5393676757812
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 제조방법",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60282135009766,
        557.5551147460938,
        263.2854919433594,
        570.5150756835938
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.60282135009766,
        557.5551147460938,
        263.2854919433594,
        570.5150756835938
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.1. 가공하지 않은 뇌 균질현탁액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64183044433594,
        604.340087890625,
        421.4293518066406,
        616.340087890625
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(crude brain homogenates)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64183044433594,
        604.340087890625,
        421.4293518066406,
        616.340087890625
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백 감염 후 약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64183044433594,
        625.9378051757812,
        538.4466552734375,
        637.9378051757812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일이 되었을 때",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64183044433594,
        625.9378051757812,
        538.4466552734375,
        637.9378051757812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상증상이 나타난 햄",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64183044433594,
        625.9378051757812,
        538.4466552734375,
        637.9378051757812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64183044433594,
        625.9378051757812,
        538.4466552734375,
        637.9378051757812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64183044433594,
        625.9378051757812,
        538.4466552734375,
        637.9378051757812
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스터의 뇌를 적출한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.641845703125,
        647.5394287109375,
        538.5520629882812,
        659.5394287109375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적출한 뇌 조직은 조직",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.641845703125,
        647.5394287109375,
        538.5520629882812,
        659.5394287109375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용하여 멸균된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.641845703125,
        647.5394287109375,
        538.5520629882812,
        659.5394287109375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.641845703125,
        647.5394287109375,
        538.5520629882812,
        659.5394287109375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "homogenizer",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.641845703125,
        647.5394287109375,
        538.5520629882812,
        659.5394287109375
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "균질액을 만든다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용할 때까지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 보관한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PBS",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64244079589844,
        669.1409912109375,
        433.6065673828125,
        681.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분획",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6423568725586,
        714.1409912109375,
        196.68145751953125,
        726.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.2. Microsomal",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6423568725586,
        714.1409912109375,
        196.68145751953125,
        726.1409912109375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백이 존재하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6423568725586,
        735.7387084960938,
        538.556396484375,
        747.7387084960938
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "microsomal 분획을 분리하기 위하여 감염 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6423568725586,
        735.7387084960938,
        538.556396484375,
        747.7387084960938
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 21 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.4461059570312,
        111.14019775390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일이 되었을 때",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.4461059570312,
        111.14019775390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상증상이 나타난 햄스터의 뇌를 적출한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.4461059570312,
        111.14019775390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적출한 뇌",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.4461059570312,
        111.14019775390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.4461059570312,
        111.14019775390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.4461059570312,
        111.14019775390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.4461059570312,
        111.14019775390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직은 조직",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용하여 멸균된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질액을 만든다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "깨지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "homogenizer",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PBS",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        120.7379150390625,
        538.430419921875,
        132.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지 않은 세포",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        142.33953857421875,
        538.5667724609375,
        154.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미토콘드리아 및 핵을 제거하기 위해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        142.33953857421875,
        538.5667724609375,
        154.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        142.33953857421875,
        538.5667724609375,
        154.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간 원심분리한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        142.33953857421875,
        538.5667724609375,
        154.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        142.33953857421875,
        538.5667724609375,
        154.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9,800×g",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        142.33953857421875,
        538.5667724609375,
        154.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64089965820312,
        142.33953857421875,
        538.5667724609375,
        154.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후 상층액을 새 튜브로 옮겨",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        163.937255859375,
        538.5670166015625,
        175.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        163.937255859375,
        538.5670166015625,
        175.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동안 초원심분리 하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        163.937255859375,
        538.5670166015625,
        175.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "얻어진 침",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        163.937255859375,
        538.5670166015625,
        175.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100,000×g",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        163.937255859375,
        538.5670166015625,
        175.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        163.937255859375,
        538.5670166015625,
        175.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        163.937255859375,
        538.5670166015625,
        175.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전을 멸균된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        185.53887939453125,
        538.5626220703125,
        197.53887939453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 간단히 초음파 분해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        185.53887939453125,
        538.5626220703125,
        197.53887939453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 재균질화 시킨다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        185.53887939453125,
        538.5626220703125,
        197.53887939453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용할",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        185.53887939453125,
        538.5626220703125,
        197.53887939453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PBS",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        185.53887939453125,
        538.5626220703125,
        197.53887939453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(sonication)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        185.53887939453125,
        538.5626220703125,
        197.53887939453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        185.53887939453125,
        538.5626220703125,
        197.53887939453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "때까지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        207.1405029296875,
        219.88232421875,
        219.1405029296875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 보관한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        207.1405029296875,
        219.88232421875,
        219.1405029296875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        207.1405029296875,
        219.88232421875,
        219.1405029296875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        207.1405029296875,
        219.88232421875,
        219.1405029296875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64117431640625,
        207.1405029296875,
        219.88232421875,
        219.1405029296875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.3. Caveolae-like domains(CLDs)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        252.14019775390625,
        273.02020263671875,
        264.14019775390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감염성 프리온 단백이 존재하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406021118164,
        273.7379150390625,
        538.5703735351562,
        285.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 분리하기 위하여 감염 후 약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406021118164,
        273.7379150390625,
        538.5703735351562,
        285.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406021118164,
        273.7379150390625,
        538.5703735351562,
        285.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLDs",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406021118164,
        273.7379150390625,
        538.5703735351562,
        285.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406021118164,
        273.7379150390625,
        538.5703735351562,
        285.7379150390625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되었을 때",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        295.33953857421875,
        538.428466796875,
        307.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상증상이 나타난 햄스터의 뇌를 적출한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        295.33953857421875,
        538.428466796875,
        307.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적출한 뇌 조직은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        295.33953857421875,
        538.428466796875,
        307.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        295.33953857421875,
        538.428466796875,
        307.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        295.33953857421875,
        538.428466796875,
        307.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ten",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        295.33953857421875,
        538.428466796875,
        307.33953857421875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        316.937255859375,
        538.43310546875,
        328.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        316.937255859375,
        538.43310546875,
        328.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 단백 분해효소 억제제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        316.937255859375,
        538.43310546875,
        328.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Broeck",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        316.937255859375,
        538.43310546875,
        328.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "homogenizer",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        316.937255859375,
        538.43310546875,
        328.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1% Triton X-100",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        316.937255859375,
        538.43310546875,
        328.937255859375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "cocktail이 포함된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        338.5388488769531,
        538.4402465820312,
        350.5388488769531
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "MBS(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        338.5388488769531,
        538.4402465820312,
        350.5388488769531
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 뇌 균질액을 만",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        338.5388488769531,
        538.4402465820312,
        350.5388488769531
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        338.5388488769531,
        538.4402465820312,
        350.5388488769531
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "든 후 뇌 균질액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 함유된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 함께 섞는다 이 시료",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2 mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "80% sucrose",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "MBS 2 mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        360.14044189453125,
        538.4554443359375,
        372.14044189453125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 초원심분리 튜브에 넣고 그 위에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        381.7381286621094,
        538.433349609375,
        393.7381286621094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 포함된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        381.7381286621094,
        538.433349609375,
        393.7381286621094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 조심스럽",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        381.7381286621094,
        538.433349609375,
        393.7381286621094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        381.7381286621094,
        538.433349609375,
        393.7381286621094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        381.7381286621094,
        538.433349609375,
        393.7381286621094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30% sucrose",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        381.7381286621094,
        538.433349609375,
        393.7381286621094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "MBS 4 mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        381.7381286621094,
        538.433349609375,
        393.7381286621094
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게 올려놓는다 다시 그 위에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        403.3397216796875,
        538.5504150390625,
        415.3397216796875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 포함된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        403.3397216796875,
        538.5504150390625,
        415.3397216796875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 조심스럽게 올려놓는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        403.3397216796875,
        538.5504150390625,
        415.3397216796875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        403.3397216796875,
        538.5504150390625,
        415.3397216796875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5% sucrose",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        403.3397216796875,
        538.5504150390625,
        415.3397216796875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "MBS 4 mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        403.3397216796875,
        538.5504150390625,
        415.3397216796875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022064208984,
        424.9374084472656,
        538.3974609375,
        436.9374084472656
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Beckman SW41 rotor를 사용해서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022064208984,
        424.9374084472656,
        538.3974609375,
        436.9374084472656
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "39,000 rpm, 4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022064208984,
        424.9374084472656,
        538.3974609375,
        436.9374084472656
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022064208984,
        424.9374084472656,
        538.3974609375,
        436.9374084472656
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동안 원심분리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022064208984,
        424.9374084472656,
        538.3974609375,
        436.9374084472656
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "°C",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022064208984,
        424.9374084472656,
        538.3974609375,
        436.9374084472656
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022064208984,
        424.9374084472656,
        538.3974609375,
        436.9374084472656
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 튜브를 조심스럽게 꺼내 위에서부터",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "씩",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획을 뽑아낸다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "12",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64022827148438,
        446.53900146484375,
        538.4368896484375,
        458.53900146484375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분획을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64042663574219,
        468.1405944824219,
        538.4456787109375,
        480.1405944824219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체를 사용하여 웨스턴 블럿을 실시하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64042663574219,
        468.1405944824219,
        538.4456787109375,
        480.1405944824219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 얻는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64042663574219,
        468.1405944824219,
        538.4456787109375,
        480.1405944824219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용할",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64042663574219,
        468.1405944824219,
        538.4456787109375,
        480.1405944824219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "caveolin",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64042663574219,
        468.1405944824219,
        538.4456787109375,
        480.1405944824219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLDs",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64042663574219,
        468.1405944824219,
        538.4456787109375,
        480.1405944824219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64042663574219,
        468.1405944824219,
        538.4456787109375,
        480.1405944824219
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "때까지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64013671875,
        489.73828125,
        219.88128662109375,
        501.73828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 보관한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64013671875,
        489.73828125,
        219.88128662109375,
        501.73828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64013671875,
        489.73828125,
        219.88128662109375,
        501.73828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64013671875,
        489.73828125,
        219.88128662109375,
        501.73828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64013671875,
        489.73828125,
        219.88128662109375,
        501.73828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.4. 정제된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64013671875,
        532.446533203125,
        172.99754333496094,
        546.73828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PrPSc",
      "font_size": 7.679999828338623,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64013671875,
        532.446533203125,
        172.99754333496094,
        546.73828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PrPSc를 분리하기 위하여 감염 후 약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64012908935547,
        554.048095703125,
        538.42919921875,
        568.33984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일이 되었을 때",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64012908935547,
        554.048095703125,
        538.42919921875,
        568.33984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상증상이 나타",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64012908935547,
        554.048095703125,
        538.42919921875,
        568.33984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "70",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64012908935547,
        554.048095703125,
        538.42919921875,
        568.33984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64012908935547,
        554.048095703125,
        538.42919921875,
        568.33984375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "난 햄스터의 뇌를 적출한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        577.9375610351562,
        538.55126953125,
        589.9375610351562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적출한 뇌 조직은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        577.9375610351562,
        538.55126953125,
        589.9375610351562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        577.9375610351562,
        538.55126953125,
        589.9375610351562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        577.9375610351562,
        538.55126953125,
        589.9375610351562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        577.9375610351562,
        538.55126953125,
        589.9375610351562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ten Broeck",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        577.9375610351562,
        538.55126953125,
        589.9375610351562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "homogenizer",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        577.9375610351562,
        538.55126953125,
        589.9375610351562
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        599.5391845703125,
        538.44140625,
        611.5391845703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        599.5391845703125,
        538.44140625,
        611.5391845703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질액으로 만든 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        599.5391845703125,
        538.44140625,
        611.5391845703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        599.5391845703125,
        538.44140625,
        611.5391845703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64070129394531,
        599.5391845703125,
        538.44140625,
        611.5391845703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 동량으로 첨가하여 재균질화 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64078521728516,
        621.1407470703125,
        538.5509033203125,
        633.1407470703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상온에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64078521728516,
        621.1407470703125,
        538.5509033203125,
        633.1407470703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간 정치한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64078521728516,
        621.1407470703125,
        538.5509033203125,
        633.1407470703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20% sarcosyl",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64078521728516,
        621.1407470703125,
        538.5509033203125,
        633.1407470703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64078521728516,
        621.1407470703125,
        538.5509033203125,
        633.1407470703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64078521728516,
        621.1407470703125,
        538.5509033203125,
        633.1407470703125
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원심분리",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상층액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17,000",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "rpm,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "400",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "µL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TBSS(0.1%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6407699584961,
        642.7384643554688,
        538.4694213867188,
        654.7384643554688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 넣어 희석한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64027404785156,
        664.340087890625,
        538.5625610351562,
        676.340087890625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64027404785156,
        664.340087890625,
        538.5625610351562,
        676.340087890625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 원심분리 한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64027404785156,
        664.340087890625,
        538.5625610351562,
        676.340087890625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SB3-14, TBS) 100 µL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64027404785156,
        664.340087890625,
        538.5625610351562,
        676.340087890625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "85,000 rpm, 4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64027404785156,
        664.340087890625,
        538.5625610351562,
        676.340087890625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64027404785156,
        664.340087890625,
        538.5625610351562,
        676.340087890625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64027404785156,
        664.340087890625,
        538.5625610351562,
        676.340087890625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        685.9378051757812,
        538.441162109375,
        697.9378051757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "얻어진 분획을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        685.9378051757812,
        538.441162109375,
        697.9378051757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용하여 간단히 초음파 분해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        685.9378051757812,
        538.441162109375,
        697.9378051757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        685.9378051757812,
        538.441162109375,
        697.9378051757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10% NaCl, 0.1% SB3-14, TBS",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        685.9378051757812,
        538.441162109375,
        697.9378051757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 후 최종",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 되게 하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "현탁된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 분획에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "400 µL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "400 µL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20% sucrose, 0.1%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64028930664062,
        707.5393676757812,
        538.4461059570312,
        719.5393676757812
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 가한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64007568359375,
        729.1409912109375,
        538.4437255859375,
        741.1409912109375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64007568359375,
        729.1409912109375,
        538.4437255859375,
        741.1409912109375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 원심분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64007568359375,
        729.1409912109375,
        538.4437255859375,
        741.1409912109375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SB3-14, 10% NaCl, TBS 100 µL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64007568359375,
        729.1409912109375,
        538.4437255859375,
        741.1409912109375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 85,000 rpm, 20",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64007568359375,
        729.1409912109375,
        538.4437255859375,
        741.1409912109375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64007568359375,
        729.1409912109375,
        538.4437255859375,
        741.1409912109375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64007568359375,
        729.1409912109375,
        538.4437255859375,
        741.1409912109375
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 22 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리 하여 얻어진 분획을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.5702514648438,
        111.14019775390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.5702514648438,
        111.14019775390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TBSS",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        99.14019775390625,
        538.5702514648438,
        111.14019775390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        120.7379150390625,
        538.4371948242188,
        132.7379150390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(50 µg/mL)를 처리하고 단백 분해효소 억제제인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        120.7379150390625,
        538.4371948242188,
        132.7379150390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "phenylmethylsulphonylfluoride",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6409912109375,
        120.7379150390625,
        538.4371948242188,
        132.7379150390625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(PMSF, 1 mM)를 처리하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64159393310547,
        140.04782104492188,
        538.4346923828125,
        154.33953857421875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrPSc를 얻는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64159393310547,
        140.04782104492188,
        538.4346923828125,
        154.33953857421875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다시 초원심분리 하여 얻어진 침전을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64159393310547,
        140.04782104492188,
        538.4346923828125,
        154.33953857421875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64159393310547,
        140.04782104492188,
        538.4346923828125,
        154.33953857421875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6419677734375,
        161.64553833007812,
        402.74212646484375,
        175.937255859375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백 검출법",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12110137939453,
        208.95315551757812,
        243.8428497314453,
        221.9131622314453
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        63.12110137939453,
        208.95315551757812,
        243.8428497314453,
        221.9131622314453
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.1. 생물시험법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        255.73809814453125,
        220.9567108154297,
        267.73809814453125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(bioassay)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64060974121094,
        255.73809814453125,
        220.9567108154297,
        267.73809814453125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시료 준비",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64061737060547,
        277.3397216796875,
        538.4894409179688,
        289.3397216796875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 생물시험법을 위한 시료는 무균적으로 준비되어야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64061737060547,
        277.3397216796875,
        538.4894409179688,
        289.3397216796875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", -20",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64061737060547,
        277.3397216796875,
        538.4894409179688,
        289.3397216796875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 그 이하에서 보관하며 얼림과 녹임",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        298.93743896484375,
        538.5577392578125,
        310.93743896484375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(freezing-thawing)의 반복을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        298.93743896484375,
        538.5577392578125,
        310.93743896484375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        298.93743896484375,
        538.5577392578125,
        310.93743896484375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        320.5390319824219,
        538.4425659179688,
        332.5390319824219
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        320.5390319824219,
        538.4425659179688,
        332.5390319824219
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        320.5390319824219,
        538.4425659179688,
        332.5390319824219
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        342.140625,
        538.4375,
        354.140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        342.140625,
        538.4375,
        354.140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        342.140625,
        538.4375,
        354.140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법에 따라 멸균한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        363.7383117675781,
        538.44921875,
        375.7383117675781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접종을 위한 시료는 멸균된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        363.7383117675781,
        538.44921875,
        375.7383117675781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회용 외과용 메스를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        363.7383117675781,
        538.44921875,
        375.7383117675781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        363.7383117675781,
        538.44921875,
        375.7383117675781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        363.7383117675781,
        538.44921875,
        375.7383117675781
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하여 잘게 부순 후 멸균된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        385.33990478515625,
        538.5578002929688,
        397.33990478515625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 사용하여 멸균된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        385.33990478515625,
        538.5578002929688,
        397.33990478515625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Dounce homogenizer",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        385.33990478515625,
        538.5578002929688,
        397.33990478515625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생리식염수로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        406.9375915527344,
        538.5546875,
        418.9375915527344
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질액을 만든다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        406.9375915527344,
        538.5546875,
        418.9375915527344
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접종할 균질액은 원심분리 하거나 항",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        406.9375915527344,
        538.5546875,
        418.9375915527344
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        406.9375915527344,
        538.5546875,
        418.9375915527344
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        406.9375915527344,
        538.5546875,
        418.9375915527344
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생제를 첨가하거나 열처리 하지 말아야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6797103881836,
        428.5391845703125,
        538.4425048828125,
        440.5391845703125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접종액과 뇌 조직액은 분주",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6797103881836,
        428.5391845703125,
        538.4425048828125,
        440.5391845703125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6797103881836,
        428.5391845703125,
        538.4425048828125,
        440.5391845703125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        450.1407775878906,
        377.9295349121094,
        462.1407775878906
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 그 이하에 보관하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        450.1407775878906,
        377.9295349121094,
        462.1407775878906
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-20",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        450.1407775878906,
        377.9295349121094,
        462.1407775878906
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        450.1407775878906,
        377.9295349121094,
        462.1407775878906
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67971801757812,
        450.1407775878906,
        377.9295349121094,
        462.1407775878906
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 실험동물 접종",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64042663574219,
        471.73846435546875,
        538.433837890625,
        483.73846435546875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64042663574219,
        471.73846435546875,
        538.433837890625,
        483.73846435546875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64042663574219,
        471.73846435546875,
        538.433837890625,
        483.73846435546875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제 제조공정 관련 산물의 접종은 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        493.3400573730469,
        538.547119140625,
        505.3400573730469
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 따라 실험",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        493.3400573730469,
        538.547119140625,
        505.3400573730469
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        493.3400573730469,
        538.547119140625,
        505.3400573730469
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물을 선택하여 접종한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        512.64599609375,
        538.5625610351562,
        526.937744140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 각 접종 시료는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        512.64599609375,
        538.5625610351562,
        526.937744140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10-1부터 10-9까지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        512.64599609375,
        538.5625610351562,
        526.937744140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배씩 계",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        512.64599609375,
        538.5625610351562,
        526.937744140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        512.64599609375,
        538.5625610351562,
        526.937744140625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단희석 하여 각 희석 시료 당 적어도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        536.539306640625,
        538.558837890625,
        548.539306640625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마리에 접종하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        536.539306640625,
        538.558837890625,
        548.539306640625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각 실험",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        536.539306640625,
        538.558837890625,
        548.539306640625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        536.539306640625,
        538.558837890625,
        548.539306640625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        536.539306640625,
        538.558837890625,
        548.539306640625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        558.1409301757812,
        538.5509643554688,
        570.1409301757812
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "햄스터의 경",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        558.1409301757812,
        538.5509643554688,
        570.1409301757812
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        558.1409301757812,
        538.5509643554688,
        570.1409301757812
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "L,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        558.1409301757812,
        538.5509643554688,
        570.1409301757812
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67984008789062,
        558.1409301757812,
        538.5509643554688,
        570.1409301757812
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67965698242188,
        579.7386474609375,
        538.4453125,
        591.7386474609375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "씩 접종한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67965698242188,
        579.7386474609375,
        538.4453125,
        591.7386474609375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조군에는 감염성 프리온 단백이 없는 시료를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67965698242188,
        579.7386474609375,
        538.4453125,
        591.7386474609375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "50",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67965698242188,
        579.7386474609375,
        538.4453125,
        591.7386474609375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "L",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67965698242188,
        579.7386474609375,
        538.4453125,
        591.7386474609375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67965698242188,
        579.7386474609375,
        538.4453125,
        591.7386474609375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67965698242188,
        579.7386474609375,
        538.4453125,
        591.7386474609375
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접종한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67975616455078,
        601.3402099609375,
        176.68756103515625,
        613.3402099609375
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 감염된 실험동물의 임상증상 관찰",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406478881836,
        622.9379272460938,
        538.4339599609375,
        634.9379272460938
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염된 실험동물은 실험 전반에 걸쳐",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406478881836,
        622.9379272460938,
        538.4339599609375,
        634.9379272460938
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.6406478881836,
        622.9379272460938,
        538.4339599609375,
        634.9379272460938
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67955017089844,
        644.53955078125,
        538.4423217773438,
        656.53955078125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 접",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67955017089844,
        644.53955078125,
        538.4423217773438,
        656.53955078125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67955017089844,
        644.53955078125,
        538.4423217773438,
        656.53955078125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종 후 각 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        666.14111328125,
        538.4292602539062,
        678.14111328125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 잠복기 표",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        666.14111328125,
        538.4292602539062,
        678.14111328125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 참고하여 공식적인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        666.14111328125,
        538.4292602539062,
        678.14111328125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        666.14111328125,
        538.4292602539062,
        678.14111328125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        666.14111328125,
        538.4292602539062,
        678.14111328125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        666.14111328125,
        538.4292602539062,
        678.14111328125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상증상 모니터링을 시작하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        687.7388305664062,
        538.4295654296875,
        699.7388305664062
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험동물은 숙련된 실험자에 의해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        687.7388305664062,
        538.4295654296875,
        699.7388305664062
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6795654296875,
        687.7388305664062,
        538.4295654296875,
        699.7388305664062
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "매일 체크되어야 하며 주별로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67958068847656,
        709.3404541015625,
        538.5623779296875,
        721.3404541015625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상증상을 나타내는 신경학적 증상에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67958068847656,
        709.3404541015625,
        538.5623779296875,
        721.3404541015625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67958068847656,
        709.3404541015625,
        538.5623779296875,
        721.3404541015625
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대해 스코어링 하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험동물은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비감염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염 가능성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”, “",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67959594726562,
        730.9381713867188,
        538.4254150390625,
        742.9381713867188
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 23 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "염 으로 분류하며 접종 후 약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "년까지 모니터링 하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험동물은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        99.14019775390625,
        538.4345092773438,
        111.14019775390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주 연속으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염 으로 분류된 후 또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주 연속 중",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염 으로 분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        120.7379150390625,
        538.426025390625,
        132.7379150390625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "류된 후 또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        142.33953857421875,
        538.4525146484375,
        154.33953857421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        142.33953857421875,
        538.4525146484375,
        154.33953857421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판정받은 상태에서 스코어링 날짜 사이에 증상이 악",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        142.33953857421875,
        538.4525146484375,
        154.33953857421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        142.33953857421875,
        538.4525146484375,
        154.33953857421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "”",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        142.33953857421875,
        538.4525146484375,
        154.33953857421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화되었을 때 섭식 능력이 없거나 움직이지 못할 때",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        163.937255859375,
        538.4299926757812,
        175.937255859375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마취하여 희생시킨 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        163.937255859375,
        538.4299926757812,
        175.937255859375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        163.937255859375,
        538.4299926757812,
        175.937255859375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67999267578125,
        163.937255859375,
        538.4299926757812,
        175.937255859375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "뇌 조직을 적출한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68020629882812,
        185.53887939453125,
        538.5606689453125,
        197.53887939453125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적출한 뇌 조직은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68020629882812,
        185.53887939453125,
        538.5606689453125,
        197.53887939453125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 그 이하에 보관하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68020629882812,
        185.53887939453125,
        538.5606689453125,
        197.53887939453125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68020629882812,
        185.53887939453125,
        538.5606689453125,
        197.53887939453125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-20℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68020629882812,
        185.53887939453125,
        538.5606689453125,
        197.53887939453125
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생화학적 시험법에 사용한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68021392822266,
        207.1405029296875,
        284.6880187988281,
        219.1405029296875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 자료 분석",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64099884033203,
        228.73822021484375,
        538.4488525390625,
        240.73822021484375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64099884033203,
        228.73822021484375,
        538.4488525390625,
        240.73822021484375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": TSE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64099884033203,
        228.73822021484375,
        538.4488525390625,
        240.73822021484375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 실험동물 수를 파악하여야 하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67969512939453,
        250.33984375,
        538.5625,
        262.33984375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 같이 바이러스 농도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67969512939453,
        250.33984375,
        538.5625,
        262.33984375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", Karber formula",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67969512939453,
        250.33984375,
        538.5625,
        262.33984375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        271.93756103515625,
        538.4539794921875,
        283.93756103515625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(titer)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        271.93756103515625,
        538.4539794921875,
        283.93756103515625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 같은 방식으로 계산한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        293.5391845703125,
        538.4437255859375,
        305.5391845703125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잠복기는 접종 후부터 사망에 이르기까지의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        293.5391845703125,
        538.4437255859375,
        305.5391845703125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        293.5391845703125,
        538.4437255859375,
        305.5391845703125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "날짜로서 계산한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        315.14080810546875,
        498.6493225097656,
        327.14080810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 각 실험군마다 평균 잠복기를 계산하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        315.14080810546875,
        498.6493225097656,
        327.14080810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68051147460938,
        315.14080810546875,
        498.6493225097656,
        327.14080810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타 시험법",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64170837402344,
        360.14080810546875,
        168.36050415039062,
        372.14080810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.2.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64170837402344,
        360.14080810546875,
        168.36050415039062,
        372.14080810546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) Protein misfolding cyclic amplification(PMCA)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64170837402344,
        381.7384948730469,
        538.4428100585938,
        393.7384948730469
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백의 검",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64170837402344,
        381.7384948730469,
        538.4428100585938,
        393.7384948730469
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64170837402344,
        381.7384948730469,
        538.4428100585938,
        393.7384948730469
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "출 민감도를 높이기 위해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68072509765625,
        403.340087890625,
        538.4855346679688,
        415.340087890625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라고 하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68072509765625,
        403.340087890625,
        538.4855346679688,
        415.340087890625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "새로운 방법이 개발되었다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68072509765625,
        403.340087890625,
        538.4855346679688,
        415.340087890625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PMCA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68072509765625,
        403.340087890625,
        538.4855346679688,
        415.340087890625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68072509765625,
        403.340087890625,
        538.4855346679688,
        415.340087890625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        424.9377746582031,
        538.4304809570312,
        436.9377746582031
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PMCA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        424.9377746582031,
        538.4304809570312,
        436.9377746582031
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전환된다는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "점을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기법에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접목시켜",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초음파",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분해 배양",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PCR",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68043518066406,
        446.53936767578125,
        538.5587158203125,
        458.53936767578125
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 증가시킴으로써 감염성 프리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        468.1409606933594,
        538.5614013671875,
        480.1409606933594
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        468.1409606933594,
        538.5614013671875,
        480.1409606933594
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(sonication-incubation) cycle",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        468.1409606933594,
        538.5614013671875,
        480.1409606933594
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증폭시키는 방법이다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        489.7386474609375,
        242.6876220703125,
        501.7386474609375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정상 햄스터 뇌 균질액과 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.64080810546875,
        511.3402099609375,
        538.4461059570312,
        523.3402099609375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 감염된 햄스",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.64080810546875,
        511.3402099609375,
        538.4461059570312,
        523.3402099609375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strain 263K",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.64080810546875,
        511.3402099609375,
        538.4461059570312,
        523.3402099609375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "터 뇌 균질액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        532.9379272460938,
        538.4254150390625,
        544.9379272460938
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 각각 준비한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        532.9379272460938,
        538.4254150390625,
        544.9379272460938
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 때 감염된 뇌 균질액과 정상 뇌",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        532.9379272460938,
        538.4254150390625,
        544.9379272460938
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10%",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        532.9379272460938,
        538.4254150390625,
        544.9379272460938
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798095703125,
        532.9379272460938,
        538.4254150390625,
        544.9379272460938
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "균질액을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 섞어 총",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 만든 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "튜브에 넣고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1:50",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "200",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "L",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "500",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "L PCR",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67981719970703,
        554.53955078125,
        538.4334716796875,
        566.53955078125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초음파",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분해는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PMCA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "microtip",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "probe",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "sonicator",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        576.14111328125,
        538.413330078125,
        588.14111328125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 사용하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        597.7388305664062,
        538.5626220703125,
        609.7388305664062
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        597.7388305664062,
        538.5626220703125,
        609.7388305664062
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초 동안 초음파 분해한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        597.7388305664062,
        538.5626220703125,
        609.7388305664062
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Branson, USA)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        597.7388305664062,
        538.5626220703125,
        609.7388305664062
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "40% power",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        597.7388305664062,
        538.5626220703125,
        609.7388305664062
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "40",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        597.7388305664062,
        538.5626220703125,
        609.7388305664062
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(pulse on = 0.5",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/ pulse off = 0.2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ").",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "microtip probe",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        619.3404541015625,
        538.5589599609375,
        631.3404541015625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여 초음파 분해할 경우",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        640.9381103515625,
        538.442626953125,
        652.9381103515625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스테인리스 스틸에 들러붙은 감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        640.9381103515625,
        538.442626953125,
        652.9381103515625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6798324584961,
        640.9381103515625,
        538.442626953125,
        652.9381103515625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 특성을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        662.5397338867188,
        538.564697265625,
        674.5397338867188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하여 오염을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        662.5397338867188,
        538.564697265625,
        674.5397338867188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제거하는 과정을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        662.5397338867188,
        538.564697265625,
        674.5397338867188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거쳐야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        662.5397338867188,
        538.564697265625,
        674.5397338867188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        662.5397338867188,
        538.564697265625,
        674.5397338867188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        662.5397338867188,
        538.564697265625,
        674.5397338867188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67982482910156,
        662.5397338867188,
        538.564697265625,
        674.5397338867188
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 이용한 초음파 분해를 피할 것을 권고한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        684.141357421875,
        538.5541381835938,
        696.141357421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        684.141357421875,
        538.5541381835938,
        696.141357421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "microtip probe",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        684.141357421875,
        538.5541381835938,
        696.141357421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        684.141357421875,
        538.5541381835938,
        696.141357421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "37℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        684.141357421875,
        538.5541381835938,
        696.141357421875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        705.739013671875,
        538.4498291015625,
        717.739013671875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 정체시켜 반응 시킨다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        705.739013671875,
        538.4498291015625,
        717.739013671875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한 초음파 분해 배양 과정을 반복",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        705.739013671875,
        538.4498291015625,
        717.739013671875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        705.739013671875,
        538.4498291015625,
        717.739013671875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        705.739013671875,
        538.4498291015625,
        717.739013671875
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        705.739013671875,
        538.4498291015625,
        717.739013671875
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 PrPres를 증폭시킨다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68029022216797,
        725.0488891601562,
        266.9302978515625,
        739.3406372070312
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 24 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특히",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.6409912109375,
        99.14019775390625,
        538.44287109375,
        111.14019775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.6409912109375,
        99.14019775390625,
        538.44287109375,
        111.14019775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 사용하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.6409912109375,
        99.14019775390625,
        538.44287109375,
        111.14019775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 수행할 경우에 고려",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.6409912109375,
        99.14019775390625,
        538.44287109375,
        111.14019775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.6409912109375,
        99.14019775390625,
        538.44287109375,
        111.14019775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "263K",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.6409912109375,
        99.14019775390625,
        538.44287109375,
        111.14019775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PMCA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.6409912109375,
        99.14019775390625,
        538.44287109375,
        111.14019775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해야 할 사항을 기술하고자 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009185791016,
        120.49957275390625,
        538.4495849609375,
        132.49957275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009185791016,
        120.49957275390625,
        538.4495849609375,
        132.49957275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009185791016,
        120.49957275390625,
        538.4495849609375,
        132.49957275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질로 사용할 경",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009185791016,
        120.49957275390625,
        538.4495849609375,
        132.49957275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009185791016,
        120.49957275390625,
        538.4495849609375,
        132.49957275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "263K",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009185791016,
        120.49957275390625,
        538.4495849609375,
        132.49957275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009185791016,
        120.49957275390625,
        538.4495849609375,
        132.49957275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우 감염된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009948730469,
        141.85894775390625,
        538.5648803710938,
        153.85894775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "뇌 균질액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009948730469,
        141.85894775390625,
        538.5648803710938,
        153.85894775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대신 혈장분획제제",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009948730469,
        141.85894775390625,
        538.5648803710938,
        153.85894775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공정 시료를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009948730469,
        141.85894775390625,
        538.5648803710938,
        153.85894775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009948730469,
        141.85894775390625,
        538.5648803710938,
        153.85894775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기질",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009948730469,
        141.85894775390625,
        538.5648803710938,
        153.85894775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68009948730469,
        141.85894775390625,
        538.5648803710938,
        153.85894775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 정상 햄스터 뇌 균질액을 사용하며 템플릿",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68031311035156,
        163.21832275390625,
        538.4263916015625,
        175.21832275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 감염",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68031311035156,
        163.21832275390625,
        538.4263916015625,
        175.21832275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(substrate)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68031311035156,
        163.21832275390625,
        538.4263916015625,
        175.21832275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(template)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68031311035156,
        163.21832275390625,
        538.4263916015625,
        175.21832275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        184.57769775390625,
        538.4381103515625,
        196.57769775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "온도와 초",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        184.57769775390625,
        538.4381103515625,
        196.57769775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        184.57769775390625,
        538.4381103515625,
        196.57769775390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음파 분해의 민감도를 높이기 위해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        205.93707275390625,
        538.437744140625,
        217.93707275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "튜브를 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        205.93707275390625,
        538.437744140625,
        217.93707275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초음파",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        205.93707275390625,
        538.437744140625,
        217.93707275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "500",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        205.93707275390625,
        538.437744140625,
        217.93707275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "L PCR",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        205.93707275390625,
        538.437744140625,
        217.93707275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        205.93707275390625,
        538.437744140625,
        217.93707275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        205.93707275390625,
        538.437744140625,
        217.93707275390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        227.30035400390625,
        538.5603637695312,
        239.30035400390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        248.65972900390625,
        538.43017578125,
        260.65972900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        248.65972900390625,
        538.43017578125,
        260.65972900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 없는 것을 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        248.65972900390625,
        538.43017578125,
        260.65972900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 첨",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        248.65972900390625,
        538.43017578125,
        260.65972900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "sonicator",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        248.65972900390625,
        538.43017578125,
        260.65972900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "microtip probe",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        248.65972900390625,
        538.43017578125,
        260.65972900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". RNA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        248.65972900390625,
        538.43017578125,
        260.65972900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        270.01910400390625,
        538.4583740234375,
        282.01910400390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 수행할 경우 배양은 반드시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        270.01910400390625,
        538.4583740234375,
        282.01910400390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        270.01910400390625,
        538.4583740234375,
        282.01910400390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PMCA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        270.01910400390625,
        538.4583740234375,
        282.01910400390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "shaking incubation(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        270.01910400390625,
        538.4583740234375,
        282.01910400390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "250",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        270.01910400390625,
        538.4583740234375,
        282.01910400390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 의한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "rpm, 37",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". PMCA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PrP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Sc의 증폭은 사용된 완충액 조성에 따",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.68032836914062,
        289.0867614746094,
        538.4381713867188,
        303.37847900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라 다른 결과를 나타낼 수가 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6802978515625,
        312.73785400390625,
        310.6802978515625,
        324.73785400390625
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 웨스턴 블럿 단백 분해효소 전처리 포함",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64079284667969,
        334.09722900390625,
        538.4588623046875,
        346.09722900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64079284667969,
        334.09722900390625,
        538.4588623046875,
        346.09722900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64079284667969,
        334.09722900390625,
        538.4588623046875,
        346.09722900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 단백 분해효소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64079284667969,
        334.09722900390625,
        538.4588623046875,
        346.09722900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(proteinase K,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        104.64079284667969,
        334.09722900390625,
        538.4588623046875,
        346.09722900390625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 만들어 분주하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이하",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PK)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20 mg/mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "stock solution",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-70℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        355.4566345214844,
        538.4407348632812,
        367.4566345214844
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 보관한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        376.8199462890625,
        538.4541015625,
        388.8199462890625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 처리할 시료가 준비되면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        376.8199462890625,
        538.4541015625,
        388.8199462890625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        376.8199462890625,
        538.4541015625,
        388.8199462890625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". PK",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        376.8199462890625,
        538.4541015625,
        388.8199462890625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "stock solution",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        376.8199462890625,
        538.4541015625,
        388.8199462890625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1~10 mg/",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67939758300781,
        376.8199462890625,
        538.4541015625,
        388.8199462890625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도로 희석한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시료에 처리할",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 최종 농도는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PK",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "50~100",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "g/mL",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "μ",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        398.1793518066406,
        538.4401245117188,
        410.1793518066406
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간 반응시킨다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백 분해효소 억제제인",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "37",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30~60",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 mM",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67929077148438,
        419.53875732421875,
        538.4453735351562,
        431.53875732421875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 처리하여 반응을 중지시킨다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67919921875,
        440.8981628417969,
        538.5660400390625,
        452.8981628417969
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각 시료의 용액 조건에 따라",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67919921875,
        440.8981628417969,
        538.5660400390625,
        452.8981628417969
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67919921875,
        440.8981628417969,
        538.5660400390625,
        452.8981628417969
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PMSF",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67919921875,
        440.8981628417969,
        538.5660400390625,
        452.8981628417969
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67919921875,
        440.8981628417969,
        538.5660400390625,
        452.8981628417969
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PK",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67919921875,
        440.8981628417969,
        538.5660400390625,
        452.8981628417969
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도를 결정하여야 한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67919921875,
        462.257568359375,
        260.68701171875,
        474.257568359375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨스턴 블럿을 수행하기 위해서는 주로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.64019775390625,
        483.6169738769531,
        538.5508422851562,
        495.6169738769531
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시스템을 사용",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.64019775390625,
        483.6169738769531,
        538.5508422851562,
        495.6169738769531
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Bio-Rad mini-gel",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        122.64019775390625,
        483.6169738769531,
        538.5508422851562,
        495.6169738769531
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67921447753906,
        504.98028564453125,
        538.5592041015625,
        516.9802856445312
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염시킨 뇌 조직액을 단백 분해효소로 처리하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67921447753906,
        504.98028564453125,
        538.5592041015625,
        516.9802856445312
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67921447753906,
        504.98028564453125,
        538.5592041015625,
        516.9802856445312
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67921447753906,
        504.98028564453125,
        538.5592041015625,
        516.9802856445312
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SDS-PAGE",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67921447753906,
        504.98028564453125,
        538.5592041015625,
        516.9802856445312
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        526.3397216796875,
        538.5576171875,
        538.3397216796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분 동안",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        526.3397216796875,
        538.5576171875,
        538.3397216796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용액에 보",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        526.3397216796875,
        538.5576171875,
        538.3397216796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "gel",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        526.3397216796875,
        538.5576171875,
        538.3397216796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        526.3397216796875,
        538.5576171875,
        538.3397216796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25 mM Tris, 90 mM glycine, 20% methanol",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        526.3397216796875,
        538.5576171875,
        538.3397216796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간 단백질을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "막으로 이동시킨다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 막",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 80 V",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30~60",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PVDF",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        547.6990966796875,
        538.5603637695312,
        559.6990966796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        569.0584716796875,
        538.5146484375,
        581.0584716796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 함유된",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        569.0584716796875,
        538.5146484375,
        581.0584716796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완충액",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        569.0584716796875,
        538.5146484375,
        581.0584716796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5% skim milk",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        569.0584716796875,
        538.5146484375,
        581.0584716796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TBST",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        569.0584716796875,
        538.5146484375,
        581.0584716796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(20 mM Tris, 137 mM NaCl, pH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67822265625,
        569.0584716796875,
        538.5146484375,
        581.0584716796875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 최소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        590.4179077148438,
        538.4404296875,
        602.4179077148438
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 보관하여 단백질이 비특이적으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        590.4179077148438,
        538.4404296875,
        602.4179077148438
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7.6, 0.1% Tween 20)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        590.4179077148438,
        538.4404296875,
        602.4179077148438
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        590.4179077148438,
        538.4404296875,
        602.4179077148438
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결합하는 것을 방지하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "막을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번 씻은 후 감염성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", PVDF",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TBST",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        611.77734375,
        538.4412231445312,
        623.77734375
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온 단백에 대해 매우 특이적으로 반응하는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        633.140625,
        538.4400634765625,
        645.140625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체 표",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        633.140625,
        538.4400634765625,
        645.140625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 처",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        633.140625,
        538.4400634765625,
        645.140625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "anti-PrP",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        633.140625,
        538.4400634765625,
        645.140625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        633.140625,
        538.4400634765625,
        645.140625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        633.140625,
        538.4400634765625,
        645.140625
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        654.5,
        538.4400024414062,
        666.5
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간 상온에서 반응시킨다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        654.5,
        538.4400024414062,
        666.5
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 결합한",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        654.5,
        538.4400024414062,
        666.5
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차 항체",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        654.5,
        538.4400024414062,
        666.5
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30~60",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        654.5,
        538.4400024414062,
        666.5
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". Peroxidase",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        654.5,
        538.4400024414062,
        666.5
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67831420898438,
        654.5,
        538.4400024414062,
        666.5
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "처리하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응시킨",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간격으로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세척한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "60",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.6783218383789,
        675.8594360351562,
        538.474365234375,
        687.8594360351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기질을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        697.2188110351562,
        538.557373046875,
        709.2188110351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        697.2188110351562,
        538.557373046875,
        709.2188110351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        697.2188110351562,
        538.557373046875,
        709.2188110351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백질은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        697.2188110351562,
        538.557373046875,
        709.2188110351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Chemiluminescent",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        697.2188110351562,
        538.557373046875,
        709.2188110351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "peroxidase",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        697.2188110351562,
        538.557373046875,
        709.2188110351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        697.2188110351562,
        538.557373046875,
        709.2188110351562
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법 또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        718.5782470703125,
        538.4368896484375,
        730.5782470703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법을 이용하여",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        718.5782470703125,
        538.4368896484375,
        730.5782470703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 표준액으로 하여 정량",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        718.5782470703125,
        538.4368896484375,
        730.5782470703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Bradford",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        718.5782470703125,
        538.4368896484375,
        730.5782470703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Lowry",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        718.5782470703125,
        538.4368896484375,
        730.5782470703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSA",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        718.5782470703125,
        538.4368896484375,
        730.5782470703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        124.67912292480469,
        739.9376220703125,
        152.6869354248047,
        751.9376220703125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 25 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.19900512695312,
        99.14019775390625,
        425.9997253417969,
        111.14019775390625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백에 대한 단클론 항체",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.19900512695312,
        99.14019775390625,
        425.9997253417969,
        111.14019775390625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        169.19900512695312,
        99.14019775390625,
        425.9997253417969,
        111.14019775390625
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3F4",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        203.16000366210938,
        129.24227905273438,
        479.37701416015625,
        140.2822723388672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1C5",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        203.16000366210938,
        129.24227905273438,
        479.37701416015625,
        140.2822723388672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3F10",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        203.16000366210938,
        129.24227905273438,
        479.37701416015625,
        140.2822723388672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "type",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        96.23829650878906,
        154.32431030273438,
        514.469482421875,
        165.3643035888672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mouse mAb(IgG2a)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        96.23829650878906,
        154.32431030273438,
        514.469482421875,
        165.3643035888672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mouse mAb(IgG1)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        96.23829650878906,
        154.32431030273438,
        514.469482421875,
        165.3643035888672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mouse mAb(IgG1)",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        96.23829650878906,
        154.32431030273438,
        514.469482421875,
        165.3643035888672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "epitope",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        87.96099853515625,
        179.52352905273438,
        488.93463134765625,
        190.5635223388672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "109-113",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        87.96099853515625,
        179.52352905273438,
        488.93463134765625,
        190.5635223388672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "119-133",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        87.96099853515625,
        179.52352905273438,
        488.93463134765625,
        190.5635223388672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "137-145",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        87.96099853515625,
        179.52352905273438,
        488.93463134765625,
        190.5635223388672
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "immunogen",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.03900909423828,
        202.48138427734375,
        494.9745788574219,
        215.6416473388672
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "263K/PrPSc",
      "font_size": 7.079999923706055,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.03900909423828,
        202.48138427734375,
        494.9745788574219,
        215.6416473388672
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "263K/PrPSc",
      "font_size": 7.079999923706055,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.03900909423828,
        202.48138427734375,
        494.9745788574219,
        215.6416473388672
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "263K/PrPSc",
      "font_size": 7.079999923706055,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.03900909423828,
        202.48138427734375,
        494.9745788574219,
        215.6416473388672
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "reactivity",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.480224609375,
        229.80484008789062,
        520.5828247070312,
        240.84483337402344
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "human, hamster, feline",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.480224609375,
        229.80484008789062,
        520.5828247070312,
        240.84483337402344
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "all mammalian",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.480224609375,
        229.80484008789062,
        520.5828247070312,
        240.84483337402344
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mouse, hamster, elk",
      "font_size": 11.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.480224609375,
        229.80484008789062,
        520.5828247070312,
        240.84483337402344
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ". 감염성 프리온 단백 감염 실험동물 부검 시 고려사항",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        283.405029296875,
        451.4453125,
        298.405029296875
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        283.405029296875,
        451.4453125,
        298.405029296875
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부검 시 참석자는 최소한의 인원으로 제한한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        333.859130859375,
        538.4368896484375,
        345.859130859375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부검에 숙련된 실험자",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        333.859130859375,
        538.4368896484375,
        345.859130859375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "병리학",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        333.859130859375,
        538.4368896484375,
        345.859130859375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        333.859130859375,
        538.4368896484375,
        345.859130859375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        333.859130859375,
        538.4368896484375,
        345.859130859375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64059448242188,
        333.859130859375,
        538.4368896484375,
        345.859130859375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        94.67959594726562,
        355.4568176269531,
        510.6484069824219,
        367.4568176269531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ", 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        94.67959594726562,
        355.4568176269531,
        510.6484069824219,
        367.4568176269531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        94.67959594726562,
        355.4568176269531,
        510.6484069824219,
        367.4568176269531
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        377.05841064453125,
        452.0386047363281,
        389.05841064453125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64020538330078,
        377.05841064453125,
        452.0386047363281,
        389.05841064453125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 1회용으로 흡수성이 없는 실험복을 착용하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64020538330078,
        398.6600036621094,
        399.0460205078125,
        410.6600036621094
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64020538330078,
        398.6600036621094,
        399.0460205078125,
        410.6600036621094
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수술용 장갑은 잘 찢어지지 않는 것을 사용하되",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.63961029052734,
        420.2576904296875,
        477.0437927246094,
        432.2576904296875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "겹으로 착용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.63961029052734,
        420.2576904296875,
        477.0437927246094,
        432.2576904296875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.63961029052734,
        420.2576904296875,
        477.0437927246094,
        432.2576904296875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.63961029052734,
        420.2576904296875,
        477.0437927246094,
        432.2576904296875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.63961029052734,
        420.2576904296875,
        477.0437927246094,
        432.2576904296875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64000701904297,
        441.8592834472656,
        538.4407958984375,
        453.8592834472656
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64000701904297,
        441.8592834472656,
        538.4407958984375,
        453.8592834472656
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.67910766601562,
        463.45697021484375,
        538.4447021484375,
        475.45697021484375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.67910766601562,
        485.0585632324219,
        134.68692016601562,
        497.0585632324219
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부검실의 오염 방지",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6401138305664,
        506.66015625,
        200.03851318359375,
        518.66015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6401138305664,
        506.66015625,
        200.03851318359375,
        518.66015625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6401138305664,
        528.2578125,
        410.2069091796875,
        540.2578125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6401138305664,
        528.2578125,
        410.2069091796875,
        540.2578125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64049530029297,
        549.8594360351562,
        440.2073059082031,
        561.8594360351562
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64049530029297,
        549.8594360351562,
        440.2073059082031,
        561.8594360351562
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6408920288086,
        571.4571533203125,
        422.20770263671875,
        583.4571533203125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6408920288086,
        571.4571533203125,
        422.20770263671875,
        583.4571533203125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64128875732422,
        593.0587158203125,
        476.2080993652344,
        605.0587158203125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64128875732422,
        593.0587158203125,
        476.2080993652344,
        605.0587158203125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오염물질 제거",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64188385009766,
        614.6602783203125,
        170.040283203125,
        626.6602783203125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64188385009766,
        614.6602783203125,
        170.040283203125,
        626.6602783203125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64188385009766,
        636.2579956054688,
        538.5641479492188,
        648.2579956054688
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64188385009766,
        636.2579956054688,
        538.5641479492188,
        648.2579956054688
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64188385009766,
        636.2579956054688,
        538.5641479492188,
        648.2579956054688
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64188385009766,
        636.2579956054688,
        538.5641479492188,
        648.2579956054688
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2 N NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64188385009766,
        636.2579956054688,
        538.5641479492188,
        648.2579956054688
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64188385009766,
        636.2579956054688,
        538.5641479492188,
        648.2579956054688
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간 또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동안 담근 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물로 헹구고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 N NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "132",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68087768554688,
        657.859619140625,
        538.4229736328125,
        669.859619140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간 고압증기멸균",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번 또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분간 고압",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(30 Lb psi",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30 Lb psi",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        679.4573364257812,
        538.445556640625,
        691.4573364257812
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증기멸균",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        701.0589599609375,
        296.0851135253906,
        713.0589599609375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        701.0589599609375,
        296.0851135253906,
        713.0589599609375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고압증기멸균 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        701.0589599609375,
        296.0851135253906,
        713.0589599609375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        701.0589599609375,
        296.0851135253906,
        713.0589599609375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        701.0589599609375,
        296.0851135253906,
        713.0589599609375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        701.0589599609375,
        296.0851135253906,
        713.0589599609375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "흡수성이 없는 테이블 커버",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수술도구",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "패드",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회용 실험복 등은 적절한 생물",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64226531982422,
        722.6605224609375,
        538.4397583007812,
        734.6605224609375
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재해 페기물 백",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        744.2582397460938,
        420.7334899902344,
        756.2582397460938
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(biohazard waste bag)에 넣어 소각한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        744.2582397460938,
        420.7334899902344,
        756.2582397460938
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68136596679688,
        744.2582397460938,
        420.7334899902344,
        756.2582397460938
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 26 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부검실 또는 부검 테이블의 오염 의심 지역은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6409912109375,
        99.14019775390625,
        538.4332275390625,
        111.14019775390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6409912109375,
        99.14019775390625,
        538.4332275390625,
        111.14019775390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 이상 적시",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6409912109375,
        99.14019775390625,
        538.4332275390625,
        111.14019775390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6409912109375,
        99.14019775390625,
        538.4332275390625,
        111.14019775390625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2 N NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6409912109375,
        99.14019775390625,
        538.4332275390625,
        111.14019775390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.6409912109375,
        99.14019775390625,
        538.4332275390625,
        111.14019775390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 것을 반복하여 오염을 제거한다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.67999267578125,
        120.7379150390625,
        302.68780517578125,
        132.7379150390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64118957519531,
        142.33953857421875,
        538.4271850585938,
        154.33953857421875
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 N",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        92.64118957519531,
        142.33953857421875,
        538.4271850585938,
        154.33953857421875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68010711669922,
        163.937255859375,
        426.6449279785156,
        175.937255859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분 동안 닦아 내고 충분한 양의 물로 씻어낸다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68010711669922,
        163.937255859375,
        426.6449279785156,
        175.937255859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68010711669922,
        163.937255859375,
        426.6449279785156,
        175.937255859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68010711669922,
        163.937255859375,
        426.6449279785156,
        175.937255859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.68010711669922,
        163.937255859375,
        426.6449279785156,
        175.937255859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백의 불활화",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        212.4830322265625,
        389.0425109863281,
        227.4830322265625
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세척 및 소독",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        212.4830322265625,
        389.0425109863281,
        227.4830322265625
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        212.4830322265625,
        389.0425109863281,
        227.4830322265625
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        212.4830322265625,
        389.0425109863281,
        227.4830322265625
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ",
      "font_size": 15.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640602111816406,
        212.4830322265625,
        389.0425109863281,
        227.4830322265625
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        260.6454162597656,
        538.5547485351562,
        274.9371337890625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 추정되며 그 크기",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        260.6454162597656,
        538.5547485351562,
        274.9371337890625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(dimer)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.6406021118164,
        260.6454162597656,
        538.5547485351562,
        274.9371337890625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 이온화 방사선 표적 입자와 비슷하다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        284.53875732421875,
        538.433837890625,
        296.53875732421875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라서 감염성 프리온 단백은 세균과 바이러",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        284.53875732421875,
        538.433837890625,
        296.53875732421875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        284.53875732421875,
        538.433837890625,
        296.53875732421875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        306.140380859375,
        538.4342041015625,
        318.140380859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또한 균일",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        306.140380859375,
        538.4342041015625,
        318.140380859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        306.140380859375,
        538.4342041015625,
        318.140380859375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        327.7380676269531,
        538.4537353515625,
        339.7380676269531
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        327.7380676269531,
        538.4537353515625,
        339.7380676269531
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        327.7380676269531,
        538.4537353515625,
        339.7380676269531
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온 단백은 바이러스와 달리 핵산 분해효소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        349.33966064453125,
        538.5473022460938,
        361.33966064453125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자외선 조사",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        349.33966064453125,
        538.5473022460938,
        361.33966064453125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 저항성을 갖",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        349.33966064453125,
        538.5473022460938,
        361.33966064453125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        349.33966064453125,
        538.5473022460938,
        361.33966064453125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(254 nm)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        349.33966064453125,
        538.5473022460938,
        361.33966064453125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고 있으며",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 양이온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "금속 이온 킬레이터",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이의 산",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포르말린",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", 2",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(chelator), pH 3~7",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        370.9373474121094,
        538.4451904296875,
        382.9373474121094
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "끓임",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        392.5389404296875,
        538.4345092773438,
        404.5389404296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        392.5389404296875,
        538.4345092773438,
        404.5389404296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "hydroxylamine,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        392.5389404296875,
        538.4345092773438,
        404.5389404296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(boiling)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        392.5389404296875,
        538.4345092773438,
        404.5389404296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지고 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        414.1405334472656,
        114.64901733398438,
        426.1405334472656
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64120483398438,
        435.73822021484375,
        538.4342041015625,
        447.73822021484375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어지는 반면",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        457.3398132324219,
        538.4847412109375,
        469.3398132324219
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ", SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        457.3398132324219,
        538.4847412109375,
        469.3398132324219
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641204833984375,
        457.3398132324219,
        538.4847412109375,
        469.3398132324219
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염력이 가장 높은 실험동물 뇌 균질액은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64093017578125,
        478.9375,
        538.5670166015625,
        490.9375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64093017578125,
        478.9375,
        538.5670166015625,
        490.9375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동안 고압증기멸균을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64093017578125,
        478.9375,
        538.5670166015625,
        490.9375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "132",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64093017578125,
        478.9375,
        538.5670166015625,
        490.9375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.5",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64093017578125,
        478.9375,
        538.5670166015625,
        490.9375
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64093017578125,
        478.9375,
        538.5670166015625,
        490.9375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요로 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641510009765625,
        500.5390930175781,
        538.3757934570312,
        512.5390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "페놀과 같은 유기용매 혹은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641510009765625,
        500.5390930175781,
        538.3757934570312,
        512.5390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 같은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641510009765625,
        500.5390930175781,
        538.3757934570312,
        512.5390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641510009765625,
        500.5390930175781,
        538.3757934570312,
        512.5390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "guanidine isothiocyanate",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641510009765625,
        500.5390930175781,
        538.3757934570312,
        512.5390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "chaotropic",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.641510009765625,
        500.5390930175781,
        538.3757934570312,
        512.5390625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64150619506836,
        522.1406860351562,
        418.1263122558594,
        534.1406860351562
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 같은 알칼리 등이 살균에 사용될 수 있다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64150619506836,
        522.1406860351562,
        418.1263122558594,
        534.1406860351562
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "reagent",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64150619506836,
        522.1406860351562,
        418.1263122558594,
        534.1406860351562
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64150619506836,
        522.1406860351562,
        418.1263122558594,
        534.1406860351562
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64150619506836,
        522.1406860351562,
        418.1263122558594,
        534.1406860351562
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프리온",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단백은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 N",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NaOH,",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mol/L",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "guanidinium hydrochloride",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.64151000976562,
        543.7384033203125,
        538.4425048828125,
        555.7384033203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64154052734375,
        565.3399658203125,
        538.4750366210938,
        577.3399658203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64154052734375,
        565.3399658203125,
        538.4750366210938,
        577.3399658203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "isocyanate, sodium hypochlorite(2% free chlorine concentration)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64154052734375,
        565.3399658203125,
        538.4750366210938,
        577.3399658203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "132",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64154052734375,
        565.3399658203125,
        538.4750366210938,
        577.3399658203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.5",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64154052734375,
        565.3399658203125,
        538.4750366210938,
        577.3399658203125
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.64154052734375,
        565.3399658203125,
        538.4750366210938,
        577.3399658203125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동안 고압증기멸균 등에 의해 불활화 되어진다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        586.9376831054688,
        538.43408203125,
        598.9376831054688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". 건조된 폐기물에 대해서는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        586.9376831054688,
        538.43408203125,
        598.9376831054688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "132℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        586.9376831054688,
        538.43408203125,
        598.9376831054688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        608.539306640625,
        538.5609741210938,
        620.539306640625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동안 고압증기멸균 하거나 소각할 것을 추천한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        608.539306640625,
        538.5609741210938,
        620.539306640625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염성 프리온 단백이",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        608.539306640625,
        538.5609741210938,
        620.539306640625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.5",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        608.539306640625,
        538.5609741210938,
        620.539306640625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640960693359375,
        608.539306640625,
        538.5609741210938,
        620.539306640625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고농도로 존재하는 많은 양의 액체 페기물은",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        630.140869140625,
        538.4758911132812,
        642.140869140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 처리하거나",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        630.140869140625,
        538.4758911132812,
        642.140869140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        630.140869140625,
        538.4758911132812,
        642.140869140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 N NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        630.140869140625,
        538.4758911132812,
        642.140869140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "132",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        630.140869140625,
        538.4758911132812,
        642.140869140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.5",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        630.140869140625,
        538.4758911132812,
        642.140869140625
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "℃",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        630.140869140625,
        538.4758911132812,
        642.140869140625
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        651.7385864257812,
        390.648193359375,
        663.7385864257812
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재사용 가능한 재료의 오염을 막기 위해",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.640380859375,
        673.3402099609375,
        538.448974609375,
        685.3402099609375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회용 플라스틱 제품을 사용하는 것을 적",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.640380859375,
        673.3402099609375,
        538.448974609375,
        685.3402099609375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.640380859375,
        673.3402099609375,
        538.448974609375,
        685.3402099609375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "극 추천한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        694.9378662109375,
        538.5546875,
        706.9378662109375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "파라포름알데히드 훈증",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        694.9378662109375,
        538.5546875,
        706.9378662109375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 감염성 프리온 단백의 감염력을",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        694.9378662109375,
        538.5546875,
        706.9378662109375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        694.9378662109375,
        538.5546875,
        706.9378662109375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(vaporization)",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        694.9378662109375,
        538.5546875,
        706.9378662109375
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제거하지 못하기 때문에",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        716.5394897460938,
        538.4490356445312,
        728.5394897460938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        716.5394897460938,
        538.4490356445312,
        728.5394897460938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 오염을 제거한 후",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        716.5394897460938,
        538.4490356445312,
        728.5394897460938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 처리하고",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        716.5394897460938,
        538.4490356445312,
        728.5394897460938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BSC",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        716.5394897460938,
        538.4490356445312,
        728.5394897460938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 N NaOH",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        716.5394897460938,
        538.4490356445312,
        728.5394897460938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1 N HCl",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        716.5394897460938,
        538.4490356445312,
        728.5394897460938
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물로 씻어낸다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        738.14111328125,
        432.2891845703125,
        750.14111328125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ". HEPA 필터는 고압증기멸균 한 후 소각하여야 한다",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        738.14111328125,
        432.2891845703125,
        750.14111328125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ".",
      "font_size": 12.0,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.640380859375,
        738.14111328125,
        432.2891845703125,
        750.14111328125
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 27 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 32,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<참고자료",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6406364440918,
        99.15615844726562,
        124.86168670654297,
        112.11616516113281
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ">",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        56.6406364440918,
        99.15615844726562,
        124.86168670654297,
        112.11616516113281
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline on the Investigation of Manufacturing Processes",
      "font_size": 15.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.67973327636719,
        223.90097045898438,
        524.2384643554688,
        239.86097717285156
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "for Plasma-Derived Medicinal Products with regard to",
      "font_size": 15.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.07813262939453,
        249.58065795898438,
        506.9541320800781,
        265.5406494140625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "vCJD Risk, EMEA, 2004",
      "font_size": 15.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        205.19912719726562,
        275.1392517089844,
        389.9229736328125,
        291.0992431640625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "European Medicines Agency",
      "font_size": 9.414793968200684,
      "font_name": "Arial",
      "bbox": [
        92.72525024414062,
        62.735870361328125,
        406.4825439453125,
        97.16556549072266
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation of Medicines for Human Use",
      "font_size": 11.275192260742188,
      "font_name": "Arial",
      "bbox": [
        92.72525024414062,
        62.735870361328125,
        406.4825439453125,
        97.16556549072266
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7 Westferry Circus, Canary Wharf, London, E14 4HB, UK",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        83.78679656982422,
        715.3641967773438,
        523.400634765625,
        757.3333740234375
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Tel. (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        83.78679656982422,
        715.3641967773438,
        523.400634765625,
        757.3333740234375
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "E-mail: mail@emea.eu.int    http://www.emea.eu.int",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        83.78679656982422,
        715.3641967773438,
        523.400634765625,
        757.3333740234375
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.",
      "font_size": 6.59579610824585,
      "font_name": "Arial",
      "bbox": [
        83.78679656982422,
        715.3641967773438,
        523.400634765625,
        757.3333740234375
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "London, 21 October 2004",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        306.04998779296875,
        97.75827026367188,
        522.6543579101562,
        169.43710327148438
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CPMP/BWP/CPMP/5136/03",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman",
      "bbox": [
        306.04998779296875,
        97.75827026367188,
        522.6543579101562,
        169.43710327148438
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        112.64199829101562,
        170.29100036621094,
        504.957275390625,
        184.85415649414062
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CHMP)",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        281.57379150390625,
        185.7085418701172,
        333.80853271484375,
        200.27169799804688
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "GUIDELINE ON THE INVESTIGATION OF MANUFACTURING",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        111.86209869384766,
        267.5948181152344,
        503.5005798339844,
        297.5754699707031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        111.86209869384766,
        267.5948181152344,
        503.5005798339844,
        297.5754699707031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WITH REGARD TO VCJD RISK",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        209.3459014892578,
        298.4296875,
        405.9701232910156,
        312.99285888671875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DISCUSSION IN THE BWP",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        390.0898132324219,
        528.672119140625,
        401.7675476074219
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "June–November 2003",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        390.0898132324219,
        528.672119140625,
        401.7675476074219
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRANSMISSION TO CPMP",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        414.2658386230469,
        528.6760864257812,
        425.9435729980469
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "November 2003",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        414.2658386230469,
        528.6760864257812,
        425.9435729980469
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RELEASE FOR CONSULTATION",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        438.3817138671875,
        528.6760864257812,
        450.0594482421875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "November 2003",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        438.3817138671875,
        528.6760864257812,
        450.0594482421875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DEADLINE FOR COMMENTS",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        462.5577392578125,
        528.6626586914062,
        474.2354736328125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "End March 2004",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        462.5577392578125,
        528.6626586914062,
        474.2354736328125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EMEA EXPERT WORKSHOP",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        486.7337341308594,
        528.6699829101562,
        498.4114685058594
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "January 2004",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        486.7337341308594,
        528.6699829101562,
        498.4114685058594
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DISCUSSION IN THE BWP",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        510.8496398925781,
        528.6781616210938,
        522.5274047851562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "July, September 2004",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        510.8496398925781,
        528.6781616210938,
        522.5274047851562
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TRANSMISSION TO CHMP",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        535.0255737304688,
        528.6503295898438,
        546.703369140625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "October 2004",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        535.0255737304688,
        528.6503295898438,
        546.703369140625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CHMP ADOPTION",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        559.2015991210938,
        528.6492919921875,
        570.87939453125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "October 2004",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        559.2015991210938,
        528.6492919921875,
        570.87939453125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DATE FOR COMING INTO OPERATION",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        106.10310363769531,
        583.317626953125,
        528.6492919921875,
        594.9954223632812
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "October 2004",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        106.10310363769531,
        583.317626953125,
        528.6492919921875,
        594.9954223632812
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 2/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "GUIDELINE ON THE INVESTIGATION OF MANUFACTURING",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        111.86209869384766,
        55.53019332885742,
        503.5005798339844,
        85.5107650756836
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        111.86209869384766,
        55.53019332885742,
        503.5005798339844,
        85.5107650756836
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "WITH REGARD TO VCJD RISK",
      "font_size": 13.135591506958008,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        209.3459014892578,
        86.36503601074219,
        405.9701232910156,
        100.92818450927734
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 9,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TABLE OF CONTENTS",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        102.95207214355469,
        369.55267333984375,
        150.13706970214844
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72506713867188,
        163.97218322753906,
        537.3670043945312,
        176.53294372558594
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "INTRODUCTION................................................................................................................... 3",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72506713867188,
        163.97218322753906,
        537.3670043945312,
        176.53294372558594
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72518920898438,
        182.8092803955078,
        537.3671264648438,
        195.4298553466797
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SCOPE OF THE DOCUMENT:............................................................................................. 3",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72518920898438,
        182.8092803955078,
        537.3671264648438,
        195.4298553466797
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        201.7060089111328,
        537.3674926757812,
        214.26695251464844
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        201.7060089111328,
        537.3674926757812,
        214.26695251464844
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00384521484375,
        220.36268615722656,
        517.031982421875,
        232.86338806152344
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "General principles.......................................................................................................... 4",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00384521484375,
        220.36268615722656,
        517.031982421875,
        232.86338806152344
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.2",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.0032730102539,
        239.13917541503906,
        517.0336303710938,
        251.6401824951172
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Scaling down process..................................................................................................... 5",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.0032730102539,
        239.13917541503906,
        517.0336303710938,
        251.6401824951172
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.3",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00383758544922,
        257.97637939453125,
        517.039794921875,
        270.4775695800781
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Choice of spiking agent.................................................................................................. 5",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00383758544922,
        257.97637939453125,
        517.039794921875,
        270.4775695800781
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.4",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00325012207031,
        276.7528381347656,
        517.0298461914062,
        289.3138732910156
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Choice of assays ............................................................................................................ 6",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00325012207031,
        276.7528381347656,
        517.0298461914062,
        289.3138732910156
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.5",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00336456298828,
        295.5297546386719,
        517.04638671875,
        308.0307922363281
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Choice of manufacturing steps........................................................................................ 7",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00336456298828,
        295.5297546386719,
        517.04638671875,
        308.0307922363281
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.6",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00312805175781,
        314.36700439453125,
        517.0448608398438,
        326.8681945800781
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Interpretation and limitations of data............................................................................... 7",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00312805175781,
        314.36700439453125,
        517.0448608398438,
        326.8681945800781
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.7",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00382995605469,
        333.1434631347656,
        517.0478515625,
        345.7044677734375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Re-evaluation of TSE clearance ...................................................................................... 8",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00382995605469,
        333.1434631347656,
        517.0478515625,
        345.7044677734375
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.8",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00344848632812,
        351.92034912109375,
        517.0414428710938,
        364.4812927246094
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sanitisation of equipment ............................................................................................... 8",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        104.00344848632812,
        351.92034912109375,
        517.0414428710938,
        364.4812927246094
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        370.8777770996094,
        537.3667602539062,
        406.6923522949219
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SUMMARY / CONCLUSION................................................................................................. 9",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        370.8777770996094,
        537.3667602539062,
        406.6923522949219
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 3/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        65.34852600097656,
        204.54002380371094,
        77.8490982055664
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "INTRODUCTION",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        65.34852600097656,
        204.54002380371094,
        77.8490982055664
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Human transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        83.72079467773438,
        522.041259765625,
        143.03067016601562
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Jakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        83.72079467773438,
        522.041259765625,
        143.03067016601562
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "January 1999, December 1999, May 2000, December 2000, June 2002 and January 2004. A revised",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        83.72079467773438,
        522.041259765625,
        143.03067016601562
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        83.72079467773438,
        522.041259765625,
        143.03067016601562
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004.1",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        83.72079467773438,
        522.041259765625,
        143.03067016601562
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "In 1996, a variant form of CJD (vCJD) was identified. The official UK figures for vCJD at the beginning",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of August 2004 were a total of 147 definite or probable vCJD cases. (One case in Hong Kong was a UK",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "case and is included in the UK figures.) Outside of the UK, there has been one case in Ireland, one in the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "USA, and one in Canada, who were probably infected while in the UK. However, none of the 7 cases in",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "France and 1 case in Italy had spent time in the UK. The possibility of cases occurring in other countries",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "cannot be excluded. All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Met) at codon 129 of the prion protein (PrP) gene. However, evidence of infection has recently been",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "reported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        149.22970581054688,
        522.0697021484375,
        244.41378784179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72640991210938,
        250.55288696289062,
        521.9098510742188,
        285.9264831542969
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "encephalopathy (BSE) in cattle.  The most likely hypothesis is that vCJD has occurred through",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72640991210938,
        250.55288696289062,
        521.9098510742188,
        285.9264831542969
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "exposure to BSE contaminated food.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72640991210938,
        250.55288696289062,
        521.9098510742188,
        285.9264831542969
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Uncertainties still exist concerning the number of cases of vCJD that will occur. In contrast to sporadic",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72537231445312,
        292.12548828125,
        522.017333984375,
        327.4991149902344
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72537231445312,
        292.12548828125,
        522.017333984375,
        327.4991149902344
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of transmission from pre-clinically infected individuals via blood or blood products.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72537231445312,
        292.12548828125,
        522.017333984375,
        327.4991149902344
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "transgenic mice as well as primates have not shown any transmission yet but some of the studies are",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "possible cases of secondary transmission after transfusion of red cells from donors who subsequently",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "case of CJD resulting from the administration of plasma-derived products (studies conducted in high",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "As of February 2004, no case of vCJD has been identified with a history of exposure to plasma-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "derived products.11",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72433471679688,
        332.3393249511719,
        522.1112060546875,
        500.6310729980469
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Plasma from donors from the UK is currently not fractionated as a precautionary measure because the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        506.8301086425781,
        522.0,
        578.0769653320312
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "UK had the highest exposure to BSE and has significantly more vCJD cases than any other country.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        506.8301086425781,
        522.0,
        578.0769653320312
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Plasma from donors from France is currently fractionated as the risk benefit ratio is considered",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        506.8301086425781,
        522.0,
        578.0769653320312
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "favourable. If other countries eventually report several cases of vCJD at some time in the future, a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        506.8301086425781,
        522.0,
        578.0769653320312
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        506.8301086425781,
        522.0,
        578.0769653320312
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of past products, and could help to justify continuing fractionation.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        506.8301086425781,
        522.0,
        578.0769653320312
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        595.840087890625,
        267.71234130859375,
        608.3406982421875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCOPE OF THE DOCUMENT:",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        595.840087890625,
        267.71234130859375,
        608.3406982421875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Available data indicate that the manufacturing processes for plasma-derived medicinal products would",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "reduce infectivity if it were present in human plasma. The 2004 Position Statement states1",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“Manufacturers are now required to estimate the potential of their specific manufacturing processes to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "reduce infectivity using a step-wise approach.”",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The aim of this document is to provide guidance on how to investigate manufacturing processes with",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "regard to vCJD risk. At this time, experience in this area has not reached a point where definitive",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "guidance can be given. Therefore, the guideline provides advice based on available experience and",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "other approaches may be acceptable. It is very important to read this document in conjunction with the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Italic",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "derived medicinal products. As indicated in the Position Statement, consultation with relevant",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        614.2123413085938,
        522.0498046875,
        733.3303833007812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 4/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "competent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528076171875,
        53.78554916381836,
        521.980224609375,
        77.16146850585938
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "available to discuss issues that arise.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528076171875,
        53.78554916381836,
        521.980224609375,
        77.16146850585938
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        94.92359924316406,
        357.4173278808594,
        107.4241714477539
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "INVESTIGATIONAL TSE CLEARANCE STUDIES",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        94.92359924316406,
        357.4173278808594,
        107.4241714477539
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.1",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        124.85859680175781,
        203.76300048828125,
        137.3591766357422
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "General principles",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        124.85859680175781,
        203.76300048828125,
        137.3591766357422
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "inactivation and removal of viruses13, should be extended to TSE agents as far as possible.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Italic",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Material from production should be spiked with a volume of not more than 10% of an appropriate",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "infectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "laboratory model. The experiments should be strictly separated from production and performed in a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "manner that is well controlled and documented, and undertaken by appropriately qualified personnel.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "As with virus validation studies, the validity of the down-scaled model should be demonstrated by",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "relevant process parameters and appropriate performance of down-scaled models.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72549438476562,
        143.29074096679688,
        522.07958984375,
        250.41104125976562
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Only those steps which are likely to contribute to inactivation/removal need to be investigated. TSE-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        256.6100769042969,
        522.04833984375,
        315.9192199707031
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "agents are expected to be resistant to most physicochemical virus inactivation procedures which are",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        256.6100769042969,
        522.04833984375,
        315.9192199707031
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "usually applied in the manufacture of plasma-derived medicinal products. Therefore, investigation",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        256.6100769042969,
        522.04833984375,
        315.9192199707031
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        256.6100769042969,
        522.04833984375,
        315.9192199707031
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "chromatography, depth filtration or nanofiltration.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        256.6100769042969,
        522.04833984375,
        315.9192199707031
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "In a virus validation study, investigation of such removal steps would include the demonstration of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/268/9513). Studies with TSEs are far more difficult and costly than for conventional",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the design of the investigational study or to use an appropriately validated in vitro assay. It should be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "borne in mind that the removal may be sensitive to variations of manufacturing parameters. Therefore,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in-process limits are important for the design of investigational studies for partitioning steps. The",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "studies should include evaluation of partitioning of prions into side fractions using an in vitro assay.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Reduction factors <1 log are not significant.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        322.0583190917969,
        522.0526123046875,
        441.1795959472656
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The design of such combined-step studies should allow determination of reduction factors from each",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "single step and from the combined steps by analysing the corresponding intermediate samples. Such",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "combined-step studies may be helpful to substantiate the additivity of low or moderate reduction",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "factors. Moreover, studying combined steps may be helpful where a significant alteration of the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "physicochemical state of the TSE material, which would influence the removal at the following step,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "may be suspected (e.g treatment with detergent preceeding a filtration step). An investigation study",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "that encompasses the entire process would be an ideal goal. However, as with viruses, the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "than one or two steps.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72457885742188,
        447.37860107421875,
        522.0245971679688,
        566.49658203125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The main points to be considered are:",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.724609375,
        572.6954956054688,
        251.02330017089844,
        584.1336669921875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        590.272705078125,
        210.4676513671875,
        601.7108764648438
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "scaling down process",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        590.272705078125,
        210.4676513671875,
        601.7108764648438
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        607.9098510742188,
        218.28103637695312,
        619.3480224609375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "choice of spiking agent",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        607.9098510742188,
        218.28103637695312,
        619.3480224609375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        625.487060546875,
        189.24009704589844,
        636.9252319335938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "choice of assays",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        625.487060546875,
        189.24009704589844,
        636.9252319335938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        643.1241455078125,
        246.38287353515625,
        654.5623168945312
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "choice of manufacturing steps",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        643.1241455078125,
        246.38287353515625,
        654.5623168945312
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        660.7013549804688,
        273.2163391113281,
        672.1395263671875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "interpretation and limitations of data",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72460174560547,
        660.7013549804688,
        273.2163391113281,
        672.1395263671875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.724609375,
        678.3385009765625,
        250.40408325195312,
        689.7766723632812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "re-evaluation of TSE clearance",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.724609375,
        678.3385009765625,
        250.40408325195312,
        689.7766723632812
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.724609375,
        695.9157104492188,
        226.61981201171875,
        707.3538818359375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "sanitisation of equipment",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.724609375,
        695.9157104492188,
        226.61981201171875,
        707.3538818359375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 5/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.2",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        54.07038497924805,
        216.2867431640625,
        66.57096099853516
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Scaling down process",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        54.07038497924805,
        216.2867431640625,
        66.57096099853516
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The principles of scaling down the manufacturing process for experimental TSE studies are the same",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        72.44265747070312,
        522.041748046875,
        119.75405883789062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "as those for virus validation studies. Manufacturers should provide data on the yield, quality and",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        72.44265747070312,
        522.041748046875,
        119.75405883789062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "composition of the product(s) or intermediates made in the scaled down version of the process, and",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        72.44265747070312,
        522.041748046875,
        119.75405883789062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "these should be comparable with those obtained in typical batches of the full-scale product(s).",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72553253173828,
        72.44265747070312,
        522.041748046875,
        119.75405883789062
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.3",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        137.51649475097656,
        225.3068389892578,
        150.01707458496094
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Choice of spiking agent",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        137.51649475097656,
        225.3068389892578,
        150.01707458496094
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Data from animals experimentally infected with TSE agents indicates that infectivity can be found in",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        155.94863891601562,
        522.0289916992188,
        215.19845581054688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "blood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        155.94863891601562,
        522.0289916992188,
        215.19845581054688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "low, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        155.94863891601562,
        522.0289916992188,
        215.19845581054688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        155.94863891601562,
        522.0289916992188,
        215.19845581054688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "the total volume to avoid distorting the nature of the fraction studied.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        155.94863891601562,
        522.0289916992188,
        215.19845581054688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The main considerations are;",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        221.39749145507812,
        215.02825927734375,
        232.83560180664062
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "i)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        238.97470092773438,
        400.69525146484375,
        250.41281127929688
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the strain of the inoculum and the species in which it was prepared;",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        238.97470092773438,
        400.69525146484375,
        250.41281127929688
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ii)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        256.6118469238281,
        235.0120391845703,
        268.0499572753906
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "its physicochemical nature.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525024414062,
        256.6118469238281,
        235.0120391845703,
        268.0499572753906
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "i)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,BoldItalic",
      "bbox": [
        92.72525024414062,
        285.6465759277344,
        202.237548828125,
        297.0846862792969
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Species and strain",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,BoldItalic",
      "bbox": [
        92.72525024414062,
        285.6465759277344,
        202.237548828125,
        297.0846862792969
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The factors governing the source of materials for use as the spike include supply, assay and likely",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "similarity of the material to the infectivity which could be present in the plasma. The supply of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "unpassaged material from cases of vCJD is limited for ethical and other reasons. While normal mice",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "may be used for the bioassay of vCJD, and there is at least one published example of the use of such",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "human material in spiking studies14, the use of vCJD is not mandatory. In principle large amounts of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "bovine brain from animals infected with BSE may be available, although in practice material of a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "suitable quality is difficult to obtain. The assay of the material is again potentially difficult. This",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie. Except for",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "demonstration projects, for example to show that a process will not only remove model agents but the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(e.g. scrapie, familial CJD, BSE or vCJD). As they differ in their pathology and strain characteristics,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "several strains have been investigated. The principles involved in their assay are well established. In",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "studies published so far there has been no clearly demonstrable effect of species or strain on removal",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "there is no reason to make a choice based on the appropriateness of the strain, so a decision can be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "made on practical grounds. The rationale for the choice of strain should be given in all cases.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72421264648438,
        303.1039733886719,
        522.091064453125,
        494.03167724609375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ii)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,BoldItalic",
      "bbox": [
        92.726806640625,
        511.6283264160156,
        288.0796203613281,
        523.0664672851562
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Physicochemical form of spiking agent",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,BoldItalic",
      "bbox": [
        92.726806640625,
        511.6283264160156,
        288.0796203613281,
        523.0664672851562
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the physicochemical nature of TSE agents in blood is unknown. It has been suggested that it might be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "more like the infectivity found in spleen than that in brain, on the assumption that it originates from a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "tissue other than brain. However it is not clear where infectivity in the blood originates in those model",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "systems where it has been demonstrated. It is possible that it represents material released as the brain",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "degenerates, in which case brain would be an appropriate spiking material. On the other hand brain",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "prions in blood. It is important to consider carefully the various possible physical types of spiking",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "agent.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        529.085693359375,
        522.0415649414062,
        636.2680053710938
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        641.1077880859375,
        521.9555053710938,
        665.8433837890625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "homogenate.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7252197265625,
        641.1077880859375,
        521.9555053710938,
        665.8433837890625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 6/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(a)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Italic",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        237.95611572265625,
        65.22366333007812
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Crude brain homogenates.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        237.95611572265625,
        65.22366333007812
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Crude brain homogenates have been used most extensively in published studies of infectivity. They",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        71.36276245117188,
        522.0741577148438,
        130.67184448242188
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "contain the highest concentration of infectivity. The homogeneity and reproducibility of such preparations",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        71.36276245117188,
        522.0741577148438,
        130.67184448242188
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "could be important factors in the studies performed. If the particle size covers a wide range there may be a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        71.36276245117188,
        522.0741577148438,
        130.67184448242188
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "correspondingly wide range of removal by a physical technique such as filtration. The reproducibility of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        71.36276245117188,
        522.0741577148438,
        130.67184448242188
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "the preparation may also be an important factor in judging the reliability of the results obtained.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        71.36276245117188,
        522.0741577148438,
        130.67184448242188
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(b)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        136.87088012695312,
        209.94171142578125,
        148.30899047851562
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Microsomal fraction.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        136.87088012695312,
        209.94171142578125,
        148.30899047851562
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        154.44808959960938,
        521.9583740234375,
        201.75949096679688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "removal of large aggregates and represent membrane-bound infectivity. While the infectivity level is",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        154.44808959960938,
        521.9583740234375,
        201.75949096679688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "lower than crude homogenates it is still high and the preparation may be expected to be more uniform",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        154.44808959960938,
        521.9583740234375,
        201.75949096679688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "than crude brain homogenates.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        154.44808959960938,
        521.9583740234375,
        201.75949096679688
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(c)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        207.95852661132812,
        253.25404357910156,
        219.39663696289062
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Caveolae-like domains (CLDs).",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72531127929688,
        207.95852661132812,
        253.25404357910156,
        219.39663696289062
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72320556640625,
        225.53573608398438,
        521.9967041015625,
        260.9093322753906
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "homogenates. The infectivity level is lower than that of microsomes and they may simulate membrane",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72320556640625,
        225.53573608398438,
        521.9967041015625,
        260.9093322753906
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "domains shed from cells.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72320556640625,
        225.53573608398438,
        521.9967041015625,
        260.9093322753906
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(d) Purified PrPSc.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        265.6904296875,
        172.02841186523438,
        278.4880676269531
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72550964355469,
        283.3275146484375,
        522.0282592773438,
        320.0606689453125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "salt precipitation and ultracentrifugation. It represents forms not associated with cells or membranes. It",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72550964355469,
        283.3275146484375,
        522.0282592773438,
        320.0606689453125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "is not clear whether such preparations resemble material which could occur naturally.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72550964355469,
        283.3275146484375,
        522.0282592773438,
        320.0606689453125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Results of precipitation studies indicated that the three membrane-bound spikes (homogenates,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        337.4775695800781,
        522.0494995117188,
        408.7261657714844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        337.4775695800781,
        522.0494995117188,
        408.7261657714844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "such investigations. Because the largest aggregates are removed, and the material may be more",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        337.4775695800781,
        522.0494995117188,
        408.7261657714844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        337.4775695800781,
        522.0494995117188,
        408.7261657714844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "preferred. In contrast, the purified PrPSc was more easily precipitated (including into the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        337.4775695800781,
        522.0494995117188,
        408.7261657714844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "cryoprecipitate) than any of the membrane fractions. Other types of spikes are also possible.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        337.4775695800781,
        522.0494995117188,
        408.7261657714844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "It is not clear whether the behaviour of any of these spiking materials is representative of the form of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72557830810547,
        414.9251708984375,
        522.0007934570312,
        462.2366027832031
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "infectivity which may be found in plasma. The spike preparation(s) that would be expected to provide",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72557830810547,
        414.9251708984375,
        522.0007934570312,
        462.2366027832031
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the greatest challenge to the process step(s) under investigation should be selected in order to evaluate",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72557830810547,
        414.9251708984375,
        522.0007934570312,
        462.2366027832031
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "under worst case conditions. The rationale for the choice of preparations should be given in all cases.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72557830810547,
        414.9251708984375,
        522.0007934570312,
        462.2366027832031
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.4",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        479.9993896484375,
        193.88040161132812,
        492.4999694824219
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Choice of assays",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        479.9993896484375,
        193.88040161132812,
        492.4999694824219
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Infectivity assays are accepted as the gold standard for the detection of TSE agents. The presence of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "neurological disease after an incubation period is the signature of the agent. Infectivity is measured by",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "end point titration in animals. The duration of the incubation period may also be used to quantify the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "infectivity present in the tested material if validated against end point titration of infectivity. The",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "existence of a species barrier to transmission and species and strain effects put constraints on the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "materials which can be assayed. For example sporadic CJD preparations from humans rarely infect",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "normal wild type mice, although transgenic mice have been prepared which can be used. This is one of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the factors in the selection of the spiking agent discussed above. However, bioassays are very complex",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "months of observation and clinical monitoring of the injected animals (e.g. hamster model, 263K), and",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "up to 15-18 months for non-transgenic murine models. In addition, for a given bioassay, the nature of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal. In",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "other words, it is not possible to test, on a given animal strain or species, all types of infectious",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "material which could be used as spiking material in a validation study. This is a further limitation",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "obstructing the design of validation studies for the manufacturing process to demonstrate partitioning",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "or inactivation of human TSEs.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72137451171875,
        498.4315490722656,
        522.0003051757812,
        701.293701171875
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72134399414062,
        707.4327392578125,
        521.9674072265625,
        730.86865234375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72134399414062,
        707.4327392578125,
        521.9674072265625,
        730.86865234375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 7/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "strains). Very few sites in Europe are able to handle a large number of animals and for a long period of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        53.78554916381836,
        522.0439453125,
        113.03475952148438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "clinical observation, in level 2 or level 3 premises. Finally, given the complexity of the assay, the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        53.78554916381836,
        522.0439453125,
        113.03475952148438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "length of the incubation period and the requested security measures, the cost of such tests is very high.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        53.78554916381836,
        522.0439453125,
        113.03475952148438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Nevertheless, most published studies of process clearance have included some element of infectivity",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        53.78554916381836,
        522.0439453125,
        113.03475952148438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "assays. If performed, a well-characterised system of strain and indicator animal should be used.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        53.78554916381836,
        522.0439453125,
        113.03475952148438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "There is still no generally applicable in vitro test available to identify presence of infectivity and to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        119.23379516601562,
        521.9691772460938,
        166.54653930664062
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "quantify the infectivity level. A few cell lines (N2a, GT1) are susceptible and can be infected by some",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        119.23379516601562,
        521.9691772460938,
        166.54653930664062
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "TSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        119.23379516601562,
        521.9691772460938,
        166.54653930664062
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "replicate some scrapie strains.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72529602050781,
        119.23379516601562,
        521.9691772460938,
        166.54653930664062
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The alternative assay which has also featured in published studies involves the detection of PrPSc.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Currently, the exact nature of the TSE agents is still unknown although numerous experimental results",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "suggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "conformation. The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "which remove PrPc. Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "marker of infectivity. However the correlation between infectivity and PrPres varies between strains",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and possibly with the methods for measuring either parameter. These considerations affect the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "confidence with which clearance measured by removal of PrPSc can be related to the clearance of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "infectivity although the relationship has been established in specific instances in a number of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "published studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "been established, demonstration of partitioning or inactivation of infectious prion proteins by the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "biochemical assay may be sufficient.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255859375,
        171.38609313964844,
        522.0350341796875,
        327.7393798828125
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72547912597656,
        333.9383850097656,
        521.9649047851562,
        369.31268310546875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Italic",
      "bbox": [
        92.72547912597656,
        333.9383850097656,
        521.9649047851562,
        369.31268310546875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "medicinal products.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72547912597656,
        333.9383850097656,
        521.9649047851562,
        369.31268310546875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.5",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        387.07489013671875,
        256.72906494140625,
        399.5754699707031
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Choice of manufacturing steps",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        387.07489013671875,
        256.72906494140625,
        399.5754699707031
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        405.4471435546875,
        522.1073608398438,
        476.694091796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "heat, the manufacturing steps for investigation should be those where some removal or partitioning of the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        405.4471435546875,
        522.1073608398438,
        476.694091796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "agent might be expected. Thus there is little point in carrying out studies of solvent/detergent and heat",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        405.4471435546875,
        522.1073608398438,
        476.694091796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "treatment processes, and attention should be focused on ethanol fractionation, precipitation,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        405.4471435546875,
        522.1073608398438,
        476.694091796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "chromatography, and filtration steps, which have been shown in a number of studies to have significant",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        405.4471435546875,
        522.1073608398438,
        476.694091796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "capability for removal of TSE agents.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        405.4471435546875,
        522.1073608398438,
        476.694091796875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        482.8930969238281,
        522.0031127929688,
        530.2045288085938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "affected by previous treatment. For example solvent detergent treatment could disaggregate infectivity",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        482.8930969238281,
        522.0031127929688,
        530.2045288085938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "so that it more readily passes a filter and studies with untreated materials would therefore overestimate",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        482.8930969238281,
        522.0031127929688,
        530.2045288085938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the clearance.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7235107421875,
        482.8930969238281,
        522.0031127929688,
        530.2045288085938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "All manufacturers must critically evaluate their manufacturing processes in the light of published data.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72354125976562,
        536.4035034179688,
        521.98974609375,
        571.7791748046875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Guidance on the step-wise approach to product-specific investigational studies is described in Section",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72354125976562,
        536.4035034179688,
        521.98974609375,
        571.7791748046875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.2.3 of the CHMP Position Statement.1",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72354125976562,
        536.4035034179688,
        521.98974609375,
        571.7791748046875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.6",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        589.481201171875,
        287.5918884277344,
        601.9818115234375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Interpretation and limitations of data",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        589.481201171875,
        287.5918884277344,
        601.9818115234375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Viral evaluation studies of processes are subject to a number of reservations, which apply with even",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        607.913330078125,
        522.0897827148438,
        691.0980834960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "greater strength to evaluation of processes with respect to their ability to remove TSEs. They include",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        607.913330078125,
        522.0897827148438,
        691.0980834960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the following:",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        607.913330078125,
        522.0897827148438,
        691.0980834960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        607.913330078125,
        522.0897827148438,
        691.0980834960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The modeling of the process may be imperfect. Steps based on separation have been difficult to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        607.913330078125,
        522.0897827148438,
        691.0980834960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        607.913330078125,
        522.0897827148438,
        691.0980834960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "which may be particularly important in the removal of TSE agents.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72554016113281,
        607.913330078125,
        522.0897827148438,
        691.0980834960938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255630493164,
        697.2969970703125,
        522.005126953125,
        732.6707153320312
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "It has been assumed that where two steps are assessed the total clearance approximates to their",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255630493164,
        697.2969970703125,
        522.005126953125,
        732.6707153320312
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "sum. This may not be the case, in particular where the spike is heterogeneous, so that one",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255630493164,
        697.2969970703125,
        522.005126953125,
        732.6707153320312
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "fraction could be preferentially removed by one step and the same subfraction by another step.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7255630493164,
        697.2969970703125,
        522.005126953125,
        732.6707153320312
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 8/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        522.03076171875,
        89.15914916992188
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Pretreatments may affect the clearance of the agent. For example if the material is treated with",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        522.03076171875,
        89.15914916992188
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "detergent it may pass through a subsequent step such as filtration more easily than if it is not",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        522.03076171875,
        89.15914916992188
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "because of dispersal of the material.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        522.03076171875,
        89.15914916992188
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72425079345703,
        95.29824829101562,
        522.0595092773438,
        142.67044067382812
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The assays which can be used are not ideal. Infectivity assays are expensive and very slow.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72425079345703,
        95.29824829101562,
        522.0595092773438,
        142.67044067382812
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "While there is generally a correlation between PrPSc content and infectivity, the relationship",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72425079345703,
        95.29824829101562,
        522.0595092773438,
        142.67044067382812
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "may depend on the method used to measure PrPSc as well as infectivity. So far most studies have",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72425079345703,
        95.29824829101562,
        522.0595092773438,
        142.67044067382812
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "been confirmed by infectivity assays which are considered to be the most relevant.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72425079345703,
        95.29824829101562,
        522.0595092773438,
        142.67044067382812
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72698974609375,
        148.80953979492188,
        522.0271606445312,
        184.18313598632812
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "The strain and species of origin of the spike may determine the assays to be used. While so far",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72698974609375,
        148.80953979492188,
        522.0271606445312,
        184.18313598632812
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "there is no evidence of a major influence on removal steps, it is still possible that the clearance",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72698974609375,
        148.80953979492188,
        522.0271606445312,
        184.18313598632812
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "recorded may be influenced by the origin of the spike.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72698974609375,
        148.80953979492188,
        522.0271606445312,
        184.18313598632812
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The physicochemical nature of the spike may be significant. There is currently no indication of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the physicochemical form of TSE agents in blood, if present. Different membrane-containing",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "spike materials have been tested in one published study, and were cleared in very similar ways",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "adsorption) steps, the opposite can occur. The spike material providing the most rigorous test",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "may therefore vary with the process step.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72697448730469,
        190.32223510742188,
        522.0035400390625,
        273.5683288574219
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        279.767333984375,
        521.9984130859375,
        315.1409606933594
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "In animal studies the amount of agent present in the blood is low, whereas the spike added will",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        279.767333984375,
        521.9984130859375,
        315.1409606933594
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "be of as high a titre as possible. It is possible that material will be removed less effectively at",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        279.767333984375,
        521.9984130859375,
        315.1409606933594
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "low than at high concentrations.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        279.767333984375,
        521.9984130859375,
        315.1409606933594
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        321.2800598144531,
        521.9894409179688,
        368.6513977050781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Evaluation of processes for viral inactivation/removal includes an assessment of the robustness",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        321.2800598144531,
        521.9894409179688,
        368.6513977050781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of the process, for example studying the effect of modification of the process parameters. The",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        321.2800598144531,
        521.9894409179688,
        368.6513977050781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "difficulties of performing such studies with TSEs, other than by using solely in vitro assay",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72614288330078,
        321.2800598144531,
        521.9894409179688,
        368.6513977050781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "methods, means that the studies are unlikely to be repeated often.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72614288330078,
        321.2800598144531,
        521.9894409179688,
        368.6513977050781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "The confidence which can be placed on a figure for the ability of a process step to remove the agent of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7271728515625,
        374.7904968261719,
        521.92333984375,
        398.226318359375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TSE is therefore lower than for its ability to remove model viruses.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7271728515625,
        374.7904968261719,
        521.92333984375,
        398.226318359375
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.7",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        415.93011474609375,
        261.3406066894531,
        428.4306945800781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Re-evaluation of TSE clearance",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        415.93011474609375,
        261.3406066894531,
        428.4306945800781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7244873046875,
        434.3622741699219,
        521.9887084960938,
        493.6714172363281
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "production process, if significant changes are made. In view of the difficulty in performing the studies",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7244873046875,
        434.3622741699219,
        521.9887084960938,
        493.6714172363281
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "and the reservations about the results obtained, such changes would probably have to be major.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7244873046875,
        434.3622741699219,
        521.9887084960938,
        493.6714172363281
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Alternatively, developments in the scientific area could make the studies easier, for instance by",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7244873046875,
        434.3622741699219,
        521.9887084960938,
        493.6714172363281
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "making in vitro infectivity assays possible, which could justify further work.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7244873046875,
        434.3622741699219,
        521.9887084960938,
        493.6714172363281
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.8",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        511.37408447265625,
        237.90594482421875,
        523.8746948242188
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sanitisation of equipment",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        511.37408447265625,
        237.90594482421875,
        523.8746948242188
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Inactivation of prions by conventional decontamination methods has been evaluated in numerous",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "studies. TSE infectivity is particularly difficult to inactivate and some samples have been shown to be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "environmentally infectious for years. A certain number of treatments are acknowledged to be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ineffective under normal application conditions (e.g. alkylating agents, detergents) while some others",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "have been recognized as quite effective (e.g. soaking in ≥ 2% bleach or in sodium hydroxide (NaOH)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time). Some",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "procedures have been adopted as reference treatments or recommendations by WHO20 and used with",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "medical devices or wastes. However, their applicability is rather limited due to a number of reasons;",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "most methods are harsh and may well damage most biological products, they have a corrosive effect",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "on the equipment used in production or show a limited efficacy against other infectious agents (e.g.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NaOH is reported as non-sporicidal). A number of experimental treatments (e.g. alkaline cleansers,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "proteases, etc.) are under evaluation for use in cleaning and decontamination procedures but not",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "applicable yet.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        529.8062744140625,
        522.0464477539062,
        685.5188598632812
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72735595703125,
        691.7177734375,
        522.023193359375,
        727.0914916992188
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "and other materials, it is particularly important to consider the sanitisation and cleaning procedures",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72735595703125,
        691.7177734375,
        522.023193359375,
        727.0914916992188
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "used for fractionation equipment for their ability to inactivate or remove TSE agents. The sanitisation",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72735595703125,
        691.7177734375,
        522.023193359375,
        727.0914916992188
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 9/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.47802734375,
        757.3433227539062
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and reuse of columns should also be considered in the light of the effect of possible treatments on TSE",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        53.78554916381836,
        522.041015625,
        101.09695434570312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "infectivity. It should be borne in mind that many fractionation processes terminate in a depth filtration",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        53.78554916381836,
        522.041015625,
        101.09695434570312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "step, where the filter aid is discarded. If this is shown to be an effective step, it decreases the risk of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        53.78554916381836,
        522.041015625,
        101.09695434570312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "contamination of the product by any infectivity that leaches from the equipment.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        53.78554916381836,
        522.041015625,
        101.09695434570312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "difficult. A model has been developed in which a steel wire dipped in a TSE preparation can be",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "implanted in the brain of a susceptible animal which then goes on to develop disease. Sanitisation of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "the wire might be monitored by such a model by loading wires with different dilutions of agent,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "treating them and then determining the loss in infectivity resulting. An example of this approach to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "investigate novel methods of disinfection of prion-contaminated medical devices has recently been",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "published.21 The extrapolation of results from such studies to equipment at a manufacturing level may",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "be difficult. NaOH solutions are commonly used for cleaning of production equipment. Treatment",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "with 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "when adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72323608398438,
        107.29598999023438,
        522.06689453125,
        226.41677856445312
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "In view of the above considerations, no specific recommendation can be given at this time until new",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7264404296875,
        232.55587768554688,
        521.942138671875,
        255.99166870117188
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "scientific information relevant to plasma processing equipment becomes available.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7264404296875,
        232.55587768554688,
        521.942138671875,
        255.99166870117188
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.",
      "font_size": 11.275192260742188,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        273.69378662109375,
        255.11227416992188,
        286.1943664550781
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SUMMARY / CONCLUSION",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72530364990234,
        273.69378662109375,
        255.11227416992188,
        286.1943664550781
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "All manufacturers must critically evaluate their manufacturing processes in the light of published data.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Guidance on the step-wise approach to product-specific investigational studies is described in Section",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Different preparations of spiking agents can be used. The spike preparation(s) that will provide the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "greatest challenge to the process step(s) under investigation should be selected in order to evaluate",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "under worst case conditions. The rationale for the choice of strain and preparations should be given in",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "all cases.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72552490234375,
        292.1259460449219,
        522.0275268554688,
        387.3088073730469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "It is recognised that there are limitations of the data because of the model character and",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        393.5078125,
        521.9735107421875,
        440.8192443847656
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "approximations that are linked to feasible experimental studies. However, it is expected that these",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        393.5078125,
        521.9735107421875,
        440.8192443847656
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "investigational studies will provide a helpful indication on the capacity for removal of the TSE agent",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        393.5078125,
        521.9735107421875,
        440.8192443847656
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "during manufacture of plasma-derived medicinal products.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        393.5078125,
        521.9735107421875,
        440.8192443847656
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "References",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman,Bold",
      "bbox": [
        92.72589111328125,
        458.5367126464844,
        143.40225219726562,
        469.9748229980469
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        476.05401611328125,
        522.0436401367188,
        511.42926025390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        476.05401611328125,
        522.0436401367188,
        511.42926025390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        476.05401611328125,
        522.0436401367188,
        511.42926025390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72589111328125,
        476.05401611328125,
        522.0436401367188,
        511.42926025390625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72671508789062,
        517.568359375,
        521.976318359375,
        541.0042114257812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72671508789062,
        517.568359375,
        521.976318359375,
        541.0042114257812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-529.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72671508789062,
        517.568359375,
        521.976318359375,
        541.0042114257812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        547.1432495117188,
        522.047607421875,
        582.5169067382812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distribution",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        547.1432495117188,
        522.047607421875,
        582.5169067382812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of infectivity in blood components and plasma derivatives in experimental models of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        547.1432495117188,
        522.047607421875,
        582.5169067382812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "transmissible spongiform encephalopathy. Transfusion 1998;38:810-816",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        547.1432495117188,
        522.047607421875,
        582.5169067382812
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        588.7158203125,
        522.0259399414062,
        636.0272827148438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH. Further studies",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        588.7158203125,
        522.0259399414062,
        636.0272827148438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        588.7158203125,
        522.0259399414062,
        636.0272827148438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        588.7158203125,
        522.0259399414062,
        636.0272827148438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Transfusion 1999;39:1169-1178",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72566223144531,
        588.7158203125,
        522.0259399414062,
        636.0272827148438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72565460205078,
        642.2261962890625,
        519.3187866210938,
        665.6021728515625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Taylor DM, Fernie K, Reichl HE, Somerville RA. Infectivity in the blood of mice with a BSE-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72565460205078,
        642.2261962890625,
        519.3187866210938,
        665.6021728515625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "derived agent. Journal of Hospital Infection 2000;46:78.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72565460205078,
        642.2261962890625,
        519.3187866210938,
        665.6021728515625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72565460205078,
        671.8011474609375,
        521.9280395507812,
        707.1748046875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72565460205078,
        671.8011474609375,
        521.9280395507812,
        707.1748046875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72565460205078,
        671.8011474609375,
        521.9280395507812,
        707.1748046875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "strains of transmissible spongiform encephalopathy. Transfusion 2003;43:1687-1694.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72565460205078,
        671.8011474609375,
        521.9280395507812,
        707.1748046875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP/BWP/5136/03",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.4786376953125,
        757.3433227539062
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EMEA 2004",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.4786376953125,
        757.3433227539062
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Page 10/10",
      "font_size": 7.4979448318481445,
      "font_name": "Arial",
      "bbox": [
        92.72530364990234,
        748.1471557617188,
        521.4786376953125,
        757.3433227539062
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        521.9605712890625,
        89.15914916992188
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        521.9605712890625,
        89.15914916992188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "transmission of bovine spongiform encephalopathy to the primate Microcebus murinus.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        521.9605712890625,
        89.15914916992188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Transfusion 2002;42:513-516",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72530364990234,
        53.78554916381836,
        521.9605712890625,
        89.15914916992188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72632598876953,
        95.29824829101562,
        522.0067749023438,
        130.67184448242188
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72632598876953,
        95.29824829101562,
        522.0067749023438,
        130.67184448242188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Transmission of prion diseases by blood transfusion. Journal of General Virology",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72632598876953,
        95.29824829101562,
        522.0067749023438,
        130.67184448242188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2002;83:2897-2905",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72632598876953,
        95.29824829101562,
        522.0067749023438,
        130.67184448242188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72632598876953,
        136.87088012695312,
        521.9244384765625,
        160.24679565429688
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72632598876953,
        136.87088012695312,
        521.9244384765625,
        160.24679565429688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "infectivity in extraneural tissues. Lancet 2001;358:208-209",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72632598876953,
        136.87088012695312,
        521.9244384765625,
        160.24679565429688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72633361816406,
        166.44583129882812,
        521.9706420898438,
        189.82174682617188
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL. Factor VIII and transmissible",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72633361816406,
        166.44583129882812,
        521.9706420898438,
        189.82174682617188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "spongiform encephalopathy: the case for safety. Haemophilia 2002;8:63-75",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72633361816406,
        166.44583129882812,
        521.9706420898438,
        189.82174682617188
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528076171875,
        196.02078247070312,
        521.97412109375,
        231.33450317382812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG. Possible",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528076171875,
        196.02078247070312,
        521.97412109375,
        231.33450317382812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 2004;363:417-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528076171875,
        196.02078247070312,
        521.97412109375,
        231.33450317382812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "421.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528076171875,
        196.02078247070312,
        521.97412109375,
        231.33450317382812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        237.53353881835938,
        522.010009765625,
        260.9094543457031
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        237.53353881835938,
        522.010009765625,
        260.9094543457031
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "blood safety. Clin Lab Med 2003;23:129-37.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        237.53353881835938,
        522.010009765625,
        260.9094543457031
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CPMP Note for guidance on virus validation studies: the design, contribution and interpretation",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "studies",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "validating",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "inactivation",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "and",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "removal",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "viruses,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "February",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(CPMP/BWP/268/95)",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72528839111328,
        267.1084899902344,
        522.0410766601562,
        314.419921875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        320.6189270019531,
        522.1099243164062,
        355.9925537109375
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        320.6189270019531,
        522.1099243164062,
        355.9925537109375
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "forms of the pathogenic prion protein during the purification of therapeutic proteins from human",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        320.6189270019531,
        522.1099243164062,
        355.9925537109375
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "plasma. Transfusion 2002;42:1497-1500",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        320.6189270019531,
        522.1099243164062,
        355.9925537109375
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        362.13165283203125,
        521.9563598632812,
        385.5674743652344
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. The",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        362.13165283203125,
        521.9563598632812,
        385.5674743652344
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Veterinary Journal 2000;159:10-17.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        362.13165283203125,
        521.9563598632812,
        385.5674743652344
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        391.7065734863281,
        521.9696655273438,
        439.0779113769531
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        391.7065734863281,
        521.9696655273438,
        439.0779113769531
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Characterization of thermodynamic diversity between transmissible spongiform encephalopathy",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        391.7065734863281,
        521.9696655273438,
        439.0779113769531
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "agent strains and its theoretical implications. Journal of Biological Chemistry 2002;277:11084-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        391.7065734863281,
        521.9696655273438,
        439.0779113769531
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11089.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72525787353516,
        391.7065734863281,
        521.9696655273438,
        439.0779113769531
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        445.2170104980469,
        521.9810791015625,
        468.65283203125
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        445.2170104980469,
        521.9810791015625,
        468.65283203125
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "plasma protein purification. Biologicals 2002;30:187-196.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        445.2170104980469,
        521.9810791015625,
        468.65283203125
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        474.79193115234375,
        519.360595703125,
        498.2277526855469
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell-",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        474.79193115234375,
        519.360595703125,
        498.2277526855469
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "based infectivity assay for mouse scrapie prions. Proc. Natl. Acad. Sci. 2003;100:11666-11671.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        474.79193115234375,
        519.360595703125,
        498.2277526855469
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "19.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        504.3668518066406,
        522.03466796875,
        551.7382202148438
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        504.3668518066406,
        522.03466796875,
        551.7382202148438
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Rubenstein R, Fournel M, Petteway SR. A direct relationship between the partitioning of the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        504.3668518066406,
        522.03466796875,
        551.7382202148438
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        504.3668518066406,
        522.03466796875,
        551.7382202148438
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "purification of plasma proteins. Transfusion 2001;41:449-455.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.72522735595703,
        504.3668518066406,
        522.03466796875,
        551.7382202148438
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        557.877197265625,
        295.19781494140625,
        569.3153686523438
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WHO Laboratory Biosafety Manual 2003",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        557.877197265625,
        295.19781494140625,
        569.3153686523438
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "21.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        575.5143432617188,
        521.1828002929688,
        610.8880004882812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P,",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        575.5143432617188,
        521.1828002929688,
        610.8880004882812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lasmézas CI, Deslys J-P. Novel methods for disinfection of prion-contaminated medical",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        575.5143432617188,
        521.1828002929688,
        610.8880004882812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "devices. Lancet 2004;364:521-526.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        575.5143432617188,
        521.1828002929688,
        610.8880004882812
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        615.7321166992188,
        480.94818115234375,
        640.4674682617188
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        615.7321166992188,
        480.94818115234375,
        640.4674682617188
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "proteinase K. Journal of General Virology 2003,84:3173-3176.",
      "font_size": 10.31684398651123,
      "font_name": "TimesNewRoman",
      "bbox": [
        92.7242202758789,
        615.7321166992188,
        480.94818115234375,
        640.4674682617188
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 39 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품국에서 발간한 행정간행물 목록",
      "font_size": 15.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        141.6020050048828,
        99.10098266601562,
        453.60107421875,
        115.06098937988281
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품 카다로그 시리즈",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        148.71530151367188,
        323.4018249511719,
        161.67530822753906
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        148.71530151367188,
        323.4018249511719,
        161.67530822753906
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가가이드 시리즈",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        416.914306640625,
        258.3627624511719,
        429.8742980957031
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.68009948730469,
        416.914306640625,
        258.3627624511719,
        429.8742980957031
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        175.77035522460938,
        515.760986328125,
        198.80848693847656
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "카다로그 (2008)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        211.52810668945312,
        527.00634765625,
        234.4490509033203
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "카다로그 (2006)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/159",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92236328125,
        248.61007690429688,
        527.0067749023438,
        271.648193359375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "카다로그 (2004)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품규격과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/56",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92205810546875,
        285.8092346191406,
        527.0064697265625,
        308.73016357421875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "카다로그 (2003)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2003",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품규격과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/43",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92166137695312,
        322.89117431640625,
        527.0060424804688,
        345.8081970214844
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품 국가표준품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "카다로그 (2002)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000547-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스제제과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/22, 23",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9212646484375,
        359.96917724609375,
        527.005126953125,
        383.0112609863281
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        439.5283508300781,
        515.760986328125,
        462.4492492675781
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국제공통기술문서 작성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인 해설",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-III. 품질",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001625-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "34)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.68013763427734,
        486.8095703125,
        352.6916809082031,
        522.8085327148438
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0391845703125,
        473.8486022949219,
        452.0382385253906,
        535.7694091796875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/315",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6016845703125,
        493.2899169921875,
        527.0064086914062,
        516.3280029296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HBsAg 진단제제의 기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 시험방법 작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000143-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "33)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/289",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.55888366699219,
        549.9304809570312,
        527.0064086914062,
        572.9685668945312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈장수출업소 실태조사",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001627-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/234",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92172241210938,
        587.129638671875,
        527.0057983398438,
        610.050537109375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HIV, HBV, HCV, HTLV",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관련 체외진단용의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 심사평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.07778930664062,
        622.770263671875,
        182.7565460205078,
        671.7301025390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001622-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "31)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/252",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5582275390625,
        635.7310791015625,
        527.0055541992188,
        658.7691650390625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대유행 인플루엔자 백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 평가 가이드 안",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001621-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/228",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4798583984375,
        684.44970703125,
        527.0053100585938,
        707.48779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자가품질관리요약서(",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001620-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가가이드 29)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/227",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        75.71791076660156,
        721.6488037109375,
        527.0057983398438,
        744.5697631835938
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 40 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불활화 인플루엔자백신",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001587-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "28)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/226",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92193603515625,
        140.61050415039062,
        527.0059814453125,
        163.53150939941406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당단백질의약품의 당구조",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석 시험법 길라잡이",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001589-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "27)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/280",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99929809570312,
        177.68844604492188,
        527.0050659179688,
        200.6094512939453
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "류마티스관절염 치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상평가지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001432-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "26)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/190",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.92034912109375,
        214.77041625976562,
        527.00439453125,
        237.8085479736328
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분획용 혈장 마스터 파일",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001560-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/210",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99771118164062,
        251.96957397460938,
        527.0035400390625,
        274.8905029296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인플루엔자백신의 자가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준 및 시험방법 작성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침 개정판",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001468-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/197",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91885375976562,
        289.0515441894531,
        527.0028686523438,
        325.05047607421875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HIV 항체 진단제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "’",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001462-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/196",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.6763916015625,
        339.2076721191406,
        527.0027465820312,
        375.0894775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세균백신 자가 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 작성 지침서",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001428-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/177",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.91802978515625,
        389.2505187988281,
        527.0018310546875,
        412.2886657714844
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이오 칩 평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-HPV DNA칩 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 작성 지침-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001165-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "21)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/154",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9171142578125,
        426.44970703125,
        527.0010986328125,
        462.3276062011719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈장분획제제 등 바이러스",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검증 평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001176-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/170",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47540283203125,
        476.4886474609375,
        527.0006713867188,
        499.53070068359375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자재조합의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산용 세포의 발현구조체",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석 및 안정성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.47494506835938,
        513.6878662109375,
        189.35682678222656,
        562.6477661132812
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001116-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "19)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/229",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55307006835938,
        526.648681640625,
        527.0004272460938,
        549.569580078125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전재재조합의약품 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단클론항체의약품의 제조",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 품질관리 자료에 관한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99382781982422,
        576.8087768554688,
        186.95382690429688,
        625.7686157226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000902-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/139",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.55242919921875,
        589.7695922851562,
        526.9996948242188,
        612.6904907226562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이종이식제제의 전임상 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험에 대한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001088-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4739990234375,
        665.8477172851562,
        352.6846008300781,
        688.8897094726562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품안전팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학지원팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0321044921875,
        639.9296875,
        452.0311584472656,
        714.8074951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/130",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5946044921875,
        672.3280029296875,
        526.9993286132812,
        695.3699951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 41 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이종이식제제의 품질관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 이식 후 감염관리에",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001086-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99993896484375,
        160.05203247070312,
        352.691162109375,
        196.0509796142578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품안전팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학지원팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0386962890625,
        140.61050415039062,
        452.0377502441406,
        215.48817443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/130",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6011962890625,
        173.00869750976562,
        527.0059204101562,
        196.05067443847656
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이종이식제제의 범위 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료동물에 대한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001087-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.398193359375,
        255.68832397460938,
        352.6908264160156,
        278.6092529296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품안전팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품관리팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학지원팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.038330078125,
        229.64920043945312,
        452.0373840332031,
        304.64794921875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/130",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.600830078125,
        262.1684875488281,
        527.0055541992188,
        285.08935546875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "암치료를 위한 수지상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제 평가 시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000888-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.44082641601562,
        318.8090515136719,
        352.69061279296875,
        354.80804443359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        362.0380859375,
        320.1293029785156,
        452.0371398925781,
        353.48779296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/116",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.6005859375,
        325.28948974609375,
        527.0053100585938,
        348.21038818359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이오칩 평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-DNA칩의 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 작성지침-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000896-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9595947265625,
        368.9692077636719,
        352.6898498535156,
        404.85101318359375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물진단제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품규격과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.119384765625,
        369.9300537109375,
        448.0953369140625,
        403.8564147949219
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/110",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5998840332031,
        375.449462890625,
        527.0045776367188,
        398.370361328125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제의 복제가능",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스 시험법에 관한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000877-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.99789428710938,
        419.008056640625,
        350.29132080078125,
        455.0109558105469
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        366.11907958984375,
        420.32830810546875,
        448.09503173828125,
        453.6907043457031
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/118",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.5995788574219,
        425.488525390625,
        527.0042724609375,
        448.530517578125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험용",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제의 특성분석,",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조 및 품질관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.3184814453125,
        469.168212890625,
        188.60595703125,
        518.1281127929688
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000876-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/107",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.556884765625,
        482.1290283203125,
        527.004150390625,
        505.1671447753906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "두창백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가시 고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000872-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/105",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.03643798828125,
        532.2891235351562,
        527.0034790039062,
        555.2100219726562
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단클론항체의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000851-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.477783203125,
        582.4491577148438,
        349.8118591308594,
        605.3700561523438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국립독성연구원",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생화학약리과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        367.075927734375,
        569.3670654296875,
        446.9968566894531,
        618.3269653320312
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/74",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        459.599365234375,
        582.448974609375,
        527.0040893554688,
        605.3698120117188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TNF 길항제 사용시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잠복결핵 치료지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000686-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/65",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.07557678222656,
        632.4879150390625,
        527.0045166015625,
        655.5299682617188
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DNA 백신의 평가지침서",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000669-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/60",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.15813446044922,
        669.6871337890625,
        527.00439453125,
        692.6080322265625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물학적제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격설정에 관한 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000538-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/59",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        74.39651489257812,
        706.7691650390625,
        527.0045776367188,
        742.7681274414062
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 42 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가자료집 시리즈",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.67969512939453,
        384.8751525878906,
        258.36236572265625,
        397.83514404296875
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3.",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        64.67969512939453,
        384.8751525878906,
        258.36236572265625,
        397.83514404296875
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.9218978881836,
        106.29037475585938,
        515.760986328125,
        129.2112579345703
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핵산증폭검사법 검증",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2003",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000277-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/44",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.9609375,
        140.61050415039062,
        527.0067138671875,
        163.53150939941406
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈장분획제제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000154-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈액제제과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/27",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92233276367188,
        177.68844604492188,
        527.0073852539062,
        200.6094512939453
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포주로부터 개발한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물공학제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스안전성 평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.96160888671875,
        214.77041625976562,
        176.88255310058594,
        263.73028564453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000144-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스제제과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/19",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        196.5592041015625,
        227.84841918945312,
        527.00732421875,
        250.76930236816406
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품의 생산에",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용되는 세포기질관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2002",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000140-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물공학과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/17",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.9224853515625,
        277.8912658691406,
        527.0073852539062,
        313.8902587890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질평가 가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2001",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000074-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가가이드",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물공학과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/54",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.92303466796875,
        328.0513610839844,
        527.0081787109375,
        350.9683837890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        411.329345703125,
        515.1589965820312,
        434.250244140625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제의 임상시험",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001586-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/259",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3199462890625,
        447.09100341796875,
        526.4039916992188,
        470.011962890625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제의 비임상시험",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001585-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "49)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/259",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39730834960938,
        487.0518493652344,
        526.4032592773438,
        509.9689025878906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산세포주 관리를 위한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000903-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "48)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/236",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.7994613647461,
        527.0088500976562,
        526.4030151367188,
        562.8906860351562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제의 자가 기준 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001457-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "47)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/195",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39633178710938,
        579.9306030273438,
        526.4021606445312,
        602.96875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈관질환 등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비임상 임상시험 사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "∙",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001441-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "46)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/233",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07521057128906,
        619.8915405273438,
        526.4013671875,
        655.8905029296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항암 유전자치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비임상 임상시험 사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "∙",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001440-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/209",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.07438659667969,
        672.9304809570312,
        526.4005126953125,
        695.8513793945312
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신 임상 평가 시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항 2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001446-10",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "44)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/192",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        86.39382934570312,
        712.8912963867188,
        526.3997192382812,
        735.808349609375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 43 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생바이러스 백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자가 기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001345-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "43)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/172",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.3198471069336,
        140.61001586914062,
        526.40380859375,
        176.4878692626953
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불활화 바이러스 백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자가 기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001346-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "42)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/173",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.80010986328125,
        193.52786254882812,
        526.403564453125,
        229.5307159423828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신의 임상 평가 시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001163-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "41)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침 150",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.35787963867188,
        246.44955444335938,
        526.4027709960938,
        269.4876708984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DNA 백신의 평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WHO 및 미국",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FDA",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001142-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/168",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        84.35697937011719,
        286.5276794433594,
        526.4019165039062,
        322.409423828125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료 임상시험-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지연성 이상반응에 대비한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자 관찰",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001141-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "39)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/157",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87622833251953,
        339.44940185546875,
        526.4015502929688,
        375.4483947753906
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성평가 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001140-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "38)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/169",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87591552734375,
        392.36724853515625,
        526.4012451171875,
        415.4093017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 및 품질",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001146-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/148",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.99665069580078,
        432.3281555175781,
        526.4010009765625,
        468.3271484375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 품질 평가시 고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001145-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/147",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43731689453125,
        485.3671569824219,
        526.4002685546875,
        521.3700561523438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(세포치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조직공학제제,",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이종이식제제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.4762191772461,
        551.3671264648438,
        188.15496826171875,
        600.3269653320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001144-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95672607421875,
        564.3279418945312,
        352.08935546875,
        587.2488403320312
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        361.4368896484375,
        538.2888793945312,
        451.4359436035156,
        613.2877197265625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/146",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        458.99554443359375,
        564.3277587890625,
        526.4002685546875,
        587.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물 생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "독성평가 사례분석 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001143-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "34)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/145",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.35494232177734,
        630.3276977539062,
        526.4000244140625,
        653.2485961914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "만성 피부 궤양 및 화상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료제 개발을 위한",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전임상 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상 관련",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        73.79629516601562,
        670.2886352539062,
        183.8344268798828,
        719.2484741210938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001228-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "33)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포조직공학제제팀 자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/144",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95643615722656,
        683.2494506835938,
        526.39990234375,
        706.1664428710938
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 44 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국 약전 세포치료제,",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직공학제제의 보조물질",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(ancillary product)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.83905792236328,
        140.61001586914062,
        184.79905700683594,
        202.5307159423828
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001109-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "32)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/143",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96026611328125,
        160.05117797851562,
        526.4037475585938,
        182.96815490722656
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국 약전 세포치료제 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-001108-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "31)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포조직공학제제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전자치료제팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침 142",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.3580322265625,
        219.57058715820312,
        526.403076171875,
        242.4876251220703
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001125-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세균백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/141",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51797485351562,
        259.5274963378906,
        526.4027709960938,
        282.44842529296875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인플루엔자 백신",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자가 기준 및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-001114-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "29)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이러스백신팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/138",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31808471679688,
        299.4883728027344,
        526.4020385742188,
        335.4873352050781
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품 허가를",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위한 Q&A",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000895-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침127",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31735229492188,
        352.4100646972656,
        526.4013061523438,
        375.44818115234375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품 길라잡이",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000893-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "27)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재조합의약품팀",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/109",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.39471435546875,
        392.3670959472656,
        526.4010620117188,
        415.4090881347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KFDA Bio Handbook",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000873-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "26)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/91",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.31637573242188,
        432.3280334472656,
        526.4008178710938,
        455.3700256347656
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 평가 -",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비교동등성 평가시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        79.91812133789062,
        472.4100341796875,
        177.8228302001953,
        521.3699340820312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000871-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/103",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.95721435546875,
        485.366943359375,
        526.4005737304688,
        508.2878723144531
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000677-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "24)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/104",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87493896484375,
        538.2887573242188,
        526.4002685546875,
        561.3268432617188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000870-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/102",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51556396484375,
        578.2495727539062,
        526.4003295898438,
        601.2876586914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "탄저백신의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000867-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/99",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.4366455078125,
        618.2064819335938,
        526.3994750976562,
        641.24853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인플루엔자백신의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 평가 2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000866-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "21)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/98",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.51390075683594,
        658.2884521484375,
        526.3986206054688,
        681.2093505859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항암 생물의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000865-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/101",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        85.435791015625,
        698.249267578125,
        526.3986206054688,
        721.1663208007812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 45 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우수심사기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000684-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/100",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        98.87893676757812,
        140.61001586914062,
        526.404296875,
        163.5309600830078
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람 세포",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직유래제품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 미",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FDA",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시설등록 및 등재 규정",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000860-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인체조직정보",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방 자료게시판",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.55859375,
        180.57083129882812,
        526.8721313476562,
        216.44874572753906
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사람 세포",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조직유래제품 제조시설의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FDA 우수조직관리기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000859-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인체조직정보",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방 자료게시판",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        69.00022888183594,
        233.48861694335938,
        526.8720092773438,
        269.4876708984375
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세포치료제 및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제 자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000685-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/78",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3597412109375,
        286.5274963378906,
        526.4050903320312,
        309.448486328125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료용",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3상 임상시험계획승인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신청시 고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.92229461669922,
        326.4883728027344,
        186.72213745117188,
        375.4482727050781
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000684-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/84",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        195.96173095703125,
        339.4491882324219,
        526.4050903320312,
        362.3701171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1상",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험계획 승인 신청시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000683-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/83",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.8788070678711,
        392.3670959472656,
        526.4041748046875,
        428.3699951171875
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품등의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효능입증을 위한 고려사항 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000682-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "13)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/82",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        68.87848663330078,
        445.4099426269531,
        526.40380859375,
        468.3269958496094
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 전반적인",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000681-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/79",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        81.3580322265625,
        485.36688232421875,
        526.4029541015625,
        508.287841796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품의 독성평가",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사례분석",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000680-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/77",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        76.31817626953125,
        525.3277587890625,
        526.402099609375,
        548.2487182617188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈액제제의 안전성 유효성",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000679-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/76",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        70.43832397460938,
        565.2886352539062,
        526.4011840820312,
        588.2095336914062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 유효성 평가시",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려사항 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000678-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/75",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        80.51599884033203,
        605.24951171875,
        526.400634765625,
        641.2484741210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유전자치료제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성평가 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000677-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/72",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        89.87490844726562,
        658.2884521484375,
        526.400146484375,
        681.2094116210938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성평가(4)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/71",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.79635620117188,
        698.2493286132812,
        526.3998413085938,
        721.1663208007812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 46 -",
      "font_size": 9.960000038146973,
      "font_name": "TT2C5D44B5tCID",
      "bbox": [
        282.60198974609375,
        789.4503784179688,
        312.5429382324219,
        799.4103393554688
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 제목",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연도",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행정간행물 번호",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "홈페이지",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재 상태",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        91.32029724121094,
        104.84835815429688,
        515.1589965820312,
        127.76924133300781
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성평가(3)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/70",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80093383789062,
        140.60989379882812,
        526.4044189453125,
        163.53089904785156
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성평가(2)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침/69",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80062866210938,
        180.57064819335938,
        526.4041137695312,
        203.4877471923828
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생명공학의약품의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성평가(1)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000676-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/68",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        88.80032348632812,
        220.52749633789062,
        526.40380859375,
        243.44850158691406
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신의 안전성평가 2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000675-14",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품평가과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/67",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.3580322265625,
        260.4883728027344,
        526.4028930664062,
        283.4093017578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진단제제의",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HBsAg",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 시험방법",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "’ 작성 지침",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000143-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "백신과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료실 간행물",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침/48",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        71.27931213378906,
        300.4491271972656,
        526.40234375,
        323.3701171875
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포치료제 조직공학제품",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․",
      "font_size": 9.960000038146973,
      "font_name": "TTA184C656tCID32K",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발동향 및 안전관리",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2003",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11-1470000-000275-01",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(생물의약품평가자료집",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생명공학의약품과",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물공학과",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ")",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "舊",
      "font_size": 8.039999961853027,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        72.95852661132812,
        340.40997314453125,
        495.8235778808594,
        363.3269958496094
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편 집 위 원 장",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.31999969482422,
        198.01922607421875,
        266.3980712890625,
        210.01922607421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김 승 희",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.31999969482422,
        198.01922607421875,
        266.3980712890625,
        210.01922607421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.31999969482422,
        198.01922607421875,
        266.3980712890625,
        210.01922607421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "집",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "강석연 김순남 오호정",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김정환 김영림",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        106.32000732421875,
        241.21844482421875,
        439.944091796875,
        253.21844482421875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김판순",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이내리 김관수 조민주",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김진아",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ",",
      "font_size": 12.0,
      "font_name": "TT6B7C195EtCID",
      "bbox": [
        220.32000732421875,
        262.820068359375,
        438.483154296875,
        274.820068359375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈장분획제제 제조공정 중 감염성 프리온 단백",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        82.55860137939453,
        476.1177062988281,
        512.6376342773438,
        522.1968383789062
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제거 조사연구 가이드라인",
      "font_size": 20.040000915527344,
      "font_name": "TTBB48454EtCID",
      "bbox": [
        82.55860137939453,
        476.1177062988281,
        512.6376342773438,
        522.1968383789062
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "════════════════════════════════════════════",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.64069366455078,
        528.3289794921875,
        517.5616455078125,
        538.2889404296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "년",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "월",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32039642333984,
        546.2732543945312,
        298.3195495605469,
        559.2332153320312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038879394531,
        569.6755981445312,
        324.96405029296875,
        582.6355590820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038879394531,
        569.6755981445312,
        324.96405029296875,
        582.6355590820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038879394531,
        569.6755981445312,
        324.96405029296875,
        582.6355590820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038879394531,
        569.6755981445312,
        324.96405029296875,
        582.6355590820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전청",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038879394531,
        569.6755981445312,
        324.96405029296875,
        582.6355590820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038879394531,
        569.6755981445312,
        324.96405029296875,
        582.6355590820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038116455078,
        593.0740356445312,
        370.44451904296875,
        606.0339965820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038116455078,
        593.0740356445312,
        370.44451904296875,
        606.0339965820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038116455078,
        593.0740356445312,
        370.44451904296875,
        606.0339965820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038116455078,
        593.0740356445312,
        370.44451904296875,
        606.0339965820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물의약품국 혈액제제과",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038116455078,
        593.0740356445312,
        370.44451904296875,
        606.0339965820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32038116455078,
        593.0740356445312,
        370.44451904296875,
        606.0339965820312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "════════════════════════════════════════════",
      "font_size": 9.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        77.64077758789062,
        616.5281372070312,
        517.5617065429688,
        626.4880981445312
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        634.476318359375,
        396.47991943359375,
        647.436279296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "락",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        634.476318359375,
        396.47991943359375,
        647.436279296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        634.476318359375,
        396.47991943359375,
        647.436279296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전청 혈액제제과",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        634.476318359375,
        396.47991943359375,
        647.436279296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ":",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        634.476318359375,
        396.47991943359375,
        647.436279296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        657.8746948242188,
        348.5801086425781,
        670.8346557617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        657.8746948242188,
        348.5801086425781,
        670.8346557617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        657.8746948242188,
        348.5801086425781,
        670.8346557617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호 :",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        657.8746948242188,
        348.5801086425781,
        670.8346557617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "02) 380-1715, 1765",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32048034667969,
        657.8746948242188,
        348.5801086425781,
        670.8346557617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팩",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32047271728516,
        681.2731323242188,
        307.78656005859375,
        694.2330932617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32047271728516,
        681.2731323242188,
        307.78656005859375,
        694.2330932617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32047271728516,
        681.2731323242188,
        307.78656005859375,
        694.2330932617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호 :",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32047271728516,
        681.2731323242188,
        307.78656005859375,
        694.2330932617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "02) 386-6584",
      "font_size": 12.960000038146973,
      "font_name": "TT1A7AAC74tCID",
      "bbox": [
        106.32047271728516,
        681.2731323242188,
        307.78656005859375,
        694.2330932617188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    }
  ],
  "markdown_content": "<!-- PAGE_1 -->\n# 혈장분획제제 제조공정 중 감염성\n\n<!-- PAGE_1 -->\n# 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n2009\n\n제·개정 이력서\n\n연번\n\n제·개정번호\n\n승인일자\n\n주요내용\n\n1\n\nB1-2009-3-020\n\n- 2009.\n제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n**[표 시작]**\n\n| 6. | The physicochemical nature of the spike may be significant. There is currently no indication of | the physicochemical form of TSE agents in blood, if present. Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g. | adsorption) steps, the opposite can occur. The spike material providing the most rigorous test | may therefore vary with the process step. | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11. | Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG. Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 2004;363:417- | 421. |\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | . | ℃ | 뇌 조직 균질액 동량을 주입한다. | 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | . | 생화학적 시험법에 사용한다. | 지침서ㆍ안내서가 있습니까? |\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs). |\n| 다. | 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1. | 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates. The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells. | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4. | (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다. | reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available. |\n| i) | the strain of the inoculum and the species in which it was prepared; | 12. | Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety. Clin Lab Med 2003;23:129-37. | 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다. 또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1. | 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | . | 3.3. Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.  The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food. | 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다. | ․ | 여압을 차단하여 준다 | . 그 작동 여부는 경보기를 통하여 알 수 있다 | . |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1. 생물시험법 | (bioassay) | ii) | its physicochemical nature. | Only those steps which are likely to contribute to inactivation/removal need to be investigated. TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products. Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration. |\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc. | 13. | CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | . | 택에 대한 이론적 근거를 제시하여야 한다. | GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1. 종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | . | 4. | SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7. | In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible. It is possible that material will be removed less effectively at | low than at high concentrations. |\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation. It represents forms not associated with cells or membranes. It | is not clear whether such preparations resemble material which could occur naturally. |\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur. In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products. | All manufacturers must critically evaluate their manufacturing processes in the light of published data. | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds. | Different preparations of spiking agents can be used. The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. The rationale for the choice of strain and preparations should be given in | all cases. | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | . 혈청 표본도 주기적으로 수집할 수 있다 | . | 따라 달라질 수 있다. |\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. | 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma. The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons. While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory. In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain. The assay of the material is again potentially difficult. This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie. Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g. scrapie, familial CJD, BSE or vCJD). As they differ in their pathology and strain characteristics, | several strains have been investigated. The principles involved in their assay are well established. In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds. The rationale for the choice of strain should be given in all cases. |\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? |\n| 시험법 선택 | 4. | 자료의 해석과 제한사항 | 6. | 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | . | 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | . 각 실험군마다 평균 잠복기를 계산하여야 한다 | . |\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | . | 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14. | Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma. Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513). Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay. It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters. Therefore, | in-process limits are important for the design of investigational studies for partitioning steps. The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay. | Reduction factors <1 log are not significant. | 8. | Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters. The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often. | 기 전에 반드시 손을 씻는다. | 있어야 한다. | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다. | 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products. | As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | . | 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | . | Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products. | Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations. Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred. In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions. Other types of spikes are also possible. | 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | . | Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다. | 면에서 더욱 주의가 필요하다. | 기타 시험법 | 4.2. | 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다. | 15. | Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. The | Veterinary Journal 2000;159:10-17. | 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다. | 하며 출입문 가까이에 위치하여야 한다. | 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다. | 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다. |\n| 용어 정의 | 2. | mouse)를 사용한다 | . | pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses. | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2. | homogenizer | stereotaxic apparatus | 가능해야 한다. |\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16. | Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG. | Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications. Journal of Biological Chemistry 2002;277:11084- | 11089. | DISCUSSION IN THE BWP | June–November 2003 | 내용입니까? |\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies. However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products. |\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | . | - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | . | 물질 선택 | - Spiking | 서 수행한다 | . 일반 실험대에서는 어떠한 작업도 수행하지 않는다 | . | 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다. |\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected. Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents. | 은 측정용 기기를 사용한다. | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma. The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. The rationale for the choice of preparations should be given in all cases. | TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1. | strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | . | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2. | 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | . | 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | . | 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made. In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major. | Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work. | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps. | The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples. Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors. Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step). An investigation study | that encompasses the entire process would be an ideal goal. However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps. | 17. | Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification. Biologicals 2002;30:187-196. | 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다. | 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다. | 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | . | ℃ | 정리한 자료입니까? |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다. |\n| 자료의 해석과 제한사항 | - | 다. | DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다. | 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | . | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. | 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18. | Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions. Proc. Natl. Acad. Sci. 2003;100:11666-11671. | 1. | CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III. 품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment. For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance. | EMEA EXPERT WORKSHOP | January 2004 | 한다. | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | . | ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | . | 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다. | 증폭시키는 방법이다. |\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | . | Infectivity assays are accepted as the gold standard for the detection of TSE agents. The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent. Infectivity is measured by | end point titration in animals. The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity. The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed. For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used. This is one of | the factors in the selection of the spiking agent discussed above. However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g. hamster model, 263K), and | up to 15-18 months for non-transgenic murine models. In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal. In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study. This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs. | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19. | Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR. A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins. Transfusion 2001;41:449-455. | Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country. | Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable. If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation. |\n| 것이 충분할 수 있다. | 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | . | 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다. | DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다. | 사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용) |\n| 2. | Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-529. | 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다. | 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4. 정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | . | Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown. It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain. However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated. It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material. On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood. It is important to consider carefully the various possible physical types of spiking | agent. | Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies. TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years. A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g. alkylating agents, detergents) while some others | have been recognized as quite effective (e.g. soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time). Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes. However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g. | NaOH is reported as non-sporicidal). A number of experimental treatments (e.g. alkaline cleansers, | proteases, etc.) are under evaluation for use in cleaning and decontamination procedures but not | applicable yet. | 고 | , 감독 및 처리가 수행되어져야 한다 | . |\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다. | All manufacturers must critically evaluate their manufacturing processes in the light of published data. | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | . | TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3. | Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy. Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | . | 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까? (민원인용) |\n| 규모 축소 공정 | 2. | 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | . |\n| 감염성 프리온 단백 제조방법 | 3. | 20. | WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | . | 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7. | 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | . | 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21. | Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P. Novel methods for disinfection of prion-contaminated medical | devices. Lancet 2004;364:521-526. | The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다. | 섬유물질로 만들어져야 한다. | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4. | Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH. Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. | Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | . | 2. | SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | . | 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까? | 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3. | (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | . | 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다. | 접종한다. |\n| 3.1. 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다. | BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs. They include | the following: | 1. | The modeling of the process may be imperfect. Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents. |\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22. | Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176. | Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma. The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk. At this time, experience in this area has not reached a point where definitive | guidance can be given. Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable. It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products. As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5. | 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다. |\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2. | 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다. | 그림 | 1. BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate. | 5. | Taylor DM, Fernie K, Reichl HE, Somerville RA. Infectivity in the blood of mice with a BSE- | derived agent. Journal of Hospital Infection 2000;46:78. | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | . | - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음. |\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2. | 는 또 하나의 제약이 된다. | 하여야 한다. | 여 사용한다 | . 명백하게 오염된 경우는 폐기하고 교체한다 | . | 적절하게 봉합하여 운반하여야 한다. |\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | . | -70 | . | ℃ | 6. | Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P. | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy. Transfusion 2003;43:1687-1694. | 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1. | strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다. | 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다. | 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | . | 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | . | 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3. Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents. The sanitisation |\n| - | sanitisation of equipment | 2. | It has been assumed that where two steps are assessed the total clearance approximates to their | sum. This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step. |\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | . |\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2. Spiking | 인되었다. | 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2. Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다.**\n**사용하지 않는다.**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ. 서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1. 목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2. 용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n<!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1. 일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2. 규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3. Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4. 시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5. 제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6. 자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7. 감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8. 장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ. 결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ. 참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### . 서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n(\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\nBSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n,\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n,\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\nvCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n<!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n. TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n<!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n,\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n(in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n. 이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n(reduction factor)\n\n1 log\n\n.\n\n개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n,\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n. 혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\nspike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n주요 고려사항은 다음과 같다.\n\n원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다. vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\nvCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n. BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\nBSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n.\n\n지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n. Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\nCLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\nmicrosomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n. Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n,\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n. Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n. Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n(end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n,\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n.\n\n,\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n,\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n,\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n- - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\nPrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n. 비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\nPrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다. PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n. 따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n, S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\nS/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n(separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\nspiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n,\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n리다\n\n. 일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n- - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n- -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\nspiking\n\n보다 쉽게 제거되었다\n\n. 흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\nspiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n. Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다. In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n. 연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n. 정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n,\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n(\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n(steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n. 0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n. 이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n<!-- PAGE_17 -->\n###### . 결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n- -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n. Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n- - 13 -\n<!-- PAGE_18 -->\n###### . 참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1. 혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2. Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3. CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4. WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5. 혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6. 혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7. 혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8. 혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9. 혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10. Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### . 서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n. 포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n<!-- PAGE_19 -->\n###### . 실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n. 즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n- - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n,\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n로 실험실이나 동물실험실 출입을 금지한다\n\n. 실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n,\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n.\n\n감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n. 1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n. 2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n.\n\n한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n. 의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n“\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n.\n\n공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n.\n\n출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n. HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n- - 19 -\n<!-- PAGE_24 -->\n###### . 감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n<!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n,\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n, 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n(sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\nhomogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\nTen\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n5% sucrose\n\nMBS 4 mL\n\n다\n\n. Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다. 튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\nPrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\nTen Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n. 85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n<!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n. 각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\nμ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n“\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n- -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\nmicrotip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\nmicrotip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n- -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\nμ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n. RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n. PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n. PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\nPK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\nPK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\nSDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n. Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n- - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### . 감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n,\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n- - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n- - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n<!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n<!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\nguanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n. 건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n(vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n. HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n- - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel. (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\nLondon, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\nINTRODUCTION................................................................................................................... 3\n\n- 2.\nSCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\nINVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\nSUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\nINTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004. A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified. The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases. (One case in Hong Kong was a UK\n\ncase and is included in the UK figures.) Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK. However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK. The possibility of cases occurring in other countries\n\ncannot be excluded. All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene. However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n- 3.\nINVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\nMaterial from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model. The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\nAs with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies. Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n- 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\nCrude brain homogenates have been used most extensively in published studies of infectivity. They\n\ncontain the highest concentration of infectivity. The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed. If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration. The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n(b)\n\nMicrosomal fraction.\n\nMicrosomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity. While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains). Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises. Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\nNevertheless, most published studies of process clearance have included some element of infectivity\n\nassays. If performed, a well-characterised system of strain and indicator animal should be used.\n\nThere is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level. A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\nThe alternative assay which has also featured in published studies involves the detection of PrPSc.\n\nCurrently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation. The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc. Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity. However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter. These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\nPretreatments may affect the clearance of the agent. For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n- 4.\nThe assays which can be used are not ideal. Infectivity assays are expensive and very slow.\n\nWhile there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity. So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n- 5.\nThe strain and species of origin of the spike may determine the assays to be used. While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity. It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded. If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\nInvestigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult. A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease. Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting. An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult. NaOH solutions are commonly used for cleaning of production equipment. Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\nBons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\nTransfusion 2002;42:513-516\n\n- 8.\nHunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion. Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\nBruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues. Lancet 2001;358:208-209\n\n- 10.\nCervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL. Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety. Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n<!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n- - 43 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n- - 44 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n- - 45 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n- - 46 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "<!-- PAGE_1 -->\n# 혈장분획제제 제조공정 중 감염성\n\n<!-- PAGE_1 -->\n# 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n2009\n\n제·개정 이력서\n\n연번\n\n제·개정번호\n\n승인일자\n\n주요내용\n\n1\n\nB1-2009-3-020\n\n- 2009.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 170,
        "word_count": 34,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# 혈장분획제제 제조공정 중 감염성\n\n<!-- PAGE_1 -->\n# 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n2009\n\n제·개정 이력서\n\n연번\n\n제·개정번호\n\n승인일자\n\n주요내용\n\n1\n\nB1-2009-3-020\n\n- 2009.\n 제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 6.  | The physicochemical nature of the spike may be significant. ",
        "original_sentence": "<!-- PAGE_1 -->\n# 혈장분획제제 제조공정 중 감염성\n\n<!-- PAGE_1 -->\n# 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n2009\n\n제·개정 이력서\n\n연번\n\n제·개정번호\n\n승인일자\n\n주요내용\n\n1\n\nB1-2009-3-020\n\n- 2009.\n"
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 333,
        "word_count": 67,
        "page_number": 2,
        "window_text": "<!-- PAGE_1 -->\n# 혈장분획제제 제조공정 중 감염성\n\n<!-- PAGE_1 -->\n# 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n2009\n\n제·개정 이력서\n\n연번\n\n제·개정번호\n\n승인일자\n\n주요내용\n\n1\n\nB1-2009-3-020\n\n- 2009.\n 제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 6.  | The physicochemical nature of the spike may be significant.  There is currently no indication of | the physicochemical form of TSE agents in blood, if present. ",
        "original_sentence": "제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "**[표 시작]**\n\n| 6. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 5,
        "window_text": "<!-- PAGE_1 -->\n# 혈장분획제제 제조공정 중 감염성\n\n<!-- PAGE_1 -->\n# 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n2009\n\n제·개정 이력서\n\n연번\n\n제·개정번호\n\n승인일자\n\n주요내용\n\n1\n\nB1-2009-3-020\n\n- 2009.\n 제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 6.  | The physicochemical nature of the spike may be significant.  There is currently no indication of | the physicochemical form of TSE agents in blood, if present.  Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g. ",
        "original_sentence": "**[표 시작]**\n\n| 6. "
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "| The physicochemical nature of the spike may be significant. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 62,
        "word_count": 10,
        "page_number": 8,
        "window_text": "<!-- PAGE_1 -->\n# 혈장분획제제 제조공정 중 감염성\n\n<!-- PAGE_1 -->\n# 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_1 -->\n# [민원인 안내서]\n\n2009\n\n제·개정 이력서\n\n연번\n\n제·개정번호\n\n승인일자\n\n주요내용\n\n1\n\nB1-2009-3-020\n\n- 2009.\n 제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 6.  | The physicochemical nature of the spike may be significant.  There is currently no indication of | the physicochemical form of TSE agents in blood, if present.  Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g.  | adsorption) steps, the opposite can occur. ",
        "original_sentence": "| The physicochemical nature of the spike may be significant. "
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "There is currently no indication of | the physicochemical form of TSE agents in blood, if present. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 99,
        "word_count": 17,
        "page_number": 8,
        "window_text": "제정\n\n2\n\n안내서-0259-01\n\n「혈장분획제제 제조공정 중 감염성 프리온\n\n단백 제거 검증 가이드라인(민원인 안내서)」\n\n명칭변경 및 제‧개정 점검표 등 추가\n\n<!-- PAGE_2 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_2 -->\n###### [민원인 안내서]\n\n지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n<!-- PAGE_3 -->\n###### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증 가이드라인\n\n<!-- PAGE_3 -->\n###### (민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 6.  | The physicochemical nature of the spike may be significant.  There is currently no indication of | the physicochemical form of TSE agents in blood, if present.  Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g.  | adsorption) steps, the opposite can occur.  The spike material providing the most rigorous test | may therefore vary with the process step. ",
        "original_sentence": "There is currently no indication of | the physicochemical form of TSE agents in blood, if present. "
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 323,
        "word_count": 45,
        "page_number": 8,
        "window_text": "**[표 시작]**\n\n| 6.  | The physicochemical nature of the spike may be significant.  There is currently no indication of | the physicochemical form of TSE agents in blood, if present.  Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g.  | adsorption) steps, the opposite can occur.  The spike material providing the most rigorous test | may therefore vary with the process step.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11. ",
        "original_sentence": "Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g. "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "| adsorption) steps, the opposite can occur. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 45,
        "word_count": 7,
        "page_number": 5,
        "window_text": "| The physicochemical nature of the spike may be significant.  There is currently no indication of | the physicochemical form of TSE agents in blood, if present.  Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g.  | adsorption) steps, the opposite can occur.  The spike material providing the most rigorous test | may therefore vary with the process step.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11.  | Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG. ",
        "original_sentence": "| adsorption) steps, the opposite can occur. "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "The spike material providing the most rigorous test | may therefore vary with the process step. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 96,
        "word_count": 16,
        "page_number": 8,
        "window_text": "There is currently no indication of | the physicochemical form of TSE agents in blood, if present.  Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g.  | adsorption) steps, the opposite can occur.  The spike material providing the most rigorous test | may therefore vary with the process step.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11.  | Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG.  Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion. ",
        "original_sentence": "The spike material providing the most rigorous test | may therefore vary with the process step. "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 247,
        "word_count": 71,
        "page_number": 3,
        "window_text": "Different membrane-containing | spike materials have been tested in one published study, and were cleared in very similar ways | by all the precipitation steps evaluated; in contrast, a non-membrane-associated spike material | was cleared more readily for certain precipitation steps.17 For certain non-precipitation (e.g.  | adsorption) steps, the opposite can occur.  The spike material providing the most rigorous test | may therefore vary with the process step.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11.  | Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG.  Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion.  Lancet 2004;363:417- | 421. ",
        "original_sentence": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11. "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "| Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 79,
        "word_count": 15,
        "page_number": 6,
        "window_text": "| adsorption) steps, the opposite can occur.  The spike material providing the most rigorous test | may therefore vary with the process step.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11.  | Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG.  Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion.  Lancet 2004;363:417- | 421.  |\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | . ",
        "original_sentence": "| Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 83,
        "word_count": 10,
        "page_number": 8,
        "window_text": "The spike material providing the most rigorous test | may therefore vary with the process step.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11.  | Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG.  Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion.  Lancet 2004;363:417- | 421.  |\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 뇌 조직 균질액 동량을 주입한다. ",
        "original_sentence": "Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion. "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "Lancet 2004;363:417- | 421. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 28,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 불활화 바이러스 백신의 | 자가 기준 및 시험방법 | 작성 지침 | 2007 | 11-1470000-001346-01 | (생물의약품평가자료집 | 42) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/173 | 11.  | Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG.  Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion.  Lancet 2004;363:417- | 421.  |\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 뇌 조직 균질액 동량을 주입한다.  | 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | . ",
        "original_sentence": "Lancet 2004;363:417- | 421. "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "|\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 104,
        "word_count": 31,
        "page_number": 2,
        "window_text": "| Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG.  Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion.  Lancet 2004;363:417- | 421.  |\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 뇌 조직 균질액 동량을 주입한다.  | 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | .  | 생화학적 시험법에 사용한다. ",
        "original_sentence": "|\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | . "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "| ℃ | 뇌 조직 균질액 동량을 주입한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 5,
        "window_text": "Possible | transmission of variant Creutzfeldt–Jakob disease by blood transfusion.  Lancet 2004;363:417- | 421.  |\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 뇌 조직 균질액 동량을 주입한다.  | 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | .  | 생화학적 시험법에 사용한다.  | 지침서ㆍ안내서가 있습니까? ",
        "original_sentence": "| ℃ | 뇌 조직 균질액 동량을 주입한다. "
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "| 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 101,
        "word_count": 31,
        "page_number": 6,
        "window_text": "Lancet 2004;363:417- | 421.  |\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 뇌 조직 균질액 동량을 주입한다.  | 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | .  | 생화학적 시험법에 사용한다.  | 지침서ㆍ안내서가 있습니까?  |\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs). ",
        "original_sentence": "| 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | . "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "| 생화학적 시험법에 사용한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 5,
        "window_text": "|\n| immunogen | 263K/PrPSc | 263K/PrPSc | 263K/PrPSc | 편 집 위 원 장 | 김 승 희 | : |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 뇌 조직 균질액 동량을 주입한다.  | 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | .  | 생화학적 시험법에 사용한다.  | 지침서ㆍ안내서가 있습니까?  |\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs).  |\n| 다. ",
        "original_sentence": "| 생화학적 시험법에 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "| 지침서ㆍ안내서가 있습니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 17,
        "word_count": 3,
        "page_number": 3,
        "window_text": "| ℃ | 뇌 조직 균질액 동량을 주입한다.  | 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | .  | 생화학적 시험법에 사용한다.  | 지침서ㆍ안내서가 있습니까?  |\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs).  |\n| 다.  | 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1. ",
        "original_sentence": "| 지침서ㆍ안내서가 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "|\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs). ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 133,
        "word_count": 28,
        "page_number": 2,
        "window_text": "| 접종에 사용되는 감염성 프리온 단백 | 과 이로부터 제조되는 동물 종 | - | strain | 인보호 장구 | , 실험실을 나갈 때 요구되는 절차 등을 표지하여 알린다 | .  | 생화학적 시험법에 사용한다.  | 지침서ㆍ안내서가 있습니까?  |\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs).  |\n| 다.  | 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1.  | 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates. ",
        "original_sentence": "|\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs). "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "|\n| 다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 7,
        "word_count": 3,
        "page_number": 5,
        "window_text": "| 생화학적 시험법에 사용한다.  | 지침서ㆍ안내서가 있습니까?  |\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs).  |\n| 다.  | 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1.  | 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates.  The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells. ",
        "original_sentence": "|\n| 다. "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "| 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 212,
        "word_count": 49,
        "page_number": 4,
        "window_text": "| 지침서ㆍ안내서가 있습니까?  |\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs).  |\n| 다.  | 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1.  | 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates.  The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4. ",
        "original_sentence": "| 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1. "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "| 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 442,
        "word_count": 56,
        "page_number": 2,
        "window_text": "|\n| 생물의약품 국가표준품 | 카다로그 (2008) | 2008 | 11-1470000-000547-10 | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/ | (c) | Caveolae-like domains (CLDs).  |\n| 다.  | 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1.  | 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates.  The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4.  | (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다. ",
        "original_sentence": "| 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 113,
        "word_count": 19,
        "page_number": 8,
        "window_text": "|\n| 다.  | 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1.  | 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates.  The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4.  | (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다.  | reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available. ",
        "original_sentence": "The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "| ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 71,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| 방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 | 류마티스관절염 치료제 | 임상평가지침 | 2007 | 11-1470000-001432-01 | (생물의약품평가가이드 | 26) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/190 | 세포주로부터 개발한 | 생물공학제제의 | 바이러스안전성 평가 | 가이드 |\n| 일반 원칙 | 1.  | 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates.  The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4.  | (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다.  | reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available.  |\n| i) | the strain of the inoculum and the species in which it was prepared; | 12. ",
        "original_sentence": "| ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4. "
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "| (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 41,
        "word_count": 13,
        "page_number": 2,
        "window_text": "| 생명공학의약품의 | 안전성평가(1) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 4) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/68 | The main considerations are; | 3.1 | General principles.......................................................................................................... 4 |\n| Guideline on the Investigation of Manufacturing Processes | These have been prepared by sucrose-density ultracentrifugation of detergent-lysed brain | homogenates.  The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4.  | (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다.  | reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available.  |\n| i) | the strain of the inoculum and the species in which it was prepared; | 12.  | Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety. ",
        "original_sentence": "| (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다. "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "| reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 458,
        "word_count": 89,
        "page_number": 6,
        "window_text": "The infectivity level is lower than that of microsomes and they may simulate membrane | domains shed from cells.  | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4.  | (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다.  | reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available.  |\n| i) | the strain of the inoculum and the species in which it was prepared; | 12.  | Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety.  Clin Lab Med 2003;23:129-37. ",
        "original_sentence": "| reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available. "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "|\n| i) | the strain of the inoculum and the species in which it was prepared; | 12. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 84,
        "word_count": 19,
        "page_number": 6,
        "window_text": "| ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 |\n| 실험실 시설 | 차 보호 시설 | 4.  | (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다.  | reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available.  |\n| i) | the strain of the inoculum and the species in which it was prepared; | 12.  | Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety.  Clin Lab Med 2003;23:129-37.  | 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다. ",
        "original_sentence": "|\n| i) | the strain of the inoculum and the species in which it was prepared; | 12. "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "| Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 108,
        "word_count": 15,
        "page_number": 5,
        "window_text": "| (2 | ) | 수준을 정량할 수 있는 in vitro 시험은 없다.  | reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available.  |\n| i) | the strain of the inoculum and the species in which it was prepared; | 12.  | Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety.  Clin Lab Med 2003;23:129-37.  | 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1. ",
        "original_sentence": "| Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety. "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "Clin Lab Med 2003;23:129-37. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 29,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| reactivity | human, hamster, feline | all mammalian | mouse, hamster, elk | 감염성 프리온 단백의 물리화학적 특성 | - | 2002 | 11-1470000-000144-01 | (생물의약품평가가이드 | 3) | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/19 | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| In view of the above considerations, no specific recommendation can be given at this time until new | scientific information relevant to plasma processing equipment becomes available.  |\n| i) | the strain of the inoculum and the species in which it was prepared; | 12.  | Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety.  Clin Lab Med 2003;23:129-37.  | 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1.  | 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | . ",
        "original_sentence": "Clin Lab Med 2003;23:129-37. "
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "| 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 219,
        "word_count": 40,
        "page_number": 2,
        "window_text": "|\n| i) | the strain of the inoculum and the species in which it was prepared; | 12.  | Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety.  Clin Lab Med 2003;23:129-37.  | 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1.  | 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | .  | 3.3. ",
        "original_sentence": "| 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 194,
        "word_count": 46,
        "page_number": 1,
        "window_text": "| Ricketts MN, Brown P. Transmissible spongiform encephalopathy update and implications for | blood safety.  Clin Lab Med 2003;23:129-37.  | 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1.  | 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | .  | 3.3.  Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.  ",
        "original_sentence": "또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1. "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 169,
        "word_count": 42,
        "page_number": 2,
        "window_text": "Clin Lab Med 2003;23:129-37.  | 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1.  | 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | .  | 3.3.  Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.   The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food. ",
        "original_sentence": "| 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | . "
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "| 3.3. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 5,
        "window_text": "| 3.2 | Scaling down process..................................................................................................... 5 | 편 | 집 | 위 | 원 | 강석연 김순남 오호정 | 김정환 김영림 | : | , | , | , | , | , |\n| 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1.  | 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | .  | 3.3.  Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.   The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food.  | 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다. ",
        "original_sentence": "| 3.3. "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.  ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 307,
        "word_count": 52,
        "page_number": 6,
        "window_text": "또한, 본 안내서는 2009년 현재의 과학적ㆍ기 | (CPMP/BWP/268/95), EMEA, 1996 | 백신의 임상 평가 시 | 고려사항 | 2006 | 11-1470000-001163-01 | (생물의약품평가자료집 | 41) | 바이러스백신팀 | 세균백신팀 | 자료실 간행물 | / | , | 지침 150 |\n| 미생물 취급 요령 | 1.  | 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | .  | 3.3.  Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.   The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food.  | 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다.  | ․ | 여압을 차단하여 준다 | . ",
        "original_sentence": "Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.  "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 98,
        "word_count": 16,
        "page_number": 6,
        "window_text": "| 분획용 혈장 마스터 파일 | 가이드라인 | 2007 | 11-1470000-001560-01 | (생물의약품평가가이드 | 25) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/210 | 중하게 고려하여 다음과 같은 | 4가지 형태의 물질 중에서 선택하여 실험한다 | .  | 3.3.  Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.   The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food.  | 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다.  | ․ | 여압을 차단하여 준다 | .  그 작동 여부는 경보기를 통하여 알 수 있다 | . ",
        "original_sentence": "The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food. "
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "| 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 5,
        "window_text": "| 3.3.  Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.   The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food.  | 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다.  | ․ | 여압을 차단하여 준다 | .  그 작동 여부는 경보기를 통하여 알 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1. ",
        "original_sentence": "| 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "| ․ | 여압을 차단하여 준다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 22,
        "word_count": 8,
        "page_number": 5,
        "window_text": "Caveolae-like domains(CLDs) | 생물의약품 국가표준품 | 카다로그 (2006) | 2006 | 11-1470000-000547-10 | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/159 | for Plasma-Derived Medicinal Products with regard to | There is strong evidence that vCJD is caused by the agent responsible for bovine spongiform | encephalopathy (BSE) in cattle.   The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food.  | 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다.  | ․ | 여압을 차단하여 준다 | .  그 작동 여부는 경보기를 통하여 알 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1.  생물시험법 | (bioassay) | ii) | its physicochemical nature. ",
        "original_sentence": "| ․ | 여압을 차단하여 준다 | . "
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "그 작동 여부는 경보기를 통하여 알 수 있다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 29,
        "word_count": 10,
        "page_number": 3,
        "window_text": "The most likely hypothesis is that vCJD has occurred through | exposure to BSE contaminated food.  | 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다.  | ․ | 여압을 차단하여 준다 | .  그 작동 여부는 경보기를 통하여 알 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1.  생물시험법 | (bioassay) | ii) | its physicochemical nature.  | Only those steps which are likely to contribute to inactivation/removal need to be investigated. ",
        "original_sentence": "그 작동 여부는 경보기를 통하여 알 수 있다 | . "
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "|\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 89,
        "word_count": 19,
        "page_number": 2,
        "window_text": "| 대한 면역검사나 테스트를 받고 그 결과를 보관 관리 하여야 한다.  | ․ | 여압을 차단하여 준다 | .  그 작동 여부는 경보기를 통하여 알 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1.  생물시험법 | (bioassay) | ii) | its physicochemical nature.  | Only those steps which are likely to contribute to inactivation/removal need to be investigated.  TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products. ",
        "original_sentence": "|\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "생물시험법 | (bioassay) | ii) | its physicochemical nature. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 55,
        "word_count": 9,
        "page_number": 6,
        "window_text": "| ․ | 여압을 차단하여 준다 | .  그 작동 여부는 경보기를 통하여 알 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1.  생물시험법 | (bioassay) | ii) | its physicochemical nature.  | Only those steps which are likely to contribute to inactivation/removal need to be investigated.  TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products.  Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration. ",
        "original_sentence": "생물시험법 | (bioassay) | ii) | its physicochemical nature. "
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "| Only those steps which are likely to contribute to inactivation/removal need to be investigated. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 99,
        "word_count": 15,
        "page_number": 8,
        "window_text": "그 작동 여부는 경보기를 통하여 알 수 있다 | .  |\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1.  생물시험법 | (bioassay) | ii) | its physicochemical nature.  | Only those steps which are likely to contribute to inactivation/removal need to be investigated.  TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products.  Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration.  |\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc. ",
        "original_sentence": "| Only those steps which are likely to contribute to inactivation/removal need to be investigated. "
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 182,
        "word_count": 26,
        "page_number": 9,
        "window_text": "|\n| 이종이식제제의 범위 및 | 원료동물에 대한 가이드 | 2006 | 11-1470000-001087-01 | (생물의약품평가가이드 | 15) | 4.1.  생물시험법 | (bioassay) | ii) | its physicochemical nature.  | Only those steps which are likely to contribute to inactivation/removal need to be investigated.  TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products.  Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration.  |\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc.  | 13. ",
        "original_sentence": "TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 176,
        "word_count": 20,
        "page_number": 6,
        "window_text": "생물시험법 | (bioassay) | ii) | its physicochemical nature.  | Only those steps which are likely to contribute to inactivation/removal need to be investigated.  TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products.  Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration.  |\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc.  | 13.  | CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | . ",
        "original_sentence": "Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration. "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "|\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 411,
        "word_count": 76,
        "page_number": 2,
        "window_text": "| Only those steps which are likely to contribute to inactivation/removal need to be investigated.  TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products.  Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration.  |\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc.  | 13.  | CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 택에 대한 이론적 근거를 제시하여야 한다. ",
        "original_sentence": "|\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc. "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "| 13. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 2,
        "window_text": "TSE- | agents are expected to be resistant to most physicochemical virus inactivation procedures which are | usually applied in the manufacture of plasma-derived medicinal products.  Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration.  |\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc.  | 13.  | CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 택에 대한 이론적 근거를 제시하여야 한다.  | GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1. ",
        "original_sentence": "| 13. "
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "| CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 368,
        "word_count": 70,
        "page_number": 8,
        "window_text": "Therefore, investigation | may focus on removal/partitioning steps such as cold ethanol fractionation, PEG-precipitation, | chromatography, depth filtration or nanofiltration.  |\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc.  | 13.  | CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 택에 대한 이론적 근거를 제시하여야 한다.  | GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1.  종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | . ",
        "original_sentence": "| CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | . "
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "| 택에 대한 이론적 근거를 제시하여야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 5,
        "window_text": "|\n| 백신의 안전성평가 2004 | 2004 | 11-1470000-000675-14 | (생물의약품평가자료집 | 3) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/67 | 백신의 안전성 유효성 | ․ | 평가 2006 | 2006 | 11-1470000-001125-01 | (생물의약품평가자료집 | 30) | 세균백신팀 | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/141 | 3.3 | Choice of spiking agent.................................................................................................. 5 | 자료실 간행물 | / | , | 지침/130 |\n| (d) Purified PrPSc.  | 13.  | CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 택에 대한 이론적 근거를 제시하여야 한다.  | GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1.  종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | .  | 4. ",
        "original_sentence": "| 택에 대한 이론적 근거를 제시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "| GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 154,
        "word_count": 29,
        "page_number": 16,
        "window_text": "| 13.  | CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 택에 대한 이론적 근거를 제시하여야 한다.  | GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1.  종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | .  | 4.  | SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7. ",
        "original_sentence": "| GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 53,
        "word_count": 15,
        "page_number": 2,
        "window_text": "| CPMP Note for guidance on virus validation studies: the design, contribution and interpretation | of | studies | validating | the | inactivation | and | removal | of | viruses, | February | 1996 | (CPMP/BWP/268/95) | http://www.emea.eu.int/pdfs/human/bwp/026895en.pdf | 김판순 | 이내리 김관수 조민주 | 김진아 | , | , | , | , |\n| 의 | 항을 참조한다 | BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 택에 대한 이론적 근거를 제시하여야 한다.  | GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1.  종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | .  | 4.  | SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7.  | In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible. ",
        "original_sentence": "종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | . "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "| 4. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "| 택에 대한 이론적 근거를 제시하여야 한다.  | GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1.  종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | .  | 4.  | SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7.  | In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible.  It is possible that material will be removed less effectively at | low than at high concentrations. ",
        "original_sentence": "| 4. "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "| SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 403,
        "word_count": 59,
        "page_number": 5,
        "window_text": "| GUIDELINE ON THE INVESTIGATION OF MANUFACTURING | PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS |\n| 술적 사실 및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정 법규 내용 | 3.1.  종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | .  | 4.  | SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7.  | In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible.  It is possible that material will be removed less effectively at | low than at high concentrations.  |\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation. ",
        "original_sentence": "| SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "| In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 135,
        "word_count": 28,
        "page_number": 8,
        "window_text": "종과 | strain | 1) 실험이 진행 중일 때는 실험실 입실을 제한하거나 금지한다 | .  | 4.  | SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7.  | In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible.  It is possible that material will be removed less effectively at | low than at high concentrations.  |\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation.  It represents forms not associated with cells or membranes. ",
        "original_sentence": "| In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "It is possible that material will be removed less effectively at | low than at high concentrations. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 100,
        "word_count": 17,
        "page_number": 25,
        "window_text": "| 4.  | SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7.  | In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible.  It is possible that material will be removed less effectively at | low than at high concentrations.  |\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation.  It represents forms not associated with cells or membranes.  It | is not clear whether such preparations resemble material which could occur naturally. ",
        "original_sentence": "It is possible that material will be removed less effectively at | low than at high concentrations. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "|\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 509,
        "word_count": 106,
        "page_number": 2,
        "window_text": "| SUMMARY / CONCLUSION | 3.4 | Choice of assays ............................................................................................................ 6 | (사유 :                                                                 ) | vCJD Risk, EMEA, 2004 |\n| 생물의약품의 생산에 | 사용되는 세포기질관리 | 가이드 | 2002 | 11-1470000-000140-14 | (생물의약품평가가이드 | 2) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/17 | 7.  | In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible.  It is possible that material will be removed less effectively at | low than at high concentrations.  |\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation.  It represents forms not associated with cells or membranes.  It | is not clear whether such preparations resemble material which could occur naturally.  |\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur. ",
        "original_sentence": "|\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "It represents forms not associated with cells or membranes. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 60,
        "word_count": 9,
        "page_number": 8,
        "window_text": "| In animal studies the amount of agent present in the blood is low, whereas the spike added will | be of as high a titre as possible.  It is possible that material will be removed less effectively at | low than at high concentrations.  |\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation.  It represents forms not associated with cells or membranes.  It | is not clear whether such preparations resemble material which could occur naturally.  |\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur.  In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products. ",
        "original_sentence": "It represents forms not associated with cells or membranes. "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "It | is not clear whether such preparations resemble material which could occur naturally. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 91,
        "word_count": 14,
        "page_number": 8,
        "window_text": "It is possible that material will be removed less effectively at | low than at high concentrations.  |\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation.  It represents forms not associated with cells or membranes.  It | is not clear whether such preparations resemble material which could occur naturally.  |\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur.  In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data. ",
        "original_sentence": "It | is not clear whether such preparations resemble material which could occur naturally. "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "|\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 219,
        "word_count": 49,
        "page_number": 6,
        "window_text": "|\n| 생물의약품 국가표준품 | 카다로그 (2004) | 2004 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/56 | 세포치료제 및 | 유전자치료제 자료집 | 2004 | 11-1470000-000685-01 | (생물의약품평가자료집 | 16) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/78 | DNA 백신의 평가 | : | WHO 및 미국 | FDA | 가이드라인 | 2006 | 11-1470000-001142-01 | (생물의약품평가자료집 | 40) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/168 | i) | Species and strain | Purified PrPSc has been prepared by repeated detergent extraction of brain homogenates followed by | salt precipitation and ultracentrifugation.  It represents forms not associated with cells or membranes.  It | is not clear whether such preparations resemble material which could occur naturally.  |\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur.  In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds. ",
        "original_sentence": "|\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 215,
        "word_count": 31,
        "page_number": 6,
        "window_text": "It represents forms not associated with cells or membranes.  It | is not clear whether such preparations resemble material which could occur naturally.  |\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur.  In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds.  | Different preparations of spiking agents can be used. ",
        "original_sentence": "In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "| All manufacturers must critically evaluate their manufacturing processes in the light of published data. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 107,
        "word_count": 15,
        "page_number": 8,
        "window_text": "It | is not clear whether such preparations resemble material which could occur naturally.  |\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur.  In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds.  | Different preparations of spiking agents can be used.  The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. ",
        "original_sentence": "| All manufacturers must critically evaluate their manufacturing processes in the light of published data. "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "| Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 310,
        "word_count": 52,
        "page_number": 8,
        "window_text": "|\n| 인플루엔자백신의 자가 | 기준 및 시험방법 작성 | 지침 개정판 | ( | ) | 2007 | 11-1470000-001468-01 | (생물의약품평가가이드 | 24) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/197 | Uncertainties still exist concerning the number of cases of vCJD that will occur.  In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds.  | Different preparations of spiking agents can be used.  The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of strain and preparations should be given in | all cases. ",
        "original_sentence": "| Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds. "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "| Different preparations of spiking agents can be used. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 56,
        "word_count": 9,
        "page_number": 8,
        "window_text": "In contrast to sporadic | CJD, the evidence of extensive lymphoreticular involvement has led to concerns about the possibility | of transmission from pre-clinically infected individuals via blood or blood products.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds.  | Different preparations of spiking agents can be used.  The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of strain and preparations should be given in | all cases.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | . ",
        "original_sentence": "| Different preparations of spiking agents can be used. "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 182,
        "word_count": 28,
        "page_number": 6,
        "window_text": "| All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds.  | Different preparations of spiking agents can be used.  The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of strain and preparations should be given in | all cases.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | .  혈청 표본도 주기적으로 수집할 수 있다 | . ",
        "original_sentence": "The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "The rationale for the choice of strain and preparations should be given in | all cases. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 88,
        "word_count": 16,
        "page_number": 7,
        "window_text": "| Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 For removal studies, there is no reason to make a choice based | on the appropriateness of the strain of TSE agent, so a decision can be made on practical grounds.  | Different preparations of spiking agents can be used.  The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of strain and preparations should be given in | all cases.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | .  혈청 표본도 주기적으로 수집할 수 있다 | .  | 따라 달라질 수 있다. ",
        "original_sentence": "The rationale for the choice of strain and preparations should be given in | all cases. "
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "| □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 212,
        "word_count": 27,
        "page_number": 2,
        "window_text": "| Different preparations of spiking agents can be used.  The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of strain and preparations should be given in | all cases.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | .  혈청 표본도 주기적으로 수집할 수 있다 | .  | 따라 달라질 수 있다.  |\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. ",
        "original_sentence": "| □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | . "
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "혈청 표본도 주기적으로 수집할 수 있다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 5,
        "window_text": "The spike preparation(s) that will provide the | greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of strain and preparations should be given in | all cases.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | .  혈청 표본도 주기적으로 수집할 수 있다 | .  | 따라 달라질 수 있다.  |\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma. ",
        "original_sentence": "혈청 표본도 주기적으로 수집할 수 있다 | . "
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "| 따라 달라질 수 있다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 5,
        "window_text": "The rationale for the choice of strain and preparations should be given in | all cases.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | .  혈청 표본도 주기적으로 수집할 수 있다 | .  | 따라 달라질 수 있다.  |\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma.  The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons. ",
        "original_sentence": "| 따라 달라질 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "|\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 43,
        "word_count": 12,
        "page_number": 4,
        "window_text": "| □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 |\n| 1) 가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 3.5 | Choice of manufacturing steps........................................................................................ 7 | 저장한다 | .  혈청 표본도 주기적으로 수집할 수 있다 | .  | 따라 달라질 수 있다.  |\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma.  The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons.  While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory. ",
        "original_sentence": "|\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "| 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 477,
        "word_count": 110,
        "page_number": 2,
        "window_text": "혈청 표본도 주기적으로 수집할 수 있다 | .  | 따라 달라질 수 있다.  |\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma.  The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons.  While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory.  In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain. ",
        "original_sentence": "| 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma. "
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 97,
        "word_count": 17,
        "page_number": 8,
        "window_text": "| 따라 달라질 수 있다.  |\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma.  The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons.  While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory.  In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain.  The assay of the material is again potentially difficult. ",
        "original_sentence": "The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons. "
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 194,
        "word_count": 38,
        "page_number": 8,
        "window_text": "|\n| 및 구체적인 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma.  The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons.  While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory.  In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain.  The assay of the material is again potentially difficult.  This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie. ",
        "original_sentence": "While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory. "
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 172,
        "word_count": 29,
        "page_number": 8,
        "window_text": "| 진단제제의 | 기준 | HBsAg | ‘ | 및 시험방법 | ’ 작성 지침 | 2004 | 11-1470000-000143-01 | (생물의약품평가자료집 | 2) | 백신과 | 자료실 간행물 | / | , | 지침/48 | 인플루엔자 백신 | 자가 기준 및 시험방법 | 작성 지침 | 2006 | 11-1470000-001114-01 | (생물의약품평가자료집 | 29) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/138 | WITH REGARD TO VCJD RISK | □ 예 | ■ 아니오 |\n| The factors governing the source of materials for use as the spike include supply, assay and likely | similarity of the material to the infectivity which could be present in the plasma.  The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons.  While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory.  In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain.  The assay of the material is again potentially difficult.  This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie.  Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g. ",
        "original_sentence": "In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain. "
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "The assay of the material is again potentially difficult. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 58,
        "word_count": 9,
        "page_number": 8,
        "window_text": "The supply of | unpassaged material from cases of vCJD is limited for ethical and other reasons.  While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory.  In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain.  The assay of the material is again potentially difficult.  This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie.  Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g.  scrapie, familial CJD, BSE or vCJD). ",
        "original_sentence": "The assay of the material is again potentially difficult. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 98,
        "word_count": 17,
        "page_number": 6,
        "window_text": "While normal mice | may be used for the bioassay of vCJD, and there is at least one published example of the use of such | human material in spiking studies14, the use of vCJD is not mandatory.  In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain.  The assay of the material is again potentially difficult.  This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie.  Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g.  scrapie, familial CJD, BSE or vCJD).  As they differ in their pathology and strain characteristics, | several strains have been investigated. ",
        "original_sentence": "This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie. "
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 223,
        "word_count": 39,
        "page_number": 6,
        "window_text": "In principle large amounts of | bovine brain from animals infected with BSE may be available, although in practice material of a | suitable quality is difficult to obtain.  The assay of the material is again potentially difficult.  This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie.  Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g.  scrapie, familial CJD, BSE or vCJD).  As they differ in their pathology and strain characteristics, | several strains have been investigated.  The principles involved in their assay are well established. ",
        "original_sentence": "Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g. "
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "scrapie, familial CJD, BSE or vCJD). ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 37,
        "word_count": 6,
        "page_number": 5,
        "window_text": "The assay of the material is again potentially difficult.  This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie.  Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g.  scrapie, familial CJD, BSE or vCJD).  As they differ in their pathology and strain characteristics, | several strains have been investigated.  The principles involved in their assay are well established.  In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds. ",
        "original_sentence": "scrapie, familial CJD, BSE or vCJD). "
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "As they differ in their pathology and strain characteristics, | several strains have been investigated. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 104,
        "word_count": 15,
        "page_number": 7,
        "window_text": "This | applies also to sheep infected with BSE, and most strongly to sheep infected with scrapie.  Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g.  scrapie, familial CJD, BSE or vCJD).  As they differ in their pathology and strain characteristics, | several strains have been investigated.  The principles involved in their assay are well established.  In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds.  The rationale for the choice of strain should be given in all cases. ",
        "original_sentence": "As they differ in their pathology and strain characteristics, | several strains have been investigated. "
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "The principles involved in their assay are well established. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 61,
        "word_count": 9,
        "page_number": 8,
        "window_text": "Except for | demonstration projects, for example to show that a process will not only remove model agents but the | agent of vCJD, it therefore seems most reasonable to use rodent adapted laboratory strains of TSEs | (e.g.  scrapie, familial CJD, BSE or vCJD).  As they differ in their pathology and strain characteristics, | several strains have been investigated.  The principles involved in their assay are well established.  In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds.  The rationale for the choice of strain should be given in all cases.  |\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? ",
        "original_sentence": "The principles involved in their assay are well established. "
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 348,
        "word_count": 60,
        "page_number": 8,
        "window_text": "scrapie, familial CJD, BSE or vCJD).  As they differ in their pathology and strain characteristics, | several strains have been investigated.  The principles involved in their assay are well established.  In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds.  The rationale for the choice of strain should be given in all cases.  |\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  |\n| 시험법 선택 | 4. ",
        "original_sentence": "In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds. "
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "The rationale for the choice of strain should be given in all cases. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 69,
        "word_count": 13,
        "page_number": 7,
        "window_text": "As they differ in their pathology and strain characteristics, | several strains have been investigated.  The principles involved in their assay are well established.  In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds.  The rationale for the choice of strain should be given in all cases.  |\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  |\n| 시험법 선택 | 4.  | 자료의 해석과 제한사항 | 6. ",
        "original_sentence": "The rationale for the choice of strain should be given in all cases. "
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "|\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 45,
        "word_count": 10,
        "page_number": 3,
        "window_text": "The principles involved in their assay are well established.  In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds.  The rationale for the choice of strain should be given in all cases.  |\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  |\n| 시험법 선택 | 4.  | 자료의 해석과 제한사항 | 6.  | 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | . ",
        "original_sentence": "|\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "|\n| 시험법 선택 | 4. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 16,
        "word_count": 6,
        "page_number": 5,
        "window_text": "In | studies published so far there has been no clearly demonstrable effect of species or strain on removal | studies14 although strains may differ in their resistance to heat inactivation.15,16 For removal studies, | there is no reason to make a choice based on the appropriateness of the strain, so a decision can be | made on practical grounds.  The rationale for the choice of strain should be given in all cases.  |\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  |\n| 시험법 선택 | 4.  | 자료의 해석과 제한사항 | 6.  | 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | .  | 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | . ",
        "original_sentence": "|\n| 시험법 선택 | 4. "
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "| 자료의 해석과 제한사항 | 6. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 20,
        "word_count": 6,
        "page_number": 3,
        "window_text": "The rationale for the choice of strain should be given in all cases.  |\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  |\n| 시험법 선택 | 4.  | 자료의 해석과 제한사항 | 6.  | 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | .  | 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | .  각 실험군마다 평균 잠복기를 계산하여야 한다 | . ",
        "original_sentence": "| 자료의 해석과 제한사항 | 6. "
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "| 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 175,
        "word_count": 24,
        "page_number": 2,
        "window_text": "|\n| 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 | 나열한 것입니까?  |\n| 시험법 선택 | 4.  | 자료의 해석과 제한사항 | 6.  | 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | .  | 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | .  각 실험군마다 평균 잠복기를 계산하여야 한다 | .  |\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | . ",
        "original_sentence": "| 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | . "
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "| 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 37,
        "word_count": 12,
        "page_number": 5,
        "window_text": "|\n| 시험법 선택 | 4.  | 자료의 해석과 제한사항 | 6.  | 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | .  | 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | .  각 실험군마다 평균 잠복기를 계산하여야 한다 | .  |\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | .  | 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14. ",
        "original_sentence": "| 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | . "
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "각 실험군마다 평균 잠복기를 계산하여야 한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 29,
        "word_count": 8,
        "page_number": 5,
        "window_text": "| 자료의 해석과 제한사항 | 6.  | 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | .  | 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | .  각 실험군마다 평균 잠복기를 계산하여야 한다 | .  |\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | .  | 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14.  | Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma. ",
        "original_sentence": "각 실험군마다 평균 잠복기를 계산하여야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "|\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 47,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| 2004 | 3.6 | Interpretation and limitations of data............................................................................... 7 | 시스템은 최소 | 년마다 점검하여야 한다 | HEPA | 1 | .  | 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | .  각 실험군마다 평균 잠복기를 계산하여야 한다 | .  |\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | .  | 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14.  | Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma.  Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513). ",
        "original_sentence": "|\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | . "
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 90,
        "word_count": 20,
        "page_number": 2,
        "window_text": "| 라 다른 결과를 나타낼 수가 있다 | 날짜로서 계산한다 | .  각 실험군마다 평균 잠복기를 계산하여야 한다 | .  |\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | .  | 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14.  | Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma.  Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513).  Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay. ",
        "original_sentence": "| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14. "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "| Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 200,
        "word_count": 33,
        "page_number": 6,
        "window_text": "각 실험군마다 평균 잠복기를 계산하여야 한다 | .  |\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | .  | 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14.  | Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma.  Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513).  Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay.  It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters. ",
        "original_sentence": "| Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma. "
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513). ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 359,
        "word_count": 53,
        "page_number": 2,
        "window_text": "|\n| 제시하고 | , 부록에서는 조사연구 관련 시험방법을 상세히 기술하였다 | .  | 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14.  | Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma.  Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513).  Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay.  It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters.  Therefore, | in-process limits are important for the design of investigational studies for partitioning steps. ",
        "original_sentence": "Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513). "
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 277,
        "word_count": 49,
        "page_number": 8,
        "window_text": "| 암치료를 위한 수지상 | 세포치료제 평가 시 | 고려사항 | 2005 | 11-1470000-000888-01 | (생물의약품평가가이드 | 14) | 14.  | Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma.  Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513).  Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay.  It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters.  Therefore, | in-process limits are important for the design of investigational studies for partitioning steps.  The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay. ",
        "original_sentence": "Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay. "
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 106,
        "word_count": 18,
        "page_number": 8,
        "window_text": "| Stenland CJ, Lee DC, Brown P, Petteway SP, Rubenstein R. Partitioning of human and sheep | forms of the pathogenic prion protein during the purification of therapeutic proteins from human | plasma.  Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513).  Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay.  It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters.  Therefore, | in-process limits are important for the design of investigational studies for partitioning steps.  The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay.  | Reduction factors <1 log are not significant. ",
        "original_sentence": "It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters. "
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "Therefore, | in-process limits are important for the design of investigational studies for partitioning steps. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 111,
        "word_count": 15,
        "page_number": 6,
        "window_text": "Transfusion 2002;42:1497-1500 | In a virus validation study, investigation of such removal steps would include the demonstration of | partitioning of the agents to the side fractions, and parameters which influence the effectiveness of a | process step to inactivate/remove agents would be explored (see Section 5.5 of Note for Guidance | CPMP/BWP/268/9513).  Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay.  It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters.  Therefore, | in-process limits are important for the design of investigational studies for partitioning steps.  The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay.  | Reduction factors <1 log are not significant.  | 8. ",
        "original_sentence": "Therefore, | in-process limits are important for the design of investigational studies for partitioning steps. "
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 111,
        "word_count": 18,
        "page_number": 8,
        "window_text": "Studies with TSEs are far more difficult and costly than for conventional | agents and it may be acceptable to review the robustness of the process on a theoretical basis as part of | the design of the investigational study or to use an appropriately validated in vitro assay.  It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters.  Therefore, | in-process limits are important for the design of investigational studies for partitioning steps.  The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay.  | Reduction factors <1 log are not significant.  | 8.  | Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters. ",
        "original_sentence": "The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay. "
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "| Reduction factors <1 log are not significant. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 48,
        "word_count": 8,
        "page_number": 2,
        "window_text": "It should be | borne in mind that the removal may be sensitive to variations of manufacturing parameters.  Therefore, | in-process limits are important for the design of investigational studies for partitioning steps.  The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay.  | Reduction factors <1 log are not significant.  | 8.  | Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters.  The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often. ",
        "original_sentence": "| Reduction factors <1 log are not significant. "
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "| 8. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "Therefore, | in-process limits are important for the design of investigational studies for partitioning steps.  The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay.  | Reduction factors <1 log are not significant.  | 8.  | Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters.  The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often.  | 기 전에 반드시 손을 씻는다. ",
        "original_sentence": "| 8. "
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "| Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 191,
        "word_count": 28,
        "page_number": 8,
        "window_text": "The | studies should include evaluation of partitioning of prions into side fractions using an in vitro assay.  | Reduction factors <1 log are not significant.  | 8.  | Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters.  The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often.  | 기 전에 반드시 손을 씻는다.  | 있어야 한다. ",
        "original_sentence": "| Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters. "
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 168,
        "word_count": 29,
        "page_number": 8,
        "window_text": "| Reduction factors <1 log are not significant.  | 8.  | Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters.  The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often.  | 기 전에 반드시 손을 씻는다.  | 있어야 한다.  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다. ",
        "original_sentence": "The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often. "
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "| 기 전에 반드시 손을 씻는다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 19,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 8.  | Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters.  The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often.  | 기 전에 반드시 손을 씻는다.  | 있어야 한다.  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다.  | 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products. ",
        "original_sentence": "| 기 전에 반드시 손을 씻는다. "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "| 있어야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 5,
        "window_text": "| Evaluation of processes for viral inactivation/removal includes an assessment of the robustness | of the process, for example studying the effect of modification of the process parameters.  The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often.  | 기 전에 반드시 손을 씻는다.  | 있어야 한다.  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다.  | 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products.  | As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | . ",
        "original_sentence": "| 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "| 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 267,
        "word_count": 70,
        "page_number": 6,
        "window_text": "The | difficulties of performing such studies with TSEs, other than by using solely in vitro assay | methods, means that the studies are unlikely to be repeated often.  | 기 전에 반드시 손을 씻는다.  | 있어야 한다.  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다.  | 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products.  | As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | .  | 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | . ",
        "original_sentence": "| 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "| 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 1352,
        "word_count": 217,
        "page_number": 2,
        "window_text": "| 기 전에 반드시 손을 씻는다.  | 있어야 한다.  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다.  | 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products.  | As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | .  | 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | .  | Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products. ",
        "original_sentence": "| 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products. "
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "| As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 165,
        "word_count": 38,
        "page_number": 2,
        "window_text": "| 있어야 한다.  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다.  | 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products.  | As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | .  | 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | .  | Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products.  | Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations. ",
        "original_sentence": "| As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | . "
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "| 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 58,
        "word_count": 19,
        "page_number": 2,
        "window_text": "| 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 세포조직공학제제팀 |\n| 치료용 | 생명공학의약품등의 | 2상 | 및 | 3상 임상시험계획승인 | 신청시 고려사항 | 생물의약품 국가표준품 | 카다로그 (2003) | 2003 | 11-1470000-000547-10 | 생물의약품규격과 | 자료실 간행물 | / | , | 지침/43 | 자료실 간행물 | / | , | 지침/116 |\n| 검증연구에 대한 일반 원칙이 감염성 프리온 단백에도 확대 적용될 수 있다.  | 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products.  | As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | .  | 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | .  | Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products.  | Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations.  Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred. ",
        "original_sentence": "| 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | . "
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "| Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 217,
        "word_count": 32,
        "page_number": 8,
        "window_text": "| 등록대상 | 유전자치료제의 | 품질평가 가이드 | 2001 | 11-1470000-000074-14 | (생물의약품평가가이드 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/54 | Data from experimental rodent models of TSEs have shown infectivity of blood components.3,4,5,6 | Infectivity has also been detected in buffy coat of a prosimian microcebe experimentally infected with | a macaque-adapted BSE strain.7 Intra-species transfusion experiments have also shown that | experimental BSE or natural scrapie infection can be transmitted between sheep by blood transfusion.8 | On the other hand, experiments to detect vCJD infectivity in human blood using wild-type mice9, | transgenic mice as well as primates have not shown any transmission yet but some of the studies are | still ongoing.10 However, tracing of recipients of blood transfusion from UK donors has revealed two | possible cases of secondary transmission after transfusion of red cells from donors who subsequently | developed symptoms of vCJD.2,11 Epidemiological studies have so far been unable to identify a single | case of CJD resulting from the administration of plasma-derived products (studies conducted in high | risk recipient populations such as hemophiliacs).10,12 The epidemiological experience is too limited to | reach conclusions on whether or not vCJD could be transmitted by plasma-derived medicinal products.  | As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | .  | 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | .  | Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products.  | Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations.  Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred.  In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions. ",
        "original_sentence": "| Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products. "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "| Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 222,
        "word_count": 32,
        "page_number": 8,
        "window_text": "| As of February 2004, no case of vCJD has been identified with a history of exposure to plasma- | derived products.11 |\n| 또는 | 단계 이상을 수행하기에는 실험에 한계가 있다 | 1 | 2 | .  | 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | .  | Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products.  | Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations.  Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred.  In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions.  Other types of spikes are also possible. ",
        "original_sentence": "| Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations. "
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 183,
        "word_count": 28,
        "page_number": 6,
        "window_text": "| 진공 라인은 액체 비 감염성 트랩과 | 필터로 보호되어야 한다 | 11) | - | HEPA | .  | Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products.  | Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations.  Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred.  In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions.  Other types of spikes are also possible.  | 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred. "
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 136,
        "word_count": 20,
        "page_number": 6,
        "window_text": "| Further guidance on the step-wise approach to the use of biochemical assays or bioassays is provided | in the CHMP Position Statement1, Section 9.2.3 Manufacturing processes for plasma-derived | medicinal products.  | Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations.  Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred.  In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions.  Other types of spikes are also possible.  | 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | . ",
        "original_sentence": "In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions. "
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "Other types of spikes are also possible. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 41,
        "word_count": 7,
        "page_number": 5,
        "window_text": "| Results of precipitation studies indicated that the three membrane-bound spikes (homogenates, | microsomes, CLDs) behave similarly, thus any of these three types may be suitable spiking agents for | such investigations.  Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred.  In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions.  Other types of spikes are also possible.  | 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | .  | Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다. ",
        "original_sentence": "Other types of spikes are also possible. "
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "| 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 412,
        "word_count": 82,
        "page_number": 5,
        "window_text": "Because the largest aggregates are removed, and the material may be more | consistently prepared whilst maintaining high levels of activity, a microsomal fraction may be | preferred.  In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions.  Other types of spikes are also possible.  | 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | .  | Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다.  | 면에서 더욱 주의가 필요하다. ",
        "original_sentence": "| 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "| □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 469,
        "word_count": 95,
        "page_number": 2,
        "window_text": "In contrast, the purified PrPSc was more easily precipitated (including into the | cryoprecipitate) than any of the membrane fractions.  Other types of spikes are also possible.  | 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | .  | Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다.  | 면에서 더욱 주의가 필요하다.  | 기타 시험법 | 4.2. ",
        "original_sentence": "| □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | . "
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "| Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 83,
        "word_count": 17,
        "page_number": 11,
        "window_text": "Other types of spikes are also possible.  | 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | .  | Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다.  | 면에서 더욱 주의가 필요하다.  | 기타 시험법 | 4.2.  | 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다. ",
        "original_sentence": "| Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다. "
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "| 면에서 더욱 주의가 필요하다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 3.7 | Re-evaluation of TSE clearance ...................................................................................... 8 |\n| 세포치료제 조직공학제품 | ․ | 개발동향 및 안전관리 | 2003 | 11-1470000-000275-01 | (생물의약품평가자료집 | 1) | 생명공학의약품과 | 생물공학과 | ( | ) | 舊 | - | HIV 항체 진단제제의 | 기준 및 시험방법 | 작성 | ‘ | ’ | 지침 | 2007 | 11-1470000-001462-01 | (생물의약품평가가이드 | 23) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/196 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | .  | Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다.  | 면에서 더욱 주의가 필요하다.  | 기타 시험법 | 4.2.  | 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다.  | 15. ",
        "original_sentence": "| 면에서 더욱 주의가 필요하다. "
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "| 기타 시험법 | 4.2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 2,
        "window_text": "| □ 예 | ■ 아니오 | 2004 | 11-1470000-000684-01 | (생물의약품평가자료집 | 15) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/84 |\n**여부**\n| 생명공학의약품 허가를 | 위한 Q&A | 2006 | 11-1470000-000895-01 | (생물의약품평가자료집 | 28) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침127 | 3.8 | Sanitisation of equipment ............................................................................................... 8 |\n| ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 | 자 | , 기구나 시료를 담을 수 있는 용기를 다룰 최소한의 보조자가 필요하다 | .  | Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다.  | 면에서 더욱 주의가 필요하다.  | 기타 시험법 | 4.2.  | 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다.  | 15.  | Taylor DM. ",
        "original_sentence": "| 기타 시험법 | 4.2. "
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "| 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 147,
        "word_count": 39,
        "page_number": 2,
        "window_text": "| Stereotaxic apparatus | Homogenizer |\n| 세척과 오염 제거 방법으로 평가 중이지만 아직까지 적용되고 있지는 않다.  | 면에서 더욱 주의가 필요하다.  | 기타 시험법 | 4.2.  | 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다.  | 15.  | Taylor DM.  Inactivation of transmissible degenerative encephalopathy agents: a review. ",
        "original_sentence": "| 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다. "
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "| 15. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 2,
        "window_text": "| 면에서 더욱 주의가 필요하다.  | 기타 시험법 | 4.2.  | 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다.  | 15.  | Taylor DM.  Inactivation of transmissible degenerative encephalopathy agents: a review.  The | Veterinary Journal 2000;159:10-17. ",
        "original_sentence": "| 15. "
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "| Taylor DM. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 5,
        "window_text": "| 기타 시험법 | 4.2.  | 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다.  | 15.  | Taylor DM.  Inactivation of transmissible degenerative encephalopathy agents: a review.  The | Veterinary Journal 2000;159:10-17.  | 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다. ",
        "original_sentence": "| Taylor DM. "
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "Inactivation of transmissible degenerative encephalopathy agents: a review. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 76,
        "word_count": 8,
        "page_number": 8,
        "window_text": "| 생물의약품 국가표준품 | 카다로그 (2002) | 2002 | 11-1470000-000547-10 | 백신과 | 바이러스제제과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/22, 23 | 조사연구 시 고려해야 할 주요 항목은 다음과 같다.  | 15.  | Taylor DM.  Inactivation of transmissible degenerative encephalopathy agents: a review.  The | Veterinary Journal 2000;159:10-17.  | 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다.  | 하며 출입문 가까이에 위치하여야 한다. ",
        "original_sentence": "Inactivation of transmissible degenerative encephalopathy agents: a review. "
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "The | Veterinary Journal 2000;159:10-17. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 41,
        "word_count": 5,
        "page_number": 2,
        "window_text": "| 15.  | Taylor DM.  Inactivation of transmissible degenerative encephalopathy agents: a review.  The | Veterinary Journal 2000;159:10-17.  | 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다.  | 하며 출입문 가까이에 위치하여야 한다.  | 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다. ",
        "original_sentence": "The | Veterinary Journal 2000;159:10-17. "
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "| 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 5,
        "window_text": "| Taylor DM.  Inactivation of transmissible degenerative encephalopathy agents: a review.  The | Veterinary Journal 2000;159:10-17.  | 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다.  | 하며 출입문 가까이에 위치하여야 한다.  | 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다.  | 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다. ",
        "original_sentence": "| 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다. "
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "| 하며 출입문 가까이에 위치하여야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 5,
        "window_text": "Inactivation of transmissible degenerative encephalopathy agents: a review.  The | Veterinary Journal 2000;159:10-17.  | 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다.  | 하며 출입문 가까이에 위치하여야 한다.  | 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다.  | 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다.  |\n| 용어 정의 | 2. ",
        "original_sentence": "| 하며 출입문 가까이에 위치하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "| 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 5,
        "window_text": "The | Veterinary Journal 2000;159:10-17.  | 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다.  | 하며 출입문 가까이에 위치하여야 한다.  | 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다.  | 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다.  |\n| 용어 정의 | 2.  | mouse)를 사용한다 | . ",
        "original_sentence": "| 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다. "
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "| 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 5,
        "window_text": "| 용기에 폐기하고 단단한 저장용기에 담아 고압증기멸균 한다.  | 하며 출입문 가까이에 위치하여야 한다.  | 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다.  | 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다.  |\n| 용어 정의 | 2.  | mouse)를 사용한다 | .  | pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses. ",
        "original_sentence": "| 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다. "
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "|\n| 용어 정의 | 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 15,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| 하며 출입문 가까이에 위치하여야 한다.  | 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다.  | 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다.  |\n| 용어 정의 | 2.  | mouse)를 사용한다 | .  | pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses.  | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2. ",
        "original_sentence": "|\n| 용어 정의 | 2. "
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "| mouse)를 사용한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 거나 화장을 하거나 음식물을 저장하거나 하는 행위 등은 금지한다.  | 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다.  |\n| 용어 정의 | 2.  | mouse)를 사용한다 | .  | pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses.  | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2.  | homogenizer | stereotaxic apparatus | 가능해야 한다. ",
        "original_sentence": "| mouse)를 사용한다 | . "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "| pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 457,
        "word_count": 100,
        "page_number": 2,
        "window_text": "| 도에 비해 저농도에서 낮은 효율로 제거될 가능성이 있다.  |\n| 용어 정의 | 2.  | mouse)를 사용한다 | .  | pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses.  | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2.  | homogenizer | stereotaxic apparatus | 가능해야 한다.  |\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16. ",
        "original_sentence": "| pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses. "
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "| □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 128,
        "word_count": 44,
        "page_number": 2,
        "window_text": "|\n| 용어 정의 | 2.  | mouse)를 사용한다 | .  | pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses.  | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2.  | homogenizer | stereotaxic apparatus | 가능해야 한다.  |\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16.  | Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG. ",
        "original_sentence": "| □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2. "
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "| homogenizer | stereotaxic apparatus | 가능해야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 49,
        "word_count": 8,
        "page_number": 5,
        "window_text": "| mouse)를 사용한다 | .  | pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses.  | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2.  | homogenizer | stereotaxic apparatus | 가능해야 한다.  |\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16.  | Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG.  | Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications. ",
        "original_sentence": "| homogenizer | stereotaxic apparatus | 가능해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "|\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 397,
        "word_count": 93,
        "page_number": 5,
        "window_text": "| pathies, WHO, 2006 |\n| 바이오칩 평가가이드 | -DNA칩의 기준 및 | 시험방법 작성지침- | 2005 | 11-1470000-000896-01 | (생물의약품평가가이드 | 13) | 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 | 기술하는 것(식품의약품안전처 지침서등의 관리에 관한 규정 제2조) | 재조합의약품팀 | 생물진단제제팀 | 생물의약품규격과 | ( | ) | 舊 |\n| 오염물질의 노출 및 피부의 상처를 피하기 위한 사전예방 조치로 | 2) | The confidence which can be placed on a figure for the ability of a process step to remove the agent of | TSE is therefore lower than for its ability to remove model viruses.  | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2.  | homogenizer | stereotaxic apparatus | 가능해야 한다.  |\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16.  | Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG.  | Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications.  Journal of Biological Chemistry 2002;277:11084- | 11089. ",
        "original_sentence": "|\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16. "
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "| Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 80,
        "word_count": 13,
        "page_number": 6,
        "window_text": "| □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/110 |\n| 규모 축소 공정 | - | 그림 | 감염성 프리온 단백 감염을 위한 | 와 | 2.  | homogenizer | stereotaxic apparatus | 가능해야 한다.  |\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16.  | Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG.  | Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications.  Journal of Biological Chemistry 2002;277:11084- | 11089.  | DISCUSSION IN THE BWP | June–November 2003 | 내용입니까? ",
        "original_sentence": "| Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG. "
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "| Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 144,
        "word_count": 16,
        "page_number": 8,
        "window_text": "| homogenizer | stereotaxic apparatus | 가능해야 한다.  |\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16.  | Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG.  | Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications.  Journal of Biological Chemistry 2002;277:11084- | 11089.  | DISCUSSION IN THE BWP | June–November 2003 | 내용입니까?  |\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies. ",
        "original_sentence": "| Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications. "
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "Journal of Biological Chemistry 2002;277:11084- | 11089. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 57,
        "word_count": 7,
        "page_number": 2,
        "window_text": "|\n| 3.5 | Choice of manufacturing steps |\n| 생명공학의약품 길라잡이 | 2005 | 11-1470000-000893-01 | (생물의약품평가자료집 | 27) | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 자료실 간행물 | / | , | 지침/109 | 세균백신 자가 기준 및 | 시험방법 작성 지침서 | 2007 | 11-1470000-001428-01 | (생물의약품평가가이드 | 22) | 세균백신팀 | 자료실 간행물 | / | , | 지침/177 | 유전자치료제의 | 안전성평가 2006 | 2006 | 11-1470000-001140-01 | (생물의약품평가자료집 | 38) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/169 | 16.  | Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG.  | Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications.  Journal of Biological Chemistry 2002;277:11084- | 11089.  | DISCUSSION IN THE BWP | June–November 2003 | 내용입니까?  |\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies.  However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products. ",
        "original_sentence": "Journal of Biological Chemistry 2002;277:11084- | 11089. "
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "| DISCUSSION IN THE BWP | June–November 2003 | 내용입니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 54,
        "word_count": 10,
        "page_number": 2,
        "window_text": "| Somerville RA, Oberthür RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG.  | Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications.  Journal of Biological Chemistry 2002;277:11084- | 11089.  | DISCUSSION IN THE BWP | June–November 2003 | 내용입니까?  |\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies.  However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products.  |\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | . ",
        "original_sentence": "| DISCUSSION IN THE BWP | June–November 2003 | 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "|\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 162,
        "word_count": 27,
        "page_number": 8,
        "window_text": "| Characterization of thermodynamic diversity between transmissible spongiform encephalopathy | agent strains and its theoretical implications.  Journal of Biological Chemistry 2002;277:11084- | 11089.  | DISCUSSION IN THE BWP | June–November 2003 | 내용입니까?  |\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies.  However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products.  |\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | .  | - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | . ",
        "original_sentence": "|\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies. "
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 199,
        "word_count": 30,
        "page_number": 6,
        "window_text": "Journal of Biological Chemistry 2002;277:11084- | 11089.  | DISCUSSION IN THE BWP | June–November 2003 | 내용입니까?  |\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies.  However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products.  |\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | .  | - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | .  | 물질 선택 | - Spiking | 서 수행한다 | . ",
        "original_sentence": "However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products. "
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "|\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 50,
        "word_count": 14,
        "page_number": 2,
        "window_text": "| DISCUSSION IN THE BWP | June–November 2003 | 내용입니까?  |\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies.  However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products.  |\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | .  | - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | .  | 물질 선택 | - Spiking | 서 수행한다 | .  일반 실험대에서는 어떠한 작업도 수행하지 않는다 | . ",
        "original_sentence": "|\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "| - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 2,
        "window_text": "|\n| It is recognised that there are limitations of the data because of the model character and | approximations that are linked to feasible experimental studies.  However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products.  |\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | .  | - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | .  | 물질 선택 | - Spiking | 서 수행한다 | .  일반 실험대에서는 어떠한 작업도 수행하지 않는다 | .  | 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다. ",
        "original_sentence": "| - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "| 물질 선택 | - Spiking | 서 수행한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 33,
        "word_count": 11,
        "page_number": 5,
        "window_text": "However, it is expected that these | investigational studies will provide a helpful indication on the capacity for removal of the TSE agent | during manufacture of plasma-derived medicinal products.  |\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | .  | - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | .  | 물질 선택 | - Spiking | 서 수행한다 | .  일반 실험대에서는 어떠한 작업도 수행하지 않는다 | .  | 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다.  |\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected. ",
        "original_sentence": "| 물질 선택 | - Spiking | 서 수행한다 | . "
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "일반 실험대에서는 어떠한 작업도 수행하지 않는다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 5,
        "window_text": "|\n| 13) BSL-3 수준의 시설 디자인과 작동 절차는 문서화되어 있어야 한다 | .  | - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | .  | 물질 선택 | - Spiking | 서 수행한다 | .  일반 실험대에서는 어떠한 작업도 수행하지 않는다 | .  | 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다.  |\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected.  Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents. ",
        "original_sentence": "일반 실험대에서는 어떠한 작업도 수행하지 않는다 | . "
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "| 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 5,
        "window_text": "| - 1회용으로 흡수성이 없는 실험복을 착용하여야 한다 | .  | 물질 선택 | - Spiking | 서 수행한다 | .  일반 실험대에서는 어떠한 작업도 수행하지 않는다 | .  | 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다.  |\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected.  Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents.  | 은 측정용 기기를 사용한다. ",
        "original_sentence": "| 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다. "
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "|\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 241,
        "word_count": 40,
        "page_number": 8,
        "window_text": "| 물질 선택 | - Spiking | 서 수행한다 | .  일반 실험대에서는 어떠한 작업도 수행하지 않는다 | .  | 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다.  |\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected.  Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents.  | 은 측정용 기기를 사용한다.  | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "|\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected. "
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 322,
        "word_count": 49,
        "page_number": 8,
        "window_text": "일반 실험대에서는 어떠한 작업도 수행하지 않는다 | .  | 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다.  |\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected.  Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents.  | 은 측정용 기기를 사용한다.  | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma. ",
        "original_sentence": "Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents. "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "| 은 측정용 기기를 사용한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 18,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 게 만드는 것도 결과의 신뢰성을 판단하는데 중요한 요소이다.  |\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected.  Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents.  | 은 측정용 기기를 사용한다.  | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma.  The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. ",
        "original_sentence": "| 은 측정용 기기를 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "| □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 3,
        "window_text": "|\n| Bearing in mind the known resistance of TSE agents to conventional virus inactivation methods such as | heat, the manufacturing steps for investigation should be those where some removal or partitioning of the | agent might be expected.  Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents.  | 은 측정용 기기를 사용한다.  | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma.  The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of preparations should be given in all cases. ",
        "original_sentence": "| □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "| □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 323,
        "word_count": 78,
        "page_number": 3,
        "window_text": "Thus there is little point in carrying out studies of solvent/detergent and heat | treatment processes, and attention should be focused on ethanol fractionation, precipitation, | chromatography, and filtration steps, which have been shown in a number of studies to have significant | capability for removal of TSE agents.  | 은 측정용 기기를 사용한다.  | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma.  The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of preparations should be given in all cases.  | TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1. ",
        "original_sentence": "| □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma. "
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 198,
        "word_count": 31,
        "page_number": 6,
        "window_text": "| 은 측정용 기기를 사용한다.  | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma.  The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of preparations should be given in all cases.  | TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1.  | strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | . ",
        "original_sentence": "The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions. "
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "The rationale for the choice of preparations should be given in all cases. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 75,
        "word_count": 13,
        "page_number": 8,
        "window_text": "| □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma.  The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of preparations should be given in all cases.  | TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1.  | strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | .  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2. ",
        "original_sentence": "The rationale for the choice of preparations should be given in all cases. "
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "| TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 70,
        "word_count": 18,
        "page_number": 2,
        "window_text": "| □ 예 | ■ 아니오 |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2001 | Ⅰ | 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 |\n| 3.7 | Re-evaluation of TSE clearance | It is not clear whether the behaviour of any of these spiking materials is representative of the form of | infectivity which may be found in plasma.  The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of preparations should be given in all cases.  | TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1.  | strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | .  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2.  | 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | . ",
        "original_sentence": "| TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1. "
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "| strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 148,
        "word_count": 37,
        "page_number": 2,
        "window_text": "The spike preparation(s) that would be expected to provide | the greatest challenge to the process step(s) under investigation should be selected in order to evaluate | under worst case conditions.  The rationale for the choice of preparations should be given in all cases.  | TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1.  | strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | .  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2.  | 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | .  | 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | . ",
        "original_sentence": "| strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | . "
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "| 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 69,
        "word_count": 19,
        "page_number": 6,
        "window_text": "The rationale for the choice of preparations should be given in all cases.  | TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1.  | strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | .  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2.  | 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | .  | 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | .  | 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made. ",
        "original_sentence": "| 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2. "
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "| 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 176,
        "word_count": 45,
        "page_number": 2,
        "window_text": "| TRANSMISSION TO CPMP | November 2003 | 표 | 감염성 프리온 단백 | 과 감염동물 | 1.  | strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | .  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2.  | 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | .  | 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | .  | 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made.  In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major. ",
        "original_sentence": "| 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | . "
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "| 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 75,
        "word_count": 22,
        "page_number": 2,
        "window_text": "| strain |\n| 유전자치료제의 복제가능 | 바이러스 시험법에 관한 | 가이드 | 2005 | 11-1470000-000877-01 | (생물의약품평가가이드 | 12) | 수술용 장갑은 잘 찢어지지 않는 것을 사용하되 | 겹으로 착용한다 | - | 2 | .  | 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2.  | 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | .  | 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | .  | 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made.  In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major.  | Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work. ",
        "original_sentence": "| 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | . "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "| 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 441,
        "word_count": 97,
        "page_number": 2,
        "window_text": "| 재조합의약품팀 | 생명공학의약품과 | ( | ) | 舊 | 유전자치료제팀 |\n| 뇌조직의 신경병리학적 관찰 | 2.2.  | 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | .  | 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | .  | 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made.  In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major.  | Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps. ",
        "original_sentence": "| 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 149,
        "word_count": 25,
        "page_number": 8,
        "window_text": "| 바이오 칩 평가 가이드 | -HPV DNA칩 기준 및 | 시험방법 작성 지침- | 2006 | 11-1470000-001165-01 | (생물의약품평가가이드 | 21) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/154 | 5) 날카로운 물질의 사용에 대해서는 안전한 취급 방법을 습득한다 | .  | 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | .  | 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made.  In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major.  | Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps.  | The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples. ",
        "original_sentence": "In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "| Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 181,
        "word_count": 27,
        "page_number": 6,
        "window_text": "| 분획 | 2) Microsomal | 위험 평가 | 조건에 따라 부가적인 환경보호 시설이 고려되어야 한다 | 14) | , | .  | 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made.  In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major.  | Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps.  | The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples.  Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors. ",
        "original_sentence": "| Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 376,
        "word_count": 92,
        "page_number": 3,
        "window_text": "| 시험법 선택 | - | 자료실 간행물 | / | , | 지침/118 |\n| 세포치료제의 | 안전성 유효성 및 품질 | ․ | 평가 2006 | 2006 | 11-1470000-001146-01 | (생물의약품평가자료집 | 37) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/148 | KFDA Bio Handbook | 2005 | 11-1470000-000873-01 | (생물의약품평가자료집 | 26) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/91 |\n| As for the virus validation studies, it may be necessary to re-evaluate TSE clearance data for a | production process, if significant changes are made.  In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major.  | Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps.  | The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples.  Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors.  Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step). ",
        "original_sentence": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "| The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 196,
        "word_count": 29,
        "page_number": 8,
        "window_text": "In view of the difficulty in performing the studies | and the reservations about the results obtained, such changes would probably have to be major.  | Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps.  | The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples.  Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors.  Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step).  An investigation study | that encompasses the entire process would be an ideal goal. ",
        "original_sentence": "| The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples. "
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 115,
        "word_count": 18,
        "page_number": 9,
        "window_text": "| Alternatively, developments in the scientific area could make the studies easier, for instance by | making in vitro infectivity assays possible, which could justify further work.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps.  | The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples.  Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors.  Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step).  An investigation study | that encompasses the entire process would be an ideal goal.  However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps. ",
        "original_sentence": "Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors. "
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step). ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 269,
        "word_count": 41,
        "page_number": 6,
        "window_text": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | □ 예 | ■ 아니오 |\n| 행정간행물 제목 | 발행 | 연도 | 행정간행물 번호 | 발행과 | 홈페이지 | 게재 상태 | RELEASE FOR CONSULTATION | November 2003 |\n| 세포치료제의 임상시험 | 사례분석 | 2007 | 11-1470000-001586-14 | (생물의약품평가자료집 | 50) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 제조공정 선택 | - | The initial spiking titre may be high enough to allow a study of a combination of two (or more) steps.  | The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples.  Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors.  Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step).  An investigation study | that encompasses the entire process would be an ideal goal.  However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps.  | 17. ",
        "original_sentence": "Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step). "
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "An investigation study | that encompasses the entire process would be an ideal goal. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 85,
        "word_count": 14,
        "page_number": 8,
        "window_text": "| The design of such combined-step studies should allow determination of reduction factors from each | single step and from the combined steps by analysing the corresponding intermediate samples.  Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors.  Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step).  An investigation study | that encompasses the entire process would be an ideal goal.  However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps.  | 17.  | Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification. ",
        "original_sentence": "An investigation study | that encompasses the entire process would be an ideal goal. "
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 162,
        "word_count": 30,
        "page_number": 6,
        "window_text": "Such | combined-step studies may be helpful to substantiate the additivity of low or moderate reduction | factors.  Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step).  An investigation study | that encompasses the entire process would be an ideal goal.  However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps.  | 17.  | Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification.  Biologicals 2002;30:187-196. ",
        "original_sentence": "However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps. "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "| 17. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 2,
        "window_text": "Moreover, studying combined steps may be helpful where a significant alteration of the | physicochemical state of the TSE material, which would influence the removal at the following step, | may be suspected (e.g treatment with detergent preceeding a filtration step).  An investigation study | that encompasses the entire process would be an ideal goal.  However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps.  | 17.  | Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification.  Biologicals 2002;30:187-196.  | 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다. ",
        "original_sentence": "| 17. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "| Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 127,
        "word_count": 22,
        "page_number": 5,
        "window_text": "An investigation study | that encompasses the entire process would be an ideal goal.  However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps.  | 17.  | Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification.  Biologicals 2002;30:187-196.  | 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다.  | 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다. ",
        "original_sentence": "| Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification. "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "Biologicals 2002;30:187-196. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 29,
        "word_count": 2,
        "page_number": 2,
        "window_text": "However, as with viruses, the | experimental limitation is that the initial spiking titre will be, in many cases, too low to follow more | than one or two steps.  | 17.  | Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification.  Biologicals 2002;30:187-196.  | 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다.  | 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다.  | 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | . ",
        "original_sentence": "Biologicals 2002;30:187-196. "
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "| 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 5,
        "window_text": "| 17.  | Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification.  Biologicals 2002;30:187-196.  | 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다.  | 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다.  | 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | .  | ℃ | 정리한 자료입니까? ",
        "original_sentence": "| 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다. "
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "| 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 71,
        "word_count": 19,
        "page_number": 6,
        "window_text": "| Vey M, Baron H, Weimer T, Gröner A. Purity of spiking agent affects partitioning of prions in | plasma protein purification.  Biologicals 2002;30:187-196.  | 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다.  | 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다.  | 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | .  | ℃ | 정리한 자료입니까?  |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다. ",
        "original_sentence": "| 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다. "
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "| 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 99,
        "word_count": 26,
        "page_number": 6,
        "window_text": "Biologicals 2002;30:187-196.  | 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다.  | 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다.  | 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | .  | ℃ | 정리한 자료입니까?  |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다.  |\n| 자료의 해석과 제한사항 | - | 다. ",
        "original_sentence": "| 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | . "
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "| ℃ | 정리한 자료입니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| 거나 튀었을 경우 효과적인 소독제를 사용하여 일상적으로 소독한다.  | 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다.  | 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | .  | ℃ | 정리한 자료입니까?  |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다.  |\n| 자료의 해석과 제한사항 | - | 다.  | DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다. ",
        "original_sentence": "| ℃ | 정리한 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_167",
      "text": "|\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 166,
        "window_size": 3,
        "char_count": 93,
        "word_count": 25,
        "page_number": 6,
        "window_text": "| 감염성 프리온 단백 strain | 감염 동물 | 잠복기(day) |\n| 같은 경우는 신뢰성 있게 모델화하는 것이 어렵다.  | 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | .  | ℃ | 정리한 자료입니까?  |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다.  |\n| 자료의 해석과 제한사항 | - | 다.  | DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다.  | 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | . ",
        "original_sentence": "|\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_168",
      "text": "|\n| 자료의 해석과 제한사항 | - | 다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 167,
        "window_size": 3,
        "char_count": 26,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 같은 정상 프리온을 PrPC | 라 명명함 | (cellular isoform of prion protein) | 하여 | 또는 그 이하에 보관하여야 한다 | -20 | .  | ℃ | 정리한 자료입니까?  |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다.  |\n| 자료의 해석과 제한사항 | - | 다.  | DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다.  | 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | .  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
        "original_sentence": "|\n| 자료의 해석과 제한사항 | - | 다. "
      }
    },
    {
      "chunk_id": "chunk_169",
      "text": "| DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 168,
        "window_size": 3,
        "char_count": 141,
        "word_count": 36,
        "page_number": 2,
        "window_text": "| ℃ | 정리한 자료입니까?  |\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다.  |\n| 자료의 해석과 제한사항 | - | 다.  | DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다.  | 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | .  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
        "original_sentence": "| DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다. "
      }
    },
    {
      "chunk_id": "chunk_170",
      "text": "| 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 169,
        "window_size": 3,
        "char_count": 52,
        "word_count": 14,
        "page_number": 6,
        "window_text": "|\n| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2002 | Ⅱ | References | 농도를 결정하여야 한다.  |\n| 자료의 해석과 제한사항 | - | 다.  | DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다.  | 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | .  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18. ",
        "original_sentence": "| 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | . "
      }
    },
    {
      "chunk_id": "chunk_171",
      "text": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 170,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 3,
        "window_text": "|\n| 자료의 해석과 제한사항 | - | 다.  | DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다.  | 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | .  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18.  | Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions. ",
        "original_sentence": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. "
      }
    },
    {
      "chunk_id": "chunk_172",
      "text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 171,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| DEADLINE FOR COMMENTS | End March 2004 |\n| 임상시험용 | 유전자치료제의 특성분석, | 제조 및 품질관리 | 평가가이드 | 생명공학의약품의 | 안전성 유효성 평가 - | ․ | 비교동등성 평가시 | 고려사항 | 다.  | 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | .  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18.  | Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions.  Proc. ",
        "original_sentence": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. "
      }
    },
    {
      "chunk_id": "chunk_173",
      "text": "| 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 172,
        "window_size": 3,
        "char_count": 203,
        "word_count": 49,
        "page_number": 2,
        "window_text": "| 일체식 | 이어야 하며 미끄럼이 방지되어야 한다 | (monolithic, | ) | .  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18.  | Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions.  Proc.  Natl. ",
        "original_sentence": "| 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18. "
      }
    },
    {
      "chunk_id": "chunk_174",
      "text": "| Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 173,
        "window_size": 3,
        "char_count": 149,
        "word_count": 24,
        "page_number": 6,
        "window_text": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18.  | Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions.  Proc.  Natl.  Acad. ",
        "original_sentence": "| Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions. "
      }
    },
    {
      "chunk_id": "chunk_175",
      "text": "Proc. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 174,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 5,
        "window_text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18.  | Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions.  Proc.  Natl.  Acad.  Sci. ",
        "original_sentence": "Proc. "
      }
    },
    {
      "chunk_id": "chunk_176",
      "text": "Natl. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 175,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 5,
        "window_text": "| 263K | golden syrian hamster | 70±10 |\n| 혈장분획제제 등 바이러스 | 검증 평가 가이드 | 2006 | 11-1470000-001176-01 | (생물의약품평가가이드 | 20) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/170 | 혈장분획제제 제조공정 중 감염성 프리온 단백 | 제거 조사연구 가이드라인 | 18.  | Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions.  Proc.  Natl.  Acad.  Sci.  2003;100:11666-11671. ",
        "original_sentence": "Natl. "
      }
    },
    {
      "chunk_id": "chunk_177",
      "text": "Acad. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 176,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 5,
        "window_text": "| Klöhn P-C, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell- | based infectivity assay for mouse scrapie prions.  Proc.  Natl.  Acad.  Sci.  2003;100:11666-11671.  | 1. ",
        "original_sentence": "Acad. "
      }
    },
    {
      "chunk_id": "chunk_178",
      "text": "Sci. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 177,
        "window_size": 3,
        "char_count": 5,
        "word_count": 1,
        "page_number": 5,
        "window_text": "Proc.  Natl.  Acad.  Sci.  2003;100:11666-11671.  | 1.  | CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III. ",
        "original_sentence": "Sci. "
      }
    },
    {
      "chunk_id": "chunk_179",
      "text": "2003;100:11666-11671. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 178,
        "window_size": 3,
        "char_count": 22,
        "word_count": 1,
        "page_number": 2,
        "window_text": "Natl.  Acad.  Sci.  2003;100:11666-11671.  | 1.  | CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III.  품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment. ",
        "original_sentence": "2003;100:11666-11671. "
      }
    },
    {
      "chunk_id": "chunk_180",
      "text": "| 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 179,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 2,
        "window_text": "Acad.  Sci.  2003;100:11666-11671.  | 1.  | CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III.  품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment.  For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance. ",
        "original_sentence": "| 1. "
      }
    },
    {
      "chunk_id": "chunk_181",
      "text": "| CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 180,
        "window_size": 3,
        "char_count": 553,
        "word_count": 98,
        "page_number": 8,
        "window_text": "Sci.  2003;100:11666-11671.  | 1.  | CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III.  품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment.  For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance.  | EMEA EXPERT WORKSHOP | January 2004 | 한다. ",
        "original_sentence": "| CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III. "
      }
    },
    {
      "chunk_id": "chunk_182",
      "text": "품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 181,
        "window_size": 3,
        "char_count": 410,
        "word_count": 84,
        "page_number": 2,
        "window_text": "2003;100:11666-11671.  | 1.  | CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III.  품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment.  For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance.  | EMEA EXPERT WORKSHOP | January 2004 | 한다.  | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | . ",
        "original_sentence": "품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment. "
      }
    },
    {
      "chunk_id": "chunk_183",
      "text": "For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 182,
        "window_size": 3,
        "char_count": 196,
        "word_count": 28,
        "page_number": 25,
        "window_text": "| 1.  | CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III.  품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment.  For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance.  | EMEA EXPERT WORKSHOP | January 2004 | 한다.  | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | . ",
        "original_sentence": "For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance. "
      }
    },
    {
      "chunk_id": "chunk_184",
      "text": "| EMEA EXPERT WORKSHOP | January 2004 | 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 183,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 2,
        "window_text": "| CHMP Position statement on Creutzfeldt-Jakob Disease and plasma-derived and urine-derived | medicinal products, June 2004 (EMEA/CPMP/BWP/2879/02/rev 1) | http://www.emea.eu.int/pdfs/human/press/pos/287902rev1.pdf | 재조합의약품과 | 바이러스백신과 | 혈액제제과 | 유전자치료제과 | 세포조직공학제제과 |\n| 3.4 | Choice of assays | 2005 | 11-1470000-000876-01 | (생물의약품평가가이드 | 11) | 생명공학의약품과 | 자료실 간행물 | / | , | 지침/107 |\n| 세포치료제 안전성 유효성 | ․ | 및 품질 평가시 고려사항 | 2006 | 2006 | 11-1470000-001145-01 | (생물의약품평가자료집 | 36) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/147 | 생물의약품 | 국제공통기술문서 작성 | 가이드라인 해설 | -III.  품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment.  For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance.  | EMEA EXPERT WORKSHOP | January 2004 | 한다.  | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | .  | 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다. ",
        "original_sentence": "| EMEA EXPERT WORKSHOP | January 2004 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_185",
      "text": "| 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 184,
        "window_size": 3,
        "char_count": 115,
        "word_count": 29,
        "page_number": 2,
        "window_text": "품질 | 2007 | 11-1470000-001625-14 | (생물의약품평가가이드 | 34) | 세포치료제의 비임상시험 | 사례분석 | 2007 | 11-1470000-001585-14 | (생물의약품평가자료집 | 49) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/259 | 임상시험의 전반적인 | 고려사항 | 2004 | 11-1470000-000681-01 | (생물의약품평가자료집 | 12) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/79 | On the other hand it should be borne in mind that the behaviour of the spike in a particular step may be | affected by previous treatment.  For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance.  | EMEA EXPERT WORKSHOP | January 2004 | 한다.  | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | .  | 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다.  | 증폭시키는 방법이다. ",
        "original_sentence": "| 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | . "
      }
    },
    {
      "chunk_id": "chunk_186",
      "text": "| ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 185,
        "window_size": 3,
        "char_count": 50,
        "word_count": 14,
        "page_number": 5,
        "window_text": "For example solvent detergent treatment could disaggregate infectivity | so that it more readily passes a filter and studies with untreated materials would therefore overestimate | the clearance.  | EMEA EXPERT WORKSHOP | January 2004 | 한다.  | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | .  | 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다.  | 증폭시키는 방법이다.  |\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | . ",
        "original_sentence": "| ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | . "
      }
    },
    {
      "chunk_id": "chunk_187",
      "text": "| 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 186,
        "window_size": 3,
        "char_count": 53,
        "word_count": 15,
        "page_number": 5,
        "window_text": "| EMEA EXPERT WORKSHOP | January 2004 | 한다.  | 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | .  | 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다.  | 증폭시키는 방법이다.  |\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | .  | Infectivity assays are accepted as the gold standard for the detection of TSE agents. ",
        "original_sentence": "| 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다. "
      }
    },
    {
      "chunk_id": "chunk_188",
      "text": "| 증폭시키는 방법이다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 187,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 5,
        "window_text": "| 2005 | 11-1470000-000871-01 | (생물의약품평가자료집 | 25) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/103 |\n| 때까지 | 에 보관한다 | -70 | .  | ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | .  | 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다.  | 증폭시키는 방법이다.  |\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | .  | Infectivity assays are accepted as the gold standard for the detection of TSE agents.  The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent. ",
        "original_sentence": "| 증폭시키는 방법이다. "
      }
    },
    {
      "chunk_id": "chunk_189",
      "text": "|\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 188,
        "window_size": 3,
        "char_count": 117,
        "word_count": 30,
        "page_number": 2,
        "window_text": "| ℃ | 7) 실험실 작업대는 최소한 하루에 한번은 소독하며 오염물질을 제거한다 | .  | 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다.  | 증폭시키는 방법이다.  |\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | .  | Infectivity assays are accepted as the gold standard for the detection of TSE agents.  The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent.  Infectivity is measured by | end point titration in animals. ",
        "original_sentence": "|\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_190",
      "text": "| Infectivity assays are accepted as the gold standard for the detection of TSE agents. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 189,
        "window_size": 3,
        "char_count": 88,
        "word_count": 15,
        "page_number": 8,
        "window_text": "| 감염성 프리온 단백 제거율 재평가 | - | 새지 않도록 뚜껑이 있는 저장용기에 보관한다.  | 증폭시키는 방법이다.  |\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | .  | Infectivity assays are accepted as the gold standard for the detection of TSE agents.  The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent.  Infectivity is measured by | end point titration in animals.  The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity. ",
        "original_sentence": "| Infectivity assays are accepted as the gold standard for the detection of TSE agents. "
      }
    },
    {
      "chunk_id": "chunk_191",
      "text": "The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 190,
        "window_size": 3,
        "char_count": 206,
        "word_count": 36,
        "page_number": 8,
        "window_text": "| 증폭시키는 방법이다.  |\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | .  | Infectivity assays are accepted as the gold standard for the detection of TSE agents.  The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent.  Infectivity is measured by | end point titration in animals.  The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity.  The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed. ",
        "original_sentence": "The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent. "
      }
    },
    {
      "chunk_id": "chunk_192",
      "text": "Infectivity is measured by | end point titration in animals. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 191,
        "window_size": 3,
        "char_count": 61,
        "word_count": 10,
        "page_number": 8,
        "window_text": "|\n| ME7 | mouse(C57BL) | 150±10 | 자료실 간행물 | / | , | 지침/315 |\n| 라미터 | (parameter)를 비교함으로써 규모 축소 모델의 타당성을 입증하여야 한다 | .  | Infectivity assays are accepted as the gold standard for the detection of TSE agents.  The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent.  Infectivity is measured by | end point titration in animals.  The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity.  The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed.  For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used. ",
        "original_sentence": "Infectivity is measured by | end point titration in animals. "
      }
    },
    {
      "chunk_id": "chunk_193",
      "text": "The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 192,
        "window_size": 3,
        "char_count": 173,
        "word_count": 28,
        "page_number": 8,
        "window_text": "| Infectivity assays are accepted as the gold standard for the detection of TSE agents.  The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent.  Infectivity is measured by | end point titration in animals.  The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity.  The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed.  For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used.  This is one of | the factors in the selection of the spiking agent discussed above. ",
        "original_sentence": "The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity. "
      }
    },
    {
      "chunk_id": "chunk_194",
      "text": "The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 193,
        "window_size": 3,
        "char_count": 141,
        "word_count": 24,
        "page_number": 8,
        "window_text": "The presence of | the agent in a tissue or fluid is established by infection of suitable animal models, where induction of a | neurological disease after an incubation period is the signature of the agent.  Infectivity is measured by | end point titration in animals.  The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity.  The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed.  For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used.  This is one of | the factors in the selection of the spiking agent discussed above.  However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g. ",
        "original_sentence": "The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed. "
      }
    },
    {
      "chunk_id": "chunk_195",
      "text": "For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 194,
        "window_size": 3,
        "char_count": 152,
        "word_count": 24,
        "page_number": 6,
        "window_text": "Infectivity is measured by | end point titration in animals.  The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity.  The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed.  For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used.  This is one of | the factors in the selection of the spiking agent discussed above.  However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g.  hamster model, 263K), and | up to 15-18 months for non-transgenic murine models. ",
        "original_sentence": "For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used. "
      }
    },
    {
      "chunk_id": "chunk_196",
      "text": "This is one of | the factors in the selection of the spiking agent discussed above. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 195,
        "window_size": 3,
        "char_count": 84,
        "word_count": 16,
        "page_number": 8,
        "window_text": "The duration of the incubation period may also be used to quantify the | infectivity present in the tested material if validated against end point titration of infectivity.  The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed.  For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used.  This is one of | the factors in the selection of the spiking agent discussed above.  However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g.  hamster model, 263K), and | up to 15-18 months for non-transgenic murine models.  In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal. ",
        "original_sentence": "This is one of | the factors in the selection of the spiking agent discussed above. "
      }
    },
    {
      "chunk_id": "chunk_197",
      "text": "However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 196,
        "window_size": 3,
        "char_count": 219,
        "word_count": 40,
        "page_number": 6,
        "window_text": "The | existence of a species barrier to transmission and species and strain effects put constraints on the | materials which can be assayed.  For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used.  This is one of | the factors in the selection of the spiking agent discussed above.  However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g.  hamster model, 263K), and | up to 15-18 months for non-transgenic murine models.  In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal.  In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study. ",
        "original_sentence": "However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g. "
      }
    },
    {
      "chunk_id": "chunk_198",
      "text": "hamster model, 263K), and | up to 15-18 months for non-transgenic murine models. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 197,
        "window_size": 3,
        "char_count": 81,
        "word_count": 13,
        "page_number": 2,
        "window_text": "For example sporadic CJD preparations from humans rarely infect | normal wild type mice, although transgenic mice have been prepared which can be used.  This is one of | the factors in the selection of the spiking agent discussed above.  However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g.  hamster model, 263K), and | up to 15-18 months for non-transgenic murine models.  In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal.  In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study.  This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs. ",
        "original_sentence": "hamster model, 263K), and | up to 15-18 months for non-transgenic murine models. "
      }
    },
    {
      "chunk_id": "chunk_199",
      "text": "In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 198,
        "window_size": 3,
        "char_count": 156,
        "word_count": 26,
        "page_number": 6,
        "window_text": "This is one of | the factors in the selection of the spiking agent discussed above.  However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g.  hamster model, 263K), and | up to 15-18 months for non-transgenic murine models.  In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal.  In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study.  This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19. ",
        "original_sentence": "In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal. "
      }
    },
    {
      "chunk_id": "chunk_200",
      "text": "In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 199,
        "window_size": 3,
        "char_count": 181,
        "word_count": 34,
        "page_number": 6,
        "window_text": "However, bioassays are very complex | to be carried out as, due to the incubation period, the most rapid of them may require at least 6 to 9 | months of observation and clinical monitoring of the injected animals (e.g.  hamster model, 263K), and | up to 15-18 months for non-transgenic murine models.  In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal.  In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study.  This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19.  | Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR. ",
        "original_sentence": "In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study. "
      }
    },
    {
      "chunk_id": "chunk_201",
      "text": "This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 200,
        "window_size": 3,
        "char_count": 167,
        "word_count": 25,
        "page_number": 8,
        "window_text": "hamster model, 263K), and | up to 15-18 months for non-transgenic murine models.  In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal.  In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study.  This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19.  | Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR.  A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins. ",
        "original_sentence": "This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs. "
      }
    },
    {
      "chunk_id": "chunk_202",
      "text": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 201,
        "window_size": 3,
        "char_count": 77,
        "word_count": 24,
        "page_number": 3,
        "window_text": "In addition, for a given bioassay, the nature of | the agent to be tested is restricted to the combination of infectious agent/strain and recipient animal.  In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study.  This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19.  | Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR.  A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins.  Transfusion 2001;41:449-455. ",
        "original_sentence": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19. "
      }
    },
    {
      "chunk_id": "chunk_203",
      "text": "| Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 202,
        "window_size": 3,
        "char_count": 127,
        "word_count": 24,
        "page_number": 6,
        "window_text": "In | other words, it is not possible to test, on a given animal strain or species, all types of infectious | material which could be used as spiking material in a validation study.  This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19.  | Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR.  A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins.  Transfusion 2001;41:449-455.  | Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country. ",
        "original_sentence": "| Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR. "
      }
    },
    {
      "chunk_id": "chunk_204",
      "text": "A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 203,
        "window_size": 3,
        "char_count": 183,
        "word_count": 24,
        "page_number": 8,
        "window_text": "This is a further limitation | obstructing the design of validation studies for the manufacturing process to demonstrate partitioning | or inactivation of human TSEs.  | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19.  | Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR.  A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins.  Transfusion 2001;41:449-455.  | Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country.  | Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable. ",
        "original_sentence": "A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins. "
      }
    },
    {
      "chunk_id": "chunk_205",
      "text": "Transfusion 2001;41:449-455. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 204,
        "window_size": 3,
        "char_count": 29,
        "word_count": 2,
        "page_number": 2,
        "window_text": "| □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | □ 예 | ■ 아니오 |\n| 부검실의 오염 방지 | 3) | 19.  | Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR.  A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins.  Transfusion 2001;41:449-455.  | Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country.  | Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable.  If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation. ",
        "original_sentence": "Transfusion 2001;41:449-455. "
      }
    },
    {
      "chunk_id": "chunk_206",
      "text": "| Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 205,
        "window_size": 3,
        "char_count": 201,
        "word_count": 35,
        "page_number": 8,
        "window_text": "| Lee DC, Stenland CJ, Miller JLC, Cai K, Ford EK, Gilligan KJ, Hartwell RC, Terry JC, | Rubenstein R, Fournel M, Petteway SR.  A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins.  Transfusion 2001;41:449-455.  | Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country.  | Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable.  If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation.  |\n| 것이 충분할 수 있다. ",
        "original_sentence": "| Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country. "
      }
    },
    {
      "chunk_id": "chunk_207",
      "text": "| Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 206,
        "window_size": 3,
        "char_count": 113,
        "word_count": 18,
        "page_number": 8,
        "window_text": "A direct relationship between the partitioning of the | pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the | purification of plasma proteins.  Transfusion 2001;41:449-455.  | Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country.  | Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable.  If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation.  |\n| 것이 충분할 수 있다.  | 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | . ",
        "original_sentence": "| Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable. "
      }
    },
    {
      "chunk_id": "chunk_208",
      "text": "If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 207,
        "window_size": 3,
        "char_count": 264,
        "word_count": 44,
        "page_number": 8,
        "window_text": "Transfusion 2001;41:449-455.  | Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country.  | Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable.  If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation.  |\n| 것이 충분할 수 있다.  | 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | .  | 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다. ",
        "original_sentence": "If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation. "
      }
    },
    {
      "chunk_id": "chunk_209",
      "text": "|\n| 것이 충분할 수 있다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 208,
        "window_size": 3,
        "char_count": 17,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| Plasma from donors from the UK is currently not fractionated as a precautionary measure because the | UK had the highest exposure to BSE and has significantly more vCJD cases than any other country.  | Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable.  If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation.  |\n| 것이 충분할 수 있다.  | 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | .  | 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다.  | DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다. ",
        "original_sentence": "|\n| 것이 충분할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_210",
      "text": "| 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 209,
        "window_size": 3,
        "char_count": 57,
        "word_count": 12,
        "page_number": 6,
        "window_text": "| Plasma from donors from France is currently fractionated as the risk benefit ratio is considered | favourable.  If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation.  |\n| 것이 충분할 수 있다.  | 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | .  | 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다.  | DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다.  | 사무의 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "| 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | . "
      }
    },
    {
      "chunk_id": "chunk_211",
      "text": "| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 210,
        "window_size": 3,
        "char_count": 180,
        "word_count": 44,
        "page_number": 6,
        "window_text": "If other countries eventually report several cases of vCJD at some time in the future, a | process previously shown to be able to reduce TSE infectivity will provide reassurance on the safety | of past products, and could help to justify continuing fractionation.  |\n| 것이 충분할 수 있다.  | 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | .  | 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다.  | DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다.  | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2. ",
        "original_sentence": "| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다. "
      }
    },
    {
      "chunk_id": "chunk_212",
      "text": "| DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 211,
        "window_size": 3,
        "char_count": 125,
        "word_count": 30,
        "page_number": 2,
        "window_text": "|\n| 것이 충분할 수 있다.  | 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | .  | 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다.  | DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다.  | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2.  | Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. ",
        "original_sentence": "| DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_213",
      "text": "| 사무의 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 212,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 후 광학현미경으로 공포현상, PrPSc | deposit과 신경아교세포의 활성화를 관찰한다 | .  | 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다.  | DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다.  | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2.  | Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW.  Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient. ",
        "original_sentence": "| 사무의 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_214",
      "text": "(공무원용) |\n| 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 213,
        "window_size": 3,
        "char_count": 14,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| 확립 및 프리온 단백항체 개발 | 식품의약품안전청 용역연구결과보고서 | ( | ), | , 2003 | Ⅲ | 장비 위생 | - | 3.8 | Sanitisation of equipment | ii) | Physicochemical form of spiking agent | 로 예상되며 감염력도 여전히 높은 편이다.  | DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다.  | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2.  | Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW.  Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient.  Lancet 2004;364:527-529. ",
        "original_sentence": "(공무원용) |\n| 2. "
      }
    },
    {
      "chunk_id": "chunk_215",
      "text": "| Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 214,
        "window_size": 3,
        "char_count": 55,
        "word_count": 11,
        "page_number": 6,
        "window_text": "| DISCUSSION IN THE BWP | July, September 2004 |\n| 유전자재조합의약품 | 생산용 세포의 발현구조체 | 분석 및 안정성 | 평가가이드 | 위해 사용되는 화학약품에 견딜 수 있어야 한다.  | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2.  | Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW.  Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient.  Lancet 2004;364:527-529.  | 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다. ",
        "original_sentence": "| Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. "
      }
    },
    {
      "chunk_id": "chunk_216",
      "text": "Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 215,
        "window_size": 3,
        "char_count": 85,
        "word_count": 13,
        "page_number": 6,
        "window_text": "| 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2.  | Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW.  Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient.  Lancet 2004;364:527-529.  | 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다.  | 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4. ",
        "original_sentence": "Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient. "
      }
    },
    {
      "chunk_id": "chunk_217",
      "text": "Lancet 2004;364:527-529. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 216,
        "window_size": 3,
        "char_count": 25,
        "word_count": 2,
        "page_number": 2,
        "window_text": "(공무원용) |\n| 2.  | Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW.  Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient.  Lancet 2004;364:527-529.  | 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다.  | 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4.  정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | . ",
        "original_sentence": "Lancet 2004;364:527-529. "
      }
    },
    {
      "chunk_id": "chunk_218",
      "text": "| 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 217,
        "window_size": 3,
        "char_count": 395,
        "word_count": 89,
        "page_number": 2,
        "window_text": "| Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW.  Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient.  Lancet 2004;364:527-529.  | 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다.  | 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4.  정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | .  | Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown. ",
        "original_sentence": "| 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다. "
      }
    },
    {
      "chunk_id": "chunk_219",
      "text": "| 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 218,
        "window_size": 3,
        "char_count": 126,
        "word_count": 30,
        "page_number": 2,
        "window_text": "Preclinical vCJD after blood | transfusion in a PRNP codon 129 heterozygous patient.  Lancet 2004;364:527-529.  | 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다.  | 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4.  정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | .  | Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown.  It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain. ",
        "original_sentence": "| 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4. "
      }
    },
    {
      "chunk_id": "chunk_220",
      "text": "정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 219,
        "window_size": 3,
        "char_count": 129,
        "word_count": 20,
        "page_number": 11,
        "window_text": "Lancet 2004;364:527-529.  | 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다.  | 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4.  정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | .  | Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown.  It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain.  However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated. ",
        "original_sentence": "정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | . "
      }
    },
    {
      "chunk_id": "chunk_221",
      "text": "| Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 220,
        "window_size": 3,
        "char_count": 163,
        "word_count": 26,
        "page_number": 25,
        "window_text": "| 139A | mouse(C57BL) | 150±10 |\n| 생명공학의약품 | 생산세포주 관리를 위한 | 시험방법 | 2007 | 11-1470000-000903-01 | (생물의약품평가자료집 | 48) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/236 | 생물의약품의 독성평가 | 사례분석 | 2004 | 11-1470000-000680-01 | (생물의약품평가자료집 | 11) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/77 | 2006 | 11-1470000-001116-01 | (생물의약품평가가이드 | 19) | 재조합의약품팀 | 자료실 간행물 | / | , | 지침/229 |\n| 대한 신뢰성은 모델 바이러스를 제거하는 능력에 대한 신뢰성보다 낮게 나타난다.  | 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4.  정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | .  | Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown.  It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain.  However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated.  It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material. ",
        "original_sentence": "| Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown. "
      }
    },
    {
      "chunk_id": "chunk_222",
      "text": "It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 221,
        "window_size": 3,
        "char_count": 174,
        "word_count": 33,
        "page_number": 25,
        "window_text": "| 두창백신의 안전성 유효성 | ․ | 평가시 고려사항 | 2005 | 11-1470000-000872-01 | (생물의약품평가가이드 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/105 | 3.4.  정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | .  | Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown.  It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain.  However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated.  It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material.  On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood. ",
        "original_sentence": "It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain. "
      }
    },
    {
      "chunk_id": "chunk_223",
      "text": "However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 222,
        "window_size": 3,
        "char_count": 123,
        "word_count": 21,
        "page_number": 8,
        "window_text": "정제된 | PrPSc | ════════════════════════════════════════════ | 3) Caveolae-like domains(CLDs) | - 부검 테이블에 흡수성이 없는 커버를 이중으로 씌운다 | .  | Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown.  It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain.  However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated.  It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material.  On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood.  It is important to consider carefully the various possible physical types of spiking | agent. ",
        "original_sentence": "However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated. "
      }
    },
    {
      "chunk_id": "chunk_224",
      "text": "It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 223,
        "window_size": 3,
        "char_count": 142,
        "word_count": 23,
        "page_number": 25,
        "window_text": "| Although TSE infectivity has been unambiguously detected in blood in animal experiments, to date | the physicochemical nature of TSE agents in blood is unknown.  It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain.  However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated.  It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material.  On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood.  It is important to consider carefully the various possible physical types of spiking | agent.  | Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies. ",
        "original_sentence": "It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material. "
      }
    },
    {
      "chunk_id": "chunk_225",
      "text": "On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 224,
        "window_size": 3,
        "char_count": 146,
        "word_count": 25,
        "page_number": 8,
        "window_text": "It has been suggested that it might be | more like the infectivity found in spleen than that in brain, on the assumption that it originates from a | tissue other than brain.  However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated.  It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material.  On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood.  It is important to consider carefully the various possible physical types of spiking | agent.  | Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies.  TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years. ",
        "original_sentence": "On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood. "
      }
    },
    {
      "chunk_id": "chunk_226",
      "text": "It is important to consider carefully the various possible physical types of spiking | agent. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 225,
        "window_size": 3,
        "char_count": 94,
        "word_count": 15,
        "page_number": 8,
        "window_text": "However it is not clear where infectivity in the blood originates in those model | systems where it has been demonstrated.  It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material.  On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood.  It is important to consider carefully the various possible physical types of spiking | agent.  | Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies.  TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years.  A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g. ",
        "original_sentence": "It is important to consider carefully the various possible physical types of spiking | agent. "
      }
    },
    {
      "chunk_id": "chunk_227",
      "text": "| Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 226,
        "window_size": 3,
        "char_count": 107,
        "word_count": 15,
        "page_number": 8,
        "window_text": "It is possible that it represents material released as the brain | degenerates, in which case brain would be an appropriate spiking material.  On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood.  It is important to consider carefully the various possible physical types of spiking | agent.  | Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies.  TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years.  A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g.  alkylating agents, detergents) while some others | have been recognized as quite effective (e.g. ",
        "original_sentence": "| Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies. "
      }
    },
    {
      "chunk_id": "chunk_228",
      "text": "TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 227,
        "window_size": 3,
        "char_count": 135,
        "word_count": 20,
        "page_number": 25,
        "window_text": "On the other hand brain | tissues containing highly aggregated insoluble forms of PrPSc may or may not resemble the infectious | prions in blood.  It is important to consider carefully the various possible physical types of spiking | agent.  | Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies.  TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years.  A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g.  alkylating agents, detergents) while some others | have been recognized as quite effective (e.g.  soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time). ",
        "original_sentence": "TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years. "
      }
    },
    {
      "chunk_id": "chunk_229",
      "text": "A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 228,
        "window_size": 3,
        "char_count": 110,
        "word_count": 16,
        "page_number": 8,
        "window_text": "It is important to consider carefully the various possible physical types of spiking | agent.  | Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies.  TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years.  A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g.  alkylating agents, detergents) while some others | have been recognized as quite effective (e.g.  soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time).  Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes. ",
        "original_sentence": "A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g. "
      }
    },
    {
      "chunk_id": "chunk_230",
      "text": "alkylating agents, detergents) while some others | have been recognized as quite effective (e.g. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 229,
        "window_size": 3,
        "char_count": 97,
        "word_count": 14,
        "page_number": 6,
        "window_text": "| Inactivation of prions by conventional decontamination methods has been evaluated in numerous | studies.  TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years.  A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g.  alkylating agents, detergents) while some others | have been recognized as quite effective (e.g.  soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time).  Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes.  However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g. ",
        "original_sentence": "alkylating agents, detergents) while some others | have been recognized as quite effective (e.g. "
      }
    },
    {
      "chunk_id": "chunk_231",
      "text": "soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time). ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 230,
        "window_size": 3,
        "char_count": 145,
        "word_count": 25,
        "page_number": 2,
        "window_text": "TSE infectivity is particularly difficult to inactivate and some samples have been shown to be | environmentally infectious for years.  A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g.  alkylating agents, detergents) while some others | have been recognized as quite effective (e.g.  soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time).  Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes.  However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g.  | NaOH is reported as non-sporicidal). ",
        "original_sentence": "soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time). "
      }
    },
    {
      "chunk_id": "chunk_232",
      "text": "Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 231,
        "window_size": 3,
        "char_count": 131,
        "word_count": 21,
        "page_number": 25,
        "window_text": "A certain number of treatments are acknowledged to be | ineffective under normal application conditions (e.g.  alkylating agents, detergents) while some others | have been recognized as quite effective (e.g.  soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time).  Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes.  However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g.  | NaOH is reported as non-sporicidal).  A number of experimental treatments (e.g. ",
        "original_sentence": "Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes. "
      }
    },
    {
      "chunk_id": "chunk_233",
      "text": "However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 232,
        "window_size": 3,
        "char_count": 278,
        "word_count": 46,
        "page_number": 6,
        "window_text": "alkylating agents, detergents) while some others | have been recognized as quite effective (e.g.  soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time).  Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes.  However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g.  | NaOH is reported as non-sporicidal).  A number of experimental treatments (e.g.  alkaline cleansers, | proteases, etc.) ",
        "original_sentence": "However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g. "
      }
    },
    {
      "chunk_id": "chunk_234",
      "text": "| NaOH is reported as non-sporicidal). ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 233,
        "window_size": 3,
        "char_count": 39,
        "word_count": 6,
        "page_number": 5,
        "window_text": "soaking in ≥ 2% bleach or in sodium hydroxide (NaOH) | 1-2N for 60 min, autoclaving at 134-138ºC under certain conditions of pressure and time).  Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes.  However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g.  | NaOH is reported as non-sporicidal).  A number of experimental treatments (e.g.  alkaline cleansers, | proteases, etc.)  are under evaluation for use in cleaning and decontamination procedures but not | applicable yet. ",
        "original_sentence": "| NaOH is reported as non-sporicidal). "
      }
    },
    {
      "chunk_id": "chunk_235",
      "text": "A number of experimental treatments (e.g. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 234,
        "window_size": 3,
        "char_count": 42,
        "word_count": 6,
        "page_number": 5,
        "window_text": "Some | procedures have been adopted as reference treatments or recommendations by WHO20 and used with | medical devices or wastes.  However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g.  | NaOH is reported as non-sporicidal).  A number of experimental treatments (e.g.  alkaline cleansers, | proteases, etc.)  are under evaluation for use in cleaning and decontamination procedures but not | applicable yet.  | 고 | , 감독 및 처리가 수행되어져야 한다 | . ",
        "original_sentence": "A number of experimental treatments (e.g. "
      }
    },
    {
      "chunk_id": "chunk_236",
      "text": "alkaline cleansers, | proteases, etc.) ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 235,
        "window_size": 3,
        "char_count": 39,
        "word_count": 5,
        "page_number": 5,
        "window_text": "However, their applicability is rather limited due to a number of reasons; | most methods are harsh and may well damage most biological products, they have a corrosive effect | on the equipment used in production or show a limited efficacy against other infectious agents (e.g.  | NaOH is reported as non-sporicidal).  A number of experimental treatments (e.g.  alkaline cleansers, | proteases, etc.)  are under evaluation for use in cleaning and decontamination procedures but not | applicable yet.  | 고 | , 감독 및 처리가 수행되어져야 한다 | .  |\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다. ",
        "original_sentence": "alkaline cleansers, | proteases, etc.) "
      }
    },
    {
      "chunk_id": "chunk_237",
      "text": "are under evaluation for use in cleaning and decontamination procedures but not | applicable yet. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 236,
        "window_size": 3,
        "char_count": 98,
        "word_count": 15,
        "page_number": 8,
        "window_text": "| NaOH is reported as non-sporicidal).  A number of experimental treatments (e.g.  alkaline cleansers, | proteases, etc.)  are under evaluation for use in cleaning and decontamination procedures but not | applicable yet.  | 고 | , 감독 및 처리가 수행되어져야 한다 | .  |\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data. ",
        "original_sentence": "are under evaluation for use in cleaning and decontamination procedures but not | applicable yet. "
      }
    },
    {
      "chunk_id": "chunk_238",
      "text": "| 고 | , 감독 및 처리가 수행되어져야 한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 237,
        "window_size": 3,
        "char_count": 31,
        "word_count": 11,
        "page_number": 5,
        "window_text": "A number of experimental treatments (e.g.  alkaline cleansers, | proteases, etc.)  are under evaluation for use in cleaning and decontamination procedures but not | applicable yet.  | 고 | , 감독 및 처리가 수행되어져야 한다 | .  |\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | . ",
        "original_sentence": "| 고 | , 감독 및 처리가 수행되어져야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_239",
      "text": "|\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 238,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 5,
        "window_text": "alkaline cleansers, | proteases, etc.)  are under evaluation for use in cleaning and decontamination procedures but not | applicable yet.  | 고 | , 감독 및 처리가 수행되어져야 한다 | .  |\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | .  | TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3. ",
        "original_sentence": "|\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다. "
      }
    },
    {
      "chunk_id": "chunk_240",
      "text": "| All manufacturers must critically evaluate their manufacturing processes in the light of published data. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 239,
        "window_size": 3,
        "char_count": 107,
        "word_count": 15,
        "page_number": 8,
        "window_text": "are under evaluation for use in cleaning and decontamination procedures but not | applicable yet.  | 고 | , 감독 및 처리가 수행되어져야 한다 | .  |\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | .  | TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3.  | Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. ",
        "original_sentence": "| All manufacturers must critically evaluate their manufacturing processes in the light of published data. "
      }
    },
    {
      "chunk_id": "chunk_241",
      "text": "| Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 240,
        "window_size": 3,
        "char_count": 202,
        "word_count": 35,
        "page_number": 8,
        "window_text": "| 고 | , 감독 및 처리가 수행되어져야 한다 | .  |\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | .  | TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3.  | Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN.  The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy. ",
        "original_sentence": "| Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | . "
      }
    },
    {
      "chunk_id": "chunk_242",
      "text": "| TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 241,
        "window_size": 3,
        "char_count": 273,
        "word_count": 64,
        "page_number": 2,
        "window_text": "|\n| 제품의 오염 위험성을 감소시킬 수 있을 것이다.  | All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | .  | TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3.  | Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN.  The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy.  Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | . ",
        "original_sentence": "| TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3. "
      }
    },
    {
      "chunk_id": "chunk_243",
      "text": "| Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 242,
        "window_size": 3,
        "char_count": 70,
        "word_count": 13,
        "page_number": 6,
        "window_text": "| All manufacturers must critically evaluate their manufacturing processes in the light of published data.  | Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | .  | TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3.  | Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN.  The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy.  Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | .  | 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까? ",
        "original_sentence": "| Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. "
      }
    },
    {
      "chunk_id": "chunk_244",
      "text": "The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 243,
        "window_size": 3,
        "char_count": 146,
        "word_count": 19,
        "page_number": 8,
        "window_text": "| Guidance on the step-wise approach to product-specific investigational studies is described in Section | 9.2.3 of the CHMP Position Statement.1 | 분획 | (subfraction)이 다른 단계에 의해 선택적으로 제거될 수 있기 때문이다 | .  | TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3.  | Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN.  The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy.  Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | .  | 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까?  (민원인용) |\n| 규모 축소 공정 | 2. ",
        "original_sentence": "The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy. "
      }
    },
    {
      "chunk_id": "chunk_245",
      "text": "Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 244,
        "window_size": 3,
        "char_count": 311,
        "word_count": 79,
        "page_number": 2,
        "window_text": "| TRANSMISSION TO CHMP | October 2004 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 |\n| 구분 | 유전자치료제의 | 안전성평가 2005 | 2005 | 11-1470000-000677-14 | (생물의약품평가자료집 | 24) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/104 | 세포조직공학제제팀 | 세균백신팀 | 바이러스백신팀 | 혈액제제팀 | 재조합의약품팀 | 유전자치료제팀 | ■예 | □ 아니오 |\n| 3.  | Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN.  The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy.  Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | .  | 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까?  (민원인용) |\n| 규모 축소 공정 | 2.  | 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | . ",
        "original_sentence": "Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | . "
      }
    },
    {
      "chunk_id": "chunk_246",
      "text": "| 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 245,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN.  The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy.  Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | .  | 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까?  (민원인용) |\n| 규모 축소 공정 | 2.  | 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | .  |\n| 감염성 프리온 단백 제조방법 | 3. ",
        "original_sentence": "| 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_247",
      "text": "(민원인용) |\n| 규모 축소 공정 | 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 246,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 2,
        "window_text": "The distribution | of infectivity in blood components and plasma derivatives in experimental models of | transmissible spongiform encephalopathy.  Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | .  | 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까?  (민원인용) |\n| 규모 축소 공정 | 2.  | 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | .  |\n| 감염성 프리온 단백 제조방법 | 3.  | 20. ",
        "original_sentence": "(민원인용) |\n| 규모 축소 공정 | 2. "
      }
    },
    {
      "chunk_id": "chunk_248",
      "text": "| 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 247,
        "window_size": 3,
        "char_count": 60,
        "word_count": 15,
        "page_number": 2,
        "window_text": "Transfusion 1998;38:810-816 | 발 | 행 | 일 | 년 | 월 | : | 2008 | 12 | 22L | mouse(C57BL) | 150±10 |\n| 세포조직공학제제 | (세포치료제 | , | 조직공학제제, | 이종이식제제 | 가이드라인 | ) | HBsAg 진단제제의 기준 | 및 시험방법 작성 지침 | 2008 | 11-1470000-000143-01 | (생물의약품평가가이드 | 33) | 생물진단의약품과 | 자료실 간행물 | / | , | 지침/289 | - 오염된 수술도구는 흡수성이 없는 패드 위에 놓고 사용한다 | .  | 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까?  (민원인용) |\n| 규모 축소 공정 | 2.  | 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | .  |\n| 감염성 프리온 단백 제조방법 | 3.  | 20.  | WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | . ",
        "original_sentence": "| 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | . "
      }
    },
    {
      "chunk_id": "chunk_249",
      "text": "|\n| 감염성 프리온 단백 제조방법 | 3. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 248,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 5,
        "window_text": "| 설명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술 | 하는 것입니까?  (민원인용) |\n| 규모 축소 공정 | 2.  | 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | .  |\n| 감염성 프리온 단백 제조방법 | 3.  | 20.  | WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | .  | 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7. ",
        "original_sentence": "|\n| 감염성 프리온 단백 제조방법 | 3. "
      }
    },
    {
      "chunk_id": "chunk_250",
      "text": "| 20. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 249,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 2,
        "window_text": "(민원인용) |\n| 규모 축소 공정 | 2.  | 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | .  |\n| 감염성 프리온 단백 제조방법 | 3.  | 20.  | WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | .  | 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7.  | 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | . ",
        "original_sentence": "| 20. "
      }
    },
    {
      "chunk_id": "chunk_251",
      "text": "| WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 250,
        "window_size": 3,
        "char_count": 343,
        "word_count": 80,
        "page_number": 2,
        "window_text": "| 전청 용역연구결과보고서, 2004 | 11) 실험에 관련되지 않는 동물은 실험실에 들이지 않는다 | .  |\n| 감염성 프리온 단백 제조방법 | 3.  | 20.  | WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | .  | 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7.  | 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21. ",
        "original_sentence": "| WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | . "
      }
    },
    {
      "chunk_id": "chunk_252",
      "text": "| 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 251,
        "window_size": 3,
        "char_count": 131,
        "word_count": 36,
        "page_number": 6,
        "window_text": "|\n| 감염성 프리온 단백 제조방법 | 3.  | 20.  | WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | .  | 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7.  | 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21.  | Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P. ",
        "original_sentence": "| 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7. "
      }
    },
    {
      "chunk_id": "chunk_253",
      "text": "| 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 252,
        "window_size": 3,
        "char_count": 68,
        "word_count": 13,
        "page_number": 2,
        "window_text": "| 20.  | WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | .  | 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7.  | 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21.  | Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P.  Novel methods for disinfection of prion-contaminated medical | devices. ",
        "original_sentence": "| 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | . "
      }
    },
    {
      "chunk_id": "chunk_254",
      "text": "| 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 253,
        "window_size": 3,
        "char_count": 59,
        "word_count": 15,
        "page_number": 6,
        "window_text": "| WHO Laboratory Biosafety Manual 2003 | 라 명명함 | isoform of prion protein) | CHMP ADOPTION | October 2004 |\n| 혈액제제의 안전성 유효성 | ․ | 평가 2004 | 2004 | 11-1470000-000679-14 | (생물의약품평가자료집 | 10) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/76 | 2006 | 11-1470000-001144-01 | (생물의약품평가자료집 | 35) | 자료실 간행물 | / | , | 지침/146 |\n| - 적출된 뇌 조직은 적당한 절단 보드 위에 놓고 절단한다 | .  | 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7.  | 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21.  | Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P.  Novel methods for disinfection of prion-contaminated medical | devices.  Lancet 2004;364:521-526. ",
        "original_sentence": "| 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21. "
      }
    },
    {
      "chunk_id": "chunk_255",
      "text": "| Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 254,
        "window_size": 3,
        "char_count": 117,
        "word_count": 22,
        "page_number": 6,
        "window_text": "| 발 | 행 | 기 | 관 | 식품의약품안전청 | : | 87V | mouse(IM, MB) | 300±10 | 생명공학의약품과 | 생물의약품평가과 | 국립독성연구원 | 생화학약리과 |\n| 감염성 프리온 단백 제거율 재평가 | 7.  | 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21.  | Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P.  Novel methods for disinfection of prion-contaminated medical | devices.  Lancet 2004;364:521-526.  | The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다. ",
        "original_sentence": "| Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P. "
      }
    },
    {
      "chunk_id": "chunk_256",
      "text": "Novel methods for disinfection of prion-contaminated medical | devices. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 255,
        "window_size": 3,
        "char_count": 72,
        "word_count": 9,
        "page_number": 8,
        "window_text": "| 의 | 항을 참조한다 | Products(CPMP/BWP/2879/02/rev 1, 2004)” | 9.2.3 | .  | 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21.  | Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P.  Novel methods for disinfection of prion-contaminated medical | devices.  Lancet 2004;364:521-526.  | The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다.  | 섬유물질로 만들어져야 한다. ",
        "original_sentence": "Novel methods for disinfection of prion-contaminated medical | devices. "
      }
    },
    {
      "chunk_id": "chunk_257",
      "text": "Lancet 2004;364:521-526. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 256,
        "window_size": 3,
        "char_count": 25,
        "word_count": 2,
        "page_number": 2,
        "window_text": "| 유전재재조합의약품 및 | 단클론항체의약품의 제조 | 및 품질관리 자료에 관한 | 평가가이드 | 21.  | Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P.  Novel methods for disinfection of prion-contaminated medical | devices.  Lancet 2004;364:521-526.  | The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다.  | 섬유물질로 만들어져야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4. ",
        "original_sentence": "Lancet 2004;364:521-526. "
      }
    },
    {
      "chunk_id": "chunk_258",
      "text": "| The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 257,
        "window_size": 3,
        "char_count": 351,
        "word_count": 80,
        "page_number": 6,
        "window_text": "| Fichet G, Emmanuel C, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, | Lasmézas CI, Deslys J-P.  Novel methods for disinfection of prion-contaminated medical | devices.  Lancet 2004;364:521-526.  | The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다.  | 섬유물질로 만들어져야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4.  | Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH. ",
        "original_sentence": "| The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_259",
      "text": "| 섬유물질로 만들어져야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 258,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 5,
        "window_text": "Novel methods for disinfection of prion-contaminated medical | devices.  Lancet 2004;364:521-526.  | The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다.  | 섬유물질로 만들어져야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4.  | Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH.  Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. ",
        "original_sentence": "| 섬유물질로 만들어져야 한다. "
      }
    },
    {
      "chunk_id": "chunk_260",
      "text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 259,
        "window_size": 3,
        "char_count": 364,
        "word_count": 89,
        "page_number": 3,
        "window_text": "Lancet 2004;364:521-526.  | The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다.  | 섬유물질로 만들어져야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4.  | Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH.  Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.  | Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | . ",
        "original_sentence": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4. "
      }
    },
    {
      "chunk_id": "chunk_261",
      "text": "| Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 260,
        "window_size": 3,
        "char_count": 73,
        "word_count": 13,
        "page_number": 6,
        "window_text": "| The main points to be considered are: |\n| 혈액제제의 자가 기준 및 | 시험방법 작성 지침 | 2007 | 11-1470000-001457-01 | (생물의약품평가자료집 | 47) | 혈액제제팀 | 자료실 간행물 | / | , | 지침/195 | 백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000870-01 | (생물의약품평가자료집 | 23) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/102 | 단클론항체의약품의 | 평가가이드 | 2005 | 11-1470000-000851-01 | (생물의약품평가가이드 | 9) | 있어야 한다.  | 섬유물질로 만들어져야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4.  | Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH.  Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.  | Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | .  | 2. ",
        "original_sentence": "| Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH. "
      }
    },
    {
      "chunk_id": "chunk_262",
      "text": "Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 261,
        "window_size": 3,
        "char_count": 207,
        "word_count": 29,
        "page_number": 8,
        "window_text": "| 섬유물질로 만들어져야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4.  | Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH.  Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.  | Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | .  | 2.  | SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | . ",
        "original_sentence": "Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. "
      }
    },
    {
      "chunk_id": "chunk_263",
      "text": "| Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 262,
        "window_size": 3,
        "char_count": 184,
        "word_count": 42,
        "page_number": 2,
        "window_text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | □ 예 | ■ 아니오 | 자료실 간행물 | / | , | 지침/74 |\n| 혈장수출업소 실태조사 | 지침 | 2007 | 11-1470000-001627-01 | (생물의약품평가가이드 | 32) | 생물의약품관리팀 | 혈액제제팀 | 자료실 간행물 | / | , | 지침/234 | DATE FOR COMING INTO OPERATION | October 2004 |\n| BSL-1 : 병을 일으키지 않는 것으로 밝혀진 미생물을 다루는 경우 | ① | - | scaling down process | 3.6 | Interpretation and limitations of data | 4.  | Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH.  Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.  | Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | .  | 2.  | SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | .  | 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까? ",
        "original_sentence": "| Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | . "
      }
    },
    {
      "chunk_id": "chunk_264",
      "text": "| 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 263,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 2,
        "window_text": "| Brown P, Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WH.  Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.  | Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | .  | 2.  | SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | .  | 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까?  | 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_265",
      "text": "| SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 264,
        "window_size": 3,
        "char_count": 75,
        "word_count": 18,
        "page_number": 6,
        "window_text": "Further studies | of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with | an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.  | Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | .  | 2.  | SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | .  | 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까?  | 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3.  | (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | . ",
        "original_sentence": "| SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | . "
      }
    },
    {
      "chunk_id": "chunk_266",
      "text": "| 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까? ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 265,
        "window_size": 3,
        "char_count": 57,
        "word_count": 18,
        "page_number": 6,
        "window_text": "| Transfusion 1999;39:1169-1178 | 2006 | 11-1470000-000902-01 | (생물의약품평가가이드 | 18) | 재조합의약품팀 | 생물의약품관리팀 | 자료실 간행물 | / | , | 지침/139 |\n| 기타 확인 | - 적출된 뇌 조직 및 절단된 조직은 플라스틱 백이나 용기에 담는다 | .  | 2.  | SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | .  | 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까?  | 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3.  | (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | .  | 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다. ",
        "original_sentence": "| 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_267",
      "text": "| 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 266,
        "window_size": 3,
        "char_count": 48,
        "word_count": 16,
        "page_number": 5,
        "window_text": "| 2.  | SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | .  | 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까?  | 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3.  | (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | .  | 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다.  | 접종한다. ",
        "original_sentence": "| 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3. "
      }
    },
    {
      "chunk_id": "chunk_268",
      "text": "| (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 267,
        "window_size": 3,
        "char_count": 47,
        "word_count": 15,
        "page_number": 2,
        "window_text": "| SCOPE OF THE DOCUMENT: | 부터 막 부분 | (membrane domain)이 떨어지도록 자극할 수 있다 | .  | 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까?  | 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3.  | (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | .  | 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다.  | 접종한다.  |\n| 3.1. ",
        "original_sentence": "| (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_269",
      "text": "| 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 268,
        "window_size": 3,
        "char_count": 39,
        "word_count": 12,
        "page_number": 5,
        "window_text": "| 발 | 행 | 부 | 서 | 생물의약품국 혈액제제과 | : | 민원인을 구속하는 내용이 있습니까?  | 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3.  | (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | .  | 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다.  | 접종한다.  |\n| 3.1.  가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다. ",
        "original_sentence": "| 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_270",
      "text": "| 접종한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 269,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 5,
        "window_text": "| 실험실 | 표준 보호장구 | BSL-3 |\n| 안전장비 | 차 보호 장비 | 3.  | (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | .  | 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다.  | 접종한다.  |\n| 3.1.  가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다.  | BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs. ",
        "original_sentence": "| 접종한다. "
      }
    },
    {
      "chunk_id": "chunk_271",
      "text": "|\n| 3.1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 270,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 2,
        "window_text": "| (1 | ) | 6) 실험실의 모든 창문은 밀폐되고 봉쇄되어 있어야 한다 | .  | 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다.  | 접종한다.  |\n| 3.1.  가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다.  | BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs.  They include | the following: | 1. ",
        "original_sentence": "|\n| 3.1. "
      }
    },
    {
      "chunk_id": "chunk_272",
      "text": "가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 271,
        "window_size": 3,
        "char_count": 216,
        "word_count": 51,
        "page_number": 6,
        "window_text": "| 은 경우에 비하여 여과와 같은 후속 공정을 쉽게 통과할 수 있다.  | 접종한다.  |\n| 3.1.  가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다.  | BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs.  They include | the following: | 1.  | The modeling of the process may be imperfect. ",
        "original_sentence": "가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다. "
      }
    },
    {
      "chunk_id": "chunk_273",
      "text": "| BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 272,
        "window_size": 3,
        "char_count": 267,
        "word_count": 51,
        "page_number": 2,
        "window_text": "| 접종한다.  |\n| 3.1.  가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다.  | BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs.  They include | the following: | 1.  | The modeling of the process may be imperfect.  Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents. ",
        "original_sentence": "| BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs. "
      }
    },
    {
      "chunk_id": "chunk_274",
      "text": "They include | the following: | 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 273,
        "window_size": 3,
        "char_count": 35,
        "word_count": 7,
        "page_number": 2,
        "window_text": "|\n| 3.1.  가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다.  | BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs.  They include | the following: | 1.  | The modeling of the process may be imperfect.  Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents.  |\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22. ",
        "original_sentence": "They include | the following: | 1. "
      }
    },
    {
      "chunk_id": "chunk_275",
      "text": "| The modeling of the process may be imperfect. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 274,
        "window_size": 3,
        "char_count": 48,
        "word_count": 9,
        "page_number": 5,
        "window_text": "가공하지 않은 뇌 균질현탁액 | (crude brain homogenates) | 구 | , 식품의약품안전청 용역연구결과보고서 | , 2005 | 세포치료제의 | 안전성 유효성 평가시 | ․ | 고려사항 2004 | 2004 | 11-1470000-000678-14 | (생물의약품평가자료집 | 9) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/75 |\n| 할 것이다.  | BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs.  They include | the following: | 1.  | The modeling of the process may be imperfect.  Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents.  |\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22.  | Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176. ",
        "original_sentence": "| The modeling of the process may be imperfect. "
      }
    },
    {
      "chunk_id": "chunk_276",
      "text": "Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 275,
        "window_size": 3,
        "char_count": 221,
        "word_count": 35,
        "page_number": 8,
        "window_text": "| BSL-2 : 병을 일으키는 것으로 밝혀진 미생물을 다루는 경우 | ② | - | choice of spiking agent | Viral evaluation studies of processes are subject to a number of reservations, which apply with even | greater strength to evaluation of processes with respect to their ability to remove TSEs.  They include | the following: | 1.  | The modeling of the process may be imperfect.  Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents.  |\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22.  | Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176.  | Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma. ",
        "original_sentence": "Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents. "
      }
    },
    {
      "chunk_id": "chunk_277",
      "text": "|\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 276,
        "window_size": 3,
        "char_count": 92,
        "word_count": 17,
        "page_number": 6,
        "window_text": "They include | the following: | 1.  | The modeling of the process may be imperfect.  Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents.  |\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22.  | Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176.  | Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma.  The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk. ",
        "original_sentence": "|\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22. "
      }
    },
    {
      "chunk_id": "chunk_278",
      "text": "| Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 277,
        "window_size": 3,
        "char_count": 149,
        "word_count": 22,
        "page_number": 5,
        "window_text": "| The modeling of the process may be imperfect.  Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents.  |\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22.  | Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176.  | Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma.  The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk.  At this time, experience in this area has not reached a point where definitive | guidance can be given. ",
        "original_sentence": "| Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176. "
      }
    },
    {
      "chunk_id": "chunk_279",
      "text": "| Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 278,
        "window_size": 3,
        "char_count": 160,
        "word_count": 23,
        "page_number": 8,
        "window_text": "Steps based on separation have been difficult to | model reliably in viral evaluation studies; this is particularly true of ethanol fractionation steps, | which may be particularly important in the removal of TSE agents.  |\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22.  | Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176.  | Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma.  The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk.  At this time, experience in this area has not reached a point where definitive | guidance can be given.  Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable. ",
        "original_sentence": "| Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma. "
      }
    },
    {
      "chunk_id": "chunk_280",
      "text": "The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 279,
        "window_size": 3,
        "char_count": 315,
        "word_count": 49,
        "page_number": 2,
        "window_text": "|\n| 오염물질 제거 | 4) | ════════════════════════════════════════════ | 사항 | 4) 정제된 | PrPSc | 22.  | Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176.  | Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma.  The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk.  At this time, experience in this area has not reached a point where definitive | guidance can be given.  Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable.  It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products. ",
        "original_sentence": "The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk. "
      }
    },
    {
      "chunk_id": "chunk_281",
      "text": "At this time, experience in this area has not reached a point where definitive | guidance can be given. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 280,
        "window_size": 3,
        "char_count": 104,
        "word_count": 19,
        "page_number": 6,
        "window_text": "| Käsermann F, Kempf C. Sodium hydroxide renders the prion protein PrPSc sensitive to | proteinase K. Journal of General Virology 2003,84:3173-3176.  | Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma.  The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk.  At this time, experience in this area has not reached a point where definitive | guidance can be given.  Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable.  It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products.  As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5. ",
        "original_sentence": "At this time, experience in this area has not reached a point where definitive | guidance can be given. "
      }
    },
    {
      "chunk_id": "chunk_282",
      "text": "Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 281,
        "window_size": 3,
        "char_count": 113,
        "word_count": 16,
        "page_number": 6,
        "window_text": "| Available data indicate that the manufacturing processes for plasma-derived medicinal products would | reduce infectivity if it were present in human plasma.  The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk.  At this time, experience in this area has not reached a point where definitive | guidance can be given.  Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable.  It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products.  As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5.  | 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다. ",
        "original_sentence": "Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable. "
      }
    },
    {
      "chunk_id": "chunk_283",
      "text": "It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 282,
        "window_size": 3,
        "char_count": 200,
        "word_count": 29,
        "page_number": 8,
        "window_text": "The 2004 Position Statement states1 | “Manufacturers are now required to estimate the potential of their specific manufacturing processes to | reduce infectivity using a step-wise approach.” | The aim of this document is to provide guidance on how to investigate manufacturing processes with | regard to vCJD risk.  At this time, experience in this area has not reached a point where definitive | guidance can be given.  Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable.  It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products.  As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5.  | 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다.  |\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2. ",
        "original_sentence": "It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products. "
      }
    },
    {
      "chunk_id": "chunk_284",
      "text": "As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 283,
        "window_size": 3,
        "char_count": 131,
        "word_count": 27,
        "page_number": 6,
        "window_text": "At this time, experience in this area has not reached a point where definitive | guidance can be given.  Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable.  It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products.  As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5.  | 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다.  |\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2.  | 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다. ",
        "original_sentence": "As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5. "
      }
    },
    {
      "chunk_id": "chunk_285",
      "text": "| 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 284,
        "window_size": 3,
        "char_count": 261,
        "word_count": 63,
        "page_number": 2,
        "window_text": "Therefore, the guideline provides advice based on available experience and | other approaches may be acceptable.  It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products.  As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5.  | 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다.  |\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2.  | 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 그림 | 1. ",
        "original_sentence": "| 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_286",
      "text": "|\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 285,
        "window_size": 3,
        "char_count": 119,
        "word_count": 33,
        "page_number": 6,
        "window_text": "It is very important to read this document in conjunction with the | revised Position Statement cited above, especially section 9.2.3 Manufacturing processes for plasma- | derived medicinal products.  As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5.  | 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다.  |\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2.  | 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 그림 | 1.  BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate. ",
        "original_sentence": "|\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2. "
      }
    },
    {
      "chunk_id": "chunk_287",
      "text": "| 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 286,
        "window_size": 3,
        "char_count": 261,
        "word_count": 59,
        "page_number": 2,
        "window_text": "As indicated in the Position Statement, consultation with relevant | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ |\n| 제조공정 선택 | 5.  | 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다.  |\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2.  | 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 그림 | 1.  BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate.  | 5. ",
        "original_sentence": "| 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_288",
      "text": "| 그림 | 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 287,
        "window_size": 3,
        "char_count": 10,
        "word_count": 4,
        "page_number": 2,
        "window_text": "| 혈관질환 등의 | 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001441-10 | (생물의약품평가자료집 | 46) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/233 | 탄저백신의 안전성 유효성 | ․ | 평가 2005 | 2005 | 11-1470000-000867-01 | (생물의약품평가자료집 | 22) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/99 | 의 전화번호 등을 기재한다.  |\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2.  | 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 그림 | 1.  BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate.  | 5.  | Taylor DM, Fernie K, Reichl HE, Somerville RA. ",
        "original_sentence": "| 그림 | 1. "
      }
    },
    {
      "chunk_id": "chunk_289",
      "text": "BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 288,
        "window_size": 3,
        "char_count": 260,
        "word_count": 55,
        "page_number": 6,
        "window_text": "|\n| HIV, HBV, HCV, HTLV | 관련 체외진단용의약품 | 안전성 유효성 심사평가 | ․ | 지침서 | - | choice of assays |\n| 감염성 프리온 단백 질환 실험동물 제조방법 | 2.  | 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 그림 | 1.  BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate.  | 5.  | Taylor DM, Fernie K, Reichl HE, Somerville RA.  Infectivity in the blood of mice with a BSE- | derived agent. ",
        "original_sentence": "BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate. "
      }
    },
    {
      "chunk_id": "chunk_290",
      "text": "| 5. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 289,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "| 생물 생명공학의약품의 | ․ | 독성평가 사례분석 2006 | 2006 | 11-1470000-001143-01 | (생물의약품평가자료집 | 34) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/145 | TNF 길항제 사용시 | 잠복결핵 치료지침 | 2005 | 11-1470000-000686-01 | (생물의약품평가가이드 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/65 | 안내서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 그림 | 1.  BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate.  | 5.  | Taylor DM, Fernie K, Reichl HE, Somerville RA.  Infectivity in the blood of mice with a BSE- | derived agent.  Journal of Hospital Infection 2000;46:78. ",
        "original_sentence": "| 5. "
      }
    },
    {
      "chunk_id": "chunk_291",
      "text": "| Taylor DM, Fernie K, Reichl HE, Somerville RA. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 290,
        "window_size": 3,
        "char_count": 49,
        "word_count": 9,
        "page_number": 5,
        "window_text": "| 그림 | 1.  BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate.  | 5.  | Taylor DM, Fernie K, Reichl HE, Somerville RA.  Infectivity in the blood of mice with a BSE- | derived agent.  Journal of Hospital Infection 2000;46:78.  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | . ",
        "original_sentence": "| Taylor DM, Fernie K, Reichl HE, Somerville RA. "
      }
    },
    {
      "chunk_id": "chunk_292",
      "text": "Infectivity in the blood of mice with a BSE- | derived agent. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 291,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 6,
        "window_text": "BSL-3 실험실과 표준 보호장구 |\n| 연 | 락 | 처 | 식품의약품안전청 혈액제제과 | : | 2007 | 11-1470000-001622-01 | (생물의약품평가가이드 | 31) | 생물진단제제팀 | 자료실 간행물 | / | , | 지침/252 |\n| Vey and co-workers17 have described studies with four types of agent, all derived from hamster brain | homogenate.  | 5.  | Taylor DM, Fernie K, Reichl HE, Somerville RA.  Infectivity in the blood of mice with a BSE- | derived agent.  Journal of Hospital Infection 2000;46:78.  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | .  | - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음. ",
        "original_sentence": "Infectivity in the blood of mice with a BSE- | derived agent. "
      }
    },
    {
      "chunk_id": "chunk_293",
      "text": "Journal of Hospital Infection 2000;46:78. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 292,
        "window_size": 3,
        "char_count": 42,
        "word_count": 5,
        "page_number": 2,
        "window_text": "| 5.  | Taylor DM, Fernie K, Reichl HE, Somerville RA.  Infectivity in the blood of mice with a BSE- | derived agent.  Journal of Hospital Infection 2000;46:78.  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | .  | - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음.  |\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2. ",
        "original_sentence": "Journal of Hospital Infection 2000;46:78. "
      }
    },
    {
      "chunk_id": "chunk_294",
      "text": "| 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 293,
        "window_size": 3,
        "char_count": 107,
        "word_count": 24,
        "page_number": 6,
        "window_text": "| Taylor DM, Fernie K, Reichl HE, Somerville RA.  Infectivity in the blood of mice with a BSE- | derived agent.  Journal of Hospital Infection 2000;46:78.  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | .  | - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음.  |\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2.  | 는 또 하나의 제약이 된다. ",
        "original_sentence": "| 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | . "
      }
    },
    {
      "chunk_id": "chunk_295",
      "text": "| - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 294,
        "window_size": 3,
        "char_count": 56,
        "word_count": 12,
        "page_number": 3,
        "window_text": "Infectivity in the blood of mice with a BSE- | derived agent.  Journal of Hospital Infection 2000;46:78.  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | .  | - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음.  |\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2.  | 는 또 하나의 제약이 된다.  | 하여야 한다. ",
        "original_sentence": "| - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음. "
      }
    },
    {
      "chunk_id": "chunk_296",
      "text": "|\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 295,
        "window_size": 3,
        "char_count": 442,
        "word_count": 103,
        "page_number": 6,
        "window_text": "Journal of Hospital Infection 2000;46:78.  | 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | .  | - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음.  |\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2.  | 는 또 하나의 제약이 된다.  | 하여야 한다.  | 여 사용한다 | . ",
        "original_sentence": "|\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2. "
      }
    },
    {
      "chunk_id": "chunk_297",
      "text": "| 는 또 하나의 제약이 된다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 296,
        "window_size": 3,
        "char_count": 18,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 세포조직공학제제팀 | 재조합의약품팀 | 생물의약품안전팀 | 생물의약품관리팀 | 국립독성연구원 | 생명공학지원팀 |\n| 대표 배치 | (batch)에서 얻어진 자료와 비교하여야 한다 | .  | - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음.  |\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2.  | 는 또 하나의 제약이 된다.  | 하여야 한다.  | 여 사용한다 | .  명백하게 오염된 경우는 폐기하고 교체한다 | . ",
        "original_sentence": "| 는 또 하나의 제약이 된다. "
      }
    },
    {
      "chunk_id": "chunk_298",
      "text": "| 하여야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 297,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 5,
        "window_text": "| - | choice of manufacturing steps | 상기 사항에 대하여 확인하였음.  |\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2.  | 는 또 하나의 제약이 된다.  | 하여야 한다.  | 여 사용한다 | .  명백하게 오염된 경우는 폐기하고 교체한다 | .  | 적절하게 봉합하여 운반하여야 한다. ",
        "original_sentence": "| 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_299",
      "text": "| 여 사용한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 298,
        "window_size": 3,
        "char_count": 13,
        "word_count": 5,
        "page_number": 5,
        "window_text": "|\n**생물로서 인체 내 기생체나 전염체를 다루는 경우**\n| 인플루엔자백신의 | 안전성 유효성 평가 2005 | ․ | 2005 | 11-1470000-000866-01 | (생물의약품평가자료집 | 21) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/98 | 유전자치료제의 | 안전성평가 2004 | 2004 | 11-1470000-000677-14 | (생물의약품평가자료집 | 8) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/72 | - | interpretation and limitations of data | 전 | 화 | 번 | 호 : | 02) 380-1715, 1765 |\n| 이종이식제제의 전임상 및 | 임상시험에 대한 가이드 | 2006 | 11-1470000-001088-01 | (생물의약품평가가이드 | 17) | 특별 사항 | 2.  | 는 또 하나의 제약이 된다.  | 하여야 한다.  | 여 사용한다 | .  명백하게 오염된 경우는 폐기하고 교체한다 | .  | 적절하게 봉합하여 운반하여야 한다.  |\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | . ",
        "original_sentence": "| 여 사용한다 | . "
      }
    },
    {
      "chunk_id": "chunk_300",
      "text": "명백하게 오염된 경우는 폐기하고 교체한다 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 299,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 5,
        "window_text": "| 는 또 하나의 제약이 된다.  | 하여야 한다.  | 여 사용한다 | .  명백하게 오염된 경우는 폐기하고 교체한다 | .  | 적절하게 봉합하여 운반하여야 한다.  |\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | .  | -70 | . ",
        "original_sentence": "명백하게 오염된 경우는 폐기하고 교체한다 | . "
      }
    },
    {
      "chunk_id": "chunk_301",
      "text": "| 적절하게 봉합하여 운반하여야 한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 300,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 하여야 한다.  | 여 사용한다 | .  명백하게 오염된 경우는 폐기하고 교체한다 | .  | 적절하게 봉합하여 운반하여야 한다.  |\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | .  | -70 | .  | ℃ | 6. ",
        "original_sentence": "| 적절하게 봉합하여 운반하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_302",
      "text": "|\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 301,
        "window_size": 3,
        "char_count": 217,
        "word_count": 61,
        "page_number": 8,
        "window_text": "| 여 사용한다 | .  명백하게 오염된 경우는 폐기하고 교체한다 | .  | 적절하게 봉합하여 운반하여야 한다.  |\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | .  | -70 | .  | ℃ | 6.  | Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P. ",
        "original_sentence": "|\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | . "
      }
    },
    {
      "chunk_id": "chunk_303",
      "text": "| -70 | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 302,
        "window_size": 3,
        "char_count": 10,
        "word_count": 4,
        "page_number": 5,
        "window_text": "명백하게 오염된 경우는 폐기하고 교체한다 | .  | 적절하게 봉합하여 운반하여야 한다.  |\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | .  | -70 | .  | ℃ | 6.  | Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.  | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy. ",
        "original_sentence": "| -70 | . "
      }
    },
    {
      "chunk_id": "chunk_304",
      "text": "| ℃ | 6. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 303,
        "window_size": 3,
        "char_count": 9,
        "word_count": 4,
        "page_number": 5,
        "window_text": "| 적절하게 봉합하여 운반하여야 한다.  |\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | .  | -70 | .  | ℃ | 6.  | Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.  | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy.  Transfusion 2003;43:1687-1694. ",
        "original_sentence": "| ℃ | 6. "
      }
    },
    {
      "chunk_id": "chunk_305",
      "text": "| Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 304,
        "window_size": 3,
        "char_count": 87,
        "word_count": 15,
        "page_number": 6,
        "window_text": "|\n| 만성 피부 궤양 및 화상 | 치료제 개발을 위한 | 전임상 및 | 임상 관련 | 고려사항 | DNA 백신의 평가지침서 | 2004 | 11-1470000-000669-01 | (생물의약품평가가이드 | 7) | 생명공학의약품과 | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/60 | 로 | 균질액을 만든다 | 사용할 때까지 | 에 보관한다 | PBS | 10% | .  | -70 | .  | ℃ | 6.  | Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.  | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy.  Transfusion 2003;43:1687-1694.  | 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1. ",
        "original_sentence": "| Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P. "
      }
    },
    {
      "chunk_id": "chunk_306",
      "text": "| Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 305,
        "window_size": 3,
        "char_count": 148,
        "word_count": 22,
        "page_number": 8,
        "window_text": "| -70 | .  | ℃ | 6.  | Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.  | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy.  Transfusion 2003;43:1687-1694.  | 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1.  | strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다. ",
        "original_sentence": "| Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy. "
      }
    },
    {
      "chunk_id": "chunk_307",
      "text": "Transfusion 2003;43:1687-1694. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 306,
        "window_size": 3,
        "char_count": 31,
        "word_count": 2,
        "page_number": 2,
        "window_text": "| ℃ | 6.  | Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.  | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy.  Transfusion 2003;43:1687-1694.  | 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1.  | strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다.  | 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다. ",
        "original_sentence": "Transfusion 2003;43:1687-1694. "
      }
    },
    {
      "chunk_id": "chunk_308",
      "text": "| 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 307,
        "window_size": 3,
        "char_count": 237,
        "word_count": 59,
        "page_number": 6,
        "window_text": "| Cervenakova L, Yakovleva O, McKenzie C, Kolchinsky S, McShane L, Drohan WN, Brown P.  | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy.  Transfusion 2003;43:1687-1694.  | 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1.  | strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다.  | 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다.  | 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | . ",
        "original_sentence": "| 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1. "
      }
    },
    {
      "chunk_id": "chunk_309",
      "text": "| strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 308,
        "window_size": 3,
        "char_count": 126,
        "word_count": 31,
        "page_number": 6,
        "window_text": "| Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS | strains of transmissible spongiform encephalopathy.  Transfusion 2003;43:1687-1694.  | 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1.  | strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다.  | 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다.  | 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | .  | 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | . ",
        "original_sentence": "| strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다. "
      }
    },
    {
      "chunk_id": "chunk_310",
      "text": "| 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 309,
        "window_size": 3,
        "char_count": 216,
        "word_count": 61,
        "page_number": 2,
        "window_text": "Transfusion 2003;43:1687-1694.  | 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1.  | strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다.  | 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다.  | 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | .  | 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | .  | 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3. ",
        "original_sentence": "| 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다. "
      }
    },
    {
      "chunk_id": "chunk_311",
      "text": "| 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 310,
        "window_size": 3,
        "char_count": 61,
        "word_count": 22,
        "page_number": 2,
        "window_text": "| 상 뇌증 | 등이 있음 | (feline spongiform encephalopathy, FSE) | 자료실 간행물 | / | , | 지침/130 |\n| 항암 유전자치료제 | 비임상 임상시험 사례분석 | ∙ | 2007 | 11-1470000-001440-10 | (생물의약품평가자료집 | 45) | 유전자치료제팀 | 자료실 간행물 | / | , | 지침/209 | 감염성 프리온 단백 | 의 실험동물 감염 | 2.1.  | strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다.  | 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다.  | 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | .  | 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | .  | 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3.  Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents. ",
        "original_sentence": "| 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | . "
      }
    },
    {
      "chunk_id": "chunk_312",
      "text": "| 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 311,
        "window_size": 3,
        "char_count": 55,
        "word_count": 17,
        "page_number": 6,
        "window_text": "| strain | BSL-4 : 감염되면 치명적일 수 있는 미생물을 다루는 경우 | ④ |\n| - | re-evaluation of TSE clearance | 이며 천연에 나타나는 물질과 공통점이 있는지는 명확하지 않다.  | 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다.  | 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | .  | 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | .  | 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3.  Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents.  The sanitisation |\n| - | sanitisation of equipment | 2. ",
        "original_sentence": "| 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | . "
      }
    },
    {
      "chunk_id": "chunk_313",
      "text": "| 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 312,
        "window_size": 3,
        "char_count": 102,
        "word_count": 24,
        "page_number": 2,
        "window_text": "| 팩 | 스 | 번 | 호 : | 02) 386-6584 | 2017 년    6 월    1 일 |\n| 대유행 인플루엔자 백신의 | 임상시험 평가 가이드 안 | ( | ) | 2007 | 11-1470000-001621-01 | (생물의약품평가가이드 | 30) | 바이러스백신팀 | 자료실 간행물 | / | , | 지침/228 | 단백 제거 조사연구를 용이하게 할 수 있을 것이다.  | 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | .  | 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | .  | 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3.  Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents.  The sanitisation |\n| - | sanitisation of equipment | 2.  | It has been assumed that where two steps are assessed the total clearance approximates to their | sum. ",
        "original_sentence": "| 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3. "
      }
    },
    {
      "chunk_id": "chunk_314",
      "text": "Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 313,
        "window_size": 3,
        "char_count": 310,
        "word_count": 48,
        "page_number": 8,
        "window_text": "| 장갑은 감염성 물질 | 감염 동물 | 오염 장비를 다룰 때 착용하여야 한다 | 2) | , | , | .  | 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | .  | 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3.  Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents.  The sanitisation |\n| - | sanitisation of equipment | 2.  | It has been assumed that where two steps are assessed the total clearance approximates to their | sum.  This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step. ",
        "original_sentence": "Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents. "
      }
    },
    {
      "chunk_id": "chunk_315",
      "text": "The sanitisation |\n| - | sanitisation of equipment | 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 314,
        "window_size": 3,
        "char_count": 56,
        "word_count": 11,
        "page_number": 8,
        "window_text": "| 는 필수이며 출입문 | 저장고에서 떨어진 장소에 위치하여야 한다 | 8) BSC | , | .  | 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3.  Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents.  The sanitisation |\n| - | sanitisation of equipment | 2.  | It has been assumed that where two steps are assessed the total clearance approximates to their | sum.  This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step.  |\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | . ",
        "original_sentence": "The sanitisation |\n| - | sanitisation of equipment | 2. "
      }
    },
    {
      "chunk_id": "chunk_316",
      "text": "| It has been assumed that where two steps are assessed the total clearance approximates to their | sum. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 315,
        "window_size": 3,
        "char_count": 105,
        "word_count": 19,
        "page_number": 25,
        "window_text": "| 2006 | 11-1470000-001228-01 | (생물의약품평가자료집 | 33) | 세포조직공학제제팀 자료실 간행물 | / | , | 지침/144 |\n| 물질 선택 | 3.  Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents.  The sanitisation |\n| - | sanitisation of equipment | 2.  | It has been assumed that where two steps are assessed the total clearance approximates to their | sum.  This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step.  |\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | .  |\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2. ",
        "original_sentence": "| It has been assumed that where two steps are assessed the total clearance approximates to their | sum. "
      }
    },
    {
      "chunk_id": "chunk_317",
      "text": "This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 316,
        "window_size": 3,
        "char_count": 183,
        "word_count": 32,
        "page_number": 6,
        "window_text": "Spiking | Because of the resistance of TSE agents to inactivation, and their propensity to stick to stainless steel | and other materials, it is particularly important to consider the sanitisation and cleaning procedures | used for fractionation equipment for their ability to inactivate or remove TSE agents.  The sanitisation |\n| - | sanitisation of equipment | 2.  | It has been assumed that where two steps are assessed the total clearance approximates to their | sum.  This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step.  |\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | .  |\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2.  Spiking | 인되었다. ",
        "original_sentence": "This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step. "
      }
    },
    {
      "chunk_id": "chunk_318",
      "text": "|\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 317,
        "window_size": 3,
        "char_count": 262,
        "word_count": 65,
        "page_number": 2,
        "window_text": "The sanitisation |\n| - | sanitisation of equipment | 2.  | It has been assumed that where two steps are assessed the total clearance approximates to their | sum.  This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step.  |\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | .  |\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2.  Spiking | 인되었다.  | 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2. ",
        "original_sentence": "|\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | . "
      }
    },
    {
      "chunk_id": "chunk_319",
      "text": "|\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 318,
        "window_size": 3,
        "char_count": 233,
        "word_count": 42,
        "page_number": 1,
        "window_text": "| It has been assumed that where two steps are assessed the total clearance approximates to their | sum.  This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step.  |\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | .  |\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2.  Spiking | 인되었다.  | 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2.  Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다.",
        "original_sentence": "|\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2. "
      }
    },
    {
      "chunk_id": "chunk_320",
      "text": "Spiking | 인되었다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 319,
        "window_size": 3,
        "char_count": 16,
        "word_count": 3,
        "page_number": 5,
        "window_text": "This may not be the case, in particular where the spike is heterogeneous, so that one | fraction could be preferentially removed by one step and the same subfraction by another step.  |\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | .  |\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2.  Spiking | 인되었다.  | 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2.  Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다. **\n**사용하지 않는다.",
        "original_sentence": "Spiking | 인되었다. "
      }
    },
    {
      "chunk_id": "chunk_321",
      "text": "| 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 320,
        "window_size": 3,
        "char_count": 38,
        "word_count": 12,
        "page_number": 2,
        "window_text": "|\n| 항암 생물의약품의 | 안전성 유효성 평가 | ․ | 2005 | 11-1470000-000865-01 | (생물의약품평가자료집 | 20) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/101 | 생명공학의약품의 | 안전성평가(4) | 2004 | 11-1470000-000676-14 | (생물의약품평가자료집 | 7) | 생물의약품평가과 | 자료실 간행물 | / | , | 지침/71 | 증기멸균 | 번 | 고압증기멸균 한다 | 6 | ) | .  |\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2.  Spiking | 인되었다.  | 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2.  Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다. **\n**사용하지 않는다. **\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. ",
        "original_sentence": "| 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2. "
      }
    },
    {
      "chunk_id": "chunk_322",
      "text": "Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다.",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 321,
        "window_size": 3,
        "char_count": 142,
        "word_count": 32,
        "page_number": 2,
        "window_text": "|\n| Bioassays have to be carried out in dedicated laboratories and animal rooms, with security levels | adapted to the manipulated strains (level 2 for characterised scrapie strains, level 3 for human and BSE |\n| 물질의 물리화학적 형태 | 3.2.  Spiking | 인되었다.  | 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2.  Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다. **\n**사용하지 않는다. **\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
        "original_sentence": "Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다."
      }
    },
    {
      "chunk_id": "chunk_323",
      "text": "**\n**사용하지 않는다.",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 322,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 5,
        "window_text": "Spiking | 인되었다.  | 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2.  Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다. **\n**사용하지 않는다. **\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n",
        "original_sentence": "**\n**사용하지 않는다."
      }
    },
    {
      "chunk_id": "chunk_324",
      "text": "**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 323,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 담당자 | 확  인(부서장) | 임종미 |\n| 분획 | 3.2.  Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다. **\n**사용하지 않는다. **\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n",
        "original_sentence": "**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_325",
      "text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 324,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 2,
        "window_text": "Microsomal | 백신 임상 평가 시 | 고려사항 2007 | 2007 | 11-1470000-001446-10 | (생물의약품평가자료집 | 44) | 세균백신팀 | 자료실 간행물 | / | , | 지침/192 |\n**하여 PrPres를 증폭시킨다. **\n**사용하지 않는다. **\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n 전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ. ",
        "original_sentence": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_326",
      "text": "지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 325,
        "window_size": 3,
        "char_count": 141,
        "word_count": 28,
        "page_number": 4,
        "window_text": "**\n**사용하지 않는다. **\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n 전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1. ",
        "original_sentence": "지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_327",
      "text": "<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 326,
        "window_size": 3,
        "char_count": 133,
        "word_count": 27,
        "page_number": 4,
        "window_text": "**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n 전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1.  목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_328",
      "text": "전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 327,
        "window_size": 3,
        "char_count": 112,
        "word_count": 21,
        "page_number": 5,
        "window_text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n 전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1.  목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2.  용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n",
        "original_sentence": "전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ. "
      }
    },
    {
      "chunk_id": "chunk_329",
      "text": "서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 328,
        "window_size": 3,
        "char_count": 180,
        "word_count": 11,
        "page_number": 5,
        "window_text": "지침서ㆍ안내서\n\n정혜주\n\n<!-- PAGE_4 -->\n###### 이 안내서는 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 검증에\n\n<!-- PAGE_4 -->\n###### 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n <!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n 전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1.  목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2.  용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n <!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1. ",
        "original_sentence": "서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_330",
      "text": "목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 329,
        "window_size": 3,
        "char_count": 177,
        "word_count": 11,
        "page_number": 5,
        "window_text": "<!-- PAGE_4 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술\n\n※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원\n\n바이오생약심사부 생물제제과에 문의하시기 바랍니다.\n\n 전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1.  목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2.  용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n <!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1.  일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2. ",
        "original_sentence": "목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_331",
      "text": "용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 330,
        "window_size": 3,
        "char_count": 238,
        "word_count": 25,
        "page_number": 5,
        "window_text": "전화번호 : 043-719-3468\n\n팩스번호 : 043-719-3450\n\n<!-- PAGE_5 -->\n## 목\n\n<!-- PAGE_5 -->\n## 차\n\n<!-- PAGE_5 -->\n###### Ⅰ.  서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1.  목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2.  용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n <!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1.  일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2.  규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3. ",
        "original_sentence": "용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_332",
      "text": "<!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 331,
        "window_size": 3,
        "char_count": 156,
        "word_count": 20,
        "page_number": 5,
        "window_text": "서론\n\n<!-- PAGE_5 -->\n###### ····························································································································1\n\n<!-- PAGE_5 -->\n###### 1.  목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2.  용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n <!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1.  일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2.  규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3.  Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4. ",
        "original_sentence": "<!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_333",
      "text": "일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 332,
        "window_size": 3,
        "char_count": 170,
        "word_count": 12,
        "page_number": 5,
        "window_text": "목적\n\n<!-- PAGE_5 -->\n###### ·························································································································2\n\n<!-- PAGE_5 -->\n###### 2.  용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n <!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1.  일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2.  규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3.  Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4.  시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5. ",
        "original_sentence": "일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_334",
      "text": "규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 333,
        "window_size": 3,
        "char_count": 163,
        "word_count": 13,
        "page_number": 5,
        "window_text": "용어 정의\n\n<!-- PAGE_5 -->\n###### ···············································································································2\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_5 -->\n###### 조사연구\n\n<!-- PAGE_5 -->\n###### .\n\n <!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1.  일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2.  규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3.  Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4.  시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5.  제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6. ",
        "original_sentence": "규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_335",
      "text": "Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 334,
        "window_size": 3,
        "char_count": 163,
        "word_count": 13,
        "page_number": 5,
        "window_text": "<!-- PAGE_5 -->\n###### (clearance)\n\n<!-- PAGE_5 -->\n###### Ⅱ\n\n<!-- PAGE_5 -->\n###### ··········································3\n\n<!-- PAGE_5 -->\n###### 1.  일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2.  규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3.  Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4.  시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5.  제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6.  자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7. ",
        "original_sentence": "Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_336",
      "text": "시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 335,
        "window_size": 3,
        "char_count": 167,
        "word_count": 12,
        "page_number": 5,
        "window_text": "일반 원칙\n\n<!-- PAGE_5 -->\n###### ···············································································································3\n\n<!-- PAGE_5 -->\n###### 2.  규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3.  Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4.  시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5.  제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6.  자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7.  감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8. ",
        "original_sentence": "시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_337",
      "text": "제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 336,
        "window_size": 3,
        "char_count": 164,
        "word_count": 12,
        "page_number": 5,
        "window_text": "규모 축소 공정\n\n<!-- PAGE_5 -->\n###### ·····································································································4\n\n<!-- PAGE_5 -->\n###### 3.  Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4.  시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5.  제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6.  자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7.  감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8.  장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ. ",
        "original_sentence": "제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6. "
      }
    },
    {
      "chunk_id": "chunk_338",
      "text": "자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 337,
        "window_size": 3,
        "char_count": 151,
        "word_count": 13,
        "page_number": 5,
        "window_text": "Spiking 물질 선택\n\n<!-- PAGE_5 -->\n###### ································································································4\n\n<!-- PAGE_5 -->\n###### 4.  시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5.  제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6.  자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7.  감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8.  장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ.  결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ. ",
        "original_sentence": "자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7. "
      }
    },
    {
      "chunk_id": "chunk_339",
      "text": "감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 338,
        "window_size": 3,
        "char_count": 136,
        "word_count": 15,
        "page_number": 5,
        "window_text": "시험법 선택\n\n<!-- PAGE_5 -->\n###### ···········································································································7\n\n<!-- PAGE_5 -->\n###### 5.  제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6.  자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7.  감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8.  장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ.  결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ.  참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### . ",
        "original_sentence": "감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8. "
      }
    },
    {
      "chunk_id": "chunk_340",
      "text": "장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 339,
        "window_size": 3,
        "char_count": 169,
        "word_count": 12,
        "page_number": 5,
        "window_text": "제조공정 선택\n\n<!-- PAGE_5 -->\n###### ·······································································································8\n\n<!-- PAGE_5 -->\n###### 6.  자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7.  감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8.  장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ.  결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ.  참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### .  서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n",
        "original_sentence": "장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ. "
      }
    },
    {
      "chunk_id": "chunk_341",
      "text": "결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 340,
        "window_size": 3,
        "char_count": 178,
        "word_count": 11,
        "page_number": 5,
        "window_text": "자료의 해석과 제한사항\n\n<!-- PAGE_5 -->\n###### ·····················································································9\n\n<!-- PAGE_5 -->\n###### 7.  감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8.  장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ.  결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ.  참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### .  서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n (\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n",
        "original_sentence": "결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ. "
      }
    },
    {
      "chunk_id": "chunk_342",
      "text": "참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 341,
        "window_size": 3,
        "char_count": 820,
        "word_count": 99,
        "page_number": 5,
        "window_text": "감염성 프리온 단백 제거율 재평가\n\n<!-- PAGE_5 -->\n###### ·······························································10\n\n<!-- PAGE_5 -->\n###### 8.  장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ.  결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ.  참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### .  서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n (\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n 는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n",
        "original_sentence": "참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_343",
      "text": "서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 342,
        "window_size": 3,
        "char_count": 232,
        "word_count": 44,
        "page_number": 6,
        "window_text": "장비 위생\n\n<!-- PAGE_5 -->\n###### ·············································································································11\n\n<!-- PAGE_5 -->\n###### Ⅲ.  결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ.  참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### .  서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n (\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n 는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n 전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n",
        "original_sentence": "서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_344",
      "text": "(\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 343,
        "window_size": 3,
        "char_count": 82,
        "word_count": 14,
        "page_number": 6,
        "window_text": "결론\n\n<!-- PAGE_5 -->\n###### ·························································································································12\n\n<!-- PAGE_5 -->\n###### Ⅳ.  참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### .  서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n (\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n 는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n 전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n",
        "original_sentence": "(\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_345",
      "text": "는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 344,
        "window_size": 3,
        "char_count": 152,
        "word_count": 33,
        "page_number": 6,
        "window_text": "참고문헌\n\n<!-- PAGE_5 -->\n###### ·················································································································13\n\n<!-- PAGE_5 -->\n###### 부록\n\n<!-- PAGE_5 -->\n###### 감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_5 -->\n###### <\n\n<!-- PAGE_5 -->\n###### >\n\n<!-- PAGE_5 -->\n###### ············································14\n\n<!-- PAGE_5 -->\n###### <참고자료\n\n<!-- PAGE_5 -->\n###### > ························································································································27\n\n<!-- PAGE_5 -->\n###### Guideline on the Investigation of Manufacturing Processes for Plasma-Derived\n\n<!-- PAGE_5 -->\n###### Medicinal Products with regard to vCJD Risk, EMEA, 2004\n\n- - 1 -\n<!-- PAGE_6 -->\n#### 혈장분획제제 제조공정 중 감염성 프리온 단백 제거\n\n<!-- PAGE_6 -->\n#### 조사연구 가이드라인\n\n<!-- PAGE_6 -->\n###### .  서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n (\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n 는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n 전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n ,\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n",
        "original_sentence": "는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_346",
      "text": "전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 345,
        "window_size": 3,
        "char_count": 173,
        "word_count": 35,
        "page_number": 6,
        "window_text": "서론\n\n<!-- PAGE_6 -->\n###### Ⅰ\n\n크로이츠펠트 야콥병 인간 광우병\n\n은 퇴행성 신\n\n(\n\n, Creutzfeldt-Jakob disease, CJD)\n\n경계 질환으로 산발성\n\n가족성\n\n의원성\n\n변종\n\n의\n\n(sporadic),\n\n(familial),\n\n(iatrogenic),\n\n(variant)\n\n가지 형태로 분류된다\n\n이 중 변종 형태인 변종 크로이츠펠트 야콥병 변종 인간 광우\n\n4\n\n.\n\n (\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n 는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n 전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n ,\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n ,\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n",
        "original_sentence": "전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_347",
      "text": "BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 346,
        "window_size": 3,
        "char_count": 80,
        "word_count": 17,
        "page_number": 6,
        "window_text": "(\n\n병\n\n이\n\n년에 처음으로 영국에서 확인되\n\n, variant Creutzfeldt-Jakob disease, vCJD)\n\n1996\n\n었다.\n\n 는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n 전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n ,\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n ,\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n 연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n",
        "original_sentence": "BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_348",
      "text": ",\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 347,
        "window_size": 3,
        "char_count": 171,
        "word_count": 40,
        "page_number": 6,
        "window_text": "는 소 해면상 뇌증 광우병\n\n을 일으\n\nvCJD\n\n(\n\n, bovine spongiform encephalopathy, BSE)\n\n키는 병원체에 의해 야기된다는 유력한 증거가 있고\n\n, 가장 가능성이 있는 가설은\n\nBSE\n\n에 오염된 음식에 노출되어 발생한다는 것이다.\n\n 전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n ,\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n ,\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n 연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n",
        "original_sentence": ",\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_349",
      "text": ",\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 348,
        "window_size": 3,
        "char_count": 66,
        "word_count": 16,
        "page_number": 5,
        "window_text": "전염성 해면상 뇌증\n\n은 실험용 설\n\n(transmissible spongiform encephalopathy, TSE)\n\n치류 모델에서 얻은 연구결과\n\n혈액 성분\n\n에 의해 감염될 수 있음\n\n,\n\n(blood components)\n\n이 밝혀졌다\n\n또한 실험실적\n\n또는 천연 스크래피\n\n감염이 양\n\n간\n\n.\n\n BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n ,\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n ,\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n 연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n 사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n",
        "original_sentence": ",\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_350",
      "text": "연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 349,
        "window_size": 3,
        "char_count": 110,
        "word_count": 26,
        "page_number": 6,
        "window_text": "BSE\n\n(scrapie)\n\n(sheep)\n\n수혈에 의해 전염될 수 있다는 사실이 밝혀졌다\n\n반면\n\n야생형 마우스\n\n형질전환\n\n(\n\n)\n\n.\n\n ,\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n ,\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n 연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n 사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n 비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n",
        "original_sentence": "연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_351",
      "text": "vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 350,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 5,
        "window_text": ",\n\n,\n\n間\n\n마우스\n\n영장류를 이용하여 사람 혈액에서\n\n감염력\n\n을 검출하는 실험에\n\n,\n\nvCJD\n\n(infectivity)\n\n서는 지금까지는 어떠한 전염도 보이지 않았으나 일부 연구들이 아직도 진행 중에 있\n\n다\n\n영국에서 헌혈자로부터 수혈을 받은 사람을 추적한 결과\n\n후에\n\n가 발병한 헌\n\n.\n\n ,\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n 연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n 사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n 비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n <!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n",
        "original_sentence": "vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_352",
      "text": "사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 351,
        "window_size": 3,
        "char_count": 161,
        "word_count": 45,
        "page_number": 6,
        "window_text": ",\n\nvCJD\n\n혈자의 적혈구를 수혈받고\n\n차 전염이 된 예가\n\n건이 보고되었다\n\n지금까지의 역학적\n\n2\n\n4\n\n.\n\n 연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n 사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n 비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n <!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n 본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n",
        "original_sentence": "사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_353",
      "text": "비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 352,
        "window_size": 3,
        "char_count": 73,
        "word_count": 15,
        "page_number": 5,
        "window_text": "연구 혈우병같이 고위험군에서 수행된 연구 에서는 혈장분획제제 투여로\n\n가 발병\n\n(\n\n)\n\nCJD\n\n한 예는\n\n건도 없었다\n\n그러나 역학적 경험이 매우 제한적이어서 혈장분획제제를 통해\n\n1\n\n.\n\n vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n 사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n 비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n <!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n 본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n 공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n",
        "original_sentence": "비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_354",
      "text": "<!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 353,
        "window_size": 3,
        "char_count": 54,
        "word_count": 10,
        "page_number": 7,
        "window_text": "vCJD가 전염되는지 아닌지 결론에 도달할 수는 없다\n\n.\n\n 사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n 비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n <!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n 본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n 공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n 1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n",
        "original_sentence": "<!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_355",
      "text": "본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 354,
        "window_size": 3,
        "char_count": 140,
        "word_count": 32,
        "page_number": 1,
        "window_text": "사람 혈장으로 제조되는 혈장분획제제를 통해\n\n또는\n\n가 전염되는 것을 사\n\nCJD\n\nvCJD\n\n전에 예방하기 위하여 헌혈 시 문진을 통해 광우병 위험 지역에 체류 또는 거주한 경\n\n- - 2 -\n우에는 체류 시점 및 그 기간에 따라 헌혈을 금지하고 있다\n\n그러나 만약의 경우를 대\n\n.\n\n 비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n <!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n 본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n 공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n 1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n 에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n",
        "original_sentence": "본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_356",
      "text": "공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 355,
        "window_size": 3,
        "char_count": 95,
        "word_count": 24,
        "page_number": 6,
        "window_text": "비하여 혈장분획제제의 제조공정을 통해 감염성 프리온 단백이 제거되는 조사연구를\n\n통하여 제품의 안전성을 보증하는 것이 필요하다.\n\n <!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n 본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n 공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n 1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n 에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n 형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n",
        "original_sentence": "공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_357",
      "text": "1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 356,
        "window_size": 3,
        "char_count": 116,
        "word_count": 24,
        "page_number": 2,
        "window_text": "<!-- PAGE_7 -->\n###### 목적\n\n<!-- PAGE_7 -->\n###### 1.\n\n 본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n 공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n 1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n 에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n 형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n 해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n. ",
        "original_sentence": "1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_358",
      "text": "에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 357,
        "window_size": 3,
        "char_count": 99,
        "word_count": 25,
        "page_number": 2,
        "window_text": "본 가이드라인은 혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구\n\n방법에 대한 가이드로서\n\n감염성 프리온 단백으로부터 혈장분획제제의 안전성을 확\n\n,\n\n보하는데 그 목적이 있다\n\n제조사는 단계적 접근을 통해 혈장분획제제의 특정 제조\n\n.\n\n 공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n 1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n 에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n 형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n 해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n.  TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n",
        "original_sentence": "에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_359",
      "text": "형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 358,
        "window_size": 3,
        "char_count": 46,
        "word_count": 12,
        "page_number": 5,
        "window_text": "공정이 오염 가능한 감염성 프리온 단백의 감염력을 감소시킬 수 있는 가능성이 있\n\n는지를 평가하여야 한다\n\n이에 감염성 프리온 단백 제거 조사연구와 관련된 지침을\n\n.\n\n 1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n 에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n 형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n 해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n.  TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n <!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n",
        "original_sentence": "형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_360",
      "text": "해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 359,
        "window_size": 3,
        "char_count": 51,
        "word_count": 15,
        "page_number": 5,
        "window_text": "1) 프리온\n\n(prion)\n\n단백질\n\n과 비리온\n\n의 합성어로 바이러스처럼 감\n\n:\n\n(protein)\n\n(virion)\n\n염력을 가진 단백질 입자로 광우병을 유발하는 인자\n\n프리온은 정상적인 상태\n\n.\n\n 에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n 형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n 해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n.  TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n <!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n 험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n",
        "original_sentence": "해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n. "
      }
    },
    {
      "chunk_id": "chunk_361",
      "text": "TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 360,
        "window_size": 3,
        "char_count": 579,
        "word_count": 118,
        "page_number": 8,
        "window_text": "에서는 뇌세포의 활동에 중요한 역할을 수행하는 것으로 알려져 있으며\n\n이와\n\n,\n\n2) 감염성 프리온 단백\n\n감염력을 가진 변형된 프리온 단백\n\n정상적 프리온이 변\n\n:\n\n.\n\n 형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n 해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n.  TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n <!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n 험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n ,\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n",
        "original_sentence": "TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n"
      }
    },
    {
      "chunk_id": "chunk_362",
      "text": "<!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 361,
        "window_size": 3,
        "char_count": 543,
        "word_count": 95,
        "page_number": 8,
        "window_text": "형이 일어난 형태로 뇌에 치명적인 질환을 일으킴\n\n단백 분해효소에 의해 분\n\n.\n\n 해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n.  TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n <!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n 험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n ,\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n 획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n",
        "original_sentence": "<!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_363",
      "text": "험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 362,
        "window_size": 3,
        "char_count": 104,
        "word_count": 24,
        "page_number": 6,
        "window_text": "해되지 않으며 자외선\n\n화학물질\n\n열 등에 저항성이 강함\n\n에 걸린 뇌 조\n\n,\n\n,\n\n.  TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n <!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n 험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n ,\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n 획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n 기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n",
        "original_sentence": "험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_364",
      "text": ",\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 363,
        "window_size": 3,
        "char_count": 203,
        "word_count": 48,
        "page_number": 6,
        "window_text": "TSE\n\n직에서 검출되며 단백 분해효소에 저항성을 나타내는 프리온을 PrPSc(scrapie\n\n3) 전염성 해면상 뇌증\n\n(TSE)\n\n원인체는 변형된 프리온으로\n\n동물 종에 따라 소\n\n:\n\n,\n\n해면상 뇌증\n\n양이나 염소의 스크래피\n\n밍크에서 발생되는 전염\n\n(BSE),\n\n(scrapie),\n\n성 밍크 뇌증\n\n사슴류의 만성 소모\n\n(transmissble mink encephalopathy, TME),\n\n성 질환\n\n고양이에서 발생되는 고양이 해면\n\n(chronic wasting disease, CWD),\n\n4) 감염성 프리온 단백\n\nstrain\n\n감염성 프리온 단백은 바이러스와 같이 여러\n\n:\n\n을 갖고 있으며 각\n\n은 종\n\n잠복기\n\n감염성 프리온 단백의\n\nstrain\n\nstrain\n\n(species),\n\n,\n\n침착 및 뇌 조직 손상부위 등 독특한 고유의 특징을 가짐\n\n- - 3 -\n5) PrPres(resistant prion protein)\n\n감염성 프리온 단백과 유사하게 단백 분해효\n\n:\n\n소인\n\n에 저항성을 나타내는 비정상적인 프리온 단백\n\nproteinase K\n\n<!-- PAGE_8 -->\n###### Ⅱ.\n\n <!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n 험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n ,\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n 획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n 기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n (in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n. ",
        "original_sentence": ",\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_365",
      "text": "획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 364,
        "window_size": 3,
        "char_count": 351,
        "word_count": 71,
        "page_number": 6,
        "window_text": "<!-- PAGE_8 -->\n###### 감염성 프리온 단백 제거율\n\n<!-- PAGE_8 -->\n###### 조사연구\n\n<!-- PAGE_8 -->\n###### (clearance)\n\n혈장분획제제 등 바이러스 검증 평가가이드 생물의약품평가가이드\n\n와\n\n“\n\n(\n\n20, 2006)”\n\nEMEA의\n\n“Note\n\nfor\n\nGuidance\n\non\n\nVirus\n\nValidation\n\nStudies:\n\nThe\n\nDesign,\n\nContribution\n\nand\n\nInterpretation\n\nof\n\nStudies\n\nValidating\n\nthe\n\nInactivation\n\nand\n\nRemoval of Viruses(CPMP/BWP/268/95, 1996)”에 제시된 바이러스 불활화 제거\n\n/\n\n감염성 프리온 단백 불활화 제거 조사연구는 실제 제조공정을 정확히 규모 축소\n\n/\n\n한 실험실 모델을 이용하여 적당한 감염성 프리온 단백을 선정하여 제\n\n(scale-down)\n\n조공정 산물에 최대\n\n가 넘지 않는 양으로\n\n하여 수행하여야 한다\n\n모든 실\n\n10%\n\nspike\n\n.\n\n 험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n ,\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n 획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n 기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n (in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n.  이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n",
        "original_sentence": "획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_366",
      "text": "기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 365,
        "window_size": 3,
        "char_count": 43,
        "word_count": 13,
        "page_number": 5,
        "window_text": "험은 제품 생산과는 엄격하게 분리되어야 하며\n\n, 적절히 훈련된 사람에 의해 관리\n\n,\n\n문서화\n\n및\n\n수행되어져야\n\n한다\n\n바이러스\n\n검증연구와\n\n마찬가지로\n\n실\n\n제조\n\n규모\n\n.\n\n ,\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n 획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n 기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n (in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n.  이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n (reduction factor)\n\n1 log\n\n.\n\n",
        "original_sentence": "기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_367",
      "text": "(in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 366,
        "window_size": 3,
        "char_count": 46,
        "word_count": 8,
        "page_number": 5,
        "window_text": ",\n\n의 제조공정과 같은 적절한 규모 축소 모델을 이용하여 감염\n\n(manufacturing scale)\n\n성 프리온 단백 불활화 제거에 기여할 것으로 생각되는 공정들을 선택하여 주요 파\n\n/\n\n감염성 프리온 단백은 혈장분획제제 제조 시 이용되는 대부분의 물리화학적인 바\n\n이러스 불활화 공정에 저항성을 나타내는 것으로 알려져 있다\n\n따라서 냉 에탄올 분\n\n.\n\n 획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n 기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n (in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n.  이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n (reduction factor)\n\n1 log\n\n.\n\n 개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n",
        "original_sentence": "(in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_368",
      "text": "이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 367,
        "window_size": 3,
        "char_count": 119,
        "word_count": 28,
        "page_number": 5,
        "window_text": "획\n\n침전\n\n크로마토그래피\n\n심층여과\n\n또는 나노\n\n(fractionation), PEG-\n\n,\n\n,\n\n(depth filtration)\n\n여과\n\n와 같은 제거 분할\n\n공정에 연구의 초점을 맞추어야\n\n(nanofiltration)\n\n/\n\n(partitioning)\n\n감염성 프리온 단백 제거 조사연구는 기존의 다른 병원체에 대한 연구보다 어렵\n\n고 비용이 많이 소요되어\n\n조사연구 디자인의 한 부분으로 이론적 근거를 토대로 제\n\n,\n\n조공정의 완건성\n\n(robustness)을 검토하거나 적절히 검증된\n\nin vitro 시험법을 사용하\n\n는 것도 가능하다\n\n감염성 프리온 단백 제거는 제조공정 파라미터 변화에 영향을 받\n\n.\n\n 기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n (in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n.  이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n (reduction factor)\n\n1 log\n\n.\n\n 개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n 석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n",
        "original_sentence": "이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_369",
      "text": "(reduction factor)\n\n1 log\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 368,
        "window_size": 3,
        "char_count": 30,
        "word_count": 5,
        "page_number": 2,
        "window_text": "기 쉽다는 점을 명심해야 한다\n\n따라서 공정 중 한계\n\n는 분할 공정\n\n.\n\n (in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n.  이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n (reduction factor)\n\n1 log\n\n.\n\n 개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n 석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n 이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n",
        "original_sentence": "(reduction factor)\n\n1 log\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_370",
      "text": "개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 369,
        "window_size": 3,
        "char_count": 110,
        "word_count": 28,
        "page_number": 2,
        "window_text": "(in-process limit)\n\n에 대한 조사연구를 디자인하는데 중요하다\n\n.  이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n (reduction factor)\n\n1 log\n\n.\n\n 개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n 석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n 이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n ,\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n",
        "original_sentence": "개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_371",
      "text": "석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 370,
        "window_size": 3,
        "char_count": 48,
        "word_count": 14,
        "page_number": 9,
        "window_text": "이 조사연구는 감염성 프리온 단백이\n\n- - 4 -\n옆 분획\n\n(side fraction)으로 분할되는 것을\n\nin vitro 시험법을 이용하여 입증하여야\n\n한다\n\n감소 인수\n\n가\n\n미만이면 유의하지 않다\n\n.\n\n (reduction factor)\n\n1 log\n\n.\n\n 개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n 석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n 이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n ,\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n 적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n",
        "original_sentence": "석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_372",
      "text": "이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 371,
        "window_size": 3,
        "char_count": 97,
        "word_count": 26,
        "page_number": 6,
        "window_text": "(reduction factor)\n\n1 log\n\n.\n\n 개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n 석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n 이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n ,\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n 적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n 산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n. ",
        "original_sentence": "이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_373",
      "text": ",\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 372,
        "window_size": 3,
        "char_count": 146,
        "word_count": 37,
        "page_number": 6,
        "window_text": "개 또는 그 이상의 단계에 대한 연구를 하기 위해서는 초기\n\n농도\n\n가\n\n2\n\nspike\n\n(titer)\n\n충분히 높아야 한다\n\n여러 단계의 연구를 디자인할 때는 해당하는 중간체 시료를 분\n\n.\n\n 석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n 이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n ,\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n 적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n 산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n.  혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n",
        "original_sentence": ",\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_374",
      "text": "적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 373,
        "window_size": 3,
        "char_count": 147,
        "word_count": 35,
        "page_number": 6,
        "window_text": "석하여 각 개별 단계 및 모든 조합된 단계로부터 감소 인수를 구할 수 있어야 한다.\n\n 이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n ,\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n 적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n 산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n.  혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n",
        "original_sentence": "적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_375",
      "text": "산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 374,
        "window_size": 3,
        "char_count": 138,
        "word_count": 34,
        "page_number": 6,
        "window_text": "이와 같은 여러 단계의 연구는 감소 인수가 낮거나 중등도인 경우 이를 더함으로써\n\n감소 인수를 구하는데 도움이 될 수 있다\n\n더욱이\n\n여러 단계의 연구는 감염성 프리\n\n.\n\n ,\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n 적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n 산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n.  혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n 주요 고려사항은 다음과 같다.\n\n",
        "original_sentence": "산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_376",
      "text": "혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 375,
        "window_size": 3,
        "char_count": 130,
        "word_count": 33,
        "page_number": 6,
        "window_text": ",\n\n온 단백의 물리화학적 상태가 유의하게 변화할 것으로 예측되는 경우에 도움이 될\n\n수 있는데\n\n계면활성제 처리 후에 여과 단계처럼 후속 단계가 감염성 프리온 단백\n\n,\n\n제거에 영향을 주는 경우가 이에 해당된다\n\n전체 공정을 포함하는 조사연구가 이상\n\n.\n\n 적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n 산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n.  혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n 주요 고려사항은 다음과 같다.\n\n 원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다. ",
        "original_sentence": "혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_377",
      "text": "spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 376,
        "window_size": 3,
        "char_count": 64,
        "word_count": 16,
        "page_number": 6,
        "window_text": "적이지만 바이러스 경우와 마찬가지로\n\n대다수의 경우 초기\n\n농도가 너무 낮아\n\n,\n\nspike\n\n감염성 프리온 단백 제거 조사연구를 위한 제조공정의 규모 축소 원리는 바이러\n\n스 검증연구와 동일하다\n\n제조사는 규모 축소 공정에서 만들어진 생성물 또는 중간\n\n.\n\n 산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n.  혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n 주요 고려사항은 다음과 같다.\n\n 원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다.  vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n",
        "original_sentence": "spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_378",
      "text": "주요 고려사항은 다음과 같다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 377,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 10,
        "window_text": "산물의 수율\n\n품질 및 조성에 관한 자료를 제공하여야 하며\n\n실 제조\n\n한\n\n,\n\n,\n\n(full-scale)\n\n감염성 프리온 단백을 실험실적으로 동물에 감염시켜 얻은 연구결과에 의하면 감\n\n염성 프리온 단백은 혈액에서 발견됨을 알 수 있다\n\n.  혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n 주요 고려사항은 다음과 같다.\n\n 원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다.  vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n. ",
        "original_sentence": "주요 고려사항은 다음과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_379",
      "text": "원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 378,
        "window_size": 3,
        "char_count": 96,
        "word_count": 23,
        "page_number": 6,
        "window_text": "혈액에서의 감염력 수준은 뇌에\n\n- - 5 -\n서 발견되는 수준에 비해 최소\n\n배 정도는 낮은 것으로 나타나 뇌 조직이 실\n\n10,000\n\n질적으로 유일한\n\n물질이다\n\n가능한 한 고농도를\n\n하여야 하나 조사연\n\nspiking\n\n.\n\n spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n 주요 고려사항은 다음과 같다.\n\n 원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다.  vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n.  BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n",
        "original_sentence": "원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_380",
      "text": "vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 379,
        "window_size": 3,
        "char_count": 102,
        "word_count": 22,
        "page_number": 6,
        "window_text": "spike\n\n구 해야 할 분획의 특성을 변화시키지 않기 위해서는 총 용량의\n\n를 초과해서는\n\n10%\n\n안 된다.\n\n 주요 고려사항은 다음과 같다.\n\n 원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다.  vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n.  BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n 에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n",
        "original_sentence": "vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_381",
      "text": "vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 380,
        "window_size": 3,
        "char_count": 96,
        "word_count": 22,
        "page_number": 6,
        "window_text": "주요 고려사항은 다음과 같다.\n\n 원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다.  vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n.  BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n 에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n",
        "original_sentence": "vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_382",
      "text": "BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 381,
        "window_size": 3,
        "char_count": 95,
        "word_count": 24,
        "page_number": 6,
        "window_text": "원료물질을 결정하는 요인으로는 공급\n\n시험법\n\n혈장 내에 존재할 수\n\nSpiking\n\n,\n\n,\n\n있는 감염성 프리온 단백과 유사한 감염력을 나타내는 물질을 꼽을 수 있다.  vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n.  BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n 에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n 감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n",
        "original_sentence": "BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_383",
      "text": "에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 382,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 5,
        "window_text": "vCJD\n\n증례로부터 얻은 계대배양하지 않은\n\n물질은 윤리적인 이유 등으로 사\n\n(unpassaged)\n\n용이 제한적이다\n\n정상 마우스를\n\n의 생물시험법\n\n에 이용할 수 있고\n\n.\n\n vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n.  BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n 에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n 감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n 백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n",
        "original_sentence": "에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_384",
      "text": "BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 383,
        "window_size": 3,
        "char_count": 56,
        "word_count": 13,
        "page_number": 6,
        "window_text": "vCJD\n\n(bioassay)\n\n,\n\n사람 유래 물질을\n\n연구에 사용한 예가 최소\n\n건 있지만\n\n를 사용하는\n\nspike\n\n1\n\n, vCJD\n\n것이 필수적이지는 않다\n\n.  BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n 에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n 감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n 백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n .\n\n",
        "original_sentence": "BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_385",
      "text": "감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 384,
        "window_size": 3,
        "char_count": 178,
        "word_count": 38,
        "page_number": 6,
        "window_text": "BSE에 감염된 동물로부터 많은 양의 소 뇌\n\n(bovine brain)\n\n를 얻는 것이 가능하지만\n\n적절한 품질의 물질을 얻는 것이 어렵다\n\n또한 그 물질\n\n,\n\n.\n\n 에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n 감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n 백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n .\n\n 지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n",
        "original_sentence": "감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_386",
      "text": "백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 385,
        "window_size": 3,
        "char_count": 110,
        "word_count": 29,
        "page_number": 6,
        "window_text": "에 대한 시험법은 더욱 힘들 가능성이 있다\n\n이러한 사실은\n\n에 감염된 양에도\n\n.\n\n BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n 감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n 백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n .\n\n 지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n 우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n",
        "original_sentence": "백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_387",
      "text": ".\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 386,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "BSE\n\n해당되며\n\n스크래피에 감염된 양의 경우 더욱 그러하다\n\n모델 병원체뿐만 아니라\n\n,\n\n.\n\n 감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n 백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n .\n\n 지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n 우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n 서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n",
        "original_sentence": ".\n\n"
      }
    },
    {
      "chunk_id": "chunk_388",
      "text": "지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 387,
        "window_size": 3,
        "char_count": 107,
        "word_count": 25,
        "page_number": 6,
        "window_text": "감염성 프리온 단백을 제거하는 것을 보여주기 위한 데모\n\n프로젝트\n\n(demonstration)\n\n를 제외하면\n\n실험실 감염성 프리온 단백\n\n예\n\n스크래피\n\n,\n\nstrain(\n\n:\n\n, familial CJD, BSE\n\n또는\n\n을 적용시킨 설치류를 사용하는 것이 가장 적합하다\n\n감염성 프리온 단\n\nvCJD)\n\n.\n\n 백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n .\n\n 지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n 우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n 서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n 조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n",
        "original_sentence": "지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_389",
      "text": "우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 388,
        "window_size": 3,
        "char_count": 156,
        "word_count": 37,
        "page_number": 6,
        "window_text": "백\n\n은 종류에 따라 병리 상태 및 특성이 다 다르기 때문에 여러\n\n을 이용\n\nstrain\n\nstrain\n\n해 조사연구 되어 왔다\n\n또한 시험법에 사용되는 원리도 잘 확립되어 있다\n\n지금까\n\n.\n\n .\n\n 지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n 우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n 서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n 조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n 리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n",
        "original_sentence": "우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_390",
      "text": "서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 389,
        "window_size": 3,
        "char_count": 91,
        "word_count": 20,
        "page_number": 6,
        "window_text": ".\n\n 지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n 우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n 서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n 조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n 리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n 면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n. ",
        "original_sentence": "서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_391",
      "text": "조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 390,
        "window_size": 3,
        "char_count": 48,
        "word_count": 10,
        "page_number": 5,
        "window_text": "지 발표된 연구에서는 열처리 불활화에 대한 저항성은\n\nstrain마다 다르긴 하지만\n\n,\n\n제거 연구에 있어서 종이나\n\n의 명백한 영향은 없었다\n\n따라서 제거 연구의 경\n\nstrain\n\n.\n\n 우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n 서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n 조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n 리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n 면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n.  Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n",
        "original_sentence": "조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_392",
      "text": "리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 391,
        "window_size": 3,
        "char_count": 59,
        "word_count": 16,
        "page_number": 6,
        "window_text": "우 실질적인 근거에 따라\n\n을 결정하고\n\n선택에 대한 이론적 근거를 제시\n\nstrain\n\nstrain\n\n혈액에서의 감염성 프리온 단백의 감염력이 동물실험에서 명백하게 확인되었\n\n- - 6 -\n음에도 불구하고 물리화학적 특성은 알려져 있지 않다\n\n감염력이 뇌 이외의 조직에\n\n.\n\n 서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n 조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n 리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n 면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n.  Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n 탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n",
        "original_sentence": "리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_393",
      "text": "면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 392,
        "window_size": 3,
        "char_count": 96,
        "word_count": 26,
        "page_number": 6,
        "window_text": "서 유래되었다고 가정하였을 때 혈액에서의 감염력은 뇌 보다는 비장에서 발견된\n\n감염력과 유사한 것으로 나타났다\n\n그러나 혈액에서의 감염력이 동물모델의 어느\n\n.\n\n 조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n 리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n 면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n.  Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n 탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n 리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n",
        "original_sentence": "면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n. "
      }
    },
    {
      "chunk_id": "chunk_394",
      "text": "Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 393,
        "window_size": 3,
        "char_count": 97,
        "word_count": 23,
        "page_number": 6,
        "window_text": "조직에서 유래되었는지는 명확하지 않다\n\n혈액에서의 감염력은 뇌가 퇴화하면서 유\n\n.\n\n 리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n 면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n.  Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n 탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n 리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n 분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n",
        "original_sentence": "Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_395",
      "text": "탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 394,
        "window_size": 3,
        "char_count": 46,
        "word_count": 11,
        "page_number": 5,
        "window_text": "리된 물질일 가능성이 있고\n\n이 경우 뇌는 적절한\n\n물질이 될 수 있다\n\n반\n\n,\n\nspiking\n\n.\n\n 면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n.  Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n 탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n 리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n 분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n",
        "original_sentence": "탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_396",
      "text": "리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 395,
        "window_size": 3,
        "char_count": 46,
        "word_count": 11,
        "page_number": 5,
        "window_text": "면\n\n, 매우 응집된 불용성의\n\nPrPSc를 함유한 뇌 조직은 혈액에서의 감염성 프리온 단\n\n백과 유사할 수도 있고 그렇지 않을 수도 있다\n\n물질의 물리적 형태를 신\n\n.  Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n 탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n 리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n 분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n",
        "original_sentence": "리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_397",
      "text": "분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 396,
        "window_size": 3,
        "char_count": 156,
        "word_count": 31,
        "page_number": 6,
        "window_text": "Spiking\n\n가공하지 않은 뇌 균질현탁액은 감염력 연구에서 가장 널리 사용되어져 왔으\n\n며 고농도를 함유하고 있다\n\n연구 수행에 있어서 가장 중요한 요소는 균질현\n\n.\n\n 탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n 리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n 분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n 침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n. ",
        "original_sentence": "분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_398",
      "text": "CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 397,
        "window_size": 3,
        "char_count": 97,
        "word_count": 19,
        "page_number": 6,
        "window_text": "탁액의 균질성과 재현성이다\n\n만약 입자 크기가 광범위하다면 여과와 같은 물\n\n.\n\n 리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n 분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n 침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n.  Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n",
        "original_sentence": "CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_399",
      "text": "microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 398,
        "window_size": 3,
        "char_count": 113,
        "word_count": 24,
        "page_number": 9,
        "window_text": "리적 기술에 의해 광범위하게 제거됨을 보여야 한다\n\n균질현탁액을 재현성 있\n\n.\n\n 분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n 침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n.  Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n ,\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n",
        "original_sentence": "microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_400",
      "text": "침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 399,
        "window_size": 3,
        "char_count": 176,
        "word_count": 37,
        "page_number": 6,
        "window_text": "분획은 뇌 균질현탁액을 분획\n\n원심분리 해서 큰 응집\n\nMicrosomal\n\n(differential)\n\n체는 제거하고 막에 결합된\n\n감염력을 나타내는 물질을 얻\n\n(membrane-bound)\n\n은 것이다\n\n감염력 수준은 뇌 균질현탁액보다 낮지만 균질성은 더 있을 것으\n\n.\n\n CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n 침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n.  Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n ,\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n 의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n",
        "original_sentence": "침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n. "
      }
    },
    {
      "chunk_id": "chunk_401",
      "text": "Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 400,
        "window_size": 3,
        "char_count": 61,
        "word_count": 11,
        "page_number": 6,
        "window_text": "CLDs는 계면활성제로 용해한 뇌 균질현탁액을 당 밀도구배\n\n- -\n(sucrose-density)\n\n초원심분리 해서 얻는다\n\n감염력 수준은\n\n분획보다 낮으며 세포로\n\n.\n\n microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n 침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n.  Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n ,\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n 의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n 그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n. ",
        "original_sentence": "Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_402",
      "text": ",\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 401,
        "window_size": 3,
        "char_count": 69,
        "word_count": 18,
        "page_number": 6,
        "window_text": "microsomal\n\n정제된 PrPSc는 뇌 균질현탁액을 계면활성제로 반복 추출한 후\n\n염\n\n으로\n\n,\n\n(salt)\n\n침전시키고 초원심분리 해서 얻는다\n\n이것은 세포나 막과는 관련이 없는 형태\n\n.\n\n 침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n.  Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n ,\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n 의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n 그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n.  Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n. ",
        "original_sentence": ",\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_403",
      "text": "의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 402,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 5,
        "window_text": "침전 연구\n\n결과에 의하면 막에 결합된\n\n물질인\n\n(precipitation studies)\n\nspiking\n\n- - 7 -\n균질현탁액\n\n분획\n\n는 유사하게 반응을 나타내어 모두\n\n물\n\n, microsomal\n\n, CLDs\n\nspiking\n\n질로 적합한 것으로 나타났다\n\n분획은 큰 응집체도 제거되고 감염력도\n\n.  Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n ,\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n 의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n 그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n.  Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n.  Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n",
        "original_sentence": "의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_404",
      "text": "그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 403,
        "window_size": 3,
        "char_count": 93,
        "word_count": 22,
        "page_number": 6,
        "window_text": "Microsomal\n\n높으면서 일관성 있게 만들어지므로\n\n물질로 좋다\n\n반면\n\n정제된\n\nspiking\n\n.\n\n ,\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n 의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n 그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n.  Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n.  Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n 델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n",
        "original_sentence": "그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n. "
      }
    },
    {
      "chunk_id": "chunk_405",
      "text": "Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 404,
        "window_size": 3,
        "char_count": 70,
        "word_count": 15,
        "page_number": 6,
        "window_text": ",\n\nPrPSc는 다\n\n른 막 분획보다 쉽게 침전 동결침전물로 침전되는 것을 포함하여\n\n된다\n\n다른 형태\n\n(\n\n)\n\n.\n\n 의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n 그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n.  Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n.  Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n 델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n (end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n",
        "original_sentence": "Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n. "
      }
    },
    {
      "chunk_id": "chunk_406",
      "text": "Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 405,
        "window_size": 3,
        "char_count": 116,
        "word_count": 24,
        "page_number": 6,
        "window_text": "의 감염성 프리온 단백도\n\nspiking 물질로 사용 가능하다\n\n.\n\n 그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n.  Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n.  Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n 델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n (end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n 간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n",
        "original_sentence": "Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_407",
      "text": "델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 406,
        "window_size": 3,
        "char_count": 95,
        "word_count": 22,
        "page_number": 6,
        "window_text": "그러나 이와 같은\n\n물질이 혈장에서 발견되는 감염력의 형태를 대표하\n\nspiking\n\n는지는 명확하지 않다\n\n물질은 공정 단계 연구에 매우 중요하며\n\n최악의 조\n\n.  Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n.  Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n 델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n (end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n 간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n 의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n",
        "original_sentence": "델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_408",
      "text": "(end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 407,
        "window_size": 3,
        "char_count": 69,
        "word_count": 13,
        "page_number": 6,
        "window_text": "Spiking\n\n,\n\n건\n\n을 평가할 수 있도록 선택되어야 한다\n\n물질의 선\n\n(worst case condition)\n\n.  Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n 델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n (end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n 간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n 의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n ,\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n",
        "original_sentence": "(end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_409",
      "text": "간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 408,
        "window_size": 3,
        "char_count": 47,
        "word_count": 12,
        "page_number": 5,
        "window_text": "Spiking\n\n감염력 시험법\n\n은 감염성 프리온 단백을 검출하는데 표준시험법\n\n(infectivity assay)\n\n으로 인정되고 있다\n\n조직이나 체액 내 감염성 프리온 단백의 존재는 적합한 동물모\n\n.\n\n 델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n (end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n 간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n 의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n ,\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n .\n\n",
        "original_sentence": "간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_410",
      "text": "의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 409,
        "window_size": 3,
        "char_count": 112,
        "word_count": 27,
        "page_number": 6,
        "window_text": "델의 감염을 통해 입증이 되었고\n\n배양기간 후에 신경질환이 발생하면 감염성 프리\n\n,\n\n온 단백이\n\n있음이\n\n입증되는\n\n것이다\n\n감염력은\n\n동물에서 종말\n\n적정법\n\n.\n\n (end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n 간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n 의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n ,\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n .\n\n ,\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n",
        "original_sentence": "의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_411",
      "text": ",\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 410,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 6,
        "window_text": "(end\n\npoint\n\n을 이용하여 측정된다\n\n만약 종말 적정법이 검증되었다면 배양기간 지속시\n\ntitration)\n\n.\n\n 간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n 의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n ,\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n .\n\n ,\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n 감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n",
        "original_sentence": ",\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_412",
      "text": ".\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 411,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "간으로 시험물질에서 나타나는 감염력을 정량할 수 있다\n\n전염에 대한 종간 벽\n\n.\n\n 의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n ,\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n .\n\n ,\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n 감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n ,\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n",
        "original_sentence": ".\n\n"
      }
    },
    {
      "chunk_id": "chunk_413",
      "text": ",\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 412,
        "window_size": 3,
        "char_count": 126,
        "word_count": 33,
        "page_number": 6,
        "window_text": "의 존재와 종 및\n\n의 영향은 분석해야 할 물질에 제약을 가져\n\n(species barrier)\n\nstrain\n\n온다\n\n예를 들면\n\n사람의 산발성\n\n의 경우 야생형 마우스는 거의 감염시키지 못\n\n.\n\n ,\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n .\n\n ,\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n 감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n ,\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n 프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n",
        "original_sentence": ",\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_414",
      "text": "감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 413,
        "window_size": 3,
        "char_count": 56,
        "word_count": 13,
        "page_number": 6,
        "window_text": ",\n\nCJD\n\n하였다\n\n생물시험법은 배양기간 때문에 수행하기가 복잡하다\n\n즉\n\n가장 빠른 경우가\n\n.\n\n .\n\n ,\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n 감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n ,\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n 프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n ,\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n",
        "original_sentence": "감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_415",
      "text": ",\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 414,
        "window_size": 3,
        "char_count": 110,
        "word_count": 25,
        "page_number": 6,
        "window_text": ".\n\n ,\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n 감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n ,\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n 프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n ,\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n - - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n",
        "original_sentence": ",\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_416",
      "text": "프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 415,
        "window_size": 3,
        "char_count": 157,
        "word_count": 34,
        "page_number": 6,
        "window_text": ",\n\n주사한 동물 예\n\n햄스터 모델\n\n의 관찰과 임상적 모니터링에 최소\n\n개월\n\n(\n\n:\n\n, 263K)\n\n6~9\n\n,\n\n비 형질전환 쥐 모델에서는\n\n개월이 소요된다\n\n또한 시험해야 할 물질에 따라\n\n- -\n15~18\n\n.\n\n 감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n ,\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n 프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n ,\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n - - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n 하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n",
        "original_sentence": "프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_417",
      "text": ",\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 416,
        "window_size": 3,
        "char_count": 56,
        "word_count": 14,
        "page_number": 6,
        "window_text": "감염성 프리온 단백\n\n과 수여받는 동물의 조합에 제한이 따른다\n\n다시 말하면\n\n/strain\n\n.\n\n ,\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n 프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n ,\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n - - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n 하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n 같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n",
        "original_sentence": ",\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_418",
      "text": "- - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 417,
        "window_size": 3,
        "char_count": 57,
        "word_count": 16,
        "page_number": 6,
        "window_text": ",\n\n검증연구 수행 시\n\n물질로 사용할 모든 형태의 감염성 프리온 단백을 주어진\n\nspiking\n\n동물\n\n이나 종에서 시험하는 것이 불가능하다는 것을 의미한다\n\n이것은 감염성\n\nstrain\n\n.\n\n 프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n ,\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n - - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n 하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n 같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n",
        "original_sentence": "- - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_419",
      "text": "하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 418,
        "window_size": 3,
        "char_count": 88,
        "word_count": 18,
        "page_number": 6,
        "window_text": "프리온 단백을 분할 또는 불활화 하는 제조공정에 대한 검증연구 디자인을 방해하\n\n생물시험법은 사용할\n\nstrain에 적합한 안전수준 감염성 프리온 단백은\n\n(\n\nbiosafety\n\n을 가진 지정된 실험실과 동물실험실에서 수행해야 한다\n\n시험의 복잡성\n\n배\n\nlevel 3)\n\n.\n\n ,\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n - - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n 하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n 같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n 리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n. ",
        "original_sentence": "하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_420",
      "text": "같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 419,
        "window_size": 3,
        "char_count": 169,
        "word_count": 38,
        "page_number": 2,
        "window_text": ",\n\n양기간\n\n요구되는 안전수준 때문에 시험 비용이 매우 비싸다\n\n그럼에도 불구하고 제\n\n,\n\n.\n\n - - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n 하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n 같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n 리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n.  비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n",
        "original_sentence": "같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_421",
      "text": "PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 420,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 5,
        "window_text": "- - 8 -\n거율에 대한 대부분의 연구가 감염력 시험법을 포함하고 있다\n\n따라서 시험을 수행\n\n.\n\n 하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n 같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n 리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n.  비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n",
        "original_sentence": "PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_422",
      "text": "리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 421,
        "window_size": 3,
        "char_count": 105,
        "word_count": 26,
        "page_number": 6,
        "window_text": "하고자 한다면 시스템이 잘 확립된\n\n과 지표\n\n동물을 사용하여 감염성\n\nstrain\n\n(indicator)\n\n프리온 단백 제거 조사연구를 수행하여야 한다.\n\n 같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n 리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n.  비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n 나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n",
        "original_sentence": "리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_423",
      "text": "비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 422,
        "window_size": 3,
        "char_count": 164,
        "word_count": 24,
        "page_number": 6,
        "window_text": "같은 일부 세포주는 감수성이 있어 마우스에 적용시킨 감염성 프리온\n\nN2a, GT1\n\n단백\n\n에 의해 감염되고\n\n유전자를\n\n한 어떤 세포주는 일부 스\n\nstrain\n\n, PrP\n\ntransfection\n\n크래피\n\n을 복제할 수 있다\n\n그러나 현재까지 감염력 존재를 확인하고 감염력\n\nstrain\n\n.\n\n PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n 리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n.  비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n 나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n 입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다. ",
        "original_sentence": "비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_424",
      "text": "PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 423,
        "window_size": 3,
        "char_count": 79,
        "word_count": 16,
        "page_number": 6,
        "window_text": "PrPSc를 검출할 수 있는 대체시험법이 문헌으로 발표되고 있다\n\n현재 감염성 프\n\n.\n\n 리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n.  비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n 나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n 입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다.  PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n. ",
        "original_sentence": "PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_425",
      "text": "나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 424,
        "window_size": 3,
        "char_count": 104,
        "word_count": 24,
        "page_number": 6,
        "window_text": "리온 단백은 숙주 단백질인\n\n가 비정상적인 형태로 축적된 것이라는 많은 연구결\n\nPrP\n\n과들이 제시되고 있지만\n\n아직도 감염성 프리온 단백의 정확한 특성은 알려져 있지\n\n,\n\n않다\n\n.  비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n 나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n 입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다.  PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n.  따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n",
        "original_sentence": "나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_426",
      "text": "입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 425,
        "window_size": 3,
        "char_count": 52,
        "word_count": 10,
        "page_number": 6,
        "window_text": "비정상적 형태의\n\nPrPSc는 상대적으로\n\nproteinase K에 저항성이 있어\n\nPrPres를\n\n생성시키고,\n\nPrPC를\n\n변성시키는\n\n같은\n\n변성제\n\nguanidinium\n\nhydrocholoride\n\n의 농도에 저항성을 나타낸다\n\n동물조직에서\n\n(denaturing agent)\n\n.\n\n PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n 나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n 입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다.  PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n.  따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n 한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n",
        "original_sentence": "입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다. "
      }
    },
    {
      "chunk_id": "chunk_427",
      "text": "PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 426,
        "window_size": 3,
        "char_count": 335,
        "word_count": 66,
        "page_number": 6,
        "window_text": "PrPSc 또는 PrPres가\n\n검출되는 것은 감염력의 대리 지표\n\n로 고려되어질 수 있다\n\n그러\n\n(surrogate marker)\n\n.\n\n 나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n 입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다.  PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n.  따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n 한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n , S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n",
        "original_sentence": "PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_428",
      "text": "따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 427,
        "window_size": 3,
        "char_count": 181,
        "word_count": 43,
        "page_number": 6,
        "window_text": "나 감염력과 PrPres의 상관관계는\n\n및 각각의 파라미터를 측정하는 방법에 따\n\nstrain\n\n라 달라질 수 있다\n\n이러한 이유로 여러 연구결과에서 특정한 경우에 있어 관련성이\n\n.\n\n 입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다.  PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n.  따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n 한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n , S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n",
        "original_sentence": "따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_429",
      "text": "한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 428,
        "window_size": 3,
        "char_count": 96,
        "word_count": 26,
        "page_number": 6,
        "window_text": "입증되었지만, PrPSc 제거율과 감염력 제거율 사이에 상관관계가 있는지는 명확하지\n\n않다.  PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n.  따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n 한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n , S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n 모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n",
        "original_sentence": "한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_430",
      "text": ", S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 429,
        "window_size": 3,
        "char_count": 69,
        "word_count": 15,
        "page_number": 6,
        "window_text": "PrPSc에 대한 생화학적 시험법과 생물시험법 사이에 상관관계가 입증되었다면\n\n생화학적 시험법을 이용하여 감염성 프리온 단백의 분할 또는 불활화를 증명하는\n\n생화학적\n\n시험법\n\n또는\n\n생물시험법에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\nEMEA\n\n“Creutzfeldt-Jakob Disease and Plasma-Derived and Urine-Derived Medicinal\n\n감염성 프리온 단백이 열처리와 같은 통상적인 바이러스 불활화 방법에 저항성을\n\n갖고 있음을 감안할 때 조사연구를 하는 제조공정 단계는 감염성 프리온 단백의 제\n\n거 또는 분할이 어느 정도 예상되는 단계이어야 한다\n\n.  따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n 한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n , S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n 모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n 품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n",
        "original_sentence": ", S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_431",
      "text": "S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 430,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 5,
        "window_text": "따라서 유기용매 계면활성제\n\n/\n\n(solvent/detergent, S/D) 처리와 열처리 공정에 대한 연구를 수행할 필요는 없으며\n\n,\n\n여러 연구에서 감염성 프리온 단백을 제거하는 능력이 탁월한 것으로 나타난 에탄\n\n- - 9 -\n올 분획\n\n침전\n\n크로마토그래피 및 여과 공정에 초점을 맞추어야 한다\n\n,\n\n,\n\n.\n\n 한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n , S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n 모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n 품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n (separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n",
        "original_sentence": "S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_432",
      "text": "모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 431,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 5,
        "window_text": "한편\n\n특정 단계에서의\n\n는 바로 전 단계에 의해 영향 받을 수 있다는 점을\n\n,\n\nspike\n\n명심하여야 한다\n\n예를 들면\n\n처리를 하면 분해\n\n되어 필터를 쉽게\n\n.\n\n , S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n 모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n 품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n (separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n",
        "original_sentence": "모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_433",
      "text": "품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 432,
        "window_size": 3,
        "char_count": 233,
        "word_count": 42,
        "page_number": 5,
        "window_text": ", S/D\n\n(disaggreate)\n\n통과한다\n\n따라서 여과와 같은 후속 단계에서\n\n처리를 하지 않은 물질은\n\n처\n\n.\n\n S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n 모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n 품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n (separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n ,\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n",
        "original_sentence": "품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_434",
      "text": "(separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 433,
        "window_size": 3,
        "char_count": 143,
        "word_count": 34,
        "page_number": 6,
        "window_text": "S/D\n\nS/D\n\n리를 한 물질에 비해 제거율이 과대평가될 수 있다.\n\n 모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n 품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n (separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n ,\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n 리다\n\n. ",
        "original_sentence": "(separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_435",
      "text": "spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 434,
        "window_size": 3,
        "char_count": 126,
        "word_count": 30,
        "page_number": 6,
        "window_text": "모든 제조사는 공개된 자료를 통해 제조공정 단계를 정확하게 평가해야 한다\n\n제\n\n.\n\n 품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n (separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n ,\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n 리다\n\n.  일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n",
        "original_sentence": "spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_436",
      "text": ",\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 435,
        "window_size": 3,
        "char_count": 104,
        "word_count": 23,
        "page_number": 6,
        "window_text": "품 특이적인\n\n조사연구에\n\n대한\n\n단계적\n\n접근\n\n방법은\n\n의\n\n- -\nEMEA\n\n“Creutzfeldt-Jakob\n\nDisease\n\nand\n\nPlasma-Derived\n\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/\n\n감염성 프리온 단백 제거 공정 평가는 바이러스 검증 평가연구 보다 다음과 같은\n\n제조공정 모델링이 불완전하다\n\n분리\n\n에 기초한 공정 단계\n\n특히\n\n1)\n\n.\n\n (separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n ,\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n 리다\n\n.  일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n 부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n",
        "original_sentence": ",\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_437",
      "text": "리다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 436,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 5,
        "window_text": "(separation)\n\n,\n\n감염성 프리온 단백을 제거하는데 중요한 것으로 여겨지는 에탄올 분획 공정\n\n두 공정 단계를 평가하는 경우 각 단계의 제거율의 총 합으로 제거율을 평가\n\n2)\n\n한다\n\n이것은\n\n물질이\n\n한 경우에는 해당되지 않는데\n\n그\n\n.\n\n spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n ,\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n 리다\n\n.  일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n 부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n - - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n",
        "original_sentence": "리다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_438",
      "text": "일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 437,
        "window_size": 3,
        "char_count": 95,
        "word_count": 22,
        "page_number": 6,
        "window_text": "spiking\n\nheterogenous\n\n,\n\n이유는 한 분획이 하나의 단계에 의해 선택적으로 제거될 수 있고\n\n, 같은\n\nsub\n\n전처리는 감염성 프리온 단백의 제거율에 영향을 미칠 수 있다\n\n예를 들면\n\n감\n\n3)\n\n.\n\n ,\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n 리다\n\n.  일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n 부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n - - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n 물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n",
        "original_sentence": "일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_439",
      "text": "부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 438,
        "window_size": 3,
        "char_count": 103,
        "word_count": 25,
        "page_number": 6,
        "window_text": ",\n\n염성 프리온 단백을 계면활성제로 처리하면 분산\n\n되어 처리하지 않\n\n(dispersal)\n\n사용되는 시험법이 이상적인 방법은 아니다\n\n감염력 시험법은 비싸고 매우 느\n\n4)\n\n.\n\n 리다\n\n.  일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n 부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n - - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n 물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n 백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n",
        "original_sentence": "부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_440",
      "text": "- - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 439,
        "window_size": 3,
        "char_count": 112,
        "word_count": 27,
        "page_number": 2,
        "window_text": "리다\n\n.  일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n 부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n - - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n 물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n 백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n - -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n",
        "original_sentence": "- - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_441",
      "text": "물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 440,
        "window_size": 3,
        "char_count": 53,
        "word_count": 12,
        "page_number": 6,
        "window_text": "일반적으로\n\nPrPSc와 감염력 사이에 상관관계가 있지만\n\n이 관련성은 감\n\n,\n\n염력뿐만 아니라 PrPSc를 측정하는 방법에 따라 달라질 수 있다\n\n지금까지 대\n\n.\n\n 부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n - - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n 물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n 백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n - -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n spiking\n\n보다 쉽게 제거되었다\n\n. ",
        "original_sentence": "물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_442",
      "text": "백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 441,
        "window_size": 3,
        "char_count": 106,
        "word_count": 23,
        "page_number": 6,
        "window_text": "부분의 연구는 가장 관련성이 높을 것으로 생각되는 감염력 시험법에 의해 확\n\n물질의\n\n과 종에 의해 시험법이 결정될 수 있다\n\n지금까지 이들\n\n5) Spiking\n\nstrain\n\n.\n\n - - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n 물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n 백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n - -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n spiking\n\n보다 쉽게 제거되었다\n\n.  흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n",
        "original_sentence": "백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_443",
      "text": "- -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 442,
        "window_size": 3,
        "char_count": 97,
        "word_count": 25,
        "page_number": 8,
        "window_text": "- - 10 -\n이 제거 공정에 중요한 영향을 미친다는 증거는 없지만\n\n기록된\n\n제\n\n,\n\n(recorded)\n\n거율이\n\nspiking 물질의 기원에 의해 영향을 받을 가능성이 여전히 존재한다\n\n.\n\n 물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n 백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n - -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n spiking\n\n보다 쉽게 제거되었다\n\n.  흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n. ",
        "original_sentence": "- -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_444",
      "text": "spiking\n\n보다 쉽게 제거되었다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 443,
        "window_size": 3,
        "char_count": 24,
        "word_count": 5,
        "page_number": 5,
        "window_text": "물질의 물리화학적 특성이 중요하다\n\n만약 혈액에 감염성 프리온 단\n\n6) Spiking\n\n.\n\n 백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n - -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n spiking\n\n보다 쉽게 제거되었다\n\n.  흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n.  Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다. ",
        "original_sentence": "spiking\n\n보다 쉽게 제거되었다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_445",
      "text": "흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 444,
        "window_size": 3,
        "char_count": 77,
        "word_count": 22,
        "page_number": 6,
        "window_text": "백이 존재한다면\n\n현재까지 혈액에서의 감염성 프리온 단백의 물리화학적 형\n\n,\n\n태의\n\n징조\n\n는\n\n없다\n\n한\n\n연구결과에\n\n의하면\n\n서로\n\n다른\n\n막 함유\n\n(indication)\n\n.\n\n - -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n spiking\n\n보다 쉽게 제거되었다\n\n.  흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n.  Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다.  In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n. ",
        "original_sentence": "흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_446",
      "text": "spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 445,
        "window_size": 3,
        "char_count": 106,
        "word_count": 24,
        "page_number": 6,
        "window_text": "- -\n물질을 시험한 결과\n\n평가한 모든 침전 공정에서 매유 유사한 방법으\n\nspiking\n\n,\n\n로 제거되었다\n\n그러나 막과 관련 없는\n\n물질은 특정 침전 공정에서\n\n.\n\n spiking\n\n보다 쉽게 제거되었다\n\n.  흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n.  Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다.  In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n.  연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n",
        "original_sentence": "spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n. "
      }
    },
    {
      "chunk_id": "chunk_447",
      "text": "Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 446,
        "window_size": 3,
        "char_count": 81,
        "word_count": 20,
        "page_number": 6,
        "window_text": "spiking\n\n보다 쉽게 제거되었다\n\n.  흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n.  Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다.  In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n.  연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n 당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n",
        "original_sentence": "Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_448",
      "text": "In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 447,
        "window_size": 3,
        "char_count": 210,
        "word_count": 52,
        "page_number": 9,
        "window_text": "흡착과 같은 비 침전 공정은 반대 결과가 나타날 수\n\n- -\n있다\n\n따라서 가장 엄격한 시험을 가능하게 하는\n\n물질은 공정 단계에\n\n.\n\n spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n.  Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다.  In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n.  연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n 당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n 통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n",
        "original_sentence": "In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_449",
      "text": "연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 448,
        "window_size": 3,
        "char_count": 90,
        "word_count": 22,
        "page_number": 6,
        "window_text": "spiking\n\n동물실험 연구에서\n\n혈액에 존재하는 감염성 프리온 단백의 양이 적기 때문에\n\n7)\n\n,\n\n첨가하는\n\n물질의 농도는 가능한 한 높아야 한다\n\n물질은 고농\n\nspiking\n\n.  Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다.  In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n.  연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n 당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n 통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n 는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n. ",
        "original_sentence": "연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_450",
      "text": "당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 449,
        "window_size": 3,
        "char_count": 118,
        "word_count": 28,
        "page_number": 16,
        "window_text": "Spiking\n\n8) 바이러스 불활화 제거 공정 평가연구는 공정 파라미터 변화에 따른 효과를 보\n\n/\n\n기 위하여 완건성 평가를 포함하고 있다.  In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n.  연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n 당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n 통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n 는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n.  정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n",
        "original_sentence": "당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n"
      }
    },
    {
      "chunk_id": "chunk_451",
      "text": "통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 450,
        "window_size": 3,
        "char_count": 94,
        "word_count": 25,
        "page_number": 6,
        "window_text": "In vitro 시험법만 단독으로 하는 경\n\n우를 제외하고\n\n감염성 프리온 단백을 가지고 완건성 평가를 수행하는 것은\n\n,\n\n어려움이 따르며 이것은 이 연구가 종종 반복 수행되지 않는다는 것을 의미한\n\n따라서 감염성 프리온 단백을 제거하는 공정 단계의 능력을 보여주는 결과 값에\n\n제조공정에 유의한 변경이 생기면 감염성 프리온 단백의 제거율 자료를 재평가하\n\n여야 한다\n\n.  연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n 당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n 통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n 는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n.  정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n ℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n",
        "original_sentence": "통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_452",
      "text": "는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 451,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 5,
        "window_text": "연구를 수행하는 것이 어렵고 얻어진 결과를 계속 유지하고자 한다면\n\n,\n\n이러한 제조공정 변경은 매우 중요하다\n\n과학 분야의 발전으로 앞으로의 연구를 정\n\n.\n\n 당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n 통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n 는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n.  정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n ℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n 이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n",
        "original_sentence": "는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_453",
      "text": "정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 452,
        "window_size": 3,
        "char_count": 198,
        "word_count": 50,
        "page_number": 6,
        "window_text": "당화할 수 있는 in vitro 감염력 시험법 등이 이용 가능하게 된다면 감염성 프리온\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 장비 위생\n\n<!-- PAGE_16 -->\n###### 8.\n\n 통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n 는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n.  정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n ℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n 이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n ,\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n",
        "original_sentence": "정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_454",
      "text": "℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 453,
        "window_size": 3,
        "char_count": 52,
        "word_count": 12,
        "page_number": 5,
        "window_text": "통상적인 오염 제거 방법에 의해 감염성 프리온 단백을 불활화 하는 것은 여러\n\n연구를 통해 평가되어 왔다\n\n감염성 프리온 단백은 특히 불활화가 어렵고 어떤 시료\n\n.\n\n 는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n.  정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n ℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n 이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n ,\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n (\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n",
        "original_sentence": "℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_455",
      "text": "이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 454,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 5,
        "window_text": "는 수년 간 환경적으로 감염력을 나타내는 것으로 나타났다\n\n.  정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n ℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n 이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n ,\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n (\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n 대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n",
        "original_sentence": "이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_456",
      "text": ",\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 455,
        "window_size": 3,
        "char_count": 161,
        "word_count": 42,
        "page_number": 6,
        "window_text": "정상적인 처리 방법 예\n\n(\n\n알킬화제\n\n계면활성제 으로는 불활화 효과가 없는 반면\n\n일부 처리 방법 예\n\n:\n\n,\n\n)\n\n,\n\n(\n\n: 2%\n\n이상의\n\n표백제\n\n또는\n\n에\n\n담금\n\n일정\n\n조건의\n\n압력과\n\n시간\n\n하에서\n\n1~2\n\nN\n\nNaOH\n\n,\n\n에서 고압증기멸균 에서는 매우 유효한 것으로 나타났다\n\n일부 세척 공정\n\n134~138\n\n)\n\n.\n\n ℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n 이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n ,\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n (\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n 대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n 이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n",
        "original_sentence": ",\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_457",
      "text": "(\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 456,
        "window_size": 3,
        "char_count": 198,
        "word_count": 53,
        "page_number": 6,
        "window_text": "℃\n\n이 표준처리법으로 채택되어 의료기기나 폐기물에 적용되고 있다\n\n그러나 여러 가지\n\n.\n\n 이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n ,\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n (\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n 대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n 이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n 이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n",
        "original_sentence": "(\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_458",
      "text": "대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 457,
        "window_size": 3,
        "char_count": 50,
        "word_count": 13,
        "page_number": 5,
        "window_text": "이유로 적용에 다소 제한이 따른다\n\n즉\n\n대부분의 방법이 가혹하여 대부분의 생물의\n\n.\n\n ,\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n (\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n 대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n 이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n 이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n (steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n",
        "original_sentence": "대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_459",
      "text": "이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 458,
        "window_size": 3,
        "char_count": 55,
        "word_count": 13,
        "page_number": 6,
        "window_text": ",\n\n약품에 손상을 가져오며\n\n제조에 사용되는 설비에 부식효과를 나타내거나 다른 감염\n\n,\n\n성 물질에 대해서는 제한적인 효과 예\n\n는 포자를 죽이지는 못하는 것으로 보\n\n(\n\n: NaOH\n\n고됨 를 나타낸다\n\n여러 가지 실험실적 처리법 예\n\n알킬화제\n\n단백 분해효소 등 이\n\n)\n\n.\n\n (\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n 대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n 이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n 이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n (steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n 의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n",
        "original_sentence": "이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_460",
      "text": "이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 459,
        "window_size": 3,
        "char_count": 139,
        "word_count": 36,
        "page_number": 6,
        "window_text": "(\n\n:\n\n,\n\n)\n\n감염성 프리온 단백은 일반적인 불활화 방법에 저항성이 있고 스테인리스 스틸이\n\n나 다른 물질에 달라붙는 경향이 있기 때문에 분획 설비에 대해 감염성 프리온 단\n\n백을 불활화 또는 제거하는 능력을 보여줄 수 있도록 위생 및 세척 공정을 고려하\n\n는 것이 특히 중요하다\n\n칼럼의 위생과 재사용 역시 감염성 프리온 단백의 감염력에\n\n.\n\n 대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n 이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n 이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n (steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n 의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n 오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n",
        "original_sentence": "이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_461",
      "text": "(steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 460,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 6,
        "window_text": "대하여 이용 가능한 처리 방법의 효과를 고려하여 판단하여야 한다\n\n많은 분획 공정\n\n.\n\n 이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n 이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n (steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n 의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n 오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n 같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n. ",
        "original_sentence": "(steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_462",
      "text": "의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 461,
        "window_size": 3,
        "char_count": 102,
        "word_count": 23,
        "page_number": 6,
        "window_text": "이 심층여과 공정에서 종료되므로 이 단계에서 필터 에이드\n\n가 제거된다\n\n만약\n\n(aid)\n\n.\n\n 이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n (steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n 의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n 오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n 같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n.  0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n. ",
        "original_sentence": "의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_463",
      "text": "오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 462,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 5,
        "window_text": "이 단계가 효과적인 단계로 밝혀진다면\n\n제조 설비로부터 나온 감염성 물질에 의한\n\n,\n\n금속 표면에 흡착된 감염성 프리온 단백의 불활화 또는 제거에 대한 연구는 매우\n\n어렵다\n\n감염성 프리온 단백에 담근 강철선\n\n을 감수성이 있는 동물의 뇌\n\n.\n\n (steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n 의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n 오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n 같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n.  0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n.  이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n",
        "original_sentence": "오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_464",
      "text": "같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 463,
        "window_size": 3,
        "char_count": 52,
        "word_count": 10,
        "page_number": 6,
        "window_text": "(steel wire)\n\n에 이식하여 질병을 유발시킨 모델이 개발되어 있다\n\n강철선의 위생은 감염성 물질\n\n.\n\n 의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n 오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n 같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n.  0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n.  이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n 상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n",
        "original_sentence": "같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_465",
      "text": "0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 464,
        "window_size": 3,
        "char_count": 92,
        "word_count": 21,
        "page_number": 2,
        "window_text": "의 농도를 달리하여 강철선에 로딩\n\n하여 동물모델에서 감염력이 소실되는\n\n(loading)\n\n것을 구함으로써 모니터링 할 수 있다\n\n이와 같은 방법으로 감염성 프리온 단백으로\n\n.\n\n 오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n 같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n.  0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n.  이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n 상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n <!-- PAGE_17 -->\n###### . ",
        "original_sentence": "0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_466",
      "text": "이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 465,
        "window_size": 3,
        "char_count": 40,
        "word_count": 11,
        "page_number": 2,
        "window_text": "오염된 의료기기를 소독하는 새로운 방법이 최근에 발표되었다\n\n설비에 대한 이와\n\n.\n\n 같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n.  0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n.  이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n 상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n <!-- PAGE_17 -->\n###### .  결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n",
        "original_sentence": "이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_467",
      "text": "상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 466,
        "window_size": 3,
        "char_count": 98,
        "word_count": 26,
        "page_number": 3,
        "window_text": "같은 연구결과를 제조공정 수준으로 외삽\n\n(extrapolation) 하는 것은 어렵다\n\n.  0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n.  이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n 상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n <!-- PAGE_17 -->\n###### .  결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n - -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n",
        "original_sentence": "상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n"
      }
    },
    {
      "chunk_id": "chunk_468",
      "text": "<!-- PAGE_17 -->\n###### . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 467,
        "window_size": 3,
        "char_count": 26,
        "word_count": 5,
        "page_number": 17,
        "window_text": "0.1 M\n\nNaOH를 처리하면 용액에 존재하거나 금속 표면에 흡착되어 있는\n\nPrPSc를 단백 분\n\n해효소에 반응성이 있는 형태로 전환시키는 것으로 나타났다\n\n.  이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n 상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n <!-- PAGE_17 -->\n###### .  결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n - -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n 경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n",
        "original_sentence": "<!-- PAGE_17 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_469",
      "text": "결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 468,
        "window_size": 3,
        "char_count": 114,
        "word_count": 25,
        "page_number": 17,
        "window_text": "이 연구결과는 감염력\n\n- - 12 -\n연구를 통해 확인이 필요하다.\n\n 상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n <!-- PAGE_17 -->\n###### .  결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n - -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n 경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n 물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n. ",
        "original_sentence": "결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_470",
      "text": "- -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 469,
        "window_size": 3,
        "char_count": 171,
        "word_count": 26,
        "page_number": 8,
        "window_text": "상기의 사항들을 고려하여 볼 때\n\n혈장 처리 공정 설비에 대한 새로운 과학적인\n\n,\n\n정보가 입수되기 전까지는 이 시점에서 어떠한 특별한 권고사항도 제시할 수는 없\n\n- 다.\n <!-- PAGE_17 -->\n###### .  결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n - -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n 경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n 물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n.  Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n",
        "original_sentence": "- -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_471",
      "text": "경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 470,
        "window_size": 3,
        "char_count": 60,
        "word_count": 12,
        "page_number": 6,
        "window_text": "<!-- PAGE_17 -->\n###### .  결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n - -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n 경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n 물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n.  Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n 모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n",
        "original_sentence": "경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_472",
      "text": "물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 471,
        "window_size": 3,
        "char_count": 105,
        "word_count": 25,
        "page_number": 5,
        "window_text": "결론\n\n<!-- PAGE_17 -->\n###### Ⅲ\n\n모든 제조사는 발표된 자료를 고려하여 그들의 제조공정을 비판적으로 평가하여야\n\n한다\n\n제품 특이적인 조사연구에 대한 단계적 접근 방법은\n\n의\n\n.\n\n - -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n 경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n 물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n.  Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n 모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n 조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n",
        "original_sentence": "물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n. "
      }
    },
    {
      "chunk_id": "chunk_473",
      "text": "Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 472,
        "window_size": 3,
        "char_count": 39,
        "word_count": 7,
        "page_number": 5,
        "window_text": "- -\nEMEA\n\n“Creutzfeldt-\n\nJakob Disease and Plasma-Derived and Urine-Derived Medicinal Products(CPMP/\n\n의\n\n항을 참조한다\n\n감염성 프리온 단백 제거 연구의\n\nBWP/2879/02/rev 1, 2004)”\n\n- 9.2.3\n.\n\n 경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n 물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n.  Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n 모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n 조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n - - 13 -\n<!-- PAGE_18 -->\n###### . ",
        "original_sentence": "Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_474",
      "text": "모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 473,
        "window_size": 3,
        "char_count": 105,
        "word_count": 23,
        "page_number": 6,
        "window_text": "경우\n\n감염성\n\n프리온\n\n단백\n\n결정은\n\n실질적인\n\n이유에\n\n근거하여\n\n내려야\n\n한다\n\nstrain\n\n.\n\n 물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n.  Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n 모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n 조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n - - 13 -\n<!-- PAGE_18 -->\n###### .  참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1. ",
        "original_sentence": "모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_475",
      "text": "조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 474,
        "window_size": 3,
        "char_count": 61,
        "word_count": 17,
        "page_number": 9,
        "window_text": "물질은 조사연구 대상 공정 단계에 가장 큰 영향\n\n을 주여야 하며\n\nSpiking\n\n(challenge)\n\n,\n\n최악의 조건을 평가할 수 있도록 선택되어야 한다\n\n및\n\n물질의 선택에\n\n.  Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n 모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n 조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n - - 13 -\n<!-- PAGE_18 -->\n###### .  참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1.  혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2. ",
        "original_sentence": "조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_476",
      "text": "- - 13 -\n<!-- PAGE_18 -->\n###### . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 475,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 18,
        "window_text": "Strain\n\nspiking\n\n대한 이론적 근거를 제시하여야 한다.\n\n 모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n 조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n - - 13 -\n<!-- PAGE_18 -->\n###### .  참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1.  혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3. ",
        "original_sentence": "- - 13 -\n<!-- PAGE_18 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_477",
      "text": "참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 476,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 18,
        "window_text": "모델 특성 및 실행 가능한 실험실적 연구결과에 따른 근사치\n\n때문\n\n(approximation)\n\n에 자료의 해석에는 한계가 있다\n\n그러나 이러한 조사연구를 통해 혈장분획제제의 제\n\n.\n\n 조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n - - 13 -\n<!-- PAGE_18 -->\n###### .  참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1.  혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3.  CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4. ",
        "original_sentence": "참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_478",
      "text": "혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 477,
        "window_size": 3,
        "char_count": 98,
        "word_count": 15,
        "page_number": 2,
        "window_text": "조공정 중 감염성 프리온 단백 제거 능력에 대하여 유용한 정보를 제공하여 줄 수 있\n\n을 것으로 기대된다.\n\n - - 13 -\n<!-- PAGE_18 -->\n###### .  참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1.  혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3.  CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4.  WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5. ",
        "original_sentence": "혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_479",
      "text": "Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 478,
        "window_size": 3,
        "char_count": 159,
        "word_count": 23,
        "page_number": 7,
        "window_text": "- - 13 -\n<!-- PAGE_18 -->\n###### .  참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1.  혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3.  CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4.  WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6. ",
        "original_sentence": "Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_480",
      "text": "CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 479,
        "window_size": 3,
        "char_count": 151,
        "word_count": 16,
        "page_number": 8,
        "window_text": "참고문헌\n\n<!-- PAGE_18 -->\n###### Ⅳ\n\n- 1.  혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3.  CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4.  WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7. ",
        "original_sentence": "CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_481",
      "text": "WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 480,
        "window_size": 3,
        "char_count": 81,
        "word_count": 11,
        "page_number": 8,
        "window_text": "혈장분획제제\n등\n\n바이러스\n\n검증\n\n평가가이드 식품의약품안전청\n\n행정간행물\n\n(\n\n11-\n\n1470000-001176-01, 생물의약품평가가이드\n\n20), 2006\n\n- 2.  Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3.  CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4.  WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8. ",
        "original_sentence": "WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5. "
      }
    },
    {
      "chunk_id": "chunk_482",
      "text": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 481,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 5,
        "window_text": "Note for Guidance on Virus Validation Studies: The Design, Contribution and\nInterpretation of Studies Validating the Inactivation and Removal of Viruses\n\n- 3.  CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4.  WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8.  혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9. ",
        "original_sentence": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6. "
      }
    },
    {
      "chunk_id": "chunk_483",
      "text": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 482,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 5,
        "window_text": "CHMP Position Statement on Creutzfeldt-Jakob Disease and Plasma-Derived\nand\n\nUrine-Derived\n\nMedicinal\n\nProducts(CPMP/BWP/2879/02/rev\n\n1),\n\nEMEA,\n\n- 4.  WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8.  혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9.  혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10. ",
        "original_sentence": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7. "
      }
    },
    {
      "chunk_id": "chunk_484",
      "text": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 483,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 5,
        "window_text": "WHO Guidelines on Tissue Infectivity in Transmissible Spongiform Encephalo-\n- 5.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8.  혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9.  혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10.  Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### . ",
        "original_sentence": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8. "
      }
    },
    {
      "chunk_id": "chunk_485",
      "text": "혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 484,
        "window_size": 3,
        "char_count": 52,
        "word_count": 14,
        "page_number": 6,
        "window_text": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 6.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8.  혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9.  혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10.  Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### .  서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n",
        "original_sentence": "혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9. "
      }
    },
    {
      "chunk_id": "chunk_486",
      "text": "혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 485,
        "window_size": 3,
        "char_count": 50,
        "word_count": 14,
        "page_number": 2,
        "window_text": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 7.  혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8.  혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9.  혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10.  Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### .  서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n 직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n. ",
        "original_sentence": "혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10. "
      }
    },
    {
      "chunk_id": "chunk_487",
      "text": "Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 486,
        "window_size": 3,
        "char_count": 162,
        "word_count": 32,
        "page_number": 19,
        "window_text": "혈액제제 생산 공정 중 감염성 프리온 단백에 대한 안정성 인증시험 기반기술의\n- 8.  혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9.  혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10.  Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### .  서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n 직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n.  포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n",
        "original_sentence": "Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_488",
      "text": "서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 487,
        "window_size": 3,
        "char_count": 259,
        "word_count": 52,
        "page_number": 19,
        "window_text": "혈액제제 제조공정 중 감염성 프리온 단백질 검출법 개발 및 검증\n식품의약품안\n\n,\n\n- 9.  혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10.  Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### .  서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n 직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n.  포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n <!-- PAGE_19 -->\n###### . ",
        "original_sentence": "서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_489",
      "text": "직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 488,
        "window_size": 3,
        "char_count": 70,
        "word_count": 18,
        "page_number": 6,
        "window_text": "혈액제제 제조공정 중 감염성 프리온 단백 제거 검증에 관한 가이드라인 기반 연\n- 10.  Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### .  서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n 직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n.  포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n <!-- PAGE_19 -->\n###### .  실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n. ",
        "original_sentence": "직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_490",
      "text": "포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 489,
        "window_size": 3,
        "char_count": 100,
        "word_count": 23,
        "page_number": 6,
        "window_text": "Laboratory Biosafety Manual 3rd Ed, WHO, 2004\n- - 14 -\n<!-- PAGE_19 -->\n###### <부록\n\n<!-- PAGE_19 -->\n###### >\n\n감염성 프리온 단백 제거 조사연구 시험방법\n\n<!-- PAGE_19 -->\n###### .  서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n 직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n.  포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n <!-- PAGE_19 -->\n###### .  실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n.  즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n",
        "original_sentence": "포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_491",
      "text": "<!-- PAGE_19 -->\n###### . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 490,
        "window_size": 3,
        "char_count": 26,
        "word_count": 5,
        "page_number": 19,
        "window_text": "서론\n\n<!-- PAGE_19 -->\n###### Ⅰ\n\n전염성 해면상 뇌증\n\n의 경우 자연\n\n(transmissible spongiform encephalopathy, TSE)\n\n적인 질병 발생에 있어서 공기 전염\n\n이 되지 않는 것으로 알려져\n\n(aerosol transmission)\n\n있지만 감염성 프리온 단백에 감염된 실험동물을 부검할 때나 감염된 조직이나 용액을\n\n다룰 때에는 에어로졸이나 작은 물방울이 생기지 않도록 주의하여야 한다\n\n감염된 조\n\n.\n\n 직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n.  포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n <!-- PAGE_19 -->\n###### .  실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n.  즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n - - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n",
        "original_sentence": "<!-- PAGE_19 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_492",
      "text": "실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 491,
        "window_size": 3,
        "char_count": 256,
        "word_count": 57,
        "page_number": 19,
        "window_text": "직이나 용액과 접촉할 가능성이 있는 피부 보호를 위해서는 반드시 액체 투과성이 없\n\n는 실험복이나 장갑을 착용해야 한다\n\n.  포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n <!-- PAGE_19 -->\n###### .  실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n.  즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n - - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n 병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n",
        "original_sentence": "실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_493",
      "text": "즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 492,
        "window_size": 3,
        "char_count": 180,
        "word_count": 47,
        "page_number": 6,
        "window_text": "포름알데히드로 고정한 조직 및 파라핀 포매한\n\n- -\n(paraffin-embedded) 조직 특히 뇌 조직 은 감염력을 가지고 있으므로 각별히 주의하\n\n(\n\n)\n\n여야 한다.\n\n <!-- PAGE_19 -->\n###### .  실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n.  즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n - - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n 병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n 전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n",
        "original_sentence": "즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_494",
      "text": "- - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 493,
        "window_size": 3,
        "char_count": 117,
        "word_count": 31,
        "page_number": 2,
        "window_text": "<!-- PAGE_19 -->\n###### .  실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n.  즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n - - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n 병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n 전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n 모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n",
        "original_sentence": "- - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_495",
      "text": "병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 494,
        "window_size": 3,
        "char_count": 98,
        "word_count": 25,
        "page_number": 6,
        "window_text": "실험실 생물안전등급\n\n<!-- PAGE_19 -->\n###### (biosafety level)\n\n<!-- PAGE_19 -->\n###### Ⅱ\n\n생물안전등급\n\n이란 어떤 미생물을 대상으로 실험할 때 미생물\n\n(biosafety level, BSL)\n\n의 감염 정도와 그 위험도에 따라 실험자 및 환경을 보호하기 위해 갖추어야 할 실험\n\n실\n\n장비 및 실험자에 대한 조건을 설정한 것으로서\n\n에서\n\n까지 분류되고 있\n\n,\n\n, level 1\n\n4\n\n다\n\n.  즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n - - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n 병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n 전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n 모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n ,\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n",
        "original_sentence": "병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_496",
      "text": "전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 495,
        "window_size": 3,
        "char_count": 82,
        "word_count": 16,
        "page_number": 6,
        "window_text": "즉\n\n,\n\nBSL-3 : 병을 일으키는 것으로 밝혀졌으며 특히 에어로졸로 전염될 수 있는 미\n\n- ③\n고위험 병원체 검사 이동 및 폐기 등에 관한 안전관리 규정 보건복지부고시 제\n\n(\n\n2006\n\n․\n\n호\n\n에 따르면 감염성 프리온 단백은\n\n에서만 취급할 수 있다\n\n- -95\n, 2006.11.28)\n\nBSL-3\n\n.\n\n - - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n 병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n 전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n 모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n ,\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n 실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n",
        "original_sentence": "전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_497",
      "text": "모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 496,
        "window_size": 3,
        "char_count": 252,
        "word_count": 59,
        "page_number": 2,
        "window_text": "- - 15 -\n는 흡입에 의한 노출로 심각하거나 잠재적으로 치명적인 병을 일으킬 수 있는\n\nBSL-3\n\n위험한 작업이 수행되는 임상\n\n진단\n\n연구 또는 생산 시설에 적용된다\n\n모든 실험자는\n\n,\n\n,\n\n.\n\n 병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n 전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n 모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n ,\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n 실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n 감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n",
        "original_sentence": "모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_498",
      "text": ",\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 497,
        "window_size": 3,
        "char_count": 91,
        "word_count": 22,
        "page_number": 6,
        "window_text": "병원체 및 잠재적으로 치명적인 물질을 다루기 위하여 특정 훈련을 받아야 하며 경험\n\n자나 전문가에 의해 관리되어야 한다\n\n또한 감염성 물질을 다루는 모든 절차는 생물안\n\n.\n\n 전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n 모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n ,\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n 실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n 감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n 로 실험실이나 동물실험실 출입을 금지한다\n\n. ",
        "original_sentence": ",\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_499",
      "text": "실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 498,
        "window_size": 3,
        "char_count": 49,
        "word_count": 11,
        "page_number": 5,
        "window_text": "전작업대\n\n또는 다른 보호시설 안에서 수행되어야 하고 적절\n\n(biosafety cabinet, BSC)\n\n한 개인보호 장비를 착용하여야 한다.\n\n 모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n ,\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n 실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n 감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n 로 실험실이나 동물실험실 출입을 금지한다\n\n.  실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n",
        "original_sentence": "실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_500",
      "text": "감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 499,
        "window_size": 3,
        "char_count": 92,
        "word_count": 22,
        "page_number": 2,
        "window_text": "모든 실험자는 생체를 취급한 후에는\n\n회용 장갑을 벗은 후와 실험실을 나가\n\n2)\n\n1\n\n실험실에서는 음식물을 먹거나 음료를 마시거나 담배를 피우거나 렌즈를 다루\n\n3)\n\n입을 이용해 시약을 빨아들이는 것\n\n을 금지하고 마이크로 피펫과 같\n\n4)\n\n(pipetting)\n\n모든 실험 절차는 튀지 않도록 하며 에어로졸의 발생을 최소화 하도록 주의한\n\n6)\n\n의 감염성 폐기물은 반드시 멸균하여 폐기한다\n\n모든 배양액\n\n저장용기\n\n8) BSL-3\n\n.\n\n ,\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n 실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n 감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n 로 실험실이나 동물실험실 출입을 금지한다\n\n.  실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n 실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n",
        "original_sentence": "감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_501",
      "text": "로 실험실이나 동물실험실 출입을 금지한다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 500,
        "window_size": 3,
        "char_count": 26,
        "word_count": 6,
        "page_number": 5,
        "window_text": ",\n\n또는 규정 폐기물은 고압증기멸균법과 같은 허용된 오염 제거 시스템으로 멸\n\n균한 후 폐기한다\n\n멸균된 폐기물은 이중 누출방지 용기에 보관하고 밀폐되어\n\n.\n\n 실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n 감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n 로 실험실이나 동물실험실 출입을 금지한다\n\n.  실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n 실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n 생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n",
        "original_sentence": "로 실험실이나 동물실험실 출입을 금지한다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_502",
      "text": "실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 501,
        "window_size": 3,
        "char_count": 61,
        "word_count": 17,
        "page_number": 2,
        "window_text": "실험실 출입구에 감염성 물질을 표지하여 알린다\n\n사용하는 물질명과 연구자\n\n9)\n\n.\n\n 감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n 로 실험실이나 동물실험실 출입을 금지한다\n\n.  실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n 실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n 생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n ,\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n",
        "original_sentence": "실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_503",
      "text": "실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 502,
        "window_size": 3,
        "char_count": 85,
        "word_count": 20,
        "page_number": 2,
        "window_text": "감염성 물질을 다룰 때 실험실 출입은 전문가나 감독자에 의해 제한되거나 통\n\n1)\n\n제되어야 한다\n\n면역력이 억제되거나 약한 사람은 감염의 위험성이 증가하므\n\n.\n\n 로 실험실이나 동물실험실 출입을 금지한다\n\n.  실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n 실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n 생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n ,\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n .\n\n",
        "original_sentence": "실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_504",
      "text": "생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 503,
        "window_size": 3,
        "char_count": 56,
        "word_count": 11,
        "page_number": 6,
        "window_text": "로 실험실이나 동물실험실 출입을 금지한다\n\n.  실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n 실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n 생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n ,\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n .\n\n 감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n",
        "original_sentence": "생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_505",
      "text": ",\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 504,
        "window_size": 3,
        "char_count": 261,
        "word_count": 61,
        "page_number": 3,
        "window_text": "실험실 감독자는 주위환경 평가\n\n- - 16 -\n와 각 실험실의 출입 허가를 결정하는 최종 책임을 갖는다.\n\n 실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n 생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n ,\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n .\n\n 감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n 실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n",
        "original_sentence": ",\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_506",
      "text": ".\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 505,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "실험실 감독자는 잠재적인 위험성을 논의하고 특별 출입이 필요한 경우 요구\n\n2)\n\n사항에 만족하는 사람만이 실험실에 출입할 수 있도록 절차를 세운다.\n\n 생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n ,\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n .\n\n 감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n 실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n 자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n. ",
        "original_sentence": ".\n\n"
      }
    },
    {
      "chunk_id": "chunk_507",
      "text": "감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 506,
        "window_size": 3,
        "char_count": 250,
        "word_count": 63,
        "page_number": 6,
        "window_text": "생물재해\n\n표지는 실험실 출입구에 붙여 놓는다\n\n사용하는 물질\n\n3)\n\n(biohazard)\n\n.\n\n ,\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n .\n\n 감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n 실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n 자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n.  1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n",
        "original_sentence": "감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_508",
      "text": "실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 507,
        "window_size": 3,
        "char_count": 46,
        "word_count": 11,
        "page_number": 5,
        "window_text": ",\n\n요구되는 면역사항\n\n감독자 이름\n\n전화번호\n\n실험실에서 착용해야 될 개\n\nBSL,\n\n,\n\n,\n\n,\n\n실험자는 다룰 예정이거나 실험 시 잠재적으로 감염 위험성이 있는 병원체에\n\n4)\n\n다루는 병원체를 고려하여 적절한 시기에 혈청 시료나 위험물질을 수집하여\n\n5)\n\n주사기\n\n주사침\n\n주사바늘\n\n슬라이드\n\n피펫\n\n외과용 메스 등 날카로운 도구들의\n\n6)\n\n,\n\n,\n\n,\n\n,\n\n,\n\n사용에 각별히 주의한다\n\n가능하다면 플라스틱 제품으로 대체한다\n\n전용 폐기\n\n.\n\n .\n\n 감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n 실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n 자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n.  1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n 실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n",
        "original_sentence": "실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_509",
      "text": "자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 508,
        "window_size": 3,
        "char_count": 49,
        "word_count": 14,
        "page_number": 5,
        "window_text": ".\n\n 감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n 실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n 자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n.  1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n 실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n 6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n",
        "original_sentence": "자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n. "
      }
    },
    {
      "chunk_id": "chunk_510",
      "text": "1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 509,
        "window_size": 3,
        "char_count": 78,
        "word_count": 21,
        "page_number": 2,
        "window_text": "감염성 물질을 다루는 모든 조작은\n\n나 다른 보호시설이 갖추어진 장소에\n\n7)\n\nBSC\n\n실험장비와 작업대의 표면은 감염성 물질을 다루는 작업 종료 시 또는 누출되\n\n8)\n\n조직\n\n표본 또는 잠재적 감염성 폐기물은 수집\n\n취급\n\n저장 및 운반하는 동안\n\n9)\n\n,\n\n,\n\n,\n\n감염성 물질에 노출되는 사고가 발생한 경우 감독자는 의료 평가를 실시하\n\n10)\n\n실험자는 실험실에 있을 때는 항상 실험복을 착용하여야 한다\n\n보호 의류는\n\n1)\n\n.\n\n 실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n 자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n.  1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n 실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n 6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n 실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n. ",
        "original_sentence": "1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n"
      }
    },
    {
      "chunk_id": "chunk_511",
      "text": "실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 510,
        "window_size": 3,
        "char_count": 62,
        "word_count": 14,
        "page_number": 5,
        "window_text": "실험실 이외의 장소에서는 입지 않는다\n\n재활용 실험복은 재사용 전에 소독하\n\n.\n\n 자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n.  1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n 실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n 6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n 실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n.  2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n",
        "original_sentence": "실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_512",
      "text": "6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 511,
        "window_size": 3,
        "char_count": 43,
        "word_count": 11,
        "page_number": 5,
        "window_text": "자주 손을 씻고 장갑은 자주 교체하는 것이 좋다\n\n회용 장갑은 세척하여 재\n\n3)\n\n.  1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n 실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n 6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n 실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n.  2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n 각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n",
        "original_sentence": "6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_513",
      "text": "실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 512,
        "window_size": 3,
        "char_count": 91,
        "word_count": 23,
        "page_number": 2,
        "window_text": "1\n\n- - 17 -\n감염성 물질의 모든 조작은\n\n또는\n\n에 해당하는\n\n안에서 수행한\n\n4)\n\nClass II\n\nIII\n\nBSC\n\n- 다.\n 실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n 6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n 실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n.  2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n 각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n 위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n",
        "original_sentence": "실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n. "
      }
    },
    {
      "chunk_id": "chunk_514",
      "text": "2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 513,
        "window_size": 3,
        "char_count": 50,
        "word_count": 15,
        "page_number": 2,
        "window_text": "실험 절차나 진행이 일반 작업대에서 진행되는 경우에는 개인보호 장비를 적\n\n5)\n\n절하게 조합하여 사용한다.\n\n 6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n 실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n.  2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n 각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n 위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n .\n\n",
        "original_sentence": "2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_515",
      "text": "각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 514,
        "window_size": 3,
        "char_count": 49,
        "word_count": 12,
        "page_number": 2,
        "window_text": "6) 호흡 장비와 안면보호 장비는 감염된 동물이 있는 방에서 사용한다\n\n.\n\n 실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n.  2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n 각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n 위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n .\n\n 한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n",
        "original_sentence": "각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_516",
      "text": "위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 515,
        "window_size": 3,
        "char_count": 102,
        "word_count": 26,
        "page_number": 6,
        "window_text": "실험실은 건물의 통제되지 않는 혼잡 지역에서 벗어나 있어야 하며 실험실 출\n\n1)\n\n입이 제한되어야 한다\n\n개의 자동문으로 된 좁은 통로가 출입구에 필수적이\n\n.  2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n 각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n 위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n .\n\n 한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n 실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n. ",
        "original_sentence": "위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_517",
      "text": ".\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 516,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "2\n\n며 문이 잠겨야 한다\n\n그 통로에 실험복을 갈아 있을 수 있는 방이 마련되어\n\n.\n\n 각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n 위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n .\n\n 한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n 실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n.  의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n",
        "original_sentence": ".\n\n"
      }
    },
    {
      "chunk_id": "chunk_518",
      "text": "한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 517,
        "window_size": 3,
        "char_count": 99,
        "word_count": 23,
        "page_number": 6,
        "window_text": "각 실험실은 손 씻는 싱크대가 있어야 한다\n\n싱크대는 자동으로 작동되어야\n\n2)\n\n.\n\n 위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n .\n\n 한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n 실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n.  의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n 적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n",
        "original_sentence": "한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_519",
      "text": "실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 518,
        "window_size": 3,
        "char_count": 124,
        "word_count": 32,
        "page_number": 6,
        "window_text": "위험 인자를 다루는 지역의 벽\n\n바닥\n\n천정의 내부 표면은 쉽게 세척\n\n3) BSL-3\n\n,\n\n,\n\n또는 소독이 가능하도록 설계되어야 한다\n\n갈라진 틈은 봉합되어야 한다\n\n또\n\n.\n\n .\n\n 한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n 실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n.  의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n 적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n “\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n",
        "original_sentence": "실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_520",
      "text": "의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 519,
        "window_size": 3,
        "char_count": 121,
        "word_count": 33,
        "page_number": 6,
        "window_text": ".\n\n 한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n 실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n.  의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n 적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n “\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n .\n\n",
        "original_sentence": "의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_521",
      "text": "적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 520,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 5,
        "window_text": "한 벽\n\n천장\n\n바닥은 실험실에서 사용되는 소독제와 시약에 견딜 수 있어야\n\n,\n\n,\n\n하고\n\n액체가\n\n침투하지\n\n않는\n\n부드러운\n\n재질이어야\n\n한다\n\n바닥은\n\n모놀리식\n\n.\n\n 실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n.  의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n 적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n “\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n .\n\n 공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n",
        "original_sentence": "적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_522",
      "text": "“\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 521,
        "window_size": 3,
        "char_count": 111,
        "word_count": 29,
        "page_number": 6,
        "window_text": "실험대는 방수 방열되고 유기용매\n\n산\n\n알칼리 및 작업대와 장비를 소독하기\n\n4)\n\n,\n\n,\n\n․\n\n실험실 가구는 충분히 튼튼해야 하며 각 가구 사이의 공간을 충분하게 확보하\n\n5)\n\n여 세척이나 소독이 쉬워야 한다\n\n.  의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n 적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n “\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n .\n\n 공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n 터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n",
        "original_sentence": "“\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_523",
      "text": ".\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 522,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": "의자와 다른 가구는 쉽게 소독 가능한 비\n\n- -\n모든 실험실 폐기물을 소독이나 멸균하는 장비는 그 시설에 비치되어 있어야\n\n7)\n\n하며 실험실 내에 갖추어져 있는 것이 좋다\n\n만일 실험실 외부로 옮겨야 하면\n\n.\n\n 적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n “\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n .\n\n 공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n 터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n .\n\n",
        "original_sentence": ".\n\n"
      }
    },
    {
      "chunk_id": "chunk_524",
      "text": "공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 523,
        "window_size": 3,
        "char_count": 93,
        "word_count": 25,
        "page_number": 6,
        "window_text": "적절한 환기 시스템이 요구된다\n\n환기 시스템은 방향성 기류를 만들어\n\n깨끗\n\n9)\n\n.\n\n “\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n .\n\n 공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n 터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n .\n\n 출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n. ",
        "original_sentence": "공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_525",
      "text": "터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 524,
        "window_size": 3,
        "char_count": 109,
        "word_count": 21,
        "page_number": 6,
        "window_text": "“\n\n한\n\n지역의 공기를 실험실로 들이고\n\n오염된\n\n지역으로 배출하는 시스템이\n\n”\n\n, “\n\n”\n\n- - 18 -\n요구된다\n\n배출 공기는 건물의 어떤 지역으로 재순환되지 않아야 한다\n\n배출\n\n.\n\n .\n\n 공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n 터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n .\n\n 출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n.  HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n",
        "original_sentence": "터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_526",
      "text": ".\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 525,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 5,
        "window_text": ".\n\n 공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n 터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n .\n\n 출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n.  HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n 눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n",
        "original_sentence": ".\n\n"
      }
    },
    {
      "chunk_id": "chunk_527",
      "text": "출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 526,
        "window_size": 3,
        "char_count": 61,
        "word_count": 16,
        "page_number": 6,
        "window_text": "공기에는 필터나 다른 처리가 요구되지 않을 수도 있으나\n\n특정 물질이나 사\n\n,\n\n용 조건에 따라 요구될 수 있다\n\n외부로의 배출은 그 지역과 공기 흡입구로부\n\n.\n\n 터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n .\n\n 출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n.  HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n 눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n - - 19 -\n<!-- PAGE_24 -->\n###### . ",
        "original_sentence": "출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n. "
      }
    },
    {
      "chunk_id": "chunk_528",
      "text": "HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 527,
        "window_size": 3,
        "char_count": 146,
        "word_count": 26,
        "page_number": 6,
        "window_text": "터 떨어져 분산되거나\n\n필터를 사용하여\n\nHEPA(high efficiency particulate air)\n\n야 한다\n\n실험자는 공기 흐름의 방향이 적절한지 잘 판단하여야 한다\n\n실험실\n\n.\n\n .\n\n 출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n.  HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n 눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n - - 19 -\n<!-- PAGE_24 -->\n###### .  감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n",
        "original_sentence": "HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_529",
      "text": "눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 528,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 2,
        "window_text": ".\n\n 출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n.  HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n 눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n - - 19 -\n<!-- PAGE_24 -->\n###### .  감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n <!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n",
        "original_sentence": "눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_530",
      "text": "- - 19 -\n<!-- PAGE_24 -->\n###### . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 529,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 24,
        "window_text": "출입구에 공기의 흐름을 확인하거나 알 수 있는 모니터를 설치하는 것이 좋\n\n다\n\n제어 시스템은 실험실의\n\n.  HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n 눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n - - 19 -\n<!-- PAGE_24 -->\n###### .  감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n <!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n ,\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n",
        "original_sentence": "- - 19 -\n<!-- PAGE_24 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_531",
      "text": "감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 530,
        "window_size": 3,
        "char_count": 157,
        "word_count": 32,
        "page_number": 24,
        "window_text": "HVAC(heating, ventilation and air conditioning)\n\n에어로졸이 발생될 수 있는 연속 회전 원심분리기나 기기가 있는 실험실의\n\n10)\n\n공기는\n\n필터를\n\n통하여\n\n방출하는\n\n장치가\n\n포함되어야\n\n한다\n\n이러한\n\nHEPA\n\n.\n\n 눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n - - 19 -\n<!-- PAGE_24 -->\n###### .  감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n <!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n ,\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n , 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n",
        "original_sentence": "감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_532",
      "text": "<!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 531,
        "window_size": 3,
        "char_count": 290,
        "word_count": 69,
        "page_number": 24,
        "window_text": "눈 세척 전용시설이 실험실에 갖추어져야 한다\n\n모든 활동에 적절한 조명이\n\n12)\n\n.\n\n - - 19 -\n<!-- PAGE_24 -->\n###### .  감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n <!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n ,\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n , 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n (sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n",
        "original_sentence": "<!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_533",
      "text": ",\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 532,
        "window_size": 3,
        "char_count": 98,
        "word_count": 24,
        "page_number": 6,
        "window_text": "- - 19 -\n<!-- PAGE_24 -->\n###### .  감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n <!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n ,\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n , 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n (sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n 7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n",
        "original_sentence": ",\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_534",
      "text": ", 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 533,
        "window_size": 3,
        "char_count": 330,
        "word_count": 71,
        "page_number": 2,
        "window_text": "감염성 프리온 단백 제거 조사연구를 위한 시험방법\n\n<!-- PAGE_24 -->\n###### Ⅲ\n\n<!-- PAGE_24 -->\n###### 공정 단계에\n\n<!-- PAGE_24 -->\n###### 할 감염성 프리온 단백 선택\n\n<!-- PAGE_24 -->\n###### 1.\n\n <!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n ,\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n , 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n (sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n 7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n",
        "original_sentence": ", 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_535",
      "text": "(sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 534,
        "window_size": 3,
        "char_count": 301,
        "word_count": 57,
        "page_number": 6,
        "window_text": "<!-- PAGE_24 -->\n###### spiking\n\n혈장분획제제 제조공정 중 감염성 프리온 단백 제거 조사연구를 위해 사용할 감\n\n염성 프리온 단백\n\n은 잠복기가 가장 짧은 햄스터 계대배양용\n\n를 추천한\n\nstrain\n\n263K\n\n감염성 프리온 단백 감염에 사용할 실험동물은 사용될 감염성 프리온 단백 strain\n\n에 적합한 실험동물 표\n\n을 구입하여 동물실험실에서 약\n\n주정도 안정화 시킨 후\n\n(\n\n1)\n\n2\n\n주된 실험동물을 사용한다\n\n그러나 실험 공간\n\n시간 및 비용 절감을 위해 형질\n\n6~7\n\n.\n\n ,\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n , 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n (sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n 7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n 조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n",
        "original_sentence": "(sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_536",
      "text": "7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 535,
        "window_size": 3,
        "char_count": 159,
        "word_count": 37,
        "page_number": 6,
        "window_text": ",\n\n전환 마우스를 사용한다면 감염성 프리온 단백\n\n과 같은 종의 프리온 단백을\n\nstrain\n\n과발현 하는 마우스를 사용하여야 한다\n\n예를 들면\n\n을 사용하고자 한다\n\n.\n\n , 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n (sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n 7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n 조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n 지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n",
        "original_sentence": "7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_537",
      "text": "homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 536,
        "window_size": 3,
        "char_count": 126,
        "word_count": 29,
        "page_number": 6,
        "window_text": ", 263K strain\n\n면 감염동물로서 햄스터 프리온 단백을 과발현 하는 형질전환 마우스(Tg-HaPrP\n\n감염성 프리온 단백에 감염된 햄스터를\n\n일을 전후하여 임상증상이 나타나면\n\n70\n\n뇌를 적출하여 뇌의 반쪽은\n\n중성 포르말린에 고정한 후 병리소견 상 신경세포\n\n10%\n\n소실에 의한 해면상 뇌증이 나타난 것을 확인한 후\n\n, 나머지 반쪽을 멸균된\n\nDounce\n\n- - 20 -\nhomogenizer를 이용하여 멸균된 인산염 완충액\n\n(phosphate buffered saline, PBS)\n\n으로\n\n균질액을 만든다\n\n감염성 프리온 단백 감염군은 동물을 전신마취\n\n1%\n\n.\n\n (sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n 7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n 조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n 지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n 감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n",
        "original_sentence": "homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_538",
      "text": "조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 537,
        "window_size": 3,
        "char_count": 63,
        "word_count": 13,
        "page_number": 6,
        "window_text": "(sodium\n\n한\n\n후\n\n를\n\n이용한\n\n미세주입\n\npentobarbital,\n\n50\n\nmg/kg)\n\nstereotaxic\n\napparatus\n\n방법으로 위에서 만든\n\n균질액을\n\n씩 각각 대뇌피질 내\n\n(microinjection)\n\n1%\n\n50\n\nL\n\nμ\n\n로 주사하여 감염시키고\n\n대조군은 같은 방법으로 정상 햄스터\n\n(intracerebral route)\n\n,\n\n대조군과 감염군의 일부는\n\n파라포름알데히드를 심장을 통해 관류\n\n고정시\n\n4%\n\n,\n\n킨 후 탈수과정을 거쳐 파라핀에 포매한다\n\n조직 절편기로\n\n두께로 뇌 절편을\n\n.\n\n 7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n 조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n 지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n 감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n",
        "original_sentence": "조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_539",
      "text": "지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 538,
        "window_size": 3,
        "char_count": 181,
        "word_count": 42,
        "page_number": 6,
        "window_text": "7\n\nm\n\nμ\n\n제작한 후\n\n염색법 및\n\n항체를 이용하여 조직면역화학염색\n\nhematoxylin-eosin\n\nPrP\n\n감염성 프리온 단백 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타난 햄\n\n70\n\nTSE\n\n스터의 뇌를 적출한다\n\n적출한 뇌 조직은 조직\n\n를 이용하여 멸균된\n\n.\n\n homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n 조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n 지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n 감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n 4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n",
        "original_sentence": "지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_540",
      "text": "감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 539,
        "window_size": 3,
        "char_count": 101,
        "word_count": 25,
        "page_number": 6,
        "window_text": "homogenizer\n\n감염성 프리온 단백이 존재하는\n\nmicrosomal 분획을 분리하기 위하여 감염 후\n\n- - 21 -\n약\n\n일이 되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌\n\n70\n\nTSE\n\n.\n\n 조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n 지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n 감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n 4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n 5% sucrose\n\nMBS 4 mL\n\n다\n\n. ",
        "original_sentence": "감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_541",
      "text": "Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 540,
        "window_size": 3,
        "char_count": 212,
        "word_count": 51,
        "page_number": 6,
        "window_text": "조직은 조직\n\n를 이용하여 멸균된\n\n로\n\n균질액을 만든다\n\n깨지\n\nhomogenizer\n\nPBS\n\n10%\n\n.\n\n 지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n 감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n 4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n 5% sucrose\n\nMBS 4 mL\n\n다\n\n.  Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다. ",
        "original_sentence": "Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_542",
      "text": "4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 541,
        "window_size": 3,
        "char_count": 110,
        "word_count": 29,
        "page_number": 6,
        "window_text": "지 않은 세포\n\n미토콘드리아 및 핵을 제거하기 위해\n\n로\n\n분간 원심분리한\n\n,\n\n9,800×g\n\n10\n\n후 상층액을 새 튜브로 옮겨\n\n로\n\n시간 동안 초원심분리 하고\n\n얻어진 침\n\n100,000×g\n\n1\n\n,\n\n전을 멸균된\n\n로 간단히 초음파 분해\n\n하여 재균질화 시킨다\n\n사용할\n\nPBS\n\n(sonication)\n\n.\n\n 감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n 4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n 5% sucrose\n\nMBS 4 mL\n\n다\n\n.  Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다.  튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n",
        "original_sentence": "4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_543",
      "text": "5% sucrose\n\nMBS 4 mL\n\n다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 542,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 5,
        "window_text": "감염성 프리온 단백이 존재하는\n\n를 분리하기 위하여 감염 후 약\n\n일이\n\nCLDs\n\n70\n\n되었을 때\n\n임상증상이 나타난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\nTSE\n\n.\n\n Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n 4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n 5% sucrose\n\nMBS 4 mL\n\n다\n\n.  Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다.  튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n 분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n",
        "original_sentence": "5% sucrose\n\nMBS 4 mL\n\n다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_544",
      "text": "Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 543,
        "window_size": 3,
        "char_count": 69,
        "word_count": 14,
        "page_number": 2,
        "window_text": "Ten\n\n조직\n\n를 이용하여\n\n과 단백 분해효소 억제제\n\nBroeck\n\nhomogenizer\n\n1% Triton X-100\n\ncocktail이 포함된\n\nMBS(\n\n로 뇌 균질액을 만\n\n25 mM Mes, pH 6.5, 150 mM NaCl) 2 mL\n\n든 후 뇌 균질액\n\n와\n\n가 함유된\n\n와 함께 섞는다 이 시료\n\n,\n\n2 mL\n\n80% sucrose\n\nMBS 2 mL\n\n.\n\n 4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n 5% sucrose\n\nMBS 4 mL\n\n다\n\n.  Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다.  튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n 분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n",
        "original_sentence": "Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다. "
      }
    },
    {
      "chunk_id": "chunk_545",
      "text": "튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 544,
        "window_size": 3,
        "char_count": 56,
        "word_count": 14,
        "page_number": 2,
        "window_text": "4\n\n를 초원심분리 튜브에 넣고 그 위에\n\n가 포함된\n\n를 조심스럽\n\nmL\n\n,\n\n30% sucrose\n\nMBS 4 mL\n\n게 올려놓는다 다시 그 위에\n\n가 포함된\n\n를 조심스럽게 올려놓는\n\n.\n\n 5% sucrose\n\nMBS 4 mL\n\n다\n\n.  Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다.  튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n 분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n",
        "original_sentence": "튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_546",
      "text": "분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 545,
        "window_size": 3,
        "char_count": 59,
        "word_count": 12,
        "page_number": 6,
        "window_text": "5% sucrose\n\nMBS 4 mL\n\n다\n\n.  Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다.  튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n 분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n 15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n",
        "original_sentence": "분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_547",
      "text": "PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 546,
        "window_size": 3,
        "char_count": 90,
        "word_count": 23,
        "page_number": 6,
        "window_text": "Beckman SW41 rotor를 사용해서\n\n39,000 rpm, 4\n\n에서\n\n시간 동안 원심분리\n\n°C\n\n16\n\n한다.  튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n 분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n 15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n 400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n",
        "original_sentence": "PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_548",
      "text": "Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 547,
        "window_size": 3,
        "char_count": 144,
        "word_count": 29,
        "page_number": 6,
        "window_text": "튜브를 조심스럽게 꺼내 위에서부터\n\n씩\n\n전체\n\n분획을 뽑아낸다\n\n각\n\n1 mL\n\n,\n\n12\n\n.\n\n 분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n 15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n 400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n 10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n. ",
        "original_sentence": "Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_549",
      "text": "15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 548,
        "window_size": 3,
        "char_count": 54,
        "word_count": 12,
        "page_number": 2,
        "window_text": "분획을\n\n항체를 사용하여 웨스턴 블럿을 실시하여\n\n를 얻는다\n\n사용할\n\ncaveolin\n\nCLDs\n\n.\n\n PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n 15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n 400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n 10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n.  85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n",
        "original_sentence": "15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_550",
      "text": "400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 549,
        "window_size": 3,
        "char_count": 126,
        "word_count": 30,
        "page_number": 2,
        "window_text": "PrPSc를 분리하기 위하여 감염 후 약\n\n일이 되었을 때\n\n임상증상이 나타\n\n70\n\nTSE\n\n난 햄스터의 뇌를 적출한다\n\n적출한 뇌 조직은\n\n조직\n\n를\n\n.\n\n Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n 15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n 400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n 10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n.  85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n 재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n",
        "original_sentence": "400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_551",
      "text": "10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 550,
        "window_size": 3,
        "char_count": 146,
        "word_count": 34,
        "page_number": 2,
        "window_text": "Ten Broeck\n\nhomogenizer\n\n이용하여\n\n로\n\n균질액으로 만든 후\n\nTBS(0.01 M Tris, 0.13 M NaCl, pH 7.4)\n\n20%\n\n을 동량으로 첨가하여 재균질화 한다\n\n상온에서\n\n분간 정치한 후\n\n20% sarcosyl\n\n.\n\n 15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n 400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n 10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n.  85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n 재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n <!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n",
        "original_sentence": "10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n. "
      }
    },
    {
      "chunk_id": "chunk_552",
      "text": "85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 551,
        "window_size": 3,
        "char_count": 203,
        "word_count": 43,
        "page_number": 2,
        "window_text": "15\n\n에서\n\n분간\n\n원심분리\n\n한다\n\n상층액\n\n에\n\n17,000\n\nrpm,\n\n4\n\n30\n\n.\n\n 400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n 10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n.  85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n 재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n <!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n 1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n",
        "original_sentence": "85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_553",
      "text": "재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 552,
        "window_size": 3,
        "char_count": 47,
        "word_count": 7,
        "page_number": 27,
        "window_text": "400\n\nµL\n\nTBSS(0.1%\n\n℃\n\n를 넣어 희석한 후\n\n에서\n\n시간 원심분리 한\n\nSB3-14, TBS) 100 µL\n\n85,000 rpm, 4\n\n1\n\n℃\n\n다\n\n얻어진 분획을\n\n를 이용하여 간단히 초음파 분해\n\n.\n\n 10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n.  85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n 재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n <!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n 1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n 용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n",
        "original_sentence": "재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n"
      }
    },
    {
      "chunk_id": "chunk_554",
      "text": "<!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 553,
        "window_size": 3,
        "char_count": 68,
        "word_count": 13,
        "page_number": 27,
        "window_text": "10% NaCl, 0.1% SB3-14, TBS\n\n한 후 최종\n\n가 되게 하고\n\n현탁된\n\n의 분획에\n\n400 µL\n\n,\n\n400 µL\n\n20% sucrose, 0.1%\n\n를 가한다\n\n에서\n\n시간 원심분\n\nSB3-14, 10% NaCl, TBS 100 µL\n\n.  85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n 재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n <!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n 1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n 용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n 1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n",
        "original_sentence": "<!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n"
      }
    },
    {
      "chunk_id": "chunk_555",
      "text": "1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 554,
        "window_size": 3,
        "char_count": 144,
        "word_count": 32,
        "page_number": 2,
        "window_text": "85,000 rpm, 20\n\n1\n\n℃\n\n- - 22 -\n리 하여 얻어진 분획을\n\n를 이용하여 부드럽게 초음파 분해 한 후 단백 분해효\n\nTBSS\n\n소\n\n(50 µg/mL)를 처리하고 단백 분해효소 억제제인\n\nphenylmethylsulphonylfluoride\n\n(PMSF, 1 mM)를 처리하여\n\nPrPSc를 얻는다\n\n다시 초원심분리 하여 얻어진 침전을\n\n.\n\n 재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n <!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n 1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n 용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n 1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n 생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n",
        "original_sentence": "1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_556",
      "text": "용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 555,
        "window_size": 3,
        "char_count": 89,
        "word_count": 23,
        "page_number": 6,
        "window_text": "재현탁 하여 사용한다(3~4 µg PrPSc/each hamster brain).\n\n <!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n 1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n 용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n 1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n 생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n 2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n. ",
        "original_sentence": "용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_557",
      "text": "1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 556,
        "window_size": 3,
        "char_count": 100,
        "word_count": 21,
        "page_number": 2,
        "window_text": "<!-- PAGE_27 -->\n###### 감염성 프리온 단백 검출법\n\n<!-- PAGE_27 -->\n###### 4.\n\n 1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n 용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n 1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n 생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n 2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n.  각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n",
        "original_sentence": "1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_558",
      "text": "생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 557,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 5,
        "window_text": "1) 시료 준비\n\n: 생물시험법을 위한 시료는 무균적으로 준비되어야 하며\n\n, -20\n\n또는 그 이하에서 보관하며 얼림과 녹임\n\n(freezing-thawing)의 반복을\n\n℃\n\n피하여야 한다\n\n조직을 보관하거나 옮길 용기나 기구들은 새로운 것을 사\n\n.\n\n 용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n 1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n 생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n 2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n.  각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n 동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n",
        "original_sentence": "생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_559",
      "text": "2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 558,
        "window_size": 3,
        "char_count": 110,
        "word_count": 27,
        "page_number": 2,
        "window_text": "용하고\n\n사용 전 멸균하여야 하며 사용 후에는 감염성 프리온 단백 불활화\n\n,\n\n방법에 따라 멸균한다\n\n접종을 위한 시료는 멸균된\n\n회용 외과용 메스를\n\n.\n\n 1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n 생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n 2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n.  각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n 동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n",
        "original_sentence": "2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_560",
      "text": "각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 559,
        "window_size": 3,
        "char_count": 84,
        "word_count": 22,
        "page_number": 2,
        "window_text": "1\n\n사용하여 잘게 부순 후 멸균된\n\n를 사용하여 멸균된\n\nDounce homogenizer\n\n생리식염수로\n\n균질액을 만든다\n\n접종할 균질액은 원심분리 하거나 항\n\n10%\n\n.\n\n 생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n 2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n.  각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n 동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n 종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n",
        "original_sentence": "각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_561",
      "text": "동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 560,
        "window_size": 3,
        "char_count": 96,
        "word_count": 24,
        "page_number": 2,
        "window_text": "생제를 첨가하거나 열처리 하지 말아야 한다\n\n접종액과 뇌 조직액은 분주\n\n.\n\n 2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n.  각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n 동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n 종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n 매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n",
        "original_sentence": "동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_562",
      "text": "μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 561,
        "window_size": 3,
        "char_count": 93,
        "word_count": 23,
        "page_number": 6,
        "window_text": "2) 실험동물 접종\n\n감염성 프리온 단백의 제거 조사연구를 위한 혈장분획제\n\n:\n\n제 제조공정 관련 산물의 접종은 감염성 프리온 단백\n\n에 따라 실험\n\nstrain\n\n동물을 선택하여 접종한다\n\n.  각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n 동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n 종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n 매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n “\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n",
        "original_sentence": "μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_563",
      "text": "종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 562,
        "window_size": 3,
        "char_count": 98,
        "word_count": 24,
        "page_number": 6,
        "window_text": "각 접종 시료는\n\n10-1부터 10-9까지\n\n배씩 계\n\n10\n\n단희석 하여 각 희석 시료 당 적어도\n\n마리에 접종하여야 한다\n\n각 실험\n\n10\n\n.\n\n 동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n 종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n 매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n “\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n 주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n",
        "original_sentence": "종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_564",
      "text": "매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 563,
        "window_size": 3,
        "char_count": 88,
        "word_count": 20,
        "page_number": 15,
        "window_text": "동물을 마취시킨 후 대뇌피질 내로 마우스의 경우는\n\n햄스터의 경\n\n20\n\nL,\n\nμ\n\n우는\n\n씩 접종한다\n\n대조군에는 감염성 프리온 단백이 없는 시료를\n\n50\n\nL\n\n.\n\n μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n 종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n 매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n “\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n 주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n - -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n",
        "original_sentence": "매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_565",
      "text": "“\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 564,
        "window_size": 3,
        "char_count": 75,
        "word_count": 23,
        "page_number": 2,
        "window_text": "μ\n\n3) 감염된 실험동물의 임상증상 관찰\n\n감염된 실험동물은 실험 전반에 걸쳐\n\n:\n\n감염성 프리온 단백의 증상을 일상적으로 모니터링 하여야 한다\n\n또한 접\n\n.\n\n 종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n 매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n “\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n 주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n - -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n 1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n",
        "original_sentence": "“\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_566",
      "text": "주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 565,
        "window_size": 3,
        "char_count": 202,
        "word_count": 58,
        "page_number": 2,
        "window_text": "종 후 각 감염성 프리온 단백\n\n의 잠복기 표\n\n를 참고하여 공식적인\n\nstrain\n\n(\n\n1)\n\n임상증상 모니터링을 시작하여야 한다\n\n실험동물은 숙련된 실험자에 의해\n\n.\n\n 매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n “\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n 주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n - -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n 1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n 기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n",
        "original_sentence": "주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_567",
      "text": "- -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 566,
        "window_size": 3,
        "char_count": 197,
        "word_count": 47,
        "page_number": 2,
        "window_text": "매일 체크되어야 하며 주별로\n\n임상증상을 나타내는 신경학적 증상에\n\nTSE\n\n대해 스코어링 하여야 한다\n\n실험동물은\n\n비감염\n\n감염 가능성\n\n및\n\n감\n\n.\n\n “\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n 주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n - -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n 1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n 기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n 균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n",
        "original_sentence": "- -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_568",
      "text": "1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 567,
        "window_size": 3,
        "char_count": 114,
        "word_count": 21,
        "page_number": 28,
        "window_text": "“\n\n”, “\n\n”\n\n“\n\n- - 23 -\n염 으로 분류하며 접종 후 약\n\n년까지 모니터링 하여야 한다\n\n실험동물은\n\n”\n\n1\n\n.\n\n 주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n - -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n 1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n 기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n 균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n",
        "original_sentence": "1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_569",
      "text": "기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 568,
        "window_size": 3,
        "char_count": 247,
        "word_count": 56,
        "page_number": 6,
        "window_text": "주 연속으로\n\n감염 으로 분류된 후 또는\n\n주 연속 중\n\n번\n\n감염 으로 분\n\n2\n\n“\n\n”\n\n3\n\n2\n\n“\n\n”\n\n류된 후 또는\n\n감염\n\n판정받은 상태에서 스코어링 날짜 사이에 증상이 악\n\n“\n\n”\n\n화되었을 때 섭식 능력이 없거나 움직이지 못할 때\n\n마취하여 희생시킨 후\n\n(\n\n)\n\n뇌 조직을 적출한다\n\n적출한 뇌 조직은\n\n또는 그 이하에 보관하며\n\n.\n\n - -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n 1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n 기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n 균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n",
        "original_sentence": "기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_570",
      "text": "균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 569,
        "window_size": 3,
        "char_count": 98,
        "word_count": 25,
        "page_number": 2,
        "window_text": "- -20℃\n4) 자료 분석\n\n임상증상을 나타낸 실험동물 및 임상증상을 나타내지 않\n\n: TSE\n\n은 실험동물 수를 파악하여야 하며\n\n와 같이 바이러스 농도\n\n, Karber formula\n\n를 측정할 때 사용하는 공식을 이용하여 감염성 프리온 단백의 농도\n\n(titer)\n\n를 같은 방식으로 계산한다\n\n잠복기는 접종 후부터 사망에 이르기까지의\n\n.\n\n 1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n 기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n 균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n 를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n",
        "original_sentence": "균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_571",
      "text": "microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 570,
        "window_size": 3,
        "char_count": 142,
        "word_count": 30,
        "page_number": 8,
        "window_text": "1) Protein misfolding cyclic amplification(PMCA)\n\n감염성 프리온 단백의 검\n\n:\n\n출 민감도를 높이기 위해\n\n라고 하는\n\n새로운 방법이 개발되었다\n\nPMCA\n\n.\n\n 기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n 균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n 를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n 37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n",
        "original_sentence": "microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n"
      }
    },
    {
      "chunk_id": "chunk_572",
      "text": "microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 571,
        "window_size": 3,
        "char_count": 106,
        "word_count": 24,
        "page_number": 11,
        "window_text": "기법은 정상 프리온 단백이 구조적인 변화로 인해 감염성 프리온\n\nPMCA\n\n단백으로\n\n전환된다는\n\n점을\n\n기법에\n\n접목시켜\n\n초음파\n\n분해 배양\n\nPCR\n\n,\n\n- -\n을 증가시킴으로써 감염성 프리온\n\n단백을\n\n(sonication-incubation) cycle\n\n정상 햄스터 뇌 균질액과 감염성 프리온 단백\n\n에 감염된 햄스\n\nstrain 263K\n\n터 뇌 균질액\n\n를 각각 준비한다\n\n이 때 감염된 뇌 균질액과 정상 뇌\n\n10%\n\n.\n\n 균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n 를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n 37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n - -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n",
        "original_sentence": "microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_573",
      "text": "를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 572,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 5,
        "window_text": "균질액을\n\n으로 섞어 총\n\n를 만든 후\n\n튜브에 넣고\n\n1:50\n\n200\n\nL\n\n500\n\nL PCR\n\nμ\n\nμ\n\n를\n\n수행한다\n\n초음파\n\n분해는\n\n가\n\n없는\n\nPMCA\n\n.\n\n microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n 를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n 37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n - -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n 263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n",
        "original_sentence": "를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_574",
      "text": "37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 573,
        "window_size": 3,
        "char_count": 53,
        "word_count": 14,
        "page_number": 2,
        "window_text": "microtip\n\nprobe\n\nsonicator\n\n를 사용하여\n\n로\n\n초 동안 초음파 분해한다\n\n(Branson, USA)\n\n40% power\n\n40\n\n초\n\n초\n\n만약\n\n를 이용하\n\n(pulse on = 0.5\n\n/ pulse off = 0.2\n\n).\n\n microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n 를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n 37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n - -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n 263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n 은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n",
        "original_sentence": "37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_575",
      "text": "- -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 574,
        "window_size": 3,
        "char_count": 106,
        "word_count": 30,
        "page_number": 2,
        "window_text": "microtip probe\n\n여 초음파 분해할 경우\n\n스테인리스 스틸에 들러붙은 감염성 프리온 단백\n\n,\n\n의 특성을\n\n고려하여 오염을\n\n제거하는 과정을\n\n거쳐야 한다\n\n가능한\n\n한\n\n.\n\n 를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n 37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n - -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n 263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n 은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n 음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n",
        "original_sentence": "- -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_576",
      "text": "263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 575,
        "window_size": 3,
        "char_count": 61,
        "word_count": 13,
        "page_number": 2,
        "window_text": "를 이용한 초음파 분해를 피할 것을 권고한다\n\n그 후\n\nmicrotip probe\n\n.\n\n 37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n - -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n 263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n 은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n 음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n. ",
        "original_sentence": "263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_577",
      "text": "은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 576,
        "window_size": 3,
        "char_count": 102,
        "word_count": 23,
        "page_number": 6,
        "window_text": "37℃\n\n에서\n\n시간 정체시켜 반응 시킨다\n\n이러한 초음파 분해 배양 과정을 반복\n\n1\n\n.\n\n - -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n 263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n 은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n 음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n.  RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n. ",
        "original_sentence": "은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_578",
      "text": "음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 577,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 5,
        "window_text": "- -\n- - 24 -\n특히\n\n감염성 프리온 단백\n\n를 사용하여\n\n를 수행할 경우에 고려\n\n,\n\n263K\n\nPMCA\n\n해야 할 사항을 기술하고자 한다\n\n만약\n\n를\n\n물질로 사용할 경\n\n.\n\n 263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n 은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n 음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n.  RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n.  PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n. ",
        "original_sentence": "음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_579",
      "text": "μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 578,
        "window_size": 3,
        "char_count": 100,
        "word_count": 23,
        "page_number": 6,
        "window_text": "263K\n\nspiking\n\n우 감염된\n\n뇌 균질액\n\n대신 혈장분획제제\n\n공정 시료를\n\n사용한다\n\n기질\n\n.\n\n 은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n 음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n.  RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n.  PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n.  PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n",
        "original_sentence": "μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n. "
      }
    },
    {
      "chunk_id": "chunk_580",
      "text": "RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 579,
        "window_size": 3,
        "char_count": 87,
        "word_count": 19,
        "page_number": 9,
        "window_text": "은 정상 햄스터 뇌 균질액을 사용하며 템플릿\n\n은 감염\n\n(substrate)\n\n(template)\n\n된 햄스터 뇌 균질액 또는 혈장분획제제 공정 시료를 사용한다\n\n온도와 초\n\n.\n\n 음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n.  RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n.  PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n.  PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n",
        "original_sentence": "RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n. "
      }
    },
    {
      "chunk_id": "chunk_581",
      "text": "PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 580,
        "window_size": 3,
        "char_count": 187,
        "word_count": 44,
        "page_number": 2,
        "window_text": "음파 분해의 민감도를 높이기 위해\n\n튜브를 사용한다\n\n초음파\n\n500\n\nL PCR\n\n.\n\n μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n.  RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n.  PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n.  PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n 1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n",
        "original_sentence": "PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n. "
      }
    },
    {
      "chunk_id": "chunk_582",
      "text": "PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 581,
        "window_size": 3,
        "char_count": 69,
        "word_count": 15,
        "page_number": 2,
        "window_text": "μ\n\n분해 시 에어로졸이나 물방울의 생성을 방지하기 위해 밀폐된 튜브를 사\n\n용하며\n\n역시\n\n가 없는 것을 사용한다\n\n를 첨\n\nsonicator\n\nmicrotip probe\n\n.  RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n.  PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n.  PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n 1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n",
        "original_sentence": "PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_583",
      "text": "PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 582,
        "window_size": 3,
        "char_count": 67,
        "word_count": 14,
        "page_number": 2,
        "window_text": "RNA\n\n가하여\n\n를 수행할 경우 배양은 반드시\n\n약\n\nPMCA\n\nshaking incubation(\n\n250\n\n한다\n\n에 의한\n\nrpm, 37\n\n)\n\n.  PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n.  PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n 1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n",
        "original_sentence": "PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_584",
      "text": "1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 583,
        "window_size": 3,
        "char_count": 56,
        "word_count": 15,
        "page_number": 2,
        "window_text": "PMCA\n\nPrP\n\n℃\n\nSc의 증폭은 사용된 완충액 조성에 따\n\n2) 웨스턴 블럿 단백 분해효소 전처리 포함\n\n(\n\n)\n\n: 단백 분해효소\n\n(proteinase K,\n\n를\n\n농도로\n\n을 만들어 분주하여\n\n이하\n\nPK)\n\n20 mg/mL\n\nstock solution\n\n- -70℃\n에 보관한다\n\n를 처리할 시료가 준비되면\n\n을\n\n.  PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n 1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n 을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n. ",
        "original_sentence": "1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_585",
      "text": "PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 584,
        "window_size": 3,
        "char_count": 92,
        "word_count": 20,
        "page_number": 9,
        "window_text": "PK\n\nstock solution\n\n1~10 mg/\n\n농도로 희석한다\n\n시료에 처리할\n\n의 최종 농도는\n\n로\n\nmL\n\n.\n\n PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n 1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n 을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n.  Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n",
        "original_sentence": "PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_586",
      "text": "SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 585,
        "window_size": 3,
        "char_count": 135,
        "word_count": 31,
        "page_number": 2,
        "window_text": "PK\n\n50~100\n\ng/mL\n\nμ\n\n하여\n\n에서\n\n분간 반응시킨다\n\n단백 분해효소 억제제인\n\n37\n\n30~60\n\n.\n\n 1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n 을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n.  Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n 기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n",
        "original_sentence": "SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_587",
      "text": "을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 586,
        "window_size": 3,
        "char_count": 272,
        "word_count": 65,
        "page_number": 2,
        "window_text": "1 mM\n\n℃\n\n를 처리하여 반응을 중지시킨다\n\n각 시료의 용액 조건에 따라\n\n의\n\nPMSF\n\n.\n\n PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n 을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n.  Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n 기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n 방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n",
        "original_sentence": "을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n. "
      }
    },
    {
      "chunk_id": "chunk_588",
      "text": "Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 587,
        "window_size": 3,
        "char_count": 69,
        "word_count": 15,
        "page_number": 2,
        "window_text": "PK\n\n웨스턴 블럿을 수행하기 위해서는 주로\n\n시스템을 사용\n\nBio-Rad mini-gel\n\n한다\n\n감염시킨 뇌 조직액을 단백 분해효소로 처리하여\n\n한 후\n\n.\n\n SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n 을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n.  Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n 기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n 방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n - - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n",
        "original_sentence": "Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_589",
      "text": "기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 588,
        "window_size": 3,
        "char_count": 56,
        "word_count": 7,
        "page_number": 6,
        "window_text": "SDS-PAGE\n\n을\n\n분 동안\n\n용액에 보\n\ngel\n\n20\n\n25 mM Tris, 90 mM glycine, 20% methanol\n\n관한 후\n\n에서\n\n분간 단백질을\n\n막으로 이동시킨다\n\n이 막\n\n, 80 V\n\n30~60\n\nPVDF\n\n.\n\n 을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n.  Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n 기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n 방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n - - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n 3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### . ",
        "original_sentence": "기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_590",
      "text": "방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 589,
        "window_size": 3,
        "char_count": 59,
        "word_count": 12,
        "page_number": 6,
        "window_text": "을\n\n가 함유된\n\n완충액\n\n5% skim milk\n\nTBST\n\n(20 mM Tris, 137 mM NaCl, pH\n\n에서 최소\n\n시간 보관하여 단백질이 비특이적으로\n\n- 7.6, 0.1% Tween 20)\n1\n\n결합하는 것을 방지하고\n\n막을\n\n로\n\n분간\n\n번 씻은 후 감염성\n\n, PVDF\n\nTBST\n\n10\n\n3\n\n프리온 단백에 대해 매우 특이적으로 반응하는\n\n항체 표\n\n를 처\n\nanti-PrP\n\n(\n\n2)\n\n리하여\n\n분간 상온에서 반응시킨다\n\n가 결합한\n\n차 항체\n\n30~60\n\n.  Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n 기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n 방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n - - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n 3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### .  감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n",
        "original_sentence": "방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_591",
      "text": "- - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 590,
        "window_size": 3,
        "char_count": 40,
        "word_count": 13,
        "page_number": 2,
        "window_text": "Peroxidase\n\n2\n\n를\n\n처리하여\n\n분간\n\n반응시킨\n\n후\n\n분\n\n간격으로\n\n번\n\n세척한다\n\n60\n\n10\n\n3\n\n.\n\n 기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n 방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n - - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n 3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### .  감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n ,\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n",
        "original_sentence": "- - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n"
      }
    },
    {
      "chunk_id": "chunk_592",
      "text": "3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### . ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 591,
        "window_size": 3,
        "char_count": 136,
        "word_count": 19,
        "page_number": 30,
        "window_text": "기질을\n\n사용하여\n\n검출한다\n\n단백질은\n\nChemiluminescent\n\nperoxidase\n\n.\n\n 방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n - - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n 3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### .  감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n ,\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n - - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n",
        "original_sentence": "3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### . "
      }
    },
    {
      "chunk_id": "chunk_593",
      "text": "감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 592,
        "window_size": 3,
        "char_count": 108,
        "word_count": 25,
        "page_number": 30,
        "window_text": "방법 또는\n\n방법을 이용하여\n\n를 표준액으로 하여 정량\n\nBradford\n\nLowry\n\nBSA\n\n한다.\n\n - - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n 3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### .  감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n ,\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n - - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n - - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n",
        "original_sentence": "감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_594",
      "text": ",\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 593,
        "window_size": 3,
        "char_count": 384,
        "word_count": 104,
        "page_number": 6,
        "window_text": "- - 25 -\n표\n\n감염성 프리온 단백에 대한 단클론 항체\n\n- 2.\n 3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### .  감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n ,\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n - - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n - - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n <!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n",
        "original_sentence": ",\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_595",
      "text": "- - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 594,
        "window_size": 3,
        "char_count": 86,
        "word_count": 26,
        "page_number": 2,
        "window_text": "3F4\n\n1C5\n\n3F10\n\ntype\n\nmouse mAb(IgG2a)\n\nmouse mAb(IgG1)\n\nmouse mAb(IgG1)\n\nepitope\n\n109-113\n\n119-133\n\n137-145\n\n<!-- PAGE_30 -->\n###### .  감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n ,\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n - - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n - - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n <!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n <!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n",
        "original_sentence": "- - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_596",
      "text": "- - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 595,
        "window_size": 3,
        "char_count": 89,
        "word_count": 26,
        "page_number": 2,
        "window_text": "감염성 프리온 단백 감염 실험동물 부검 시 고려사항\n\n<!-- PAGE_30 -->\n###### Ⅳ\n\n부검 시 참석자는 최소한의 인원으로 제한한다\n\n부검에 숙련된 실험자\n\n병리학\n\n1)\n\n.\n\n ,\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n - - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n - - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n <!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n <!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n 스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n",
        "original_sentence": "- - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_597",
      "text": "<!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 596,
        "window_size": 3,
        "char_count": 101,
        "word_count": 20,
        "page_number": 31,
        "window_text": ",\n\n두개골 개방 시 주로 에어로졸이 발생하기 때문에 전동 톱의 사용을 금지하며\n\n- -\n수동 톱을 이용하여 절단할 때에도 적당한 마스크 및 보안경을 착용하여야\n\n수술도구 및 기구는 커다란 스테인리스 스틸 용기에 넣고\n\n에\n\n시\n\n- -\n2 N NaOH\n\n1\n\n간 또는\n\n에\n\n시간 동안 담근 후\n\n물로 헹구고\n\n에서\n\n시간 동\n\n1 N NaOH\n\n2\n\n,\n\n132\n\n1\n\n℃\n\n안\n\n에서\n\n분간 고압증기멸균\n\n번 또는\n\n에서\n\n분간 고압\n\n(30 Lb psi\n\n18\n\n3\n\n30 Lb psi\n\n3\n\n흡수성이 없는 테이블 커버\n\n수술도구\n\n패드\n\n회용 실험복 등은 적절한 생물\n\n- -\n,\n\n,\n\n, 1\n\n재해 페기물 백\n\n(biohazard waste bag)에 넣어 소각한다\n\n.\n\n - - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n - - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n <!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n <!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n 스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n 하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n",
        "original_sentence": "<!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n"
      }
    },
    {
      "chunk_id": "chunk_598",
      "text": "<!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 597,
        "window_size": 3,
        "char_count": 160,
        "word_count": 36,
        "page_number": 31,
        "window_text": "- - 26 -\n부검실 또는 부검 테이블의 오염 의심 지역은\n\n로\n\n시간 이상 적시\n\n- -\n2 N NaOH\n\n1\n\n는 것을 반복하여 오염을 제거한다.\n\n - - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n <!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n <!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n 스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n 하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n 프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n",
        "original_sentence": "<!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_599",
      "text": "스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 598,
        "window_size": 3,
        "char_count": 51,
        "word_count": 13,
        "page_number": 5,
        "window_text": "- - 부검 시 오염된 수술도구 또는 오염 조직이 피부에 노출되었을 때에는\n1 N\n\n로\n\n분 동안 닦아 내고 충분한 양의 물로 씻어낸다\n\nNaOH\n\n5\n\n.\n\n <!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n <!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n 스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n 하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n 프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n 정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n",
        "original_sentence": "스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_600",
      "text": "하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 599,
        "window_size": 3,
        "char_count": 50,
        "word_count": 13,
        "page_number": 5,
        "window_text": "<!-- PAGE_31 -->\n###### 감염성 프리온 단백의 불활화\n\n<!-- PAGE_31 -->\n###### 세척 및 소독\n\n<!-- PAGE_31 -->\n###### .\n\n <!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n 스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n 하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n 프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n 정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n 감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n",
        "original_sentence": "하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_601",
      "text": "프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 600,
        "window_size": 3,
        "char_count": 201,
        "word_count": 46,
        "page_number": 2,
        "window_text": "<!-- PAGE_31 -->\n###### ,\n\n<!-- PAGE_31 -->\n###### Ⅴ\n\n가장 작은 감염성 프리온 단백 입자는 PrPSc의 이중체\n\n로 추정되며 그 크기\n\n(dimer)\n\n는 이온화 방사선 표적 입자와 비슷하다\n\n따라서 감염성 프리온 단백은 세균과 바이러\n\n.\n\n 스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n 하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n 프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n 정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n 감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n",
        "original_sentence": "프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_602",
      "text": "정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 601,
        "window_size": 3,
        "char_count": 98,
        "word_count": 23,
        "page_number": 6,
        "window_text": "스를 효과적으로 제거하는 대부분의 필터에 의해서 제거되지 않을 수 있다\n\n또한 균일\n\n.\n\n 하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n 프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n 정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n 감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n 감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n. ",
        "original_sentence": "정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_603",
      "text": "감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 602,
        "window_size": 3,
        "char_count": 90,
        "word_count": 23,
        "page_number": 2,
        "window_text": "하지 않은 크기의 입자로 응집되며 일반적인 세제에 용해되지 않을 수 있다\n\n감염성\n\n.\n\n 프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n 정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n 감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n 감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n.  건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n",
        "original_sentence": "감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_604",
      "text": "guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 603,
        "window_size": 3,
        "char_count": 86,
        "word_count": 15,
        "page_number": 6,
        "window_text": "프리온 단백은 바이러스와 달리 핵산 분해효소\n\n자외선 조사\n\n에 저항성을 갖\n\n,\n\n(254 nm)\n\n고 있으며\n\n가 양이온\n\n금속 이온 킬레이터\n\n사이의 산\n\n포르말린\n\n, 2\n\n,\n\n(chelator), pH 3~7\n\n,\n\n,\n\n끓임\n\n또는 단백 분해효소에 의해 불활화 되지 않는 특성을 가\n\nhydroxylamine,\n\n(boiling)\n\n지고 있다.\n\n 정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n 감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n 감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n.  건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n 고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n",
        "original_sentence": "guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_605",
      "text": "감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 604,
        "window_size": 3,
        "char_count": 185,
        "word_count": 31,
        "page_number": 2,
        "window_text": "정제된 시료에서의 프리온 단백의 감염력은 단백 분해효소를 장시간 처리하면 감소\n\n되어지는 반면\n\n, SDS와 요소를 첨가하여 끓인 결과 감염력 상실이 다양하게 나타난다\n\n.\n\n 감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n 감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n.  건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n 고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n 재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n",
        "original_sentence": "감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_606",
      "text": "건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 605,
        "window_size": 3,
        "char_count": 77,
        "word_count": 18,
        "page_number": 2,
        "window_text": "감염력이 가장 높은 실험동물 뇌 균질액은\n\n에서\n\n시간 동안 고압증기멸균을\n\n132\n\n- 4.5\n℃\n\n필요로 한다\n\n페놀과 같은 유기용매 혹은\n\n와 같은\n\n.\n\n guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n 감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n.  건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n 고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n 재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n (vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n. ",
        "original_sentence": "건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_607",
      "text": "고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 606,
        "window_size": 3,
        "char_count": 96,
        "word_count": 24,
        "page_number": 2,
        "window_text": "guanidine isothiocyanate\n\nchaotropic\n\n또는\n\n와 같은 알칼리 등이 살균에 사용될 수 있다\n\nreagent\n\nNaOH\n\n.\n\n 감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n.  건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n 고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n 재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n (vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n.  HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n",
        "original_sentence": "고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_608",
      "text": "재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 607,
        "window_size": 3,
        "char_count": 93,
        "word_count": 23,
        "page_number": 2,
        "window_text": "감염성\n\n프리온\n\n단백은\n\n또는\n\n1 N\n\nNaOH,\n\n4\n\nmol/L\n\nguanidinium hydrochloride\n\n로\n\n에서\n\nisocyanate, sodium hypochlorite(2% free chlorine concentration)\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 등에 의해 불활화 되어진다\n\n.  건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n 고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n 재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n (vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n.  HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n - - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel. ",
        "original_sentence": "재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_609",
      "text": "(vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 608,
        "window_size": 3,
        "char_count": 89,
        "word_count": 21,
        "page_number": 6,
        "window_text": "건조된 폐기물에 대해서는\n\n132℃\n\n에서\n\n시간 동안 고압증기멸균 하거나 소각할 것을 추천한다\n\n감염성 프리온 단백이\n\n- 4.5\n.\n\n 고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n 재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n (vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n.  HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n - - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel.  (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n",
        "original_sentence": "(vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n. "
      }
    },
    {
      "chunk_id": "chunk_610",
      "text": "HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 609,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 5,
        "window_text": "고농도로 존재하는 많은 양의 액체 페기물은\n\n를 처리하거나\n\n에서\n\n1 N NaOH\n\n132\n\n- 4.5\n℃\n\n시간 동안 고압증기멸균 함으로서 완벽하게 살균할 수 있다.\n\n 재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n (vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n.  HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n - - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel.  (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n",
        "original_sentence": "HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n"
      }
    },
    {
      "chunk_id": "chunk_611",
      "text": "- - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 610,
        "window_size": 3,
        "char_count": 193,
        "word_count": 33,
        "page_number": 32,
        "window_text": "재사용 가능한 재료의 오염을 막기 위해\n\n회용 플라스틱 제품을 사용하는 것을 적\n\n1\n\n극 추천한다\n\n파라포름알데히드 훈증\n\n은 감염성 프리온 단백의 감염력을\n\n.\n\n (vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n.  HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n - - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel.  (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n INTRODUCTION................................................................................................................... 3\n\n- 2.\n",
        "original_sentence": "- - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel. "
      }
    },
    {
      "chunk_id": "chunk_612",
      "text": "(44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 611,
        "window_size": 3,
        "char_count": 243,
        "word_count": 34,
        "page_number": 2,
        "window_text": "(vaporization)\n\n제거하지 못하기 때문에\n\n는\n\n로 오염을 제거한 후\n\n을 처리하고\n\nBSC\n\n1 N NaOH\n\n1 N HCl\n\n물로 씻어낸다\n\n.  HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n - - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel.  (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n INTRODUCTION................................................................................................................... 3\n\n- 2.\n SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n",
        "original_sentence": "(44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n"
      }
    },
    {
      "chunk_id": "chunk_613",
      "text": "London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 612,
        "window_size": 3,
        "char_count": 437,
        "word_count": 63,
        "page_number": 33,
        "window_text": "HEPA 필터는 고압증기멸균 한 후 소각하여야 한다\n\n.\n\n - - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel.  (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n INTRODUCTION................................................................................................................... 3\n\n- 2.\n SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n",
        "original_sentence": "London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n"
      }
    },
    {
      "chunk_id": "chunk_614",
      "text": "INTRODUCTION................................................................................................................... 3\n\n- 2.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 613,
        "window_size": 3,
        "char_count": 136,
        "word_count": 4,
        "page_number": 5,
        "window_text": "- - 27 -\n<!-- PAGE_32 -->\n###### <참고자료\n\n<!-- PAGE_32 -->\n###### >\n\nEuropean Medicines Agency\n\nEvaluation of Medicines for Human Use\n\n7 Westferry Circus, Canary Wharf, London, E14 4HB, UK\n\nTel.  (44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n INTRODUCTION................................................................................................................... 3\n\n- 2.\n SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n",
        "original_sentence": "INTRODUCTION................................................................................................................... 3\n\n- 2.\n"
      }
    },
    {
      "chunk_id": "chunk_615",
      "text": "SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 614,
        "window_size": 3,
        "char_count": 124,
        "word_count": 7,
        "page_number": 5,
        "window_text": "(44-20) 74 18 84 00   Fax (44-20) 74 18 85 45\n\nE-mail: mail@emea.eu.int    http://www.emea.eu.int\n\n©EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.\n\n London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n INTRODUCTION................................................................................................................... 3\n\n- 2.\n SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004. ",
        "original_sentence": "SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n"
      }
    },
    {
      "chunk_id": "chunk_616",
      "text": "INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 615,
        "window_size": 3,
        "char_count": 107,
        "word_count": 8,
        "page_number": 5,
        "window_text": "London, 21 October 2004\n\n<!-- PAGE_33 -->\n###### CPMP/BWP/CPMP/5136/03\n\n<!-- PAGE_33 -->\n###### COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE\n\n<!-- PAGE_33 -->\n###### (CHMP)\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 2/10\n\n<!-- PAGE_34 -->\n###### GUIDELINE ON THE INVESTIGATION OF MANUFACTURING\n\n<!-- PAGE_34 -->\n###### PROCESSES FOR PLASMA-DERIVED MEDICINAL PRODUCTS\n\n<!-- PAGE_34 -->\n###### WITH REGARD TO VCJD RISK\n\nTABLE OF CONTENTS\n\n- 1.\n INTRODUCTION................................................................................................................... 3\n\n- 2.\n SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004.  A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified. ",
        "original_sentence": "INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n"
      }
    },
    {
      "chunk_id": "chunk_617",
      "text": "SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 616,
        "window_size": 3,
        "char_count": 167,
        "word_count": 11,
        "page_number": 5,
        "window_text": "INTRODUCTION................................................................................................................... 3\n\n- 2.\n SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004.  A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified.  The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases. ",
        "original_sentence": "SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n"
      }
    },
    {
      "chunk_id": "chunk_618",
      "text": "INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 617,
        "window_size": 3,
        "char_count": 294,
        "word_count": 38,
        "page_number": 8,
        "window_text": "SCOPE OF THE DOCUMENT:............................................................................................. 3\n\n- 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004.  A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified.  The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases.  (One case in Hong Kong was a UK\n\ncase and is included in the UK figures.) ",
        "original_sentence": "INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004. "
      }
    },
    {
      "chunk_id": "chunk_619",
      "text": "A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 618,
        "window_size": 3,
        "char_count": 171,
        "word_count": 28,
        "page_number": 6,
        "window_text": "INVESTIGATIONAL TSE CLEARANCE STUDIES ............................................................ 4\n\n- 4.\n SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004.  A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified.  The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases.  (One case in Hong Kong was a UK\n\ncase and is included in the UK figures.)  Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK. ",
        "original_sentence": "A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified. "
      }
    },
    {
      "chunk_id": "chunk_620",
      "text": "The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 619,
        "window_size": 3,
        "char_count": 119,
        "word_count": 22,
        "page_number": 6,
        "window_text": "SUMMARY / CONCLUSION................................................................................................. 9\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 3/10\n\n- 1.\n INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004.  A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified.  The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases.  (One case in Hong Kong was a UK\n\ncase and is included in the UK figures.)  Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK.  However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK. ",
        "original_sentence": "The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases. "
      }
    },
    {
      "chunk_id": "chunk_621",
      "text": "(One case in Hong Kong was a UK\n\ncase and is included in the UK figures.) ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 620,
        "window_size": 3,
        "char_count": 74,
        "word_count": 16,
        "page_number": 6,
        "window_text": "INTRODUCTION\n\nHuman transmissible spongiform encephalopathies (TSEs), including in particular variant Creutzfeldt-\n\nJakob disease (vCJD), were addressed in expert meetings/workshops at the EMEA in January 1998,\n\nJanuary 1999, December 1999, May 2000, December 2000, June 2002 and January 2004.  A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified.  The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases.  (One case in Hong Kong was a UK\n\ncase and is included in the UK figures.)  Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK.  However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK.  The possibility of cases occurring in other countries\n\ncannot be excluded. ",
        "original_sentence": "(One case in Hong Kong was a UK\n\ncase and is included in the UK figures.) "
      }
    },
    {
      "chunk_id": "chunk_622",
      "text": "Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 621,
        "window_size": 3,
        "char_count": 135,
        "word_count": 27,
        "page_number": 6,
        "window_text": "A revised\n\nCHMP Position Statement on variant CJD and plasma-derived medicinal products was issued in June\n\n- 2004.1\nIn 1996, a variant form of CJD (vCJD) was identified.  The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases.  (One case in Hong Kong was a UK\n\ncase and is included in the UK figures.)  Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK.  However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK.  The possibility of cases occurring in other countries\n\ncannot be excluded.  All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene. ",
        "original_sentence": "Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK. "
      }
    },
    {
      "chunk_id": "chunk_623",
      "text": "However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 622,
        "window_size": 3,
        "char_count": 86,
        "word_count": 19,
        "page_number": 2,
        "window_text": "The official UK figures for vCJD at the beginning\n\nof August 2004 were a total of 147 definite or probable vCJD cases.  (One case in Hong Kong was a UK\n\ncase and is included in the UK figures.)  Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK.  However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK.  The possibility of cases occurring in other countries\n\ncannot be excluded.  All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene.  However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n",
        "original_sentence": "However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK. "
      }
    },
    {
      "chunk_id": "chunk_624",
      "text": "The possibility of cases occurring in other countries\n\ncannot be excluded. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 623,
        "window_size": 3,
        "char_count": 75,
        "word_count": 11,
        "page_number": 8,
        "window_text": "(One case in Hong Kong was a UK\n\ncase and is included in the UK figures.)  Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK.  However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK.  The possibility of cases occurring in other countries\n\ncannot be excluded.  All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene.  However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n - 3.\n",
        "original_sentence": "The possibility of cases occurring in other countries\n\ncannot be excluded. "
      }
    },
    {
      "chunk_id": "chunk_625",
      "text": "All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 624,
        "window_size": 3,
        "char_count": 133,
        "word_count": 23,
        "page_number": 6,
        "window_text": "Outside of the UK, there has been one case in Ireland, one in the\n\nUSA, and one in Canada, who were probably infected while in the UK.  However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK.  The possibility of cases occurring in other countries\n\ncannot be excluded.  All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene.  However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n - 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n",
        "original_sentence": "All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene. "
      }
    },
    {
      "chunk_id": "chunk_626",
      "text": "However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 625,
        "window_size": 3,
        "char_count": 316,
        "word_count": 46,
        "page_number": 6,
        "window_text": "However, none of the 7 cases in\n\nFrance and 1 case in Italy had spent time in the UK.  The possibility of cases occurring in other countries\n\ncannot be excluded.  All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene.  However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n - 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model. ",
        "original_sentence": "However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n"
      }
    },
    {
      "chunk_id": "chunk_627",
      "text": "- 3.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 626,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "The possibility of cases occurring in other countries\n\ncannot be excluded.  All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene.  However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n - 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model.  The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n",
        "original_sentence": "- 3.\n"
      }
    },
    {
      "chunk_id": "chunk_628",
      "text": "INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 627,
        "window_size": 3,
        "char_count": 258,
        "word_count": 37,
        "page_number": 2,
        "window_text": "All vCJD clinical cases, which have been genotyped so far, are homozygotes (Met-\n\nMet) at codon 129 of the prion protein (PrP) gene.  However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n - 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model.  The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n",
        "original_sentence": "INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n"
      }
    },
    {
      "chunk_id": "chunk_629",
      "text": "Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 628,
        "window_size": 3,
        "char_count": 211,
        "word_count": 31,
        "page_number": 8,
        "window_text": "However, evidence of infection has recently been\n\nreported in a patient without disease, who was a heterozygote (Met-Val) at codon 129.2\n\nCPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 4/10\n\ncompetent authorities is encouraged and CHMP and its Biotechnology Working Party (BWP) will be\n\navailable to discuss issues that arise.\n\n - 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model.  The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies. ",
        "original_sentence": "Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model. "
      }
    },
    {
      "chunk_id": "chunk_630",
      "text": "The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 629,
        "window_size": 3,
        "char_count": 182,
        "word_count": 25,
        "page_number": 8,
        "window_text": "- 3.\n INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model.  The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies.  Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n",
        "original_sentence": "The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n"
      }
    },
    {
      "chunk_id": "chunk_631",
      "text": "As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 630,
        "window_size": 3,
        "char_count": 179,
        "word_count": 24,
        "page_number": 6,
        "window_text": "INVESTIGATIONAL TSE CLEARANCE STUDIES\n\n- 3.1\nGeneral principles\n\nThe principles, which are outlined in Note for Guidance CPMP/BWP/268/95 for studies validating the\n\ninactivation and removal of viruses13, should be extended to TSE agents as far as possible.\n\n Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model.  The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies.  Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n - 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n",
        "original_sentence": "As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n"
      }
    },
    {
      "chunk_id": "chunk_632",
      "text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 631,
        "window_size": 3,
        "char_count": 208,
        "word_count": 31,
        "page_number": 2,
        "window_text": "Material from production should be spiked with a volume of not more than 10% of an appropriate\n\ninfectious preparation and TSE inactivation/removal should be studied in an exactly down-scaled\n\nlaboratory model.  The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies.  Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n - 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n",
        "original_sentence": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies. "
      }
    },
    {
      "chunk_id": "chunk_633",
      "text": "Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 632,
        "window_size": 3,
        "char_count": 258,
        "word_count": 39,
        "page_number": 6,
        "window_text": "The experiments should be strictly separated from production and performed in a\n\nmanner that is well controlled and documented, and undertaken by appropriately qualified personnel.\n\n As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies.  Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n - 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n Crude brain homogenates have been used most extensively in published studies of infectivity. ",
        "original_sentence": "Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n"
      }
    },
    {
      "chunk_id": "chunk_634",
      "text": "- 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 633,
        "window_size": 3,
        "char_count": 526,
        "word_count": 91,
        "page_number": 5,
        "window_text": "As with virus validation studies, the validity of the down-scaled model should be demonstrated by\n\nrelevant process parameters and appropriate performance of down-scaled models.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies.  Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n - 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n Crude brain homogenates have been used most extensively in published studies of infectivity.  They\n\ncontain the highest concentration of infectivity. ",
        "original_sentence": "- 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n"
      }
    },
    {
      "chunk_id": "chunk_635",
      "text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 634,
        "window_size": 3,
        "char_count": 72,
        "word_count": 9,
        "page_number": 2,
        "window_text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 5/10\n\n- 3.2\nScaling down process\n\nThe principles of scaling down the manufacturing process for experimental TSE studies are the same\n\nas those for virus validation studies.  Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n - 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n Crude brain homogenates have been used most extensively in published studies of infectivity.  They\n\ncontain the highest concentration of infectivity.  The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed. ",
        "original_sentence": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n"
      }
    },
    {
      "chunk_id": "chunk_636",
      "text": "Crude brain homogenates have been used most extensively in published studies of infectivity. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 635,
        "window_size": 3,
        "char_count": 93,
        "word_count": 13,
        "page_number": 25,
        "window_text": "Manufacturers should provide data on the yield, quality and\n\ncomposition of the product(s) or intermediates made in the scaled down version of the process, and\n\nthese should be comparable with those obtained in typical batches of the full-scale product(s).\n\n - 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n Crude brain homogenates have been used most extensively in published studies of infectivity.  They\n\ncontain the highest concentration of infectivity.  The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed.  If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration. ",
        "original_sentence": "Crude brain homogenates have been used most extensively in published studies of infectivity. "
      }
    },
    {
      "chunk_id": "chunk_637",
      "text": "They\n\ncontain the highest concentration of infectivity. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 636,
        "window_size": 3,
        "char_count": 56,
        "word_count": 7,
        "page_number": 8,
        "window_text": "- 3.3\nChoice of spiking agent\n\nData from animals experimentally infected with TSE agents indicates that infectivity can be found in\n\nblood of which about half is found in the plasma and half in the buffy coat.3 The level of infectivity is\n\nlow, at least 10,000 times less than found in brain so that brain tissue is the only practicable source of\n\nspiking material.4 While the highest possible titre should be used, the spike should not exceed 10% of\n\nthe total volume to avoid distorting the nature of the fraction studied.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n Crude brain homogenates have been used most extensively in published studies of infectivity.  They\n\ncontain the highest concentration of infectivity.  The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed.  If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration.  The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n",
        "original_sentence": "They\n\ncontain the highest concentration of infectivity. "
      }
    },
    {
      "chunk_id": "chunk_638",
      "text": "The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 637,
        "window_size": 3,
        "char_count": 111,
        "word_count": 15,
        "page_number": 8,
        "window_text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 6/10\n\n(a)\n\nCrude brain homogenates.\n\n Crude brain homogenates have been used most extensively in published studies of infectivity.  They\n\ncontain the highest concentration of infectivity.  The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed.  If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration.  The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n (b)\n\nMicrosomal fraction.\n\n",
        "original_sentence": "The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed. "
      }
    },
    {
      "chunk_id": "chunk_639",
      "text": "If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 638,
        "window_size": 3,
        "char_count": 139,
        "word_count": 24,
        "page_number": 8,
        "window_text": "Crude brain homogenates have been used most extensively in published studies of infectivity.  They\n\ncontain the highest concentration of infectivity.  The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed.  If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration.  The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n (b)\n\nMicrosomal fraction.\n\n Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity. ",
        "original_sentence": "If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration. "
      }
    },
    {
      "chunk_id": "chunk_640",
      "text": "The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 639,
        "window_size": 3,
        "char_count": 125,
        "word_count": 19,
        "page_number": 8,
        "window_text": "They\n\ncontain the highest concentration of infectivity.  The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed.  If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration.  The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n (b)\n\nMicrosomal fraction.\n\n Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity.  While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n",
        "original_sentence": "The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n"
      }
    },
    {
      "chunk_id": "chunk_641",
      "text": "(b)\n\nMicrosomal fraction.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 640,
        "window_size": 3,
        "char_count": 27,
        "word_count": 3,
        "page_number": 5,
        "window_text": "The homogeneity and reproducibility of such preparations\n\ncould be important factors in the studies performed.  If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration.  The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n (b)\n\nMicrosomal fraction.\n\n Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity.  While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains). ",
        "original_sentence": "(b)\n\nMicrosomal fraction.\n\n"
      }
    },
    {
      "chunk_id": "chunk_642",
      "text": "Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 641,
        "window_size": 3,
        "char_count": 169,
        "word_count": 20,
        "page_number": 8,
        "window_text": "If the particle size covers a wide range there may be a\n\ncorrespondingly wide range of removal by a physical technique such as filtration.  The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n (b)\n\nMicrosomal fraction.\n\n Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity.  While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains).  Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises. ",
        "original_sentence": "Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity. "
      }
    },
    {
      "chunk_id": "chunk_643",
      "text": "While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 642,
        "window_size": 3,
        "char_count": 165,
        "word_count": 27,
        "page_number": 8,
        "window_text": "The reproducibility of\n\nthe preparation may also be an important factor in judging the reliability of the results obtained.\n\n (b)\n\nMicrosomal fraction.\n\n Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity.  While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains).  Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises.  Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n",
        "original_sentence": "While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n"
      }
    },
    {
      "chunk_id": "chunk_644",
      "text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains). ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 643,
        "window_size": 3,
        "char_count": 51,
        "word_count": 6,
        "page_number": 2,
        "window_text": "(b)\n\nMicrosomal fraction.\n\n Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity.  While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains).  Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises.  Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays. ",
        "original_sentence": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains). "
      }
    },
    {
      "chunk_id": "chunk_645",
      "text": "Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 644,
        "window_size": 3,
        "char_count": 150,
        "word_count": 29,
        "page_number": 8,
        "window_text": "Microsomal fractions are prepared by differential centrifugation of brain homogenates, leading to\n\nremoval of large aggregates and represent membrane-bound infectivity.  While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains).  Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises.  Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays.  If performed, a well-characterised system of strain and indicator animal should be used.\n\n",
        "original_sentence": "Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises. "
      }
    },
    {
      "chunk_id": "chunk_646",
      "text": "Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 645,
        "window_size": 3,
        "char_count": 156,
        "word_count": 26,
        "page_number": 6,
        "window_text": "While the infectivity level is\n\nlower than crude homogenates it is still high and the preparation may be expected to be more uniform\n\nthan crude brain homogenates.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains).  Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises.  Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays.  If performed, a well-characterised system of strain and indicator animal should be used.\n\n There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level. ",
        "original_sentence": "Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n"
      }
    },
    {
      "chunk_id": "chunk_647",
      "text": "Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 646,
        "window_size": 3,
        "char_count": 109,
        "word_count": 14,
        "page_number": 6,
        "window_text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 7/10\n\nstrains).  Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises.  Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays.  If performed, a well-characterised system of strain and indicator animal should be used.\n\n There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level.  A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n",
        "original_sentence": "Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays. "
      }
    },
    {
      "chunk_id": "chunk_648",
      "text": "If performed, a well-characterised system of strain and indicator animal should be used.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 647,
        "window_size": 3,
        "char_count": 90,
        "word_count": 13,
        "page_number": 6,
        "window_text": "Very few sites in Europe are able to handle a large number of animals and for a long period of\n\nclinical observation, in level 2 or level 3 premises.  Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays.  If performed, a well-characterised system of strain and indicator animal should be used.\n\n There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level.  A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n",
        "original_sentence": "If performed, a well-characterised system of strain and indicator animal should be used.\n\n"
      }
    },
    {
      "chunk_id": "chunk_649",
      "text": "There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 648,
        "window_size": 3,
        "char_count": 139,
        "word_count": 21,
        "page_number": 8,
        "window_text": "Finally, given the complexity of the assay, the\n\nlength of the incubation period and the requested security measures, the cost of such tests is very high.\n\n Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays.  If performed, a well-characterised system of strain and indicator animal should be used.\n\n There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level.  A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation. ",
        "original_sentence": "There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level. "
      }
    },
    {
      "chunk_id": "chunk_650",
      "text": "A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 649,
        "window_size": 3,
        "char_count": 205,
        "word_count": 35,
        "page_number": 2,
        "window_text": "Nevertheless, most published studies of process clearance have included some element of infectivity\n\nassays.  If performed, a well-characterised system of strain and indicator animal should be used.\n\n There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level.  A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation.  The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc. ",
        "original_sentence": "A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n"
      }
    },
    {
      "chunk_id": "chunk_651",
      "text": "The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 650,
        "window_size": 3,
        "char_count": 101,
        "word_count": 15,
        "page_number": 8,
        "window_text": "If performed, a well-characterised system of strain and indicator animal should be used.\n\n There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level.  A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation.  The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc.  Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity. ",
        "original_sentence": "The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n"
      }
    },
    {
      "chunk_id": "chunk_652",
      "text": "Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 651,
        "window_size": 3,
        "char_count": 219,
        "word_count": 32,
        "page_number": 6,
        "window_text": "There is still no generally applicable in vitro test available to identify presence of infectivity and to\n\nquantify the infectivity level.  A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation.  The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc.  Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity.  However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter. ",
        "original_sentence": "Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation. "
      }
    },
    {
      "chunk_id": "chunk_653",
      "text": "The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 652,
        "window_size": 3,
        "char_count": 213,
        "word_count": 30,
        "page_number": 6,
        "window_text": "A few cell lines (N2a, GT1) are susceptible and can be infected by some\n\nTSE strains adapted to mice18, whereas some cell lines, transfected with the PrP gene are able to\n\nreplicate some scrapie strains.\n\n The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation.  The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc.  Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity.  However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter.  These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n",
        "original_sentence": "The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc. "
      }
    },
    {
      "chunk_id": "chunk_654",
      "text": "Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 653,
        "window_size": 3,
        "char_count": 104,
        "word_count": 17,
        "page_number": 8,
        "window_text": "The alternative assay which has also featured in published studies involves the detection of PrPSc.\n\n Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation.  The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc.  Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity.  However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter.  These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n",
        "original_sentence": "Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity. "
      }
    },
    {
      "chunk_id": "chunk_655",
      "text": "However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 654,
        "window_size": 3,
        "char_count": 141,
        "word_count": 19,
        "page_number": 8,
        "window_text": "Currently, the exact nature of the TSE agents is still unknown although numerous experimental results\n\nsuggest that they could be composed entirely of the host protein, PrP, accumulating with an abnormal\n\nconformation.  The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc.  Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity.  However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter.  These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n Pretreatments may affect the clearance of the agent. ",
        "original_sentence": "However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter. "
      }
    },
    {
      "chunk_id": "chunk_656",
      "text": "These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 655,
        "window_size": 3,
        "char_count": 466,
        "word_count": 67,
        "page_number": 8,
        "window_text": "The protein in its abnormal conformation (PrPSc) is relatively resistant to proteinase K\n\n(giving rise to PrPres), and to concentrations of  denaturing agents such as guanidinium hydrochloride\n\nwhich remove PrPc.  Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity.  However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter.  These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n Pretreatments may affect the clearance of the agent.  For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n",
        "original_sentence": "These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n"
      }
    },
    {
      "chunk_id": "chunk_657",
      "text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 656,
        "window_size": 3,
        "char_count": 46,
        "word_count": 7,
        "page_number": 2,
        "window_text": "Detection of PrPSc or PrPres in animal tissues can be considered as a surrogate\n\nmarker of infectivity.  However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter.  These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n Pretreatments may affect the clearance of the agent.  For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n - 4.\n",
        "original_sentence": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n"
      }
    },
    {
      "chunk_id": "chunk_658",
      "text": "Pretreatments may affect the clearance of the agent. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 657,
        "window_size": 3,
        "char_count": 53,
        "word_count": 8,
        "page_number": 8,
        "window_text": "However the correlation between infectivity and PrPres varies between strains\n\nand possibly with the methods for measuring either parameter.  These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n Pretreatments may affect the clearance of the agent.  For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n - 4.\n The assays which can be used are not ideal. ",
        "original_sentence": "Pretreatments may affect the clearance of the agent. "
      }
    },
    {
      "chunk_id": "chunk_659",
      "text": "For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 658,
        "window_size": 3,
        "char_count": 182,
        "word_count": 32,
        "page_number": 8,
        "window_text": "These considerations affect the\n\nconfidence with which clearance measured by removal of PrPSc can be related to the clearance of\n\ninfectivity although the relationship has been established in specific instances in a number of\n\npublished studies.19 When the correlation between a biochemical assay for PrPSc and a bioassay has\n\nbeen established, demonstration of partitioning or inactivation of infectious prion proteins by the\n\nbiochemical assay may be sufficient.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n Pretreatments may affect the clearance of the agent.  For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n - 4.\n The assays which can be used are not ideal.  Infectivity assays are expensive and very slow.\n\n",
        "original_sentence": "For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n"
      }
    },
    {
      "chunk_id": "chunk_660",
      "text": "- 4.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 659,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 8/10\n\n- 3.\n Pretreatments may affect the clearance of the agent.  For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n - 4.\n The assays which can be used are not ideal.  Infectivity assays are expensive and very slow.\n\n While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity. ",
        "original_sentence": "- 4.\n"
      }
    },
    {
      "chunk_id": "chunk_661",
      "text": "The assays which can be used are not ideal. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 660,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 5,
        "window_text": "Pretreatments may affect the clearance of the agent.  For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n - 4.\n The assays which can be used are not ideal.  Infectivity assays are expensive and very slow.\n\n While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity.  So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n",
        "original_sentence": "The assays which can be used are not ideal. "
      }
    },
    {
      "chunk_id": "chunk_662",
      "text": "Infectivity assays are expensive and very slow.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 661,
        "window_size": 3,
        "char_count": 49,
        "word_count": 7,
        "page_number": 5,
        "window_text": "For example if the material is treated with\n\ndetergent it may pass through a subsequent step such as filtration more easily than if it is not\n\nbecause of dispersal of the material.\n\n - 4.\n The assays which can be used are not ideal.  Infectivity assays are expensive and very slow.\n\n While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity.  So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n - 5.\n",
        "original_sentence": "Infectivity assays are expensive and very slow.\n\n"
      }
    },
    {
      "chunk_id": "chunk_663",
      "text": "While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 662,
        "window_size": 3,
        "char_count": 167,
        "word_count": 26,
        "page_number": 8,
        "window_text": "- 4.\n The assays which can be used are not ideal.  Infectivity assays are expensive and very slow.\n\n While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity.  So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n - 5.\n The strain and species of origin of the spike may determine the assays to be used. ",
        "original_sentence": "While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity. "
      }
    },
    {
      "chunk_id": "chunk_664",
      "text": "So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 663,
        "window_size": 3,
        "char_count": 110,
        "word_count": 18,
        "page_number": 8,
        "window_text": "The assays which can be used are not ideal.  Infectivity assays are expensive and very slow.\n\n While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity.  So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n - 5.\n The strain and species of origin of the spike may determine the assays to be used.  While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n",
        "original_sentence": "So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n"
      }
    },
    {
      "chunk_id": "chunk_665",
      "text": "- 5.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 664,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 5,
        "window_text": "Infectivity assays are expensive and very slow.\n\n While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity.  So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n - 5.\n The strain and species of origin of the spike may determine the assays to be used.  While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity. ",
        "original_sentence": "- 5.\n"
      }
    },
    {
      "chunk_id": "chunk_666",
      "text": "The strain and species of origin of the spike may determine the assays to be used. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 665,
        "window_size": 3,
        "char_count": 83,
        "word_count": 16,
        "page_number": 7,
        "window_text": "While there is generally a correlation between PrPSc content and infectivity, the relationship\n\nmay depend on the method used to measure PrPSc as well as infectivity.  So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n - 5.\n The strain and species of origin of the spike may determine the assays to be used.  While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity.  It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded. ",
        "original_sentence": "The strain and species of origin of the spike may determine the assays to be used. "
      }
    },
    {
      "chunk_id": "chunk_667",
      "text": "While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 666,
        "window_size": 3,
        "char_count": 171,
        "word_count": 31,
        "page_number": 8,
        "window_text": "So far most studies have\n\nbeen confirmed by infectivity assays which are considered to be the most relevant.\n\n - 5.\n The strain and species of origin of the spike may determine the assays to be used.  While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity.  It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded.  If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n",
        "original_sentence": "While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n"
      }
    },
    {
      "chunk_id": "chunk_668",
      "text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 667,
        "window_size": 3,
        "char_count": 159,
        "word_count": 25,
        "page_number": 2,
        "window_text": "- 5.\n The strain and species of origin of the spike may determine the assays to be used.  While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity.  It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded.  If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult. ",
        "original_sentence": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity. "
      }
    },
    {
      "chunk_id": "chunk_669",
      "text": "It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 668,
        "window_size": 3,
        "char_count": 135,
        "word_count": 22,
        "page_number": 8,
        "window_text": "The strain and species of origin of the spike may determine the assays to be used.  While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity.  It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded.  If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult.  A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease. ",
        "original_sentence": "It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded. "
      }
    },
    {
      "chunk_id": "chunk_670",
      "text": "If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 669,
        "window_size": 3,
        "char_count": 150,
        "word_count": 26,
        "page_number": 6,
        "window_text": "While so far\n\nthere is no evidence of a major influence on removal steps, it is still possible that the clearance\n\nrecorded may be influenced by the origin of the spike.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity.  It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded.  If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult.  A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease.  Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting. ",
        "original_sentence": "If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n"
      }
    },
    {
      "chunk_id": "chunk_671",
      "text": "Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 670,
        "window_size": 3,
        "char_count": 111,
        "word_count": 16,
        "page_number": 8,
        "window_text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 9/10\n\nand reuse of columns should also be considered in the light of the effect of possible treatments on TSE\n\ninfectivity.  It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded.  If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult.  A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease.  Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting.  An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult. ",
        "original_sentence": "Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult. "
      }
    },
    {
      "chunk_id": "chunk_672",
      "text": "A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 671,
        "window_size": 3,
        "char_count": 171,
        "word_count": 32,
        "page_number": 25,
        "window_text": "It should be borne in mind that many fractionation processes terminate in a depth filtration\n\nstep, where the filter aid is discarded.  If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult.  A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease.  Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting.  An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult.  NaOH solutions are commonly used for cleaning of production equipment. ",
        "original_sentence": "A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease. "
      }
    },
    {
      "chunk_id": "chunk_673",
      "text": "Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 672,
        "window_size": 3,
        "char_count": 184,
        "word_count": 29,
        "page_number": 8,
        "window_text": "If this is shown to be an effective step, it decreases the risk of\n\ncontamination of the product by any infectivity that leaches from the equipment.\n\n Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult.  A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease.  Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting.  An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult.  NaOH solutions are commonly used for cleaning of production equipment.  Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n",
        "original_sentence": "Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting. "
      }
    },
    {
      "chunk_id": "chunk_674",
      "text": "An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 673,
        "window_size": 3,
        "char_count": 248,
        "word_count": 35,
        "page_number": 8,
        "window_text": "Investigation of inactivation or removal of TSE agents adhering to metal surfaces may be extremely\n\ndifficult.  A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease.  Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting.  An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult.  NaOH solutions are commonly used for cleaning of production equipment.  Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n",
        "original_sentence": "An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult. "
      }
    },
    {
      "chunk_id": "chunk_675",
      "text": "NaOH solutions are commonly used for cleaning of production equipment. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 674,
        "window_size": 3,
        "char_count": 71,
        "word_count": 10,
        "page_number": 8,
        "window_text": "A model has been developed in which a steel wire dipped in a TSE preparation can be\n\nimplanted in the brain of a susceptible animal which then goes on to develop disease.  Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting.  An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult.  NaOH solutions are commonly used for cleaning of production equipment.  Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n",
        "original_sentence": "NaOH solutions are commonly used for cleaning of production equipment. "
      }
    },
    {
      "chunk_id": "chunk_676",
      "text": "Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 675,
        "window_size": 3,
        "char_count": 214,
        "word_count": 35,
        "page_number": 2,
        "window_text": "Sanitisation of\n\nthe wire might be monitored by such a model by loading wires with different dilutions of agent,\n\ntreating them and then determining the loss in infectivity resulting.  An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult.  NaOH solutions are commonly used for cleaning of production equipment.  Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n Transfusion 2002;42:513-516\n\n- 8.\n",
        "original_sentence": "Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n"
      }
    },
    {
      "chunk_id": "chunk_677",
      "text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 676,
        "window_size": 3,
        "char_count": 47,
        "word_count": 7,
        "page_number": 2,
        "window_text": "An example of this approach to\n\ninvestigate novel methods of disinfection of prion-contaminated medical devices has recently been\n\npublished.21 The extrapolation of results from such studies to equipment at a manufacturing level may\n\nbe difficult.  NaOH solutions are commonly used for cleaning of production equipment.  Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n Transfusion 2002;42:513-516\n\n- 8.\n Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion. ",
        "original_sentence": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n"
      }
    },
    {
      "chunk_id": "chunk_678",
      "text": "Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 677,
        "window_size": 3,
        "char_count": 164,
        "word_count": 24,
        "page_number": 6,
        "window_text": "NaOH solutions are commonly used for cleaning of production equipment.  Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n Transfusion 2002;42:513-516\n\n- 8.\n Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion.  Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n",
        "original_sentence": "Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n"
      }
    },
    {
      "chunk_id": "chunk_679",
      "text": "Transfusion 2002;42:513-516\n\n- 8.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 678,
        "window_size": 3,
        "char_count": 34,
        "word_count": 4,
        "page_number": 2,
        "window_text": "Treatment\n\nwith 0.1 M NaOH has been shown to convert PrPSc into a protease-sensitive form, either in solution or\n\nwhen adsorbed to a metallic surface.22 The results need to be confirmed by studies of infectivity.\n\n CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n Transfusion 2002;42:513-516\n\n- 8.\n Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion.  Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n Bruce ME, McConnell I, Will RG, Ironside JW. ",
        "original_sentence": "Transfusion 2002;42:513-516\n\n- 8.\n"
      }
    },
    {
      "chunk_id": "chunk_680",
      "text": "Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 679,
        "window_size": 3,
        "char_count": 141,
        "word_count": 23,
        "page_number": 6,
        "window_text": "CPMP/BWP/5136/03\n\nEMEA 2004\n\nPage 10/10\n\n- 7.\n Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n Transfusion 2002;42:513-516\n\n- 8.\n Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion.  Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n Bruce ME, McConnell I, Will RG, Ironside JW.  Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues. ",
        "original_sentence": "Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion. "
      }
    },
    {
      "chunk_id": "chunk_681",
      "text": "Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 680,
        "window_size": 3,
        "char_count": 53,
        "word_count": 7,
        "page_number": 2,
        "window_text": "Bons N, Lehmann S, Mestre-Francès N, Dormont D, Brown P. Brain and buffy coat\n\ntransmission of bovine spongiform encephalopathy to the primate Microcebus murinus.\n\n Transfusion 2002;42:513-516\n\n- 8.\n Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion.  Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n Bruce ME, McConnell I, Will RG, Ironside JW.  Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues.  Lancet 2001;358:208-209\n\n- 10.\n",
        "original_sentence": "Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n"
      }
    },
    {
      "chunk_id": "chunk_682",
      "text": "Bruce ME, McConnell I, Will RG, Ironside JW. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 681,
        "window_size": 3,
        "char_count": 45,
        "word_count": 8,
        "page_number": 5,
        "window_text": "Transfusion 2002;42:513-516\n\n- 8.\n Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion.  Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n Bruce ME, McConnell I, Will RG, Ironside JW.  Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues.  Lancet 2001;358:208-209\n\n- 10.\n Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL. ",
        "original_sentence": "Bruce ME, McConnell I, Will RG, Ironside JW. "
      }
    },
    {
      "chunk_id": "chunk_683",
      "text": "Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 682,
        "window_size": 3,
        "char_count": 84,
        "word_count": 9,
        "page_number": 8,
        "window_text": "Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F.\n\nTransmission of prion diseases by blood transfusion.  Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n Bruce ME, McConnell I, Will RG, Ironside JW.  Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues.  Lancet 2001;358:208-209\n\n- 10.\n Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL.  Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety. ",
        "original_sentence": "Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues. "
      }
    },
    {
      "chunk_id": "chunk_684",
      "text": "Lancet 2001;358:208-209\n\n- 10.\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 683,
        "window_size": 3,
        "char_count": 31,
        "word_count": 4,
        "page_number": 2,
        "window_text": "Journal of General Virology\n\n2002;83:2897-2905\n\n- 9.\n Bruce ME, McConnell I, Will RG, Ironside JW.  Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues.  Lancet 2001;358:208-209\n\n- 10.\n Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL.  Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety.  Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n",
        "original_sentence": "Lancet 2001;358:208-209\n\n- 10.\n"
      }
    },
    {
      "chunk_id": "chunk_685",
      "text": "Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 684,
        "window_size": 3,
        "char_count": 55,
        "word_count": 10,
        "page_number": 6,
        "window_text": "Bruce ME, McConnell I, Will RG, Ironside JW.  Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues.  Lancet 2001;358:208-209\n\n- 10.\n Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL.  Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety.  Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n <!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n",
        "original_sentence": "Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL. "
      }
    },
    {
      "chunk_id": "chunk_686",
      "text": "Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety. ",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 685,
        "window_size": 3,
        "char_count": 79,
        "word_count": 10,
        "page_number": 8,
        "window_text": "Detection of variant Creutzfeldt-Jakob disease\n\ninfectivity in extraneural tissues.  Lancet 2001;358:208-209\n\n- 10.\n Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL.  Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety.  Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n <!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n",
        "original_sentence": "Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety. "
      }
    },
    {
      "chunk_id": "chunk_687",
      "text": "Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 686,
        "window_size": 3,
        "char_count": 155,
        "word_count": 27,
        "page_number": 43,
        "window_text": "Lancet 2001;358:208-209\n\n- 10.\n Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL.  Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety.  Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n <!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n- - 43 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n- - 44 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n- - 45 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n- - 46 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n",
        "original_sentence": "Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n"
      }
    },
    {
      "chunk_id": "chunk_688",
      "text": "<!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 687,
        "window_size": 3,
        "char_count": 68,
        "word_count": 11,
        "page_number": 43,
        "window_text": "Cervenáková L, Brown P, Hammond DJ, Lee CA, Saenko EL.  Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety.  Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n <!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n- - 43 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n- - 44 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n- - 45 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n- - 46 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n",
        "original_sentence": "<!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_689",
      "text": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 688,
        "window_size": 3,
        "char_count": 812,
        "word_count": 134,
        "page_number": 46,
        "window_text": "Factor VIII and transmissible\n\nspongiform encephalopathy: the case for safety.  Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n <!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n- - 43 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n- - 44 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n- - 45 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n- - 46 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n",
        "original_sentence": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n"
      }
    },
    {
      "chunk_id": "chunk_690",
      "text": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n- - 43 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n- - 44 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n- - 45 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n- - 46 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n",
      "metadata": {
        "source": "혈장분획제제+제조공정+중+감염성+프리온+단백+제거+검증+가이드라인(민원인안내서).pdf",
        "chunk_index": 689,
        "window_size": 3,
        "char_count": 1709,
        "word_count": 279,
        "page_number": 5,
        "window_text": "Haemophilia 2002;8:63-75\n\n- - 39 -\n<!-- PAGE_43 -->\n##### 생물의약품국에서 발간한 행정간행물 목록\n\n<!-- PAGE_43 -->\n###### 생물의약품 국가표준품 카다로그 시리즈\n\n<!-- PAGE_43 -->\n###### 1.\n\n <!-- PAGE_43 -->\n###### 생물의약품평가가이드 시리즈\n\n<!-- PAGE_43 -->\n###### 2.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n바이러스백신\n\n자가품질관리요약서(\n\nⅠ)\n\n2007\n\n11-1470000-001620-01\n\n(생물의약품평\n\n가가이드 29)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/227\n\n- - 40 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n불활화 인플루엔자백신\n\n평가 지침\n\n2007\n\n11-1470000-001587-01\n\n(생물의약품평가가이드\n\n28)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/226\n\n당단백질의약품의 당구조\n\n분석 시험법 길라잡이\n\n2007\n\n11-1470000-001589-01\n\n(생물의약품평가가이드\n\n27)\n\n재조합의약품팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/280\n\n- - 41 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n이종이식제제의 품질관리\n\n및 이식 후 감염관리에\n\n대한 가이드\n\n2006\n\n11-1470000-001086-01\n\n(생물의약품평가가이드\n\n16)\n\n세포조직공학제제팀\n\n재조합의약품팀\n\n생물의약품안전팀\n\n생물의약품관리팀\n\n국립독성연구원\n\n생명공학지원팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/130\n\n생명공학의약품/\n\n생물학적제제의\n\n규격설정에 관한 가이드\n\n2004\n\n11-1470000-000538-01\n\n(생물의약품평가가이드\n\n6)\n\n생명공학의약품과\n\n자료실 간행물\n\n/\n\n,\n\n지침/59\n\n- - 42 -\n<!-- PAGE_46 -->\n###### 생물의약품평가자료집 시리즈\n\n<!-- PAGE_46 -->\n###### 3.\n\n 행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n- - 43 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n- - 44 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n- - 45 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n- - 46 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n",
        "original_sentence": "행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n핵산증폭검사법 검증\n\n가이드라인\n\n2003\n\n11-1470000-000277-01\n\n(생물의약품평가가이드\n\n5)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/44\n\n혈장분획제제\n\n품질평가 가이드\n\n2002\n\n11-1470000-000154-01\n\n(생물의약품평가가이드\n\n4)\n\n혈액제제과\n\n자료실 간행물\n\n/\n\n,\n\n지침/27\n\n- - 43 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생바이러스 백신의\n\n자가 기준 및 시험방법\n\n작성 지침\n\n2007\n\n11-1470000-001345-01\n\n(생물의약품평가자료집\n\n43)\n\n바이러스백신팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/172\n\n유전자치료 임상시험-\n\n지연성 이상반응에 대비한\n\n환자 관찰\n\n2006\n\n11-1470000-001141-01\n\n(생물의약품평가자료집\n\n39)\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/157\n\n- - 44 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n미국 약전 세포치료제,\n\n유전자치료제 및\n\n조직공학제제의 보조물질\n\n(ancillary product)\n\n평가자료집\n\n2006\n\n11-1470000-001109-01\n\n(생물의약품평가자료집\n\n32)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침/143\n\n미국 약전 세포치료제 및\n\n유전자치료제\n\n2006\n\n11-1470000-001108-01\n\n(생물의약품평가자료집\n\n31)\n\n세포조직공학제제팀\n\n유전자치료제팀\n\n자료실 간행물\n\n/\n\n,\n\n지침 142\n\n- - 45 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n우수심사기준\n\n2005\n\n11-1470000-000684-01\n\n(생물의약품평가자료집\n\n19)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/100\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품\n\n: 미\n\nFDA\n\n시설등록 및 등재 규정\n\n2005\n\n11-1470000-000860-01\n\n(생물의약품평가자료집\n\n18)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n4\n\n사람 세포\n\n조직\n\n세포 및\n\n,\n\n,\n\n조직유래제품 제조시설의\n\n미\n\nFDA 우수조직관리기준\n\n2005\n\n11-1470000-000859-01\n\n(생물의약품평가자료집\n\n17)\n\n생명공학의약품과\n\n인체조직정보\n\n방 자료게시판\n\n/\n\n/\n\n5\n\n생명공학의약품등의\n\n1상\n\n임상시험계획 승인 신청시\n\n고려사항\n\n2004\n\n11-1470000-000683-01\n\n(생물의약품평가자료집\n\n14)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/83\n\n생물의약품등의\n\n효능입증을 위한 고려사항 2004\n\n11-1470000-000682-01\n\n(생물의약품평가자료집\n\n13)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/82\n\n- - 46 -\n행정간행물 제목\n\n발행\n\n연도\n\n행정간행물 번호\n\n발행과\n\n홈페이지\n\n게재 상태\n\n생명공학의약품의\n\n안전성평가(3)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n6)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/70\n\n생명공학의약품의\n\n안전성평가(2)\n\n2004\n\n11-1470000-000676-14\n\n(생물의약품평가자료집\n\n5)\n\n생물의약품평가과\n\n자료실 간행물\n\n/\n\n,\n\n지침/69\n"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 690,
    "avg_chunk_length": 125.9376811594203,
    "min_chunk_length": 3,
    "max_chunk_length": 1709,
    "total_characters": 86897,
    "total_words": 17017,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 4572,
    "heading_count": 106,
    "paragraph_count": 2604,
    "list_item_count": 91,
    "table_cell_count": 1771,
    "tables_detected": 2,
    "chunks_generated": 690
  }
}